Chancellor 1 of 108

CURRICULUM VITAE

Chancellor, Michael B., M.D.

EDUCATION and TRAINING

Undergraduate: 1976-1979, University of Michigan, Ann Arbor, MI Early Acceptance into Medical School, Biology

Medical School: 1979-1983, Medical College of Wisconsin, Milwaukee, WI., M.D.

Intern, Surgery: 1983-1984, University of Michigan Medical Center, Ann Arbor, MI., Director: Dr. Laser Greenfield

Resident, Surgery: 1984-1985, University of Michigan Medical Center, Ann Arbor, MI., Director: Dr. Laser Greenfield

Resident, Urology: 1985-1988, University of Michigan Medical Center, Ann Arbor, MI., Director: Dr. Edward J. McGuire

Fellowship: 1989-1990, Neuro-Urology, College of Physicians and Surgeons, Columbia University, New York, NY, Director: Dr. Jerry G. Blaivas

Graduate Education: 1999, Biomedical Technology-Based Venture Courses, Carnegie Mellon University, Pittsburgh PA

Graduate Education: 1999, Physician in Management Courses, American College of Physician Executives

Chancellor 2 of 108 APPOINTMENTS and POSITIONS

1989-1990 Department of Urology, Instructor of Urology College of Physicians and Surgeons, Columbia University, New York, NY 1990-1994 Department of Urology, Assistant Professor Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 1995-1996 Department of Urology, Associate Professor Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 1996-1999 Department of Surgery, Division of Urologic Associate Professor Surgery, University of Pittsburgh School of Medicine 1999-2000 Department of Urology Associate Professor University of Pittsburgh School of Medicine 2000-2000 Department of Obstetrics and Gynecology Associate Professor Surgery, University of Pittsburgh School of Medicine 2001-2007 Department of Urology, Obstetrics & Gynecology Professor University of Pittsburgh School of Medicine 2001-2008 McGowan Institute for Regenerative Medicine Faculty Pittsburgh, Pennsylvania 2008 Department of Urology Director of Neurourology Program -Present William Beaumont Hospital, Royal Oak, Michigan 2009 Department of Urology Professor -Present Oakland University William Beaumont School of Medicine, Royal Oak, Michigan 2014 The Robert B. and Ann S. Aikens Center for Director -Present Neurourology Research

CERTIFICATION and LICENSURE Specialty Certification: Certifying Board Year ID Number American Board of Urology 1991 9980 Recertification ABU 1999 Recertification ABU 2009

Medical Professional Licensure: Certifying Board Year ID Number Michigan Board of Medicine 2008 4301048056 Pennsylvania 1990 MD-041546-L Diplomat of the Nation Board Medical Examiners 1984 Michigan Board of Medicine 1984 044856 New Jersey Board of Medicine (inactive) 1988 51108 New York Board of Medicine, (inactive) 1989 177945

PROFESSIONAL and SCIENTIFIC SOCIETIES

1. International Neurotoxin Association 2012-Present 2. Oakland University William Beaumont Institute for Stem Cell and Regenerative Medicine (OUWB ISCRM), 2011- Present 3. Sexual Medicine Society of North America, 2007-Present 4. Association of Reproductive Health Professionals (ARHP), 2007-Present 5. International Society of Sexual Medicine, 2006-Present Chancellor 3 of 108 6. International Neurotoxins Advisory Council, 2005-Present 7. Institute of Food Technologists, 2004-Present 8. Executive Committee, Northeaster Section, American Urological Association, 2000-2002 9. Biotech Medical Management Association (BMMA), 2000 10. Society of Regenerative Medicine and Stem Cell Biology, 2000 11. American Society of Gene Therapy, Active Member, 1999 12. American College of Physician Executives, 1999 13. Society for Urodynamics & Female Urology, 1998 14. Pittsburgh Urological Association, 1997 15. Allegheny County Medical Society, 1997 16. Female Urology and Neuro-Urology Group, 1995 17. Society of University Urologists, Active Member, 1994 18. Society for Basic Urologic Research, 1994 19. American Public Heath Association, 1994 20. Samuel D. Gross Associates, 1994 21. American Association of Clinical Urologists, 1992 22. National Association for Continence, 1992 23. Pennsylvania Medical Society, 1991 24. Diplomat, American Urological Association, 1991 25. American Uro-Gynecology Society, 1991 26. North-Eastern Section, American Urological Association, Active Member, 1990 27. American Paraplegia Society, 1990 28. American Spinal Injury Association, Active Member, 1990 29. American Congress of Rehabilitation Medicine. 1990 30. International Continence Society, 1989 31. Full Member, Urodynamics Society, 1989 32. Philadelphia Urological Society, 1991 33. The New York Academy of Science, 1989 34. American Medical Association, 1988 35. Reed M. Nesbit Urological Society, 1988 36. New Jersey Urological Society, 1988 37. New Jersey Medical Society, 1988 38. Burlington County Medical Society, 1988 39. Albert Schweitzer Hospital Alumni Association, 1986

HONORS AND AWARDS

1. College of Language, Science and Arts, Honors Scholarship, University of Michigan, Ann Arbor, MI 1978. 2. James B. Angell Academic Scholarship, University of Michigan, Ann Arbor, MI, 1979. 3. Medical Degree with Honors in Research, Medical College of Wisconsin, Milwaukee, WI, 1983. 4. Traveling Fellowship of the North-Central Section of American Urological Association, Second Place Award, Detroit, MI, 1987. 5. Michigan Branch of American Urology Association Residency Essay Competition, Ann Arbor, MI, 1987. 6. Michigan Branch of American Urology Association Residency Essay Competition, Honorable Mention, Ann Arbor, MI, 1988. 7. The Annual Meeting of the American Spinal Injury Association Poster Competition, Third Place Award, 1992. 8. Grand Prize Winner, Essay Contest of the Endourology Society and the World Congress of Endourology. "Prospective Comparison of External Sphincter Prosthesis Placement with External Sphincterotomy in Spinal Cord Injured Men". Florence, Italy, Co-investigator, 1993. 9. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Grand Prize Winner "Evaluation of Skeletal Muscle Wrap of the Urinary Bladder and Function Neuromuscular Electrical Stimulated Detrusor Myoplasty", 1993. 10. Philadelphia Urological Association Annual Resident Essay Contest Second Prize, Basic Research "Micturition Patterns in Rat Model Spinal Cord Injury", Mentor, 1993. Chancellor 4 of 108 11. Philadelphia Urological Association Annual Resident Essay Contest, Third Prize, Clinical Research, "Latex Allergy in Spinal Cord Injury", Mentor, 1994. 12. The Annual Meeting of the American Spinal Injury Association Poster Competition, "Three Year Follow-up of the Urinary Sphincter Stent for the Treatment of Sphincter Dyssynergia in Spinal Cord Injury Patients", First Place Award, Mentor, 1994. 13. The Annual Meeting of the American Spinal Injury Association Poster Competition, "Complications of Vacuum Constriction Device for Treatment of Erectile Dysfunction in Spinal Cord Injury Men", First Place Award, Urology Section, Mentor, 1994. 14. The Annual Meeting of the American Spinal Injury Association Poster Competition "Detrusor-Myoplasty: Skeletal Muscle Wrap of the Urinary Bladder; Animal and Clinical Experience". Second Place Award, Mentor, 1994. 15. Paul Zimkin Award, The Urodynamics Society, 1994. 16. Philadelphia Urological Association Annual Resident Essay Contest, First Prize, Clinical Research, "Management of Sphincter Dyssynergia in SCI Men With Indwelling Catheter Using the Sphincter Stent Prosthesis", Mentor, 1995. 17. Annual Meeting of the American Spinal Injury Association Poster Competition, "Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience", First Place Award, 1995. 18. Resident Essay Competition Second Place. 53 rd Annual Meeting of the Mid-Atlantic Section, AUA "Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience", Mentor, 1995. 19. President’s Award for Best Poster “Gracilis Urethral Myoplasty, The Creation of a New Autologous Neosphincter, Japan Urological Association Annual Meeting, Mentor, Okayama, Japan, 1996. 20. The Annual Meeting of the American Spinal Injury Association Poster Competition, "Gracilis Urethromyoplasty-The Creation of a New Autologous Urinary Sphincter in Neurologically Impaired Patients” Second Place Award, 1996. 21. Pfizer Scholar Award in Urology: Dr. Watanabe, Toyohiko, Mentor, 1996-1997. 22. Resident Prize Essay Competition. 54 rd Annual Meeting of the Mid-Atlantic Section, AUA "Effect of Urinary Tract Reconstruction in Neurologically Impaired Women", Mentor, 1996. 23. International Jack Lapides Essay Contest: Second Prize Winner "Gracilis Urethral Myoplasty-The Creation of a New Autologous Urinary Sphincter", 1997. 24. The Pfizer-American Urological Association Visiting Professorship Award, November, 1997. 25. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Second Prize Winner, Co- investigator "The Development of Non-Invasive Pressure-Flow Video-urodynamics Using Doppler Ultrasonography in Experimental Urethral Model and Clinical Results", 1998. 26. AUA/Circon ACMI Prize Essay Contest, Third Prize “Sphincter Stent versus External Sphincterotomy in Spinal Cord Injured Men; Prospective Randomized Multicenter Trial”, 1998. 27. American Foundation for Urologic Disease Neuro-urology Traveling Fellowship for 1998 AUA Meeting (Dr. John P. Lavelle), Mentor, 1998. 28. Grand Prize Winner, Urodynamic Society’s 19th Annual Meeting Essay Contest, Clinical Research Category: Ozawa, Hideo, M.D., “Non-invasive velocity-flow urodynamic study using Doppler ultrasonography; from concept to clinical application”. Mentor, 1998. 29. Grand Prize Winner, Urodynamic Society’s 19th Annual Meeting Essay Contest, Basic Research Category: Suk Young Jung, M.D. “Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability”. Mentor, 1998. 30. Pittsburgh Urologic Society’s Resident Prize Essay Competition Grand Prize Winner Mentor (Phelan, Michael) "Successful Gene Transfer of Nerve Growth Factor (NGF) Using Herpes Simplex Virus (HSV) Vectors for Diabetic Bladder Dysfunction", Pittsburgh, PA, 1999. 31. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Grand Prize Winner, "Successful Gene Transfer of Nerve Growth Factor (NGF) Using Herpes Simplex Virus (HSV) Vectors for Diabetic Bladder Dysfunction", 1999. 32. Urodynamic Society’s 20th Annual Meeting Best Poster Essay Contest Mentor (Yoshimura, Naoki), "Nerve Growth Factor (NGF) Gene Therapy Using Replication Defective Herpes Simplex Virus (HSV) Vectors for Diabetic Bladder Dysfunction", Dallas, May 1, 1999. 33. Grand Prize Winner Mentor (Yokoyama, Teruhiko), Urodynamic Society’s 20th Annual Meeting Essay Contest, Basic Research Category: "Differentiation of primary myoblast injection into the lower urinary tract; creation of detrusor cellular myoplasty. Dallas, May 1, 1999. 34. 94th American Urological Association Annual Meeting Best Poster Contest in Urinary Incontinence Mentor (Yoshimura, Naoki): "Nerve Growth Factor (NGF) Gene Therapy Using Replication Defective Herpes Simplex Virus Vectors for Diabetic Bladder Dysfunction” Dallas, May 3, 1999. 35. The Best Doctors in America, 1999. Chancellor 5 of 108 36. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Grand Prize Winner; Yokoyama, Teruhiko (Mentor) "The Development of Autologous Muscle Derived Stem Cell Treatment of Stress Urinary Incontinence and Impaired Detrusor Contractility", 2000. 37. Society for Urodynamics and Female Urology 2000 Annual Meeting Best Essay Contest Grand Prize Winner; Yokoyama, Teruhiko (Mentor) "Autologous Muscle Derived Stem Cell Treatment of Stress Urinary Incontinence and Impaired Detrusor Contractility", Atlanta, GA, April 30, 2000. 38. Society for Urodynamics and Female Urology 2000 Annual Meeting Best Poster Contest Grand Prize Winner; Mentor (Franks, Michael) ": Gene therapy for urogenital pain, proof of concept with Herpes simplex virus with preproenkephalin [HSV-PPE]", Atlanta, GA, April 30, 2000. 39. 95th American Urological Association Annual Meeting Yamanouchi Best Poster Contest; Urinary Incontinence Category; Mentor (Phelan, Michael): "Nerve Growth Factor (NGF) Gene Therapy, Atlanta, GA, May 1, 2000. 40. Pittsburgh Urologic Society’s Resident Essay Competition 1st Prize Winner Mentor (Franks, Michael) ": Gene therapy for urogenital pain, proof of concept with HSV-PPE", Pittsburgh, PA, June 16, 2000. 41. Pittsburgh Urologic Society’s Resident Prize Essay Competition 2nd Prize Winner Mentor (Phelan, Michael) "Nerve growth factor (NGF) gene therapy improves Rat diabetic cystopathy, but does not increase pain sensation", Pittsburgh, PA, June 16, 2000. 42. Pfizer Competitive Awards in Medical Research, 2000. 43. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: 2nd Prize Winner; Franks, Michael (Mentor) "Gene therapy of visceral bladder pain and recombinant herpes simplex virus expressing preproenkephalin", 2001. 44. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Yao-Chi Chuang (Mentor) "New insights on the etiology and treatment of interstitial cystitis", 2001. 45. 2001 AUA Prize Essay Contest in clinical research category, 2nd Place Winner: Phelan, Michael (Mentor) "Vertical tilt table and intravesical pressure clamp", 2001. 46. 96th American Urological Association Annual Meeting Yamanouchi Best Poster Contest; Urinary Incontinence Category; Mentor (Sasaki, Katsumi): "Nerve Growth Factor (NGF) Gene Therapy Mediated by HSV Reverses Bladder Dysfunction and the Decline in NGF Expression in L6-S1 Afferent Neurons in Diabetic Rats. Anaheim, CA, June 5, 2001. 47. Innovator of the Year, Pittsburgh Magazine, 2002. 48. Urology Specialty; The Best Doctors in America, 2002. 49. International Jack Lapides Essay Contest: Honorable Mention Winner; Sasaki, Katsumi (Mentor) "The relation between the progress of bladder dysfunction and deceased nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia in diabetic rats: A possible pathogenesis of diabetic cystopathy", Orlando, May 24, 2002. 50. 97th American Urological Association Annual Meeting Yamanouchi Best Poster Contest; Impotence Category; Mentor (John Kim): "Herpes simplex virus mediated gene therapy for neurogenic impotence: Proof of concept for afferent and efferent neuron transfection”, Orlando, May 27, 2002. 51. Best Poster Contest: Pradeep Tyagi (Mentor); Neuroscience Meeting: Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. 2002. 52. Fishbein Family Award for Center of Urology Research Excellence – Interstitial Cystitis (CURE-IC), 2002. 53. McGowan Institute for Regenerative Medicine Travel Award for Master’s student Rachelle Prantil (Mentor) to present at the 2003 American Urological Association Annual Meeting: Urethral Biomechanics. 54. 2003 AUA Prize Essay Award Contest 2nd place: Muscle-derived stem cells seeded acellular scaffolds develop calcium dependent contractile activity that is modulated by nicotinic receptors. Winner: Henry Lu (Mentor), 2003. 55. Society for Urodynamics and Female Urology 2003 Annual Meeting Best Basic Research Contest Grand Prize Winner; Mentor (Henry Lu): Muscle-derived stem cells seeded acellular scaffolds develop calcium dependent contractile activity that is modulated by nicotinic receptors. 56. International Jack Lapides Essay Contest: Honorable Mention Winner; Henry Lu (Mentor): Muscle-derived stem cells seeded acellular scaffolds develop calcium dependent contractile activity that is modulated by nicotinic receptors. Chicago, April 25, 2003. 57. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Teruyuki Ogawa (Mentor): Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rat. San Francisco, May 8, 2004. 58. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Jang H. Kim (Mentor): Neurotrophic factor gene therapy: Potential cure for post radical prostatectomy erectile dysfunction. San Francisco, May 8, 2004 Chancellor 6 of 108 59. American Foundation for Urologic Disease Research Scholar, Brandon S. Minnery: Muscle derived stem cells as treatment for nerve injury induced erectile dysfunction. 60. UROLOGY 2003 resident/fellow essay contest grand prize winner Cannon, T.W.: Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Mentor, May 11, 2004. 61. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Hitoshi Masuda (Co-Mentor): Roles of bladder nicotinic receptors in the micturition reflex in rat. San Antonio, May 21, 2005. 62. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Yao-Chi Chuang (Mentor): Botulinum toxin type A induces prostate apoptosis, decreases alpha 1A adrenoceptor and improves benign prostatic hyperplasia symptoms. San Antonio, May 21, 2005. 63. Best Doctors in Pittsburgh (Urology), Pittsburgh, PA, 2005. 64. University of Pittsburgh Innovator Award, 2005. 65. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Chuang Cheng Wang (Mentor): Diabetes induced alternations in the biomechanical properties of the urinary bladder wall. Atlanta, May 23, 2006. 66. International Jack Lapides Essay Contest: Honorable Mention Winner; Yao-Chi Chang (Mentor): Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. Atlanta, May 23, 2006. 67. International Jack Lapides Essay Contest: Second Place Winner; Yongtae Kim (Mentor): Periurethral cellular injections: comparison of muscle derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of SUI. Atlanta, May 23, 2006. 68. University of Pittsburgh Innovator Award, 2006. 69. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Second Place Winner; Ryuichi Kato (Mentor): Herpes simplex virus vector-mediated delivery of glial cell line derived neurorophic factor (GDNF) rescues erectile dysfunction following cavernous nerve injury. Los Angeles, Atlanta, May 19, 2007. 70. Society of Women in Urology (SWIU) 2007 Mentorship Award, May 22, 2007 71. Best Poster Award, Consortium of Multiple Sclerosis Centers Annual Meeting: Borello-France, D., DiBlassio, J., Marx, S., Erickson, J., Leng, W., Chancellor, M.B., O’Leary, M, Washington, DC, May 30-June 2, 2007. 72. First Prize, Annual Meeting of the American Urological Association North East Section; Matthew H. Hayne (Mentor): Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Rochester NY, October 1, 2007. 73. Best Doctors in America 2007-2008. 74. International Jack Lapides Essay Contest on Urodynamic and Neuro-urology Research: Honorable Mention Winner; Matthew H. Hayne (Mentor): Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Orlando, FL, May 17, 2008. 75. Best Poster Ribbon: Miyazato, M., Kaiho, Y., Sugaya, K., Ogawa, Y., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: The role of serotonergic mechanisms in sneeze-induced urethral continence reflex in rats. 2008 AUA Meeting, J. Urology, 174 Supp: 566, 2008. 76. NIDDK New Research Directions in Urinary Incontinence Symposium best basic research grant prize: Tyagi, P, Jacobs, B., Qu X, Barclay D, Vodovotz Y, Leng, W, Nikolavsky D, Kuo HC, Peters K, Chancellor MB: Urinary inflammatory chemokines are novel biomarkers for the diagnosis. Washington DC, January 7-9, 2009. 77. Society of Urodynamics & Female Urology 2009 Winter Meeting: First Place Clinical Research Essay Winner: Tyagi, P., Nikolavsky, D., Peters, K., Tyagi, V., Barclay, D., Vodovotz, Y., Kuo, H.C., Chancellor, M.B.: Hypothesis driven urine proteinomic study on interstitial cystitis/painful bladder syndrome (IC/PBS) patients. 78. Society of Urodynamics & Female Urology 2009 Winter Meeting: First Place Basic Research Essay Winner: Miyazato, M., Sugaya, K., Chancellor, M.B, Goins, W., Goss, J., de Groat, W.C., Glorioso, J., Yoshimura, N.: Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord injured rats. 79. International Jack Lapides Essay Contest: Honorable Mention Winner; Akira Furuta (Co-Mentor): Suppression of alpha2-adrenoceptors as a new treatment of stress urinary incontinence – a pharmacological study on urethral continence reflexes during valsalva-like stress conditions in rats. Chicago, April 25, 2009. 80. International Jack Lapides Essay Contest: 2nd Place Winner; Yao-Chi Chuang (Mentor): Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. Chicago, April 25, 2009. 81. International Jack Lapides Essay Contest: Grand Prize Winner; Minoru Miyazato (Co-Mentor): Therapeutic effects of herpes simplex virus vector-mediated GABA gene therapy on neurogenci detrusor overactivity in spinal cord injured research. Chicago, April 25, 2009. Chancellor 7 of 108 82. Metro Detroit’s Best Doctors 2010. 83. International Jack Lapides Essay Contest: Grand Prize Winner; Pradeep Tyagi (Mentor): Ghrelin-A putative mechanistic link between OAB and obesity. San Francisco, May 29, 2010. 84. 2010 AUA/Olympus Prize Essay Contest (Lab Research Category):Ghrelin-A putative mechanistic link between OAB and obesity. Vikas Tyagi, San Francisco, June 1, 2010. 85. Tyagi, V., Sugino, Y., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Liposomes assisted bladder uptake of antisense oligonucleotides ameliorate symptoms of detrusor overactivity in rat model. Mentor, Society of Urodynamics & Female Urology 2011 Winter Meeting: First Place Research Essay Winner. 86. Chuang, Y.C. Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes, Best Poster Award, Mentor. AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 87. 2012 Outstanding Doctor’s Award. Beaumont Health System Medical Research Award, 2012. 88. OU-Beaumont Biomedical Research Symposium. Best Paper Award, Royal Oak, MI, November 14, 2012 89. Underactive Bladder Research & Education Appreciation Award, 2014 90. Lifetime Achievement Award, Society of Urodynamics and Female Urology, 2014 91. Best Poster: Rajaganapathy BR, Janicki J, Levanovich P, Tyagi P, Hafron J, Chancellor MB, Krueger S, Marples B: Intrvesical liposomal tacrolimus protects against radiation cystitis induced by 3-D beam targeted bladder radiation. New Orleans, AUA 2015. 92. Best Poster: Ozawa H, Chancellor MB, Nagai K, Kumon H: Non invasive velocity-flow videourodynamics using Doppler ultrasounography detection of periodic detrusor arrest during micturition in men underactive bladder syndrome. New Orleans, AUA 2015. 93. Urology Care Foundation Rising Star Research Award 2016; Lysanne Campeau, MD, Mentor; “The Effect of Cannabinoid Receptor Modulation on Voiding Dysfunction Associated with Metabolic Syndrome.” 94. 2017 Best Poster AUA: Laura Lamb, Joseph Janicki, Sarah Bartolone, Interstitial Cystitis Association, Bernadette Zwaans, Kenneth Peters, Michael Chancellor: MP29-07 DEVELOPMENT OF THE ULCERATIVE INTERSTITIAL CYSTITIS RISK SCORE (ICUS): A URINE-BASED MULTIPLE PROTEIN ASSAY TO PREDICT ULCERATIVE INTERSTITIAL CYSTITIS. 95. The Journal of Urology, Vol. 197, Issue 4, e382 96. 2017 Best Poster AUA: Laura Lamb, Sarah Bartolone, Michael Conway, Maya Tree, Olivia Lossia, Gary Dunbar, Julien Rossignol, Christopher Smith, Michael Chancellor: MP23-03 URINE BASED RAPID MOLECULAR DIAGNOSIS OF ZIKA VIRUS. Journal of Urology, Vol. 197, Issue 4, e293–e29. 97. National Association for Continence’s Continene Care Champion Award 2018 98. Best Poster Award AUA 2019 MP77-19 DEVELOPMENT OF RADIATION CYSTITIS BIOMARKER: ELEVATED FIBROTIC MARKERS IN URINE OF RADIATION CYSTITIS PATIENTS. Bernadette M.M. Zwaans*, Heinz E. Nicholai, Klaudia Stangel-Wójcikiewicz, Michael B. Chancellor, Laura E. Lamb https://doi.org/10.1097/01.JU.0000557331.48467.97 Honors and Awards has restrictions.

PEER-REVIEWED PUBLICATIONS

1. Abrams, S.E., Reynolds, A.C. and Chancellor, M.B.: A Comparison of Analgesic Effects of Electroacupuncture, Placebo Electroacupunture and Transcutaneous Electrical Stimulation. Anesthesiology Review, 10:26-31, 1983. 2. Chancellor, M.B., Konnak, J.W. and Grossman, H.B.: Diagnostic Value of Routine Scintigraphy Renal Imaging in Renal Carcinoma. Urology, 33:440-442, 1989. 3. Chancellor, M.B.., Grossman, H.B., Konnak, J.W., Diokno, A.C., Gonzalez, J.E., Pontes, J.E., Huben, R.P. and King, G.W.: Biocarbone Ureterostomy Device for Urinary Diversion, Urology, 34:18-21, 1989. 4. Sonda, L.P., Mazo, R. and Chancellor, M.B.: The Role of Yohimbine for the Treatment of Erectile Impotence. J. Sex & Marital Therapy. 16 (1):15-21, 1990. 5. Chancellor, M.B., Dato, V.M. and Yang, J.Y.: Lyme disease presenting as Urinary Retention. J. Urol., 143:1223- 1224, 1990. 6. Chancellor, M.B., Blaivas, J.G., Kaplan, S.A. and Axelrod, S.: Bladder Outlet Obstruction Versus Impaired Detrusor Contractility: Role of Uroflow. J. Urol., 145:810-812, 1991. 7. Kaplan, S.A., Chancellor, M.B. and Blaivas, J.G.: Bladder and Sphincter Behavior in Patients with Spinal Cord Lesions. J. Urol., 146:113-117, 1991. 8. Chancellor, M.B., Otter, M.W., Kaplan, S.A., Schuessler, G.B. and Blaivas, J.G.: A New Method of Measuring Uroflow in the Rat Bladder. Neuro-urology and Urodynamics, 11:123-129, 1992. Chancellor 8 of 108 9. Chancellor, M.B., Kaplan, S.A., and Blaivas, J.G.: The Cholinergic and Purinergic Components of Detrusor Contractility in a Whole Rabbit Bladder Model. J. Urol. 148:906-909, 1992. 10. Chancellor, M.B., Hirsch, I.H., Kiilholma, P. and Staas, W.E.: Technique of External Sphincter Balloon Dilatation. Urology, 40:308-310, 1992. 11. Chancellor, M.B., McGinnis, E.E., Shenot, P.J., Hirsch I.H. and Kiilholma, P.J.: Lyme Cystitis and Neurogenic Bladder Dysfunction Secondary to Lyme Disease, Lancet, 339:1237-1238, 1992. 12. Hanau, C.A., Chancellor, M.B., Alexander, A., Rishi, M., Jordan, A.G.: Fine Needle Aspiration of a Periurethral Teflon Filled Cyst Following Radical Prostatectomy. Diagnostic Cytopathology, 8:614-616, 1992. 13. Chancellor, M.B., McGinnis, D.E., Shenot, P.J., Kiilholma, P., Hirsch, I.H. and Dato, V.M.: Urinary Dysfunction in Lyme Disease., J. Urol., 149:26-30, 1993. 14. Chancellor, M.B., and VanAppledorn, C.A.S.: Transurethral Prostate Ultrasonography before Transurethral Prostatectomy, Its Value in Screening for Stage A Cancer. Urology, 41:590-593, 1993. 15. Kiilholma, P., Chancellor, M.B., Makinen, J., Hirsch, I.H. and Klemi, P.J.: Complications of Teflon Injections for Stress Urinary Incontinence. Neurourology & Urodynamics, 12:131-137, 1993. 16. Kiilholma, P., Chancellor, M.B., Pikanen, Y. and Hirvonen, T.: Modified Burch Colposuspension for Female Stress Urinary Incontinence. Two year follow-up in 186 patients. Surgery, Gynecology and Obstetrics, 176:111-115, 1993. 17. Kiilholma, P., Chancellor, M.B. and Ryynanen, M.: Lyme Virtsaamishairioiden Aiheuttajana. Suomen Laakarilehti, Finland, (Finnish Medical Journal, in Finnish) 35:3342-3344, 1993. 18. Chancellor, M.B., Tammela, T.L.J. and Kiilholma, P.J.: Urinary Undiversion by Cecoileourethroplasty and Pubovaginal Sling Operation, Int. Urogynecology J., 4:56-58, 1993. 19. Chancellor, M.B., Blaivas, J.G., Kaplan, S.A. and Axelrod, S.: Bladder Outlet Obstruction Versus Impaired Detrusor Contractility: Role of Uroflow. Comment in: J. Urol., 149:378-379, 1993. 20. Tammela, T.L.J., Kiilholma, P.J. and Chancellor, M.B.: Effect of Atropine, Glucagon, Bethanechol on Urodynamics of Continent Cecal Urinary Reservation. Before and After Complete, Partial and Sham Detubularization in a dog model, Neurourology & Urodynamics, 12:81-89, 1993. 21. Chancellor, M.B., Erhard, M.J., Strup, S., Tammela, T.C.J: Bladder Augmentation Using the Stomach in Spinal Cord Injured Patients With Impaired Renal Function. Archives of Physical Medicine and Rehabilitation, 74:1222- 1224, 1993. 22. Chancellor, M.B., Karasick, S., Strup, S., Abdill, C.K., Hirsch, I.H., Staas, W.E.: Transurethral Balloon Dilatation of the External Urinary Sphincter: Effectiveness in Spinal Cord Injured Men with Detrusor Sphincter Dyssynergia. Radiology, 187:557-560, 1993. 23. Chancellor, M.B., Karasick, S., Erhard, M.J., Abdill, C.K., Liu, J.B., Goldberg, B.B., Staas, W.E.: Intraurethral Wire Mesh Prosthesis Placement in the External Urinary Sphincter of Spinal Cord Injured Men. Radiology, 187:551-555, 1993. 24. Hirsch, I.H., Kulp, D., Sedor, J., McCue, P., Chancellor, M.B., Staas, W.E.: Simplified and Objective Assessment of Spermatogenesis in SCI Men by Flow Cystometry Analysis. Paraplegia, 31:785-792, 1993. 25. Chancellor, M.B., Rivas, D.A., Erhard, M.J., Hirsch, I.H., Bagley, D.H.: Flexible Cystoscopy During Urodynamics of Spinal Cord Injured Patients. J. Endourology, 7:531-535, 1993. 26. Rivas, D.A., Chancellor, M.B., Hill, K., Friedman, M.: Neurologic Manifestations of Baclofen Withdrawal. J. Urol., 150:1903-1905, 1993. 27. Chancellor, M.B., Rivas, D.A.: The American Urological Association Symptom Index for Women with Voiding Symptoms: Lack of Index Specificity for Benign Prostate Hyperplasia. J. Urol., 150:1706-1709, 1993. 28. Chancellor, M.B., Erhard, M.J, Rivas, D.A.: Clinical Effect of Alpha-1 Antagonist Terazosin on External and Internal Urinary Sphincter. J. American Paraplegia Society, 16:207-214, 1993. 29. Abdill, C.K., Rivas, D.A., Chancellor, M.B.: Transurethral Placement of External Sphincter Wire Mesh Stent for Neurogenic Bladder. Journal of American Association of Spinal Cord Injury Nurses, 11:38-45, 1994. 30. Chancellor, M.B., Erhard, M.J., Hirsch, I.H., Staas, W.E.: Prospective Evaluation of Terazosin for the Treatment of Autonomic Dysreflexia. J. Urology, 151:111-113, 1994. 31. Chancellor, M.B., Rivas, D.A., Huang, B., Kelly, G., Salzman, S.K.: Micturition Patterns After Spinal Trauma as a Measure of Autonomic Functional Recovery. J. Urology, 151:250-254, 1994. 32. Chancellor, M.B., Erhard, M.J., Kiilholma, P.J. and Rivas, D.A.: Functional Urethral Closure with Pubovaginal Sling for Destroyed Urethra after Long-Term Urethral Catheterization. Urology, 43:499-505, 1994. 33. Chancellor, M.B., Rivas, D.A., Abdill, C.K., Karasick, S., Ehrlich S.M, Staas, W.E. Prospective Comparison of External Sphincter Balloon Dilatation and Prosthesis Placement with External Sphincterotomy in Spinal Cord Injured Men. Arch. of Physical Med. and Rehab, 75:297-305, 1994. Chancellor 9 of 108 34. Chancellor, M.B., Rivas, D.A., Liberman, S.N., Moore, J., Staas, W.E.: Cystoscopic Autogenous Fat Injection for the Treatment of Vesicoureteral Reflux in Spinal Cord Injury. J. of American Paraplegia Society, 17: 50-54, 1994. 35. Chancellor, M.B., Rivas, D.A., Panzer, D.E., Friedman, M., Staas, W.E: Prospective Comparison of Topical Minoxidil to Vacuum Constriction Device and Intracorporeal Papaverine Injection in the Treatment of Erectile Dysfunction Due to Spinal Cord Injury. Urology, 43:365-369, 1994. 36. Chancellor, M.B., Rivas, D.A. and Salzman, S.K.: Detrusor-Myoplasty to Restore Micturition. Lancet, 343:669, 1994. 37. Rivas, D.A., and Chancellor, M.B.: Complications Associated with the Use of Vacuum/Constriction Devices for Erectile Dysfunction in the Spinal Cord Injured Population. J. American Paraplegia Society, 17:136-139, 1994. 38. Rivas, D.A., Chancellor, M.B., Bagley, D.H.: Prospective Comparison of External Sphincter Prosthesis Placement with External Sphincterotomy in Spinal Cord Injured Men. J. Endourology, 8:89-93, 1994. 39. Rivas, D.A., Chancellor, M.B.: Flexible Cystoscopy in Spinal Cord Injury. Paraplegia, 32:452-462, 1994. 40. Chancellor, M.B., Rivas, D.A., Ackman, D., Appell, R.A., Binard, J., Boon, T.B., Roehrborn, C.G., Chetner, M.P., Thorndyke, W.C., Defalco, A., Mayo, M., Gajewski, J., Green, B., Bennett, J., Foote, J., Juma, S., Linsenmeyer, T., McMillan, R., Stone, A., Vasquez, A.: Multicenter Trials of Urolume Endourethral Wallstent Prosthesis for the Urinary Sphincter in Spinal Cord Injured Men. J. Urol., 152:914-930, 1994. 41. Chancellor, M.B., Rivas, D.A., Keeley, F.X., Lofti, M.A., Gomella, L.G.: Similarity of the American Urological Association Symptom Index Among Men with Benign Prostatic Hyperplasia (BPH), Urethral Obstruction Not Due to BPH, and Detrusor Hyperreflexia Without Outlet Obstruction. Brit. J. Urol., 74:200-203, 1994. 42. Rivas, D.A., Chancellor, M.B: Comparison of the American Urological Association Symptom Index. Int. Urogyn. J., 5:202-207, 1994. 43. Chancellor, M.B., Rivas, D.A. and Staas, W.E.: DDAVP in the Urological Management of the Difficult Neurogenic Bladder in Spinal Cord Injury. J. American Paraplegia Society, 17:165-167, 1994. 44. Osterling, J.E., Kaplan, S.A., Epstein, H.B., Defalco, A.J., Reddy, P.K., Chancellor, M.B.: The North American Experience with the UroLume Endoprosthesis as a Treatment for Benign Prostatic Hyperplasia: Long-term Results. Urology, 44:353-362, 1994. 45. Hirsch, I.H., Smith, R.L., Chancellor, M.B., Bagley, D.H., Carsello, J., Staas, W.E.: Use of Intracavernous Injection of Prostaglandin E1 for Neuropathic Erectile Dysfunction. Paraplegia, 32:661-664, 1994. 46. Chancellor, M.B., Blaivas, J.G.: Urological and sexual problems in multiple sclerosis, Clinical Neuroscience, 2: 189-195, 1994. 47. Shenot, P., Rivas, D.A., Kalman, D.D., Staas, W.E. Jr. and Chancellor, M.B.: Latex Allergy Manifested in Urological Care of Adult Spinal Cord Injury Patients. Arch. of Physical Med. and Rehab., 75:1263-1265, 1994. 48. Chancellor, M.B., Acosta, R., Rivas, D.A., Erhard, M.J., Moore, J., Salzman, S.K.: Detrusor-Myoplasty and Function Neuromuscular Electrical Stimulation of the Urinary Bladder after Experimental Spinal Trauma. Neurourology & Urodynamics, 13:547-558, 1994. 49. Rivas, D.A., Chancellor, M.B., Huang, B., Salzman, S.K.: Erectile Response to Topical, Intraurethral, and Intracorporal Pharmacotherapy in a Rat Model of Spinal Cord Injury. J. Spinal Cord Research, 18: 245-250, 1995. 50. Chancellor, M.B., Liu, J.B., Rivas, D.A., Karasick, S., Alexander, A., Martin, D.M., Bagley, D.H., Goldberg, B.: Intraoperative Endoluminal Ultrasound Evaluation of Urethral Diverticulum. J. Urol., 153:72-75, 1995. 51. Gomella, L.G., Lofti, M.A., Rivas, D.A., Chancellor, M.B.: Contract Laser Vaporization Techniques for Benign Prostatic Hyperplasia. J. Endourology, 9:117-123, 1995. 52. Rivas, D.A., Chancellor, M.B., Huang, B., Salzman, S.K.: Autonomic Dysreflexia in Rat Model of Spinal Cord Injury: Effect of Pharmacologic Agents. Neurourology & Urodynamics, 14:141-152, 1995. 53. Chancellor, M.B., Rivas, D.A., Abdill, C.K., Staas, W.E., Bennett, C.J., Finocchiaro, M.V., Razi, S., Bennett, J.K., Green, B.G., Foote, J.E., Kiillorian, R.W.: Management of Sphincter Dyssynergia Using the Sphincter Stent Prosthesis in Chronically Catheterized SCI Men. J. Spinal Cord Medicine, 18:88-94, 1995. 54. Rivas, D.A. Chancellor, M.B.: Neurogenic Vesical Dysfunction. Urol. Clin. North Amer., 22:579-591, 1995. 55. Virtanen, H.S., Kiilholma P.J.A., Mäkinen J.I., Nurmi M.J. and Chancellor M.B.: Ureteral Injuries in Conjunction with Burch Colpsuspension. Int. UroGynecol., 6:114-118, 1995. 56. Moreno, J.G., Chancellor, M.B., Karasick, S., King, S., Abdill, C.K., Rivas, D.A.: Improved Quality of Life and Sexuality with Continent Urinary Diversion in Quadriplegic Women with Umbilical Stoma. Archives of Physical Medicine and Rehabilitation, 76: 758-762, 1995. 57. Rivas, D.A., Karasick, S. and Chancellor, M.B.: Cutaneous Ileocystostomy (A Bladder Chimney) For the Treatment of Severe Neurogenic Vesical Dysfunction. Paraplegia, 33:530-535, 1995. 58. Kiilholma, P., Haarala, M., Makinen, J., Polvi, H. and Chancellor, M.B.: Sutureless Endoscopic Colposuspension with Fibrin Sealant. Techniques in Urology, 1:81-83, 1995. Chancellor 10 of 108 59. Rivas, D.A., Figueroa, T.E., Chancellor, M.B.: Bladder Auto-augmentation. Techniques in Urology, 1:181-187, 1995. 60. Rivas, D.A., Chancellor, M.B., Staas, W.E. and Gomella, L.G.: Contact Nd: YAG Laser Ablation of the External Sphincter in Spinal Cord Injured Men with Detrusor Sphincter Dyssynergia. Urology, 45:1028-1031, 1995. 61. Chancellor, M.B., Shenot, P.J., Rivas, D.A., Mandel, S. and Schwartzman, R.J.: Urological Manifestations of Reflex Sympathetic Dystrophy. J. Urology, 155: 634-637, 1996. 62. Rivas, D.A., Chancellor, M.B., Liu, J.B., Hanau, C., Bagley, D.H. and Goldberg, B.: Endoluminal Ultrasound and Histological Evaluation of Periurethral Collagen Injection. J Endourology, 10: 61-66, 1996. 63. Chancellor, M.B., Rivas, D.A., Watanabe, T., Bennett, J.K., Foote, J.E., Green, B.G., Kiilorin E.W., MacMillan, R.: Reversible Clinical Outcome After Sphincter Stent Prosthesis Removal, J. Urol., 155: 1992-1994, 1996. 64. Crewalk, J.A., Shenot, P.J., Rivas, D.A., Chancellor, M.B.: Mixed Urinary Incontinence Secondary to Lead Poisoning. J. Urol., 155: 2029, 1996. 65. Watanabe, T., Rivas, D.A., Miettinen, M. and Gomella, L. and Chancellor, M.B.: Total Incontinence Secondary to Sphincter Destruction after Prostate Cryotherapy. Int. J. Urology, 3: 324-325, 1996. 66. Chancellor, M.B., Rivas, D.A., Bourgois, I.M.: Laplace’s Law and The Risks and Prevention of Bladder Rupture After Enterocystoplasty and Bladder Autoaugmentation. Neurourology & Urodynamics, 15: 223-233, 1996. 67. Chancellor, M.B., Shenot, P.J., Hong, R.D., Watanabe, T., Rivas, D.A.: Fascial Sling Correction of Kinked Efferent Limb in Patients with Continent Diversion and Catheterization Difficulty, J. Urol., 156: 162-163, 1996. 68. Das, A., Chancellor, M.B., Watanabe, T., Sedor, J., Rivas, D.A.: Intravesical Capsaicin in Neurologically Impaired Patients with Detrusor Hyperreflexia. J. Spinal Cord Medicine, 19:190-193, 1996. 69. Watanabe, T., Chancellor, M.B., Rivas, D.A., Hirsch, I.H., Bennett, C.J., Finocchairo, M.V., Razi, S., Bennett, J.K., Green, B.G., Foote, J.E., Killorian, R.W., Juma, S., Lindseymeyer, T., Lloyd, K.: Epidemiology of Current Treatment for Sexual Dysfunction in Spinal Cord Injured Men in the USA Model Spinal Cord Injury Centers. J. Spinal Cord Medicine, 19:186-189, 1996. 70. Fitzpatrick, K.J., Chancellor, M.B., Rivas, D.A., Mandel, S., Manon-Espaillat, R.: Urologic Manifestation of Spinal Cord Sarcoidosis, J. Spinal Cord Medicine, 19:201-203, 1996. 71. Watanabe, T., Rivas, D.A., Huang, B., Epple, A.W., Figueroa, T.E., Chancellor, M.B.: Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience. J Urol., 156:1507-1510, 1996. 72. Fabrizio, M.D., Chancellor, M.B., Rivas, D.A., Richard, M.D., Intenzo, C.M.: The Role of Renal Scintigraphy in the Evaluation of Spinal Cord Injury Patients with Presumed Urosepsis. J. Urol., 156:1730-1734, 1996. 73. Chancellor, M.B., Rivas, D.A., Shenot, P.J., Schwartzman, R.J.: Letter to the Editor: Urological Manifestations of Reflex Sympathetic Dystrophy. J. Urology, 156:1782-1783, 1996 74. Watanabe, T., Rivas, D.A., Smith, R., Staas, W.E., Chancellor, M.B.: The Effect of Urinary Tract Reconstruction on Neurologically Impaired Women Previously Managed with An Indwelling Urethral Catheter. J. Urol., 156:1926- 1928, 1996. 75. Weiss, D.J., Fried, G.W., Chancellor, M.B., Herbison, G.J., Ditunno, J.F., Jr., Staas, W.E.,Jr.: Spinal cord injury and bladder recovery, Archives of Physical Medicine & Rehabilitation, 77:1133-1135, 1996. 76. Rivas, D.A., Chancellor, M.B., Huang, B., Ellpe, A., Figueroa, T.E., Salzman, S.K.: A Comparison of Bladder Rupture Pressure after Intestinal Bladder Augmentation (Ileocystoplasty) and Myomyotomy (Autoaugmentation). Urology, 48: 40-46, 1996. 77. Watanabe, T., Rivas, D.A., Chancellor, M.B.: Urodynamics of spinal cord injury, Urol. Clin. N. America, 23:459- 473, 1996. 78. Shenot, P.J., Chancellor, M.B., Rivas, D.A., Watanabe, T., Kumon, H., Figueroa, T.E.: In-vivo Whole Bladder Response to Anticholinergic and Musculotropic Agents in Spinal Cord Injured Rats. J. Spinal Cord Medicine, 20:31-35, 1997. 79. Chancellor, M.B., Strup, S., Rivas, D.A., Watanabe, T., Gomella, L.G.: Rectus Urethromyoplasty of Radical Prostatectomy Anastomosis Decreases Postoperative Incontinence and Anastomotic Strictures; Technique and Preliminary Results. J. Urol., 157:371-375, 1997. 80. Chancellor, M.B., Editorial: Used, T., Yoshimura, N., Yoshida, O.: Diabetic cystopathy: Relationship to autonomic neuropathy detected by sympathetic skin response. J. Urol., 157:580-584, 1997. 81. Chancellor, M.B., Editorial: Nitti, V.R., Kim, Y., Combs, A.J.: Voiding dysfunction following transurethral resection of the prostate: Symptoms and urodynamic findings.. J. Urol., 157:600-603, 1997. 82. Rivas, D.A., Chancellor, M.B., Shupp-Byrne, D., Shenot, P.J., McHugh, K., McCue, P.: A Molecular Marker for the Development of Interstitial Cystitis in a Rat Model: Isoactin Gene Expression, J. Urol., 157:1937-1940, 1997. Chancellor 11 of 108 83. Chancellor, M.D., Hong, R.D., Rivas, D.A., Watanabe, T., Crewalk, J.A., and Bourgeois, I.: Gracilis urethromyoplasty-an autologous urinary sphincter for neurologically impaired patients with stress incontinence. Spinal Cord. 35:546-549, 1997. 84. Chancellor, M.B.: Should we be using chili pepper extracts to treat overactive bladder? J. Urol., 158:2097, 1997. 85. Chancellor, M.B., Rivas, D.A., Hong, R., Kumon, H., Watanabe, T., Bourgeois, I., Gracilis urethral myoplasty: Preliminary experience using an autologous urinary sphincter for post-prostatectomy incontinence. J. Urol., 158:1372-1375, 1997. 86. Chancellor, M.B., Heesakker, J.P., Janknegt, R.A.: Gracilis muscle transposition with electrical stimulation for sphincter incontinence: A new approach. World J. Urology, 15:320-328, 1997. 87. Watanabe, T., Vaccaro, A.R., Kumon, H., Welch, W.C., Rivas, D.A., Chancellor, M.B.: High incidence of occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal injuries. J. Urol., 159:965-968, 1998. 88. Shenot, P.J., Rivas, D.A., Watanabe, T., Kumon, H., Chancellor, M.B.: Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourology & Urodynamics, 17:25-30, 1998. 89. Kumon, H., Ozawa, H., Yokoyama, T., Watanabe, T., Chancellor, M.B.: Inguinal cystoceles: a previously overlooked etiology of prostatism in men without bladder outlet obstruction. J. Urol., 159:766-771, 1998. 90. Byrne D.S, Das, A., Sedor, J.F., Huang, B., Rivas, D.A., Flood, H.J., de Groat, W., Jordan, M.L., Chancellor, M.B., McCue, P.: Effect of intravesical capsaicin and vehicle on bladder integrity in control and spinal cord injured rats. J. Urol., 159:1074-1078, 1998. 91. Chancellor, M.B., Rivas, D.A., Mulholland, S.G., Drake, W.M.Jr.,: The invention of the modern uroflowmeter by Willard M. Drake, Jr., at Jefferson Medical College. Urology, 51:671-674, 1998. 92. Chancellor, M.B., Lavelle, J., Ozawa, H., Jung, S.Y., Watanabe, T., Crewalk, J.A., Kumon, H.: The ice-water test in the urodynamic evaluation of spinal cord injured patients. Technique in Urol., 4:87-91, 1998. 93. Nezu, F.M., Dhir, R., Logan, T.F., Lavelle, J., Becich, M.J., Chancellor, M.B.: Malignant priapism as the initial clinical manifestation of metastatic renal cell carcinoma with invasion of both corpora cavernosum and spongiosum. International J. Impotence Research, 10:101-102, 1998. 94. Chancellor, M.B., Editorial: Peters, K.M., Diokno, A.C., Steinert, B.W. and Gonzalez, J.A.: The efficacy of intravesical bacillus calmette-guerin in the treatment of interstitial cystitis: long-term followup. J. Urol., 159:1485- 1487, 1998. 95. Olson, M.E., Morck, D.W., Ceri, H., Lee, C.C., Chancellor, M.B.: The evaluation of autologous fat implantation in the rat urinary bladder submucosa. Urology, 52: 915-919, 1998. 96. Ozawa, H., Kumon, H., Yokoyama, T. Watanabe, T., Chancellor, M.B.: Development of non invasive velocity- flow videourodynamics using Doppler sonography; Part I: Experimental urethra. J. Urol., 160: 1787-1791, 1998. 97. Ozawa, H., Kumon, H., Yokoyama, T. Watanabe, T., Chancellor, M.B.: Development of non invasive velocity- flow videourodynamics using Doppler sonography; Part II: Clinical application in bladder outlet obstruction. J. Urol., 160: 1792-1796, 1998. 98. Chancellor, M.B., Editorial: VanKerrebrueck, P.E., VA., Amarenco, G., Thuroff, J.W., Madersbacher, H.G., Lock, M.T.W.T., Messelink, E.J., and Soler, J.M.: Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurology & Urodynamics, 17: 499-512, 1998. 99. Ozawa, H., Kumon, H., Chancellor, M.B.: Gracilis myoplasty. Voiding Disorders Digest, 6:14-20,1998. 100. Chancellor, M.B.: Cranberry juice, UTI’s and tolterodine. Review in Urology, 1:19-20, 1999. 101. Chancellor, M.B., Editorial: Rhodes, T., Girman, C.J., Jacobsen, S.J., Roberts, R.O., Guess, H.A. and Lieber, M.M.: Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J. Urol., 161:1174-1179, 1999. 102. Chancellor, M.B., Gajewski, J., Ackman, C.F.D., Appell, R.A., Bennett, J., Binard, J., Boone, T.B., Chetner, M.P. Crewalk, J.A., Defalco, A., Foote, J., Green, B. Juma, S., Jung, S.Y., Linsenmeyer, T., MacMillan, R., Mayo, M., Ozawa, H., Roehrborn, C.G., Shenot, P.J., Stone, A., Vazquez, A. and Rivas, D.A.: Long-term (5 years) follow-up TM of the North American Multicenter UroLume trial for the treatment of detrusor-external sphincter dyssynergia. J. Urol., 161:1545-1550, 1999. 103. Hirsch, I.R., Huang, B., Chancellor, M.B., Rivas, D.A., Salzman, S.K., Jost, L.K. Everson, D.P.: Spermatogenesis in early and chronic phases of experimental spinal cord injury in the rodent model. J. Andrology, 20:63-71, 1999. 104. Lavelle, J.P., Teahan, S., Kim, D.Y., Chancellor, M.B.: Medical and minimally invasive treatment of urinary incontinence. Rev. Urol., 1:111-120, 1999. 105. Ozawa, H., Jung, S.Y., Fraser, M.O., Rivas, D.A., Chancellor, D.A.: Intravesical Capsaicin Therapy. J. Spinal Cord Medicine, 22:114-118, 1999. Chancellor 12 of 108 106. Chancellor, M.B., Bennett, C., Simoneau, A., Finocchiaro, M.V., Kline, C., Bennett, J.K., Foote, J.E., Green, B.G., Killorian, R.W., Martin, S.H., Crewalk, J.A., Rivas. D.A.: Sphincter stent versus external sphincterotomy in spinal cord injured men; prospective randomized multicenter trial. J. Urol, 161:1893-1898, 1999. 107. Fagerli, J. Fraser, M.O., de Groat, W.C., Chancellor, M.B., Flood, H.D., Smith, D. and Jordan M.L.: Intravesical capsaicin for the treatment of interstitial cystitis: a pilot study. Can. J. Urol., 6: 737-744, 1999. 108. Sathyan, G., Hu, W. Chancellor, M.B., Gupta, S.: Comparison of CYP3A4 inhibitor effects on the stereoselective pharmacokinetics of extended release oxybutynin and conventional oxybutynin. Pharm. Sci. 1:2056-2059, 1999. 109. Chancellor, M.B and de Groat, W.C.: Intravesical capsaicin and resiniferatoxin therapy; spicing up the ways to treat the overactive bladder. J. Urol., 162:3-11, 1999. 110. Jung, S.Y., Fraser, M.O., Ozawa, H., Yokoyama, O., Yoshiyama, M., de Groat, W.C. and Chancellor, M.D.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J. Urol., 162:204-212, 1999. 111. Chancellor, M.B.: Mapping the future for incontinence treatment worldwide. Rev. in Urology, 1:145-148, 1999. 112. Atan, A., Konety, B.R., Erickson, J.R., Yokoyama, T., Kim, D.Y. and Chancellor, M.B.: Tolterodine for overactive bladder; time to onset of action, preferred dosage, and nine months follow-up. Tech. Urology, 5:67-70, 1999. 113. Chancellor, M.B.: Treating Incontinence and the Tip of the Iceberg. Rev. in Urology, 1:153-154, 1999. 114. Phelan, M.W. and Chancellor, M.B.: Pharmacological therapy of the overactive bladder: State of the art. Brazil. J. Urol., 25:415-424, 1999. 115. Chancellor, M.B., Rivas, D.A., Watanabe, T., Tai, H.L., Kumon, H.: Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia. Technique in Urology, 5:191-194, 1999. 116. Ozawa, H., Chancellor, M.B., Jung, S.Y., Yokoyama, T., Yu, Y.B., de Groat, W.C. and Yoshimura, N.: Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J. Urol., 162:2211-2216, 1999. 117. Yoshiyama, M., Nezu, F.M. Yokoyama, O., Chancellor, M.B. and de Groat, W.C.: Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury. Exp. Neurology, 159:250-257, 1999. 118. Chancellor, M.B.: Managing stress incontinence and classifying detrusor instability. Review in Urology, 1(4): 205-296, 1999. 119. Atan, A., Konety, B.R., Chancellor, M.B.: Advantages and risks of ileovesicostomy for the management of neuropathic bladder. Urology, 54:636-640, 1999. 120. Yoshiyama, M., Nezu, F.M. Yokoyama, O., de Groat, W.C. and Chancellor, M.B.: Changes in micturition after spinal cord injury in conscious rat. Urology, 54:929-933, 1999. 121. Chancellor, M.B., A gathering of urologists and urogynecologists (World Health Organization). Review in Urology, 2:11-15, 2000. 122. Chancellor, M.B., Editorial: SNS for management of voiding dysfunction. Review in Urology, 2:43-52, 2000. 123. Yokoyama, T., Chuang, Y.C., Chancellor, M.B.: Advances in urologic drug delivery. Contemporary Urology 12:91-95, 2000. 124. Chancellor, M.B.: What is best way to treat incontinence: behavioral or drug treatment. Review in Urology, 2:30-31, 2000. 125. Van Savage, J.G., Chancellor, M.B., Slaughenhoupt, B.: Transverse retubularized ileovesicostomy continent urinary diversion to the umbilicus. Tech. Urology, 6:29-33, 2000. 126. Gajewski, J.B., Chancellor, M.B., Ackman, C.F.D., Appell, R.A., Bennett, J., Binard, J., Boone, T.B., Chetner, M.P. Crewalk, J.A., Defalco, A., Foote, J., Green, B. Juma, S., Jung, S.Y., Linsenmeyer, T., MacMillan, R., Mayo, M., Ozawa, H., Roehrborn, C.G., Shenot, P.J., Stone, A., Vazquez, A. and Rivas, D.A.: Removal of Urolume endoprosthesis: experience of the North American study group for detrusor-external sphincter dyssynergia. J. Urol., 163:773-776, 2000. 127. Chancellor, M.B., Freedman, S., Mitcheson, H.D., Antoci, J., Primus, Wein, A.: Tolterodine, an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms. Clin Drug Invest 19:83- 91, 2000. 128. Yokoyama, T., Huard, J. and Chancellor, M.B.: Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J. Urology, 18:56-61, 2000. 129. Chancellor, M.B., Yokoyama, T., Tirney, S., Mattes, C.E., Ozawa, H., Yoshimura, N., de Groat, W.C. and Huard, J.: Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourology & Urodynamics, 19:279-287, 2000. 130. Franks, M., Chartier-Kastler, E., Chancellor, M.B.: New pharmacologic and minimally invasive therapies for the overactive bladder. Drug Benefit Trends, May: 49-57, 2000. Chancellor 13 of 108 131. Ozawa, H., Kumon, H., Chancellor, M.B.: Non-invasive velocity-flow videourodynamics using Doppler sonography. Voiding Disorder Digest, 8:49-55, 2000. 132. Chancellor, M.B.: Resiniferatoxin, Preliminary Data. Urology, 55 (5A): 65-66, 2000. 133. Kim, D.Y., Chancellor, M.B.: Intravesical neuromodulatory drugs: Capsaicin and resiniferatoxin to treat the overactive bladder. J. Endourology, 14:97-103, 2000. 134. Konety, B.R., Phelan, W.P., O’Donnell, W.F., Antiles, L., Chancellor, M.B.: Urolume stent placement for the treatment of post-brachytherapy bladder outlet obstruction. Urology, 55:721-724, 2000. 135. Chancellor, M.B. and Chartier-Kastler, E.J.: Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. J. Neuromodulation, 3:15-26, 2000. 136. Ozawa, H., Chancellor, M.B., Ding, Y.Y., Nasu, Y., Yokoyama, T., Kumon, H.: Noninvasive urodynamic evaluation of bladder outlet obstruction using Dopplerultrasonography. Urology, 56:408-412, 2000. 137. Chartier-Kastler, E.J., Bosch, R., Perrigot, M., Chancellor, M.B., Richard, J., Denys, P.: Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J. Urol., 164:1476-1480, 2000. 138. Chartier-Kastler, E.J., Thomas, L., Bussel, B., Chancellor, M.B., Richard, F., Denys, P.: A urethral stent for the treatment of detrusor-straited sphincter dyssynergia. Br.J.Urol., 86:52-57, 2000. 139. Chartier-Kastler, E.J., Mongiat-Artus, P., Bitker, M.O., Chancellor, M.B., Richard, F., Denys, P.: Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord, 38:490-494, 2000. 140. Yoshimura, N., Smith, C.P., Chancellor, M.B., de Groat, W.C.: Pharmacologic and potential biologic interventions to restore bladder function after spinal cord injury. Current Opinion in Neurology 13:677-681, 2000. 141. Franks, M.E., Lavelle, J.P., Yokoyama, T., Chuang, Y.C., Chancellor, M.B.: Metastatic osteomyelitis after pubovaginal sling using bone anchors. Urology, 56:330-331, 2000. 142. Chancellor, M.B.: Stress urinary incontinence. Review in Urology, 2:174-177, 2000. 143. Ding, Y.Y., Ozawa, H., Yokoyama, T., Nasu, Y., Chancellor, M.B., Kumon, H.: Reliability of color Doppler ultrasound urodynamics in the evaluation of bladder outlet obstruction. Urology. 56:967-71, 2000. 144. Smith, C.P., Chancellor, M.B.: Genitourinary tract patent update. Exp. Opin. Ther. Patents, 11:17-21, 2001. 145. Chartier-Kastler, E.J., Denys, P., Chancellor, M.B., Haertig, A., Bussel, B., Richard, F.: Urodynamic monitoring during percutaneous sacral nerve neurostimulation in patients with neurogenic detrusor hyperreflexia. Neurourology and Urodynamics 20:61-71, 2001. 146. Yokoyama, T., Yoshimura, N., Dhir, R., Qu, Z., Fraser, M.O., Kumon, H., de Groat, W.C., Huard, J., Chancellor, M.B.: Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J. Urology, 165:271-276, 2001. 147. Jonas, U., Fowler, C.J., Chancellor, M.B., Elhilali, M.M., Fall, M., Gajewski, J.B., Grunewald, V., Hassouna, M.M., Hombergh, U.V.D., Janknegt, R., van Kerrebroeck, P.E.V., Lylcklama, A.A.B., Siegel, S.W., Schmidt, R.A.: Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J. Urology, 165:15- 19, 2001. 148. Chuang, Y.C., Fraser, M.O., Yu, Y., Chancellor, M.C., de Groat W.C., Yoshimura, N.: The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J. Urology, 165:975-979, 2001. 149. Yokoyama, T., Chancellor, M.B., Yoshimura, N., Huard, J., Kumon, H.: Gene therapy and tissue engineering for urological dysfunction: status and prospects. Molecular Urology, 5:67-70, 2001. 150. Chancellor, M.B., Sathyan, G., Peeples, P., Gupta, S.: Comparison of pharmacokinetic and pharmacodynamic properties of controlled-release and immediate-release oxybutynin chloride. Clinical Therapeutics, 23:753-760, 2001. 151. Chancellor, M.B., Yoshimura, N., Pruchnic, R., Huard, J. Gene therapy strategies for urological dysfunction. Trends in Molecular Medicine, 7:301-306, 2001. 152. Sathyan, G., Chancellor, M.B., Gupta, S.: Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride. Br. J. Clin. Pharmacol. 52:409-417, 2001. 153. Phelan, M.W., Franks, M., Somogyi, G.T., Yokoyama, T., Fraser, M.O., Lavelle, J.P., Yoshimura, N., Chancellor, M.B.: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J. Urol, 165:1107-1110, 2001. 154. Goins, W.F., Yoshimura, N., Phelan, M.W., Ozawa, H., Yokoyama, T., Bennett, N. Jr., de Groat, W.C., Glorioso, J.C., Chancellor, M.B.: Gene therapy using herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J. Urol., 165:1748-1754, 2001. Chancellor 14 of 108 155. Yokoyama, T., Huard, J., Yoshimura, N., Pruchnic, R., Qu, Z., Cao, B., de Groat, W.C., Kumon, H., Chancellor, M.B.: Muscle derived cells transplantation and differentiation into the lower urinary tract smooth muscle. Urology, 57:826-831, 2001. 156. Chartier-Kastler, E.J., Denys, P., Thomas, L., Bussel, L., Chancellor, M.B., Richard, F.: Feasibility of a temporary urethral stents through the striated sphincter in patients in the early phase (6 months) of spinal cord injury, European Urology, 39:326-331, 2001. 157. Sasaki, K., Smith, C.P., Chung, Y.C., Lee, J.Y., Kim, J.C., Chancellor, M.B.: Oral gabapentin (Neurontin) treatment of refractory genitourinary tract pain. Tech. Urology, 7; 47-49, 2001. 158. de Groat, W.C., Fraser, M.O., Yoshimyama, M., Smerin, S., Tai, C., Chancellor, M.B., Yoshimura, N., Roppolo, J.R.: Neural control of the urethra, Scan J Urol Nephrol Suppl 207:35-43, 2001. 159. Tirney, S., Mattes, C.E., Yoshimura, N., Yokayma, T., Ozawa, H., Tzeng, E., Birder, L.A., Kanai, A.J., Huard, J., de Groat, W.C., Chancellor, M.B.: Nitric oxide synthase (NOS) gene therapy for erectile dysfunction; comparison between plasmid, adenovirus and adenovirus transduced myoblast vectors, Molecular Urology, 5: 175-180, 2001. 160. Yoshimura N. Seki S. Erickson V. Erickson K. Kassotakis L. Novakovic S. Fraser MO. Chancellor MB. de Groat WC. Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain. Urology. 57(6 Suppl 1):116-7, 2001. 161. Yoshimura N. Franks ME. Sasaki K. Goins WF. Goss J. Yokoyama T. Fraser MO. Seki S. Fink J. Glorioso J. de Groat WC. Chancellor MB. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology. 57(6 Suppl 1):116, 2001. 162. Fraser MO. Chuang YC. Kim DY. Brady CM. Beckel JM. Yoshimura N. de Groat WC. Chancellor MB. Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation. Urology. 57(6 Suppl 1):111-2, 2001. 163. Chancellor MB. RTX exotoxins. Urology. 57(6 Suppl 1):106-7, 2001. 164. Chuang YC. Chancellor MB. Yu TJ. 31-Year-old bladder diverticulocutaneous fistula with a giant stone as a complication of pelvic fracture. Techniques in Urology. 7(4):302-4, 2001. 165. Yoshimura N. Seki S. Novakovic SD. Tzoumaka E. Erickson VL. Erickson KA. Chancellor MB. de Groat WC. The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain. Journal of Neuroscience. 21(21):8690-6, 2001. 166. Chuang YC. Fraser MO. Yu Y. Beckel JM. Seki S. Nakanishi Y. Yokoyama H. Chancellor MB. Yoshimura N. de Groat WC. Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. [Journal Article] American Journal of Physiology - Regulatory Integrative & Comparative Physiology. 281(4):R1302-10, 2001 Oct. 167. Yokoyama, T., Pruchnic, R., Kumon, H., Chuang, Y.C., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: Autologous primary muscle derived cells (MDC) transfer into the lower urinary tract: a combination of MDC transplantation and gene therapy. Tissue Engineering, 7: 395-404, 2001. 168. Chuang, Y.C., Fraser, M.O., Yu, Y.B., Seki, S., Chancellor, M.B., Yoshimura, N., de Groat, W.C.: Analysis of the afferent limb of the vesico-vascular reflex using the neurotoxins, resiniferatoxin and capsaicin. Am. J. Physiology, 281:R1302-R1310, 2001. 169. O’Leary, M., Chancellor, M.B.: Is nighttime voiding normal or anomalous? Reviews Urol., 3: 106-107, 2001. 170. Franks, M., Zyczynski, H., Capelle, S., Moalli, P., Sagan, E., Chancellor, M.B.: Clinical outcome and cost comparison with the pubovaginal sling procedure using autologous fascia versus cadaveric dermal patch. J. Pelvic Surgery, 8:19-22, 2002. 171. Smith, C.P., Somogyi, G.T., Bird, E.T, Chancellor, M.B., Boone, T.B.: Neurogenic bladder model for spinal cord injury: spinal cord microdialysis and chronic urodynamics. Brain Research Protocols, 9:57-64, 2002. 172. Konety, B.R., Somogyi, G., Atan, A., Muindi, J., Chancellor, M.B., Getzenberg, R.H.: Evaluation of intraprostatic metabolism of 1, 25-dihydroxyvitamine D3 (Calcitrol) using a microdialysis technique. Urology, 59:947-952, 2002. 173. O’Leary M.L., Smith, C.P., Erickson, J., R., Eidelman, B.H., Chancellor, M.B.: Neurovesical dysfunction in postural tachycardia syndrome (POTS). Int. Urogynecology J. and Pelvic Floor Dysfunction, 13:139-140, 2002. 174. Yoshimura N. Seki S. Chancellor MB. de Groat WC. Ueda T. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 59(5 Suppl 1):61-7, 2002. 175. Smith, C.P., O’Leary, M., Erickson, J., Somogyi, G.T., Chancellor, M.B.: Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int. Urogynecology J. and Pelvic Floor Dysfunction, 13:185-186, 2002. 176. Schwarz, N.T., Jung, S.Y., Kalff, J.C., Chancellor, M.B., Bauer, A.J.: Bacterial toxin f-MLP acutely contracts human and rabbit detrusor through the release of eicosanoids. J. Urol., 167:2603-2612, 2002. Chancellor 15 of 108 177. Cannon, T.W., Chancellor, M.B.: Pharmacotherapy of the overactive bladder and advances in drug delivery. Clin. Ob. Gyn., 45: 205-217, 2002. 178. Gloeckner, D.C., Sacks, M.S., Fraser, M.O., Somogyi, G.S., de Groat, W.C., Chancellor, M.B.: Passive Biaxial mechanical properties of the rat urinary bladder wall after spinal cord injury. J. Urol., 167:2247-2252, 2002. 179. O’Leary, M.L., Smith, C.P., Erickson, J.R., Heyman, R.A., Chancellor, M.B.: Botulinum toxin urethral sphincter injection to restore bladder emptying in a woman with multiple sclerosis, International J. of MS Care, 4:70-72, 2002. 180. Sasaki, K., Chancellor, M.B., Phelan, M.W., Yokoyama, T., Fraser, M.O., Seki, S., Kubo, K., Kumon, H., de Groat, W.D., Yoshimura, N.: Diabetic cystopathy correlates with long-term decrease in nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia. J. Urol., 168:1259-1264, 2002. 181. Lu, S-H., Tsuyoshi, Y., Kaoru, A., Sun, L, Smith, C.P., Yoshimura, N., Chancellor, M.B., de Groat, W.C.: Effect of KW-7158, a putative afferent nerve inhibitor, on bladder and vesico-vascular reflexes in rats. Brain Research, 946; 72-78, 2002. 182. Seki, S., Sasaki, K., Fraser, M.O., Igawa, Y., Nishizawa, O., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Immunoneutralization of nerve growth factor in the lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J. Urology, 168:2269-2274, 2002. 183. O’Leary, M.L., Erickson, J.R., Smith, C.P., Cannon, T.W., Fraser, M., Boyd, M., Heyman, R.A., Chancellor, M.B.: Changes in voiding patterns in patients with MS and extended-release oxybutynin. International J. of MS Care, 4:116-119, 2002. 184. Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Curr. Urol. Rep., 3:382-287, 2002. 185. Lu, S-H., Lavelle, J., Chancellor, M.B.: Prostatic stents. Atlas of Urologic Clinics of North America, 10:111-118, 2002. 186. Yoshimura, N., Chancellor, M.B.: Current and future pharmacological therapy of the overactive bladder. J. Urol., 168: 1897-1913, 2002. 187. Pruchnic, R. Yokoyama, T., Lee, J.Y., Smith, C.P., Yoshimura, N., Qu, Z., Kumon, H., de Groat, W.C., Huard, J., Chancellor, M.B.: Muscle derived cells mediated ex-vivo gene transfer to the lower urinary tract; comparison of viral vectors. Urol., Research, 30:310-316, 2002. 188. Somogyi, G.T., Szell, E.A., Yokoyama, T., Smith, C.P., de Groat, W.C., Huard, J., Chancellor, M.B.: Effect of cryoinjury on the contractile parameters of bladder strips: a model of impaired detrusor contractility. Brain Res. Bull. 59: 23-28, 2002. 189. Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Botulinum toxin treatment of urethral and bladder dysfunction. Int Braz J Urol., 28:545-552, 2002. 190. Huard, J., Pruchnic, R., Yokoyama, T., Smith, C.P., Qu, Z., Kumon, H., Yoshimura, N., Somogyi, G., de Groat, W.C., Chancellor, M.B.: Muscle based gene therapy and tissue for urological dysfunction. Gene Therapy, 9:1617- 1626, 2002. 191. Chung, S.Y., Franks, M., Smith, C.P., Lee, J.Y., Lu, S-H., Chancellor, M.B.: Technique of combined pubovaginal sling and cystocele repair using a single piece of cadaveric dermal graft. Urology, 59:538-541, 2002. 192. Yokoyama, T., Kumon, H., Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Botulinum toxin treatment of urethral and bladder dysfunction. Acta Med. Okayama, 565:271-277, 2002. 193. Smith, C.P., Franks, M.E., McNeil, B.K., Gosh, R., de Groat, W.C., Chancellor, M.C., Somogyi, G.T.: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J. Urol., 169:1896-1900, 2003. 194. Sasaki, K., Yoshimura, N., Chancellor, M.B.: Implications of diabetes mellitus in urology. Urology Clinical of North American, 30:1-12, 2003. 195. Lee, J.Y., Cannon, T.W., Fraser, M.O., Qu, Z., Pruchnic, R., Smith, C.P., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: The effects of periurethral muscle derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int. Urogynecology J. and Pelvic Floor Dysfunction, 14:31-37, 2003. 196. Kim, D.K., Chancellor, M.B.: New frontiers in the treatment of overactive bladder. J. Korean Continence Society, 7: 1-8, 2003. 197. Chuang, Y-C., Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Botulinum toxin treatment of urethral and bladder dysfunction. J. Formos Med Assoc., 102:5-11, 2003. 198. Appell, R.A., Chancellor, M.B., Zobrist, H., Thoas, H., Sanders, S.W.: Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. May Clin Proc. 78:696-702, 2003. 199. Horton, J.A., Chancellor, M.B., Labatia, I.: Bladder management for the evolving spinal cord injury: options and considerations. Top. Spinal Cord Inj. Rehabil. 9:36-52, 2003. Chancellor 16 of 108 200. Chuang, Y.C., Chou, A.K., Wu, P.C., Chiang, P.H., Yu, T.J., Yang, L.C., Yoshimura, N., Chancellor, M.B.: Gene therapy for bladder pain with gene gun particle encoding pro-opiomelanocortin cDNA. J. Urol., 170:2044-2048, 2003. 201. Lu, S-H, Cannon, T.W., Chermansky, C., Pruchnic, R., Somogyi, G., Sacks, M.S., de Groat, W.C., Huard, J., Chancellor, M.B.: Muscle-derived stem cells seeded acellular scaffolds develop calcium dependent contractile activity that is modulated by nicotinic receptors. Urology, 651:1285-1291, 2003. 202. Fraser, M.O., Chancellor, M.B.: Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. Brit. J. Urol. International 91:743-748, 2003. 203. Chermansky, C.J., Chancellor, M.B.: Transdermal oxybutynin in the treatment of overactive bladder. Today Therapeutic Trends. 21:295-306, 2003. 204. Chancellor, M.B., Tirney, S., Mattes, C.E., Birder, L.A., Kanai, A.J.,de Groat, W.C., Huard, J., Yoshimura, N.: Nitric oxide synthase gene transfer for erectile dysfunction in a rat model, BJU International, 91:691-696, 2003. 205. O'Leary, M., Erickson, J.R., Smith, C.P., McDermott, C., Horton, J., Chancellor, M.B.: Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury. J Spinal Cord Med. 265:159-1652, 2003. 206. Chancellor, M.B: Editorial Comments. Yang, C.C., Lee, J.C., Kromm, B.G., Ciol, M.A., Berger, R.E.: Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? 170:823-827, 2003. 207. Yoshimura, N., Seki, S., Erickson, K.A., Erickson, V.L., Chancellor, M.B., de Groat, W.C.: Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J. Neuroscience 23:4355-4361, 2003. 208. Chuang, Y.C., Chancellor, M.B., Seki, S., Yoshimura, N., Lavelle, J.P., de Groat, W.C., Fraser, M.O.: Intravesical protamine sulfate and potassium chlorides as a model of bladder hyperactivity. Urology, 61:664-670, 2003. 209. Chancellor, M.B.: Transdermal oxybutynin. Drug & Aging. 20:865-866, 1003. 210. Kim, J.H., Rivas, D.A., Shenot, J.P, Green, B., Kennelly, M., Erickson, J.R., O’Leary, M., Yoshimura, N., Chancellor, M.B.: Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinder, randomized, placebo-controlled trial. J. SCI Medicine, 26: 358-363, 2003. 211. Yoshimura, N., Kuno, S., Chancellor, M.B., de Groat, W.C., Seki, S.: Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br. J. Pharmacol., 139:1425-1432, 2003. 212. Jankowski, R.J., Prantil, R.L., Fraser, M.O., Chancellor, M.B., de Groat, W.C., Huard, J., Vorp, D.A.: Development of an experimental system for the study of urethral biomechanical function. Am J. Physiol. Renal Physiol., 268F225-232, 2004. 213. Pezzone, M.A., Watkins, S.C., Alber, S.M., King, W.E., de Groat, W.C., Chancellor, M.B., Fraser, M.O.: Identification of c-kit-positive cells in the mouse ureter: the interstitial cells of Cajal of the urinary tract. Am. J. Physiol. Renal Physiol., 284:F925-929, 2003. 214. Cannon, T.W., Lee, J.Y., Somogyi, G., Pruchnic, R., Smith, C.P. Huard, J., Chancellor, M.B.: Improved sphincter contractility after allergenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology; 62:958-963, 2003. 215. Smith, C.P., Boone, T.B., de Groat, W.C., Chancellor, M.B., Somogyi, G.T.: Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull., 61:165-171, 2003. 216. Kamo, I., Torimoto, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Urethral closure mechanisms under sneeze-induced stress condition in rats - a new animal model for evaluation of stress urinary incontinence. Am. J. Physiol. Regul. Integr. Physiol., 285:R356-E265, 2003. 217. Fraser, M.O., Chancellor, M.B., Yokoyama, T., Yoshimura, N., Huang, L., de Groat, W.C., Chuang, Y.C.: Intravesical liposome administration – a novel treatment for the hyperactive bladder in cat. Urology, 61:656-663, 2003. 218. Cannon, T.W., Yoshimura, N., Chancellor, M.B.: Innovations in pharmacotherapy for stress urinary incontinence. Int. Urogynecolo. J., 14:367-372, 2003. 219. Seki, S., Sasaki, K., Fraser, M.O., Igawa, Y., Nishizawa, O., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in the lumbosacral spinal cord in spinal cord injured rats. J. Urology, 171:478-482, 2004. 220. Tyagi, P., Chancellor, M., Li, Z.H., de Groat, W.C., Yoshimura, N., Fraser, M., Huang, L.: Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. J. Urol., 171:483-489, 2004. 221. Chermansky, C., Cannon, T.W., Torimoto, J., Fraser, M.O., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: A model of intrinisic sphincter deficiency in the rat. Electrocauterization. Neurourology and Urodynamics, 23:166- 171, 2004. Chancellor 17 of 108 222. Nishiguchi, J., Sasaki, S., Seki, S., Chancellor, M.B., Erickson, K.A., de Groat, W.C., Kumon, H., Yoshimura, N.: Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. European J. Neuroscience, 20:474-482, 2004. 223. Bennett, N., O’Leary, M., Patel, A.S., Xavir, M., Erickson, J.R., Chancellor, M.B.: Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J. Urology, 171: 749-751, 2004. 224. Chuang, Y.C., Yoshimura, N., Huang, C.C., Chiang, P.H., Chancellor, M.B.: Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats. J. Urol., 172: 1529- 1532, 2004. 225. Borello-France, D., Leng, W., O’Leary, M., Xavier, M., Erickson, J., Chancellor, M.B., Cannon, T.W.: Bladder and sexual function among women with multiple sclerosis. Multiple Sclerosis, 1-7, 2004. 226. Smith, C.P., Chancellor, M.B.: Emerging role of botulinum toxin in the management of voiding dysfunction. J. Urology, 171:2128-2137, 2004. 227. Torimoto, K., Fraser, M.O., Hirao, Y., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Urethral dysfunction in diabetic rats. J. Urology, 171:1959-1964, 2004. 228. Chancellor, M.B.: Editoral Comment. Reitz, A., Schurch, B.: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J. Urol., 171:804-805, 2004. 229. Kamo, I., Cannon, T.W., Conway, D.A, Torimoto, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am. J. Physiol. Renal Physiol., 287:F434- F441, 2004. 230. Nagatomi, J., Gloeckner, D.C., Chancellor, M.B., de Groat, W.C., Sacks, M.S.: Changes in biaxial viscoelastic response of the urinary bladder following spinal cord injury. Annals of Biomedical Engineering, 32: 1409-1419, 2004. 231. Leng, W.W., Davies, B.J., Tarin, T., Sweeney, D.D., Chancellor, M.B.: Delayed treatment of bladder outlet obstruction after sling surgery: association with irreversible bladder dysfunction. J. Urol., 172:1379-1381, 2004. 232. Ogawa, T., Kamo, I., Pflug, B.R., Nelson, J.B., Seki, S., Igawa, Y., Nishizawa, O., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rats. J. Urol., 172:1533-1537, 2004. 233. Chancellor, M.B., Yoshimura, N.: Treatment of interstitial cystitis. Urology 63 (Suppl 3A): 85-92, 2004. 234. Kim, Y.T., Kwon, D.D., Kim,, J., Lee, J.Y., Chancellor, M.B.: Gabapentin for overactive bladder and nocturia after anticholinergic failure. Int. Brazile J. Urol., 30:275-278, 2004. 235. Stein, R.J., Santos, S., Nagatomi, J., Hayashi, Y., Minnery, B.S., Xavier, M., Patel, A.S., Nelson, J.B., Futrell, W.J., Yoshimura, N., Chancellor, M.B., de Miguel, F.: Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J. Urol., 172:1175-1178, 2004. 236. Lee, J.Y., Kim, H.W., Lee, S.J., Koh, J.S., Suh, H.J., Chancellor, M.B.: Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU International, 94:817-820, 2004. 237. Sesaki, K., Chancellor, M.B., Goins, W.F., Phelan, M.W., Gloriso, J.C. de Groat, W.C., Yoshimura, N.: Gene therapy using replication-defective herpes simplex virus expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes, 53:2723-2730, 2004. 238. Chermansky, C., Tarin, T., Cannon, T., de Groat, W., Huard, J., Chancellor, M.B.: Intraurethral muscle derived cell injections increase leak point pressure in a rat model of intrinsic deficiency. Urology, 63: 780-785, 2004 239. Chancellor, M.B.: Editorial: Urgency, botulinum toxin and how botulinum toxin can help urgency. J. Urology, 174:818, 2005. 240. Chancellor, M.B.: Editorial: Apostolidis, A., Popat, R., Yiangou, Y., cockayne, D., Ford, A.P.D.W., David, J.B., Dasgupta, P., Folwer, C.J., Anand, P.: Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J. Urology 174:977-983, 2005. 241. Smaldone, M.C., Chancellor, M.B.: Bladder or urethra injection of botulinum toxin type A: One institution’s experience. Am. J. Urol. Review, 3:1-5, 2005. 242. Chancellor, M.B., Smith, C.P.: Pittsburgh experience with lower urinary tract botulinum toxin A injection. Current Urology Reports, 6:235-236, 2005. 243. Kamo, I., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Differential effects of activation of peripheral and spinal tachykinin neurokinin 3 receptors on the micturition reflex in the rats. J. Urology, 174:776-781, 2005. 244. Lu, S.H., Sacks, M.S., Chung, S., Gloeckner, D.C., Pruchnic, R., Huard, J., de Groat, W.C., Chancellor, M.B.: Biaxial mechanical properties of muscle-derived stem cell seeded small intestinal submucosa for bladder wall reconstitution. Biomaterials. 26:443-449, 2005. Chancellor 18 of 108 245. Kwon, D.D., Minnery, B., Kim, Y.T., Kim, J.H., de Miguel, F., Yoshimura, N., Chancellor, M.B.: Neurologic recovery and improved detrusor contractility using muscle-derived cells in rat model of unilateral pelvic nerve transition. Urology, 65:1249-1253, 2005. 246. Lavelle, J., Shenot, P., Smith, C., Chancellor, M.B.: Letter to Editor: Secondary malignancies in different forms of urinary diversion using isolated gut, J. Urol., 95:733-738, 2005. 247. Bennett, N.E., Kim, J.H., Wolfe, D.P., Sasaki, K., Yoshimura, N., Goins, W.F., Huang, S., Nelson, J.B., de Groat, W.C., Glorioso, J.C, Chancellor, M.B.: Improvement of erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J. Urol., 173, 1820-1824, 2005. 248. Yoshimura, N., Chancellor, M.B., Andersson, K.E., Christ, G.J.: Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU International, 95:733-738, 2005. 249. Leng, W., Chancellor, M.B: How sacral nerve stimulation neuromodulation works. Urology Clinical of North America. 32:11-18, 2005. 250. Torimoto, K., Hirao, Y., Matsuyoshi, H., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Alpha 1-A adrenergic mechanism in diabetic urethral dysfunction in rats. J. Urology, 173:1027-1032, 2005. 251. Seki, S., Erickson, K.A., Seki, M., Nishizawa, O., Igawa, Y., Ogawa, T., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Elimination of rat spinal neurons expressing neurokinin 1 receptors reduces bladder overactivty and spinal c-fos expression induced by bladder irritation. Am. J. Physiology, 288:F466-473, 2005. 252. Nagatomi, J., de Miguel, F., Torimoto, K., Chancellor, M.B., Getzenberg, R.H., Sacks, M.S.: Early molecular-level changes in rat bladder wall tissue following spinal cord injury. Biochemcial & Biophysical Research Communications. 334:1159-1164, 2005. 253. Nagatomi, J., Toosi, K.K., Grashow, J.S., Chancellor, M.B., Sacks, M.S.: Quantification of bladder smooth muscle orientation in normal and spinal cord injured rats. Annals of Biomedical Engineering. 33”1078-1089. 2005. 254. Chancellor, M.B., Perkin, H., Yoshimura, N.: Recent advances in neurophysiology of stress urinary incontinence. Scandinavian J. Urology Nephrology, 39:21-24, 2005. 255. Chuang, Y.C, Yang, L.C, Chiang, P.H., Kang, H.Y., Ma, W.L., Wu, P.C., de Miguel, F., Chancellor, M.B., Yoshimura, N.: Gene gun particle encoding preproenkephalin (PPE) cDNA produces analgesia against capsaicin induced bladder pain in rats. Urology, 65:804-810, 2005. 256. Kim, Y.T., Yoshimura, N., Misuda, H., de Miguel, F., Chancellor, M.B.: Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Urology, 65:238-242, 2005. 257. Smith, C., P., Radziszewski, P., Borkowski, A., Somogyi, G.T., Boone, T.B., Chancellor, M.B: Botulinum toxin-A has antinocipceptive effects in treating interstitial cystitis. Urology, 64:871-875, 2004. 258. Smith, C.P., Nishiguchi, J., O’Leary, M., Yoshimura, N., Chancellor, M.B.: Single institution experience in 110 patients with botulinum toxin-A injection into the bladder or urethra. Urology, 65: 37-41, 2005. 259. Brown, J.S., Wessells, H., Chancellor, M.B., Howards, S.S., Stamm, W.E., Stapleton, A.E., Steers, W.D., Can Den Eeden, S.K., McCary, K.T.: Urologic complications of diabetes, Diabetes Care, 28:177-185, 2005. 260. Semins, M.J., Chancellor, M.B.: Diagnosis and management of patients with over bladder syndrome and abnormal detrusor activity. Nature Clinical Practice Urology, 1:78-84, 2005. 261. Chancellor, M.B: Editorial: Duloxetine for treatment of stress urinary incontinence. Evidence Based OBGYN, 6:196-199, 2005. 262. Cannon, T.Y., Sweeney, D.D., Conway, D.A., Kamo, I., Yoshimura, N., Chancellor, M.B.: A tissue-engineered suburethral sling in an animal model of stress urinary incontinence. BJU International, 96:664-669, 2005. 263. Nishiguchi, J., Hayashi, Y., Chancellor, M.B., de Miguel, F., de Groat, W.C., Kumon, H., Yoshimura, N.: Detrusor overactivity induced by intravesical application of adenosine 5-triphosphate under different delivery conditions in rats. Urology, 66:1332-1337, 2005. 264. Conway, D.A., Kamo, U., Yoshimura, N., Chancellor, M.B., Cannon, T.: Comparison of leak point pressure methods in an animal model of stress urinary incontinence. Int. Urogynecology J. Oelvic Floor Dysfunction, 16:359-363, 2005. 265. Masuda, H., Chancellor, M.B., Kihara, K., Yoshimura, N.: The cyclopentenone prostaglandin, 15-deoxy-12,14- PGJ2, attenuates the development of cyclophosphamide induced cystitis. Urology, 67: 435–439, 2006. 266. Long, R.A., Nagatomi, J., Chancellor, M.B. and Sacks, M.S.: The role of MMP-1 up-regulation in the increased compliance in muscle-derived stem cell-seeded small intestinal submucosa. Biomaterials, 27:2398-2404, 2006. 267. Chuang, Y.C, Huang, C.C., Kang, H.Y., Chiang, P.H.,de Miguel, F., Yoshimura, N. and Chancellor, M.B.: Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J. Urol., 175:1158-1163, 2006. Chancellor 19 of 108 268. Jankowski, R.J., Prantil. R.L., Chancellor, M.B., de Groat, W.C., Huard, J., Vorp, D.A.: Biomechanical characterization of the urethral musculature. A. J. Phy. Renal Physiology. Published online (Dec 20), 2005. 269. Smith, C.P., Chancellor, M.B.: Simplified botulinum toxin delivery technique using flexible cystoscope and 10 sites of injection. J. Endourology, 19:880-882, 2005. 270. Chancellor, M.B., Anderson, R.U. and Boone,T.B.: Pharmacotherapy for neurogenic detrusor overactivity. 85:536- 545, 2006. 271. Masuda, H., Hayashi, Y., Chancellor, M.B., Kihara, K., de Groat, W.C., de Miguel, F., Yoshimura, N.: Role of peripheral and central nicotinic receptors in the micturition reflex in rats. J.Urol., 176:374-379, 2006. 272. Chuang, C.C., Tu, C.H., Huang, C.C., Lin H.J., Chiang, P.H., Yoshimura, N., Chancellor, M.B.: Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urology, 6:12, 2006. 273. Patel, A.S., O’Leary, M.L., Stein, R.J., Leng, W.W., Chancellor, M.B., Patel, S.G., Borello-France, D.: The relationship between overactive bladder and sexual activity in women. International Braz. J. Urol., 32:77-87, 2006. 274. Ogawa, T., Seki, S., Masuda, H., Igawa, Y., Nishizawa, O., Kuno, S., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Dopaminergic mechanisms controlling urethral function in rats. Neurourology & Urodynamics, 25:480-489, 2006. 275. Kwon, D.D., Kim, Y.T., Pruchnic, R., Jankowski, R., Usiene, I., de Miguel, F., Huard, J., Chancellor, M.B.: Periurethral cellular injection: comparison of muscle derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of SUI, Urology, 68:449-454, 2006. 276. de Miguel, F., Chancellor, M.B.: Pittsburgh experience with botulinum toxin A injection. Actas Urologicas Espanolas, 30:310-314, 2006 277. Chuang, Y.C., Giannantoni, A. and Chancellor, M.B.: The potential and promise of using botulinum toxin in the prostate gland. BJU International, 98:28-32, 2006. 278. Kim, Y.T., de Miguel, F., Usiene, I., Kwon, D.D., Yoshimura, N., Huard, J., Chancellor, M.B.: Injection of skeletal muscle-derived cells into the penis improves erectile function. Int. J.Impotence Research. 18:329-334, 2006. 279. Masuda, N., Hayashi, Y., Matsuyoshi, H., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Characterization of hyperpolarization-activated current (Ih) in dorsal root ganglion neurons innervating rat urinary bladder. Brain Research. 1096:40-52, 2006. 280. Chancellor, D.D., Tyagi, S., Bazaco, M., Bacvinskas, S., Chancellor, M.B., Dato, V.M., de Miguel, F.: Green onion: potential mechanism of hepatitis A contamination. J. Food Protection. 69:1468-1472, 2006. 281. Kim, Y.T., Yoshimura, N., Masuda, H., de Miguel, F. and Chancellor, M.B.: Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity. BJU International, 97:400-403, 2006. 282. Kamo, I., Kaiho, Y., Cannon, T., Chancellor, M.B., de Groat, W.C., Prantil, R.L., Vorp, D.A., Yoshimura, N.: Functional analysis of active urethral closure mechanisms under sneeze-induced stress condition in a rat model of birth trauma. J. Urology, 176:2711-2715, 2006. 283. Tyagi, P., Wu, P.C., Chancellor, M.B., Yoshimura, N., Huang, L.: Recent advances in intravesical drug/gene delivery, Molecular Pharmacetica, 3:369-379, 2006. 284. Tyagi, P., Banerjee, R., Basu, S., Yoshimura, N., Chancellor, M.B., Huang, L.: Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates. Molecular Pharmaceutics, 3:398-406, 2006. 285. Yoshimura, N., Bennett, N.E., Hayashi, Y., Ogawa, T., Nishizawa, O., Chancellor, M.B., de Groat, W.C., Seki, S.: Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J. Neuroscience, 26:10847-10855, 2006. 286. Chancellor, M.B.: Overactive Bladder Prefact, UCNA, 33: xv-xvi, 2006. 287. Kim, D.K., Chancellor, M.B.: A gathering of urologists and gynecologists in Montreal: a report from the 35th annual meeting of the International Continence Society. Reviews Urol., 8:76-82, 2006. 288. Kim, D.K., Chancellor, M.B.: Is estrogen for urinary incontinence good or bad? Reviews Urol., 8:91-92, 2006. 289. Kim, D.K., Chancellor, M.B.: What is the effect of overactive bladder medication on sleep? Reviews Urol., 8:92, 2006. 290. Tyagi, S., Thomas, C.A., Hayashi, Y., Chancellor, M.B.: The overactive bladder: epidemiology and morbidity. UCNA, 33:433-438, 2006. 291. Kim, D.K., Thomas, C.A., Smith, C., Chancellor, M.B.: The case for bladder botulinum toxin application. UCNA, 33:503-510, 2006. 292. Masuda, H., Kim, Y.T., Tyagi, S., Chancellor, M.B., de Miguel, F., Yoshimura, N.: Local effects of antimuscarinics. UCNA, 33:511-518, 2006. Chancellor 20 of 108 293. Lee, J.Y., Kim, D.K., Chancellor, M.B.: When to use antimuscarinics in men who have lower urinary tract symptoms. UCNA, 33:531-537, 2006. 294. Furuta, A., Thomas, C.A., Higaki, M., Chancellor, M.B., Yoshimura, N., Yamaguchi, O.: The promise of beta3- adrenoceptor agonists to treat overactive bladder. UCNA, 33:539-543, 2006. 295. Chuang, Y.C., Chiang, P.H.,Yoshimura, N., deMiguel, F., Chancellor, M.B.: Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU International, 98:1033-1037, 2006. 296. Chuang, Y.C., Chancellor, M.B.: The application of botulinum toxin in the prostate. J. Urol., 176:2376-2382, 2006. 297. Matsuyoshi, H., Masuda, N., Chancellor, M.B., Erickson, V.L., Hirao, Y., de Groat, W.C., Wanaka, A., Yoshimura, N.: Expression of hyperpolarization activated cyclic nucleotide-gated cation channels in rat dorsal root ganglion neurons innervating urinary bladder. Brain Research, 1119:115-123, 2006. 298. Gilbert, T.W., Sacks, M.S., Grashow, J.S., Woo, S.L., Badylak, S.F., Chancellor, M.B.: Fiber kinematics of small intestinal submucosa under biaxial and uniaxial stretch. J. Biomechanical Engineering, 128:890-898, 2006. 299. Thomas, C.A., Guercini, F., Chuang, Y.C., and Chancellor, M.B.: Botulinum-A toxin an exciting new treatment option for prostatic disease. Int J Clin Practice, 60:1-5, 2006. 300. Giannantoni, A., Di Stasi, S.M., Chancellor, M.B., Costantini, E., Porena, M.: New frontiers in intravesical therapies and drug delivery. European Urol., 50:1183-1193, 2006. 301. Furuta, A., Chancellor, M.B.: Health care usage, botulinum toxin for overactive bladder. Reviews Urol., 8:234-235, 2006. 302. Thomas, C.A., Chuang, Y.C., Giannantoni, A. and Chancellor, M.B.: Botulinum: A toxin for the treatment of BPH/LUTS. Current Urology Reports, 7:266-271, 2006. 303. Nishiguchi, J., Kwon, D.D., Kaiho, Y., Chancellor, M.B., Kumon, H., Snyder, P.B., Yoshimura, N.: Suppression of detrusor overactivity in rats with bladder outlet obstruction by type 4 phosphodiesterase inhibitor. BJU International, 99:680-686, 2006. 304. Ogan, K., Kawai, K., Gill, I.S., Naito, S., Isaacs, W.B., Suzuki, K., Kibel, A.S., Kakehi, Y., Yoshimura, N., Yokoyama, O., Chancellor, M.B., Takahashi, S.: The second joint meeting of the AUA/JUA International Program on the 102nd annual meeting of the AUA at Anaheim 2007. International J. Urology, 14:1116-1123, 2007. 305. Prantil, R.L., Jankowski, R.J., Kaiho, Y., de Groat, W.C., Chancellor, M.B., Yoshimura, N., Vorp., D.A.: Ex vivo biomechanical properties of the female urethra in a rat model of birth trauma. Am. J. Physiol. Renal Physiol., 292:F1299-1237, 2007. 306. Kaiho, Y., Kamo, I., Chancellor, M.B., Arai, Y., de Groat, W.C., Yoshimura, N.: Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am. J. Physiol. Renal Physiol., 292:F639-F646, 2007. 307. Brawer, M.K., Makarov, D.V., Partin, A.W., Roehrborn, C.G., Nickel, C.J., Chancellor, M.B., Assimos, D.G., Shapiro, E., Rajfer, J.: Best of the 2007 AUA Annual Meeting. Reviews in Urology 9:133-154, 2007. 308. Chuang, Y-C, Yoshimura, N., Wu, M., Huang, C.C., Chiang, P-H., Tyagi, P. Chancellor, M.B.: Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects on botulinum toxin A. European Urology 51:1119-1127, 2007. 309. Chancellor, M.B.: What happened when I took OAB drugs? Neurourology and Urodynamics, 26:1057, 2007. 310. Chancellor, M.B., de Migeul, F.: Selective use of anticholinergic agents with low drug-drug interaction potential. Geriatrics, 62:15-24, 2007. 311. Thomas, C.A., Guercini, F., Chuang, Y-C, Chancellor, M.B.: Botulinum-A toxin: an exciting new treatment option for prostatic disease. Int. J. Clin. Pract., 60 (Suppl.151) 33-37, 2007. 312. Morrisroe, S.N., Chancellor, M.B.: Botulinum toxin A in the treatment of neurogenic and idiopathic urinary incontinence. Reviews in Urology, 9:44-45, 2007. 313. Furuta, A., Jankowski, R.J., Pruchnic, R., Yoshimura, N., Chancellor, M.B.: The potential of muscle-derived stem cell for stress urinary incontinence. Expert Opinion on Biological Therapy, 7:1483-1486, 2007. 314. Masuda, H., Kim, J.H., Kihara, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Inhibitory roles of peripheral nitroergic mechanisms in capsaicin-induced detrusor over activity in the rat. BJU International, 100:912-918, 2007. 315. Furuta, A., Chancellor, M.B.: Lower urinary tract symptoms and the placebo effect, Review in Urology, 9:161-162, 2007. 316. Chuang, Y-C, Yoshimura, N., Tyagi, P., Chancellor, M.B.: Intravesical liposomes relieve painful bladder. Incont. Pelvic Floor Dysfunction, 2:61, 2007. 317. Chancellor, M.B.: A multidisciplinary consensus meeting on IC/PBS. Reviews in Urology, 9:81-83, 2007. 318. Furuta, A., Carr, L.K., Yoshimura, N., Chancellor, M.B.: Advances in the understanding of stress urinary incontinence and the promise of stem-cell therapy, Reviews in Urology, 9:106-11, 2007. Chancellor 21 of 108 319. Costa, F., Chancellor, M.B.: Curing stress urinary incontinence, or shades of dryness, Reviews in Urology 9:241- 242, 2007. 320. Saitoh, C., Kitada, C., Uchida, W., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder. European J Pharmacology, 570:182-187, 2007. 321. Furuta, A., Jankowski, R.J., Pruchnic, R., Yoshimura, N., Chancellor, M.B.: The promise of stem cell therapy to restore urethral sphincter function. Current Urology Reports 8:373-378, 2007. 322. Borello-France, D, Misplay, S., Cannon-Smith, T., Dusi, J., Okonski, J., Chancellor, M.B., O’Leary, M., Leng, W.: Test-retest reliability of the urge-urinary distress inventory and female sexual function index in women with multiple sclerosis. 323. Furuta. A., Jankowski, R.J., Honda, M., Pruchnic, R., Yoshimura, N., Chancellor, M.B.: State of the art of where we are at using stem cells for stress urinary incontinence. Neurourology & Urodynamics, 26:966-971, 2007. 324. Thomas, C., Kim, J.H., Torimoto, K., Kwon, D.D., Kim, Y.T., Tyagi, P., Yoshimura, N., Chancellor, M.B.: Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury. Biomedical Research, 28:255- 259, 2007. 325. Hiragata, S., Ogawa, T., Hayashi, Y., Tyagi, P., Seki, S., Nishizawa, O., de Miguel, F., Chancellor, M.B., Yoshimura, N.: Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology, 70:202-208, 2007. 326. Kim, J., Kim, D.K., Jankowski, R., Pruchnic, R., Usiene, I., Chancellor, M.B.: Human muscle derived cell injection in a nude rat model of stress urinary incontinence. Muscle and Nerve, 36:391-393, 2007. 327. Morrisore, S., Chancellor, M.B.: Botulinum toxin use in the lower urinary tract. TSW Urology, 2:82-91, 2007. 328. Kato, R., Coyle, C., Nelson, J., Glorioso, J., Goins, W., Wolfe, D., Chancellor, M.B., Yoshimura, N.: Herpes simplex virus vector-mediated delivery of GDNF rescues erectile dysfunction following cavernous nerve injury. Gene Therapy, 14:1344-1352, 2007. 329. Thomas, C.A., Tyagi, S., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Effect of hyperforin-enriched extract on pro- ejaculatory effect of 8-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats. Urology, 70:813-816, 2007. 330. Kaiho, Y., Nishiguchi, J., Kwon, D.D., Chancellor, M.B., Arai, Y., Snyder, P.B., Yoshimura, N.: The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. BJU International, 101: 615-620, 2007. 331. Tyagi, P., Chancellor, M.B., Yoshimura, N., Huang, L.: Activity of different phospholipids in attenuating hyperactivity in bladder irritation. BJU International, 101: 615-620, 2007. 332. Masuda, H., Kihara, K., Saito, K., Matsuoka, Y., Yoshida, S., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU International, 101:775-780, 2008. 333. Saitoh, C., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J. Urology, 179:359-364, 2008. 334. Thomas, C., Kim, J.H., Torimoto, K., Kown, D.D., Kim, Y.T., Tyagi, P., Yoshimura, N., Chancellor, M.B.: Early capsaicin intervention for neurogenic bladder in rat model of spinal cord injury. Biomedical Research , 28:255- 259, 2007. UI 18000338. 335. Miyazato, M., Sasatomi, K., Hiragata, S., Sugaya, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: GABA- receptor activation at the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injury rats. J. Urol., 179:1178-1183, 2008. 336. Smaldone, M.C., Chancellor, M.B.: Neuromodulation versus neurotoxin for the treatment of refractory detrusor overactivity: for neurotoxin. Nature Clinical Practice, 5:120-121, 2008 337. Ogawa, T., Sasatomi, K., Hiragata, S., Seki, S., Nishizawa, O., Chermansky, C.J., Pflug, B.R., Nelson, J.B., Chancellor, M.B., Yoshimura, N.: Therapeutic effects of endothelin-A receptor antagonist on bladder overactivity in rats with chronic spinal cord injury. Urology, 71:341-345, 2008. 338. Kuo, H.C., Chuang, Y.C., Chancellor, M.B.: Neurology, diet and painful bladder. Reviews in Urol., 10:1-3, 2008. 339. Chancellor, M.B., Costa, F., Kuo, H.C.: Neurotoxin versus neuromodulation for the treatment of refractory overactive bladder syndrome. Tzu Chi Medical J. 20:109-111, 2008. 340. Chancellor, M.B, Kianifard, F., Beamer, E, Mongay, L, Ebinger, U., Hicks, G., DelConte, A.: A comparison of the efficacy of darifenacin alone vs. darifenacin plus a behavioral modification program upon the symptoms of overactive bladder, Int. J. Clin. Pract. 62:606-613, 2008. Chancellor 22 of 108 341. Miyazato M. Sasatomi K. Hiragata S. Sugaya K. Chancellor MB. de Groat WC. Yoshimura N. Suppression of detrusor-sphincter dyssynergia by GABA-receptor activation in the lumbosacral spinal cord in spinal cord-injured rats. Am. J. Physiology. 295:R336-R342, 2008 . 342. Miyazato M. Kaiho Y. Kamo I. Chancellor MB. Sugaya K. de Groat WC. Yoshimura N. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. Am. J. Physiology.. 295:F264-271, 2008. 343. Carr, L.K., Steele, D.,Steele, S., Wagner, D., Pruchnic, R., Jankowski, R., Erickson, J., Huard, J., Chancellor, M.B.: 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int. Urogynecology J. 19:881-883, 2008. 344. Chuang YC. Yoshimura N. Huang CC. Wu M. Chiang PH. Chancellor MB. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J. Urology. 180:742-748, 2008. 345. Brawer MK. Makarov DV. Partin AW. Roehrborn CG. Nickel JC. Lu SH. Yoshimura N. Chancellor MB. Assimos DG. Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL. Reviews in Urology. 10:136-156, 2008. 346. Kim DK. Chancellor MB. Men reporting lasting longer with hyperforin. International Braz J Urol. 34:370-371, 2008. 347. Coyle CH. Philips BJ. Morrisroe SN. Chancellor MB. Yoshimura N. Antioxidant effects of green tea and its polyphenols on bladder cells. Life Sciences. 83:12-18, 2008. 348. Yoshimura N. Kaiho Y. Miyazato M. Yunoki T. Tai C. Chancellor MB. Tyagi P. Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn-Schmiedebergs Archives of Pharmacology. 377:437-48, 2008. 349. Gray MA. Wang CC. Sacks MS. Yoshimura N. Chancellor MB. Nagatomi J. Time-dependent alterations of select genes in streptozotocin-induced diabetic rat bladder. Urology. 71:1214-1219, 2008. 350. Chancellor MB. Fowler CJ. Apostolidis A. de Groat WC. Smith CP. Somogyi GT. Aoki R.: Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nature Clinical Practice Urology. 5:319-228, 2008. 351. Furuta A. Kita M. Suzuki Y. Egawa S. Chancellor MB. de Groat WC. Yoshimura N. Association of overactive bladder and stress urinary incontinence in rats with pudendal nerve ligation injury. Am. J. Physiology - Regulatory Integrative & Comparative Physiology. 294:R1510-1516, 2008. 352. Tai C. Shen B. Wang J. Chancellor MB. Roppolo JR. de Groat WC. Inhibitory and excitatory perigenital-to-bladder spinal reflexes in the cat. Am. J. Physiology - Renal Physiology. 294:F591-602, 2008. 353. Tyagi P. Chen X. Hayashi Y. Yoshimura N. Chancellor MB. de Miguel F. Proteomic investigation on chronic bladder irritation in the rat. Urology. 71:536-540, 2008. 354. Kaplan, S.A., Roehrborn, C.G., Chancellor, M.B., Carlsson, M., Bavendam, T., Guan, Z.H.: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: Effects on urinary symptoms assessed by the international prostate symptom score. BJU International, 102:1133-1139, 2008. 355. Dicianno, B.E., Kurowski, B.G., Yang, J.M.J., Chancellor, M.B., Bejjani, G.K., Fairman, A.D., Lewis, N., Sotirake, J.: Rehabilitation and medical management of the adult with spina bifida. Am. J. Phys. Med. Rehabil, 87:1026- 1050, 2008. 356. Masuda, N., Hitoshi, M., Matsuyoshi, H., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Effects of intrathecal injection of a hyperpolarization-activated channel (Ih) inhibitor ZD7288 on bladder function in urethane- anesthetized rats. Neuro. & Urodynam., 27:838-844, 2008. 357. Liu, H.T., Chancellor, M.B., Kuo, H.C.: Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women. BJU International, 102:1440-1444, 2008. 358. Furuta, A., Jankowski, R.J., Pruchnic, R., Egawa, S., Yoshimura, N., Chancellor, M.B.: Physiological effects of human muscle-derived stem cell implantation on urethral smooth muscle function. Int. Urogyn. J. 19:1229-1234, 2008. 359. Chuang, Y.C, Thomas, C.A., Tyagi, S., Yoshimura, N., Tyagi, P., Chancellor, M.B.: Human urine with solifeancin intake but not tolerodine or darifenacin intake blocks detrusor overactivity. Int Urogyencol J, 19:1353-1357, 2008. 360. Sasatomi, K., Hiragata, S., Miyazato, M., Chancellor, M.B., Morris, S.M., Yoshimura, N.: Nitric oxide – mediated suppression of detrusor overactivity by arginase inhibitor in rats with chronic spinal cord injury. Urology 72:696- 700, 2008. 361. Tai, C., Wang, J., Chancellor, M.B., Roppolo, J.R., de Groat, W.C., Influence of temperature on pudendal nerve block induced by high frequency biphasic electrical current. J. Urology, 180:1173-1178, 2008. Chancellor 23 of 108 362. Chuang, C.C., Kim, D.K, Chiang, P.H., Chancellor, M.B.: Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU International, 102:704-706, 2008. 363. Jankowski, R., Pruchnic, R., Wagner, D., Chancellor, M.B.: Regenerative therapy for stress urinary incontinence. Tzu Chi Med J., 20:169-176, 2008. 364. Toosi, K.K., Nagatomi, J., Chancellor, M.B., Sacks, M.S.: The effects of long-term spinal cord injury on mechanical properties of the rat urinary bladder. Annals Biomedical Engineering. 36:1470-80, 2008. 365. Chancellor, M.B., Hasenau, D.L.: Is behavioral therapy plus antimuscarinic better than drug alone for overactive bladder? Rev. Urol., 10:306-308, 2008. 366. Kim, D.D., Chancellor, M.B.: Men reporting lasting longer with hyperforin. Int. Braz. J. Urol, 34:365-371, 2008. 367. Chancellor, M.B., Zinner, N., Whitmore, K., Kobashi, L., Snyder , J.A., Siami, P., Karram, M., Laramee, C., Capo, J.P., Seifeldin, Ra., Forero-Schwanhaeuser, S., Nandy, I.: Efficacy of solifenacin in patients previously treated with tolterodine extended release 4ml: Results of a 12-week, multicenter, open-label, flexible-dose study. Clin. Ther. 30:1766-1781, 2008. 368. Chancellor, M.B.: A comparison of the efficacy of darifenacin alone versus darifenacin plus a behavioral modification program upon the symptoms of overactive bladder. Int. J. Clinical Practice, 62:606-613, 2008. UI 19324952. 369. Chancellor, M.B., Peters, K.M.: Diagnosis of incontinence. Rev. Urol., 10:242-243, 2008. 370. Chancellor, M.B., Kaufman, J.: Case for pharmacotherapy development for underactive bladder. Urology, 72:966- 967, 2008. 371. Liu, H.T., Chancellor, M.B., Kuo, H.C.: Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. European Urology, 56:700-706, 2009. UI 18472208. 372. Hayn, M.H., Ballesteros, I., de Miguel, F., Coyle, C.H., Tyagi, S., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Functional and immunohistochemical characterization of XB1 and XB2 receptors in rat bladder. Urology, 72:1174- 1178, 2008. 373. Nagatomi, J., Chancellor, M.B., Parekh, A., Sacks, M.M.: Contribution of extracellular matrix to the viscoelastic behavior of the urinary bladder wall. Biomechanics and Modeling in Mchanobiology, 7:395-404, 2008. UI 17690929. 374. Kuo, H.C., Chancellor, M.B.: Comparison of intravesical botulinum toxin A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU International, 104:657-661, 2009. UI 19338543. 375. Yokoyama, H., Sasaki, K., Franks, M., Goins, W.F., Goss, J.R., de Groat, W.C., Glorioso, J.C., Chancellor, M.B., Yoshimura, N.: Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Therapy 20:63-71, 2009. 376. Kato, R., Wofle, D., Coyle, C.H., Wechuck, J.B., Tyagi, P., Tsukamoto, T., Nelson, J.B., Glorioso, J.C., Chancellor, M.B., Yoshimura, N.: Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy, 16:26-33, 2009. 377. Hayashi, Y., Takimoto, K., Chancellor, M.B., Erickson, K.A, Erickson, V.L., Kirimoto, T., Nakano, J., de Groat, W.C., Yoshimura, N.: Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R1661-R1670, 2009. 378. Tyagi, V., Philips, B.J., Su, R., Smaldone, M.C., Erickson, V.L., Chancellor, M.B., Yoshimura, N., Tyagi, P.: Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J. Urology 181:1932-1938, 2009. 379. Smaldone, M.C., Vodovotz, Y., Tyagi, P., Barclay, D., Philips, B.J., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induce cystitis. Urology 73:421- 426, 2009. 380. Nikolavsky, D., Chancellor, M.B.: Stress incontinence and prolapse therapy assessment. Rev. Urol., 11:41-43, 2009. Chancellor 24 of 108 381. Chuang, Y.C., Chancellor, M.B.: Treatment of painful bladder syndrome and pelvic organ prolapse. Rev. Urol., 11:28-32, 2009. 382. Tyagi, P., Thomas, C.A., Yoshimura, N., Chancellor, M.B.: Investigations into the presence of functional beta 1, beta 2 and beta 3 adrenoceptors in urothelium and detrusor of human bladder. Int. Braz. J. Urol., 35:76-83, 2009. 383. Tyagi, P., Hsieh, V.C., Yoshimura, N., Kaufman, J., Chancellor, M.B.: Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity. BJU International 104:1689-1692, 2009. 384. Furuta, A., Asano, K., Egawa, S., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Role of alpha-2 adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats. J. Urology, 181:1467-1473, 2009. 385. Ilie, C.P., Chancellor, M.B.: Perspective of Botox for treatment of male lower urinary tract symptoms. Curr. Opin. Urol., 19:20-25, 2009. 386. Smaldone, M.C., Chen, M.L., Chancellor, M.B.: Stem cell therapy for urethral sphincter regeneration. Minerva Urologica Nefrologica. 61:27-40,2009. 387. Liu, H.T., Chancellor, M.B., Kuo, H.C.: Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU International, 103:1668-1672,,2009. 388. Goins, W.F., Goss, J.R., Chancellor, M.B., de Groat, W.C., Glorisos, J.C., Yoshimura, N.: Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Therapy, 16:558-569, 2009. 389. Liu, H.T., Tyagi, P., Chancellor, M.B., Kuo, H.C.: Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU International, 104:1476- 1481, 2009. 390. Miyazato, M., Sugaya, K., Goins, W.F., Wolfe, D., Goss, J.R., Chancellor, M.B., de Groat, W.C., Glorioso, J.C., Yoshimura, N.: Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Therapy, 16:660-668, 2009. 391. Wang, C.C., Nagatomi, J., Toosi, K., Yoshimura, N., Hsieh, J.H., Chancellor, M.B., Sacks, M.S.: Diabetes-induced alternations in the biomechanical properties of the urinary bladder wall in rats. J. Urology, 73:911-915, 2009. 392. Kim, D.K., Jankowski, R., Pruchnic, R., deMiguel, F., Woshimura, N., Honda, M., Furuta, A., Chancellor, M.B.: The in vitro and in vivo effect of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence. Urology, 73:437-441, 2009. 393. Parekh, A., Long, R.A., Iannone, E.A., Chancellor, M.B., Sacks, M.S.: Title: Assessing the effects of TGF-b1 on bladder smooth muscle cell phenotype. I. modulation of in vitro contractility. J. Urology, 182:1210-1215, 2009. 394. Parekh, A., Long, R.A., Chancellor, M.B., Sacks, M.S.: Assessment the effects of TGF-b1 on bladder smooth muscle cell phenotype. II. Modulation of collagen organization. J. Urology, 182:1216-1221, 2009. 395. Kim, D.K., Kaufman, J., Guan, Z.H., Tyagi, Pl., Yoshimura, N., Killinger, J.A., Peters, K.M., Chancellor, M.B.: Cystometric changes in pressure-guided acute distension rat model of the underactive bladder. Tzu Chi Med J. 21:136-139, 2009. 396. Chuang, Y.C., Tyagi, P., Huang, C.C., Yoshimura, N., Wu, M., Kaufman, J., Chancellor, M.B.: Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. J. Urology 182:786- 792, 2009. 397. Tyagi, P., Tyagi, V., Yoshimura, N., Chancellor, M.B., Yamaguch, O.: Beta 3 adrenoceptor agonists for the treatment of overactive bladder. Drugs of the Future; 34:635-640, 2009. 398. Costa, F.J., Greco, F.D., Chancellor, M.B.: Female Urology: Training and Regulations, Rev. Urology, 11:3, 1-3, 2009. 399. Chuang, Y.C., Lee, W.C., Lee. W.C., Chiang. P.H.: Intravesical liposome versus oral pentosan polysulate for interstitial cystitis/painful bladder syndrome. J. Urology, 182:1393-1400, 2009. 400. Philips, B.J., Coyle, C.H., Morrisroe, S.H., Chancellor, M.B., Yoshimura, N.: Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomedical Research 30:207-215, 2009. 401. Kuo, H.C., Chancellor, M.B.: Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU International, 104:657-661, 2009. Chancellor 25 of 108 402. Miyazato, M., Kaiho, Y., Kamo, I., Kitta, T., Chancellor, M.B., Sugaya, K., Arai, Y., de Groat, W.C., Yoshimura, N.: Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats. Am. J. Physiol. Renal Physiol., 297:F1024-F1031, 2009. 403. Yokoyama, Ho., Sasaki, K., Franks, M.E., Goins, W.F., Goss, J.R., de Groat, W.C., Glorioso, J.C., Chancellor, M.B., Yoshimura, N.: Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Therapy, 20:63-71, 2009. 404. Chuang, Y.C., Yoshimura, N., Huang, C.C., Wu, M., Chiang, P.H., Chancellor, M.B.: Intravesical botulinum toxin A administration inhibits COX-2 and expression and suppresses bladder hyperactivity in cyclophosphamide induced cystitis in rats. European Urology 56:159-166, 2009. UI 185143386. 405. Masuda H., Chancellor, M.B., Kihara, K., Sakai, Y., Koga, F., Azuma, H., de Groat, W.C., Yoshimura, N.: Effects of cholinesterase inhibition in suprspinal and spinal neuron pathways on the micturition reflex in rats. BJU International, 104:1163-1168, 2009. UI 19338542. 406. Wang, C.C., Chancellor, M.B., Lin, J.M., Hsieh, J.H., Yu, H.J.: Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years. BJU International 105:1136-1140, 2009. 407. Masuda, H., Ichiyanagi, N., Yokoyama, M., Sakai, Y., Kihara, K., Chancellor, M.B., Yoshimura, N.: Muscarinic receptor activation in the lumbosacral spinal cord and bladder irritation in rat cystitis models. BJU International, 104:1531-1537, 2009. 408. Lu, S.H., Wei, C.F., Yang, A.H., Chancellor, M.B., Wang, L.S., Chen, K.K.: Isolation and characterization of human muscle-derived cells. Urology, 74:440-445, 2009. UI 19362337. 409. Liu, H.T., Liu, A.B., Chancellor, M.B., Kuo, H.C.: Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident. BJU International, 104:1158-1162. UI 19338537. 410. Lu, S.H., Yang, A.H., Wei, C.F., Chiang, H.S, Chancellor, M.B.: Multi-potent differentiation of human purified muscle-derived cells: potential for tissue regeneration. BJU International, 105:1174-1180, 2009. 411. Chung, S.D., Chiu, B., Kuo, H.C., Chuang, Y.C., Wang, C.C., Guan, Z., Chancellor, M.B.: Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder. BJU International, 105:668-672, 2009. 412. Nikolavsky, D., Chancellor M.B.: Stem cell therapy for stress urinary incontinence. Neurourol & Urodynam 29:S36-S41, 2010. 413. Saitoh, C., Yokoyama, H., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone. Neurourol & Urodynam 29:501-505, 2010. 414. Chancellor, M.B., Oefelein, M.G., Vasavada, S.: Obesity is associated with a more severe overactive bladder state that is effectively treated with once-daily administration of trospium chloride extended release. Neurourology & Urodynamics, 29:551-554, 2010. PMID: 20583230. 415. Kuo, H.C., Liu, H.T., Chancellor, M.B.: Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol & Urodynam 29:482-287, 2010. 416. Chuang, Y.C., Kuo, H.C., Chancellor, M.B.: Botulinum toxin for the lower urinary tract. BJU International, 105:1046-1058, 2010. 417. Kuo, H.C., Liu, H.T., Chancellor, M.B.: Urinary growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourology and Urodynamics, 29:482-487, 2010. UI 19367641. 418. Matsumoto, Y., Miyazato, M., Furuta, A., Torimoto, K., Hirao, Y., Chancellor, M.B., Yoshimura, N.: Differential roles of M2 and M2 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology., 75:862-867, 2010. 419. Tyagi, P., Tyagi, V., Yoshimura, N., Chancellor, M.B.: Functional role of cannabinoid receptors in urinary bladder. Indian J Urol 26:26-35, 2010. 420. Saitoh, C., Yokoyama, H., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone. Neurourol. & Urodynam. 29:501-505, 2010. UI 19618450. 421. Chancellor, M.B.: Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int. Urol. Nephrol., Chancellor, M.B.: Ten years single surgeon experience Chancellor 26 of 108 with botulinum toxin in the urinary tract; clinical observations and research discovery. Int. Urol. Nephrol., 42:383- 391, 2010. UI: 19572209 422. Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan S. Cost Analysis of Interventions for Antimuscarinic Refractory Patients with Overactive Bladder. Urology. 76(4):835-40, 2010. 423. Kuo, H.C., Liu, H.T., Tyagi, P., Chancellor, M.B.: Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency symptoms. LUTS, 2:88-94, 2010. 424. Yoshimura N. Kato R. Chancellor MB. Nelson JB. Glorioso JC. Gene therapy as future treatment of erectile dysfunction. [Review] Expert Opinion on Biological Therapy. 10(9):1305-14, 2010 Sep. UI: 20662742 425. Prantil-Baun R. de Groat WC. Miyazato M. Chancellor MB. Yoshimura N. Vorp DA. Ex vivo biomechanical, functional, and immunohistochemical alterations of adrenergic responses in the female urethra in a rat model of birth trauma. American Journal of Physiology - Renal Physiology. 299(2):F316-24, 2010 Aug. UI: 20444739 426. Kitta T. Miyazato M. Chancellor MB. de Groat WC. Nonomura K. Yoshimura N. Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats. Journal of Urology. 184(2):762-8, 2010 Aug. UI: 20639053 427. Stangel-Wojcikiewicz K. Majka M. Basta A. Stec M. Pabian W. Piwowar M. Chancellor MB. Adult stem cells therapy for urine incontinence in women. [Review] Ginekologia Polska. 81(5):378-81, 2010 May. UI: 20568520 428. Parekh A. Cigan AD. Wognum S. Heise RL. Chancellor MB. Sacks MS. Ex vivo deformations of the urinary bladder wall during whole bladder filling: contributions of extracellular matrix and smooth muscle. Journal of Biomechanics. 43(9):1708-16, 2010 Jun 18.UI: 20398903 429. Stangel-Wojcikiewicz K. Malgorzata S. Nikolavsky D. Chancellor MB. Cellular therapy for treatment of stress urinary incontinence. [Review] Current Stem Cell Research & Therapy. 5(1):57-62, 2010 Mar. UI: 19951258 430. Chuang YC. Yoshimura N. Huang CC. Wu M. Tyagi P. Chancellor MB. Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats. BJU International. 106(11):1782-7, 2010 Dec. UI: 20346049 431. Liu HT. Tyagi P. Chancellor MB. Kuo HC. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU International. 106(11):1681- 5, 2010 Dec. UI: 19751258 432. Irwin DE. Milsom I. Chancellor MB. Kopp Z. Guan Z. Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review. European Urology. 58(4):532-43, 2010 Oct. UI: 20573443 433. Nickel JC. Furuta A. Chancellor MB. Roehrborn CG. Assimos DG. Shapiro E. Brawer MK. Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA. Reviews in Urology. 12(2-3):e134-46, 2010. UI: 20811551 434. Ilie CP. Chancellor MB. Emerging Therapies for Incontinence: Highlights From the International Continence Society 39th Annual Meeting, September 29-October 3, 2009, San Francisco, CA. Reviews in Urology. 12(1):44- 51, 2010. UI: 20428293 435. Ilie CP. Chancellor MB. Female urology-future and present. Reviews in Urology. 12(2-3):e154-6, 2010. UI: 20811554 436. Mashni J. Chancellor MB. A New Journal Called LUTS: Lower Urinary Tract Symptoms. Reviews in Urology. 11(4):219-20, 2009. UI: 20130796 437. Tyagi P. Barclay D. Zamora R. Yoshimura N. Peters K. Vodovotz Y. Chancellor M. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. International Urology & Nephrology. 42(3):629-35, 2010 Sep. UI: 19784793 438. Kuo, H.C., Liu, H.T., Chancellor, M.B.: Can urinary nerve growth factor be a biomarker for overactive bladder?. Reviews in Urology. 12(2-3):e69-77, 2010. UI: 20811555 439. Nikolavasky, D., Chancellor, M.B.: Stem cell therapy for stress urinary incontinence. Neurourology & Urodynamics, 20:S36-S41, 2010, DOI: 10.1002/nau.20833. 440. Miyazato M. Sugaya K. Saito S. Chancellor MB. Goins WF. Goss JR. de Groat WC. Glorioso JC. Yoshimura N. Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats. Journal of Urology. 184(3):1204-10, 2010 Sep. UI: 20663524 441. Chuang, Y.C., Tyagi, P., Huang, H.Y., Yoshimura, N., Kaufman, J., Chancellor, M.B.: Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis. Neurourology & Uroydnamics, 20:421-427, 2011. DOI 10.1002/nau20981. 442. Wang, H.J., Chuang, Y.C., Chancellor, M.B.: Neurotoxin use for voiding dysfunction. Curr Bladder Dysfunct Rep 2011, DOI 10.1007/s11884-011-0096-5. 443. Nikolavasky, D., Stangel-Wojcikiewicz, K., Stec, M., Chancellor, M.B.: Stem cell therapy: A future treatment of stress urinary incontinence. Semin Reprod Med 29:61-70, 2011, DOI: 10.1055/s-0030-1268705. Chancellor 27 of 108 444. Honda, M., Takenaka, A., Inoue, S., Chancellor, M.B., Yoshimura, N.: Sensory neurone-specific receptor-mediated regulation of micturition reflex in urethrane-anaesthetized rats. BJU International 109:628-633, 2012. UI: 21729234 445. Glavind, K., Chancellor, M.: Antimuscarincs for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity. Int. Urogynecology J. 33:907-917, 2011, IU: 21468739 446. Tyagi, P., Tyagi, V., Chancellor, M.B.: Mirabegron: a safety review. Expert Opinion Drug Safety. 2011, DOI: 10.1517/14740338. 447. Kuo, H.C., Liu, H.T., Guan, Z.H., Tyagi, P., Chancellor, M.B.: Promise of urinary nerve growth factor for assessment of overactive bladder syndrome. LUTS, 3:2-9,2011. DOI: 10/1111/j.1757-5672,2011. 448. Chancellor, M.B., Boone, T.: Anticholinergics for overactive bladder therapy: central nervous system effects. CNS Neuoscience & Therapeutics, 00:1-8,2011, DOI: 10.1111/j.1755-5949,2011. 449. Watanabe, T., Inoue, M., Sasaki, K., Araki, M., Uehara, S., Monden, K., Saika, T., Nasu, Y., Kumon, H., Chancellor, M.B.: Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. 2011 Jul;108(2):248-51. doi: 10.1111/j.1464-410X.2010.09716.x. Epub 2010 Sep 30. PMID: 20883485 450. Kaufman, J., Tyagi, V., Anthony, M., Chancellor, M.B., Tyagi, P.:. State of the art in intravesical therapy for lower urinary tract symptoms. Rev Urol. 2010 Fall;12(4):e181-9. PMID: 21234261 451. Heise, R.L., Parekh, A., Joyce, E.M., Chancellor, M.B., Sacks, M.S.: Strain history and TGF-β1 induce urinary bladder wall smooth muscle remodeling and elastogenesis. Biomech Model Mechanobiol. 11:131-145, 2012 UI: 21384200 452. Wang, H.J., Chuang, Y.C., Chancellor, M.B.: Development of cellular therapy for the treatment of stress urinary incontinence. Int. Urogynecology Journal 22:1075-1083, 2011; DOI 10.1007/s00192-011-1432-1. 453. Furuta, A., Suzuki, Y., Honda, M., Koike, Y., Naruoka, T., Asano, K., Chancellor, M., Egawa, S., Yoshimura, N.: Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus. BJU International 109:306-210, 2011. DOI 10.1111/j.1464- 410X2011.10258.x 454. Matsumoto, Y., Miyazato, M., Yokoyama, H., Kita, M., Hirao, Y, Chancellor, M.B., Yoshimura, N.: Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats. Urology 79: 1184.e15-1184.e20, 2012. Doi:10.1016/j.urology.2012.01.022 455. Tyagi, P., Killinger, K., Tyagi, V., Nirmal, J., Chancellor, M.B., Peters, K.: Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J. Urology 187:2243-2248, 2012. DOI:10.1016/J.juro.2012.01.034 456. Chancellor, M.B., Staskin, D.R., Kay, G.G., Sandage, B.W., Oefelein, M.G., Tsao, J.W.: Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Drugs Aging 29:259-273, 2012. DOI:1170-229X/12/0004-0259/$49.95/0 457. Kitta, T., Chancellor, M.B., de Groat, W.C., Kuno, S., Nonomura, K., Yoshimura, N.: Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease. J. Urology, 187:1890-1897, 2012. DOI:10.1016/j.juro.2011.12.062 458. Yokoyama, T., Chancellor, M.B., Oguma, K., Yamamoto, Y., Suzuki, T., Kumon, H., Nagai, A.: Botulinum toxin type A for the treatment of lower urinary tract disorders. Int. J. Urology 19:202-215, 2012. DOI:10.1111/j.1442- 2042.2011.02946.x 459. Liu, R.T., Chung. M.S., Chuang, Y.C. Lee, J.J., Lee, W.C., Chang, H.W., Yang, K.D., Chancellor, M.B.: The presence of overactive bladder wet increased the risk and severity of erectile dysfunction in men with type 2 diabetes. Int. Sex Med., 9:1913-1922, 2012. DOI:10.1111/j.1743-6109.2012.02738.x 460. Miyazato, M., Oshiro, T., Chancellor, M.B., de Groat, W.C., Yoshimura, N. Saito, S.: An alpha1-adrenoceptor blocker terazosin improves urine storage function in the spinal cord injured rats. Life Sciences 2013 Feb 7;92(2):125-30 hppt://dx.doi.org/10.1016/j.lfs.2012.11.006. PMID: 23178151 461. Honda, M., Yoshimura, N., Inoue, S., Hinata, N., Chancellor, M.B., Takenaka A.: Inhibitory effect of somatostatin receptor subtype-5 agonist NNC 26-9100 on micturition reflex in rats. Urology 80:1291.e9-1391.e13, 2012. http://dx.doi.org/10.1016j.urology.2012.07.007 462. Kupelian, V., Rosen, R.C., Roehrborn, C.G., Tyagi, P., Chancellor, M.B., McKinlay, J.B.: Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU Int. 110(3):401-7, 2012. doi: 10.1111/j.1464-410X.2011.10769.x. Epub 2011 Dec 16. 463. Chuang, Y.C., Chung, M.S., Wang, P.W., Lee, W.C., Chen, C.D., Chang, H.W., Yang, K.D., Chancellor, M.B., Liu, R.T.: Albumiuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2012 Apr;9(4):1055-64. doi: 10.1111/j.1743-6109.2011.02586.x. Epub 2012 Jan 3. Chancellor 28 of 108 464. Chuang, Y.C., Tyagi, P., Huang, C.C., Chancellor, M.B., Yoshimura, N.: Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats. BJU Int. 2012, 110(10):1558-64. doi: 10.1111/j.1464-410X.2012.11096.x. Epub 2012 Mar 27. 465. Yoshimura, N., Miyazato, M., Sasaki, K., Yokoyama, H., Oguchi, T., Chancellor, M.B., Funahashi, Y.: Gene therapy for lower urinary tract dysfunction. Int J Urol. 2012 Nov 7. doi: 10.1111/j.1442-2042.2012.03226.x. [Epub ahead of print] 466. Nirmal, J., Tyagi, P., Chancellor, M.B., Kaufman, J., Anthony, M., Chancellor, D.D., Chen, Y.T., Chuang, Y.C.: Development of Potential Orphan Drug Therapy of Intravesical Liposomes Tacrolimus for Hemorrhagic Cystitis by Increased Local Drug Exposure. J Urol. 2012 Nov 2. pii: S0022-5347(12)05441-9. doi: 10.1016/j.juro.2012.10.123. [Epub ahead of print] 467. Honda, M., Yoshimura, N., Hikita, K., Hinata, N., Muraoka, K., Saito, M., Chancellor, M.B., Takenaka, A.: Supraspinal and spinal effects of L-trans-PDC, an inhibitor of glutamate transporter, on the micturition reflex in rats. Neurourol Urodyn. 2012 Nov 20. doi: 10.1002/nau.22351. [Epub ahead of print] 468. Carr, L.K., Robert, M., Kultgen, P.L., Herschorn, S., Birch, C., Murphy, M., Chancellor, M.B.: Autologous muscle derived cell therapy for stress urinary incontinence: A prospective, dose ranging study. J Urol. 2012 Dec 19. pii: S0022-5347(12)04840-9. doi: 10.1016/j.juro.2012.09.028. PMID: 23260547 469. Soler R, Andersson KE, Chancellor MB, Chapple CR, de Groat WC, Drake MJ, Gratzke C, Lee R, Cruz F: Future Direction in Pharmacotherapy for Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2013 May 7. doi:pii: S0302-2838(13)00465-X. 10.1016/j.eururo.2013.04.042. PMID: 23711541 470. Watanabe T, Chancellor MB: Pelvic surgeons caught in the meshes of the law. Rev Urol. 2012;14(1-2):35-6. PMID: 23172999 471. Esquenazi A, Albanese A, Chancellor MB, Elovic E, Segal KR, Simpson DM, Smith CP, Ward AB: Evidence- based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon. 2013 Jun 1;67:115-28. doi: 10.1016/j.toxicon.2012.11.025. Epub 2012 Dec 5. PMID: 23220492 472. Hsu CC, Chuang YC, Chancellor MB: Intravesical drug delivery for dysfunctional bladder. Int J Urol. 2013 Jun;20(6):552-62. doi: 10.1111/iju.12085. Epub 2013 Jan 22. PMID: 23336527 473. Chancellor MB, Elovic E, Esquenazi A, Naumann M, Segal KR, Schiavo G, Smith CP, Ward AB: Evidence- based review and assessment of botulinum neurotoxin for the treatment of urologic conditions. Toxicon. 2013 Jun 1;67:129-40. doi: 10.1016/j.toxicon.2013.01.020. Epub 2013 Feb 13. PMID: 23415704 474. Miyazato M, Yoshimura N, Chancellor MB: The other bladder syndrome: underactive bladder.Rev Urol. 2013;15(1):11-22. PMID: 23671401 475. Liu RT, Chung MS, Wang PW, Chen CD, Lee JJ, Lee WC, Chancellor MB, Yang KD, Chuang YC: The Prevalence and Predictors of Androgen Deficiency in Taiwanese Men With Type 2 Diabetes. Urology. 2013 May 12. doi:pii: S0090-4295(13)00390-7. 10.1016/j.urology.2013.03.023. PMID: 23676359 476. Yokoyama T, Chuang YC, Chancellor MB: Update in the use of botulinum toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms. Curr Bladder Dysfunct Rep 2013; 8;174-179. 477. Hanna-Mitchell AT, Wolf-Johnston AS, Barrick SR, Kanai AJ, Chancellor MB, de Groat WC, Birder LA: Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn. 2013 Oct 26. doi: 10.1002/nau.22508. PMID:24167028 478. Chancellor MB, Migliaccio-Walle K, Bramley TJ, Chaudhari SL, Corbell C, Globe D: Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. Clin Ther. 2013 Nov;35(11):1744-51. doi: 10.1016/j.clinthera.2013.08.017. Epub 2013 Oct 3. PMID: 24091072 479. Honda M, Yoshimura N, Inoue S, Hikita K, Muraoka K, Saito M, Chancellor MB, Takenaka A: Inhibitory role of the spinal galanin system in the control of micturition. Urology. 2013 Nov;82(5):1188.e9-13. doi: 10.1016/j.urology.2013.06.056. Epub 2013 Sep 12. PMID: 24035037 480. Kitta T, Chancellor MB, de Groat WC, Kuno S, Nonomura K, Yoshimura N: Roles of adenosine A1 and A2A receptors in the control of micturition in rats. Neurourol Urodyn. 2014 Nov;33(8):1259-65. doi: 10.1002/nau.22487. PMID: 24014261 481. Chancellor MB, Patel V, Leng WW, Shenot PJ, Lam W, Globe DR, Loeb AL, Chapple CR: OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity. Neurology. 2013 Aug 27;81(9):841-8. doi: 10.1212/WNL.0b013e3182a2ca4d. Epub 2013 Jul 26. PMID: 23892704 482. Toler SM, Yohannes D, Lippiello PM, Chancellor MB: Anticholinergic therapy for overactive bladder: a nicotinic modality? Med Hypotheses. 2013 Sep;81(3):456-8. doi: 10.1016/j.mehy.2013.06.008. Epub 2013 Jul 5. PMID: 23834857 Chancellor 29 of 108 483. Honda M, Yoshimura N, Hikita K, Hinata N, Muraoka K, Saito M, Chancellor MB, Takenaka A: Supraspinal and spinal effect of L-trans-PDC, an inhibitor of glutamate transporter, on the micturition reflex in rats. Neurourol & Urodynamics 21:1026-1030, 2013. 484. Kashyap M, Kawamorita N, Tyagi V, Sugino Y, Chancellor MB, Yoshimura N, Tyagi P: Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder. J. Urology 190:757-764, 2013. http://dx.doi.org/10.1016/j.juro2013.02..090 485. Cheng YT, Chung YH, Kang HY, Tai MH, Chancellor MB, Chuang YC: OnobotulinumtoxinA has no effects on growth of LNCaP and PC3 human prostate cancer cells. LUTS 5:168-172, 2013. 486. Rajaganapathy BR, Jayabalan N, Tyagi, P, Kaufman J, Chancellor MB: Advances in therapeutic development for radiation cystitis. LUTS. 2013; DOI 10.1111/luts/12045. 487. Peters KM, Dmochowski RR, Carr LK, Robert M, Kaufman MR, Sirls LT, Herschorn S, Birch C, Kultgen PL, Chancellor MB. Autologous Muscle Derived Cells for Treatment of Stress Urinary Incontinence in Women. J Urol. 192:469-476, 2014. doi: 10.1016/j.juro.2014.02.047. PMID: 24582537 488. Peters KM, Hasenau D, Killinger KA, Chancellor MB, Anthony M, Kaufman J: Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation. Int Urol Nephrol. 2014; 46(12):2291-5. doi: 10.1007/s11255-014-0828- 5. PMID: 25209396 489. Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014; 46(7):1269-75. doi: 10.1007/s11255-014-0669-2. 490. Nirmal J, Tyagi P, Chuang YC, Lee WC, Yoshimura N, Huang CC, Rajaganapathy B, Chancellor MB: Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin- induced diabetic rat. PLoS One. 2014 Jul 22;9(7):e102644. doi: 10.1371/journal.pone.0102644. PMID: 25050870 491. Yoshimura N, Ogawa T, Miyazato M, Kitta T, Furuta A, Chancellor MB, Tyagi P. Neural Mechanisms Underlying Lower Urinary Tract Dysfunction. Korean J Urol. 2014 Feb;55(2):81-90. Epub 2014 Feb 14. Review. PMID: 24578802 492. Kuo HC, Liu HT, Chuang YC, Birder LA, Chancellor MB. Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-Eur Urol. 2014 Jun;65(6):1117-24. doi: 10.1016/j.eururo.2014.01.036. Epub 2014 Feb 11. PMID: 24555904 493. Nirmal J, Wolf-Johnston AS, Chancellor MB, Tyagi P, Anthony M, Kaufman J, Birder LA. Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells. International Urology and Nephrology. 2014 Oct;46(10):1947-52. PMID: 24875005 494. Peters KM, Jayabalan N, Bui D, Killinger K, Chancellor MB, Tyagi P: Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients. LUTS 7:77-83, 2015 495. Yoshikawa S, Kawamorita N, Oguchi T, Funahashi Y, Tyagi P, Chancellor MB, Yoshimura N.Pelvic organ cross- sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience. 2015 Jan 22;284:422-9. doi: 10.1016/j.neuroscience.2014.08.064. Epub 2014 Oct 15. PMID: 25445197 496. Honda M, Yoshimura N, Kawamoto B, Kobayashi N, Hikita K, Muraoka K, Saito M, Sejima T, Chancellor MB, Takenaka A. Effects of sensory neuron-specific receptor agonist on bladder function in a rat model of cystitis induced by cyclophosphaide. Int Urol Nephrol. 46:1953-1959, 2014; PMID: 24824147 497. Yoshimura N, Oguchi T, Yokoyama H, Funahashi Y, Yoshikawa S, Sugino Y, Kawamorita N, Kashyap MP, Chancellor MB, Tyagi P, Ogawa T: Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.Int J Urol. 2014 Apr;21 Suppl 1:18-25. doi: 10.1111/iju.12308. PMID: 24807488 498. Chuang YC, Kaufmann JH, Chancellor DD, Chancellor MB, Kuo HC: Bladder Instillation of Liposome Encapsulated OnabotulinumtoxinA Improves Overactive Bladder Symptoms: A Prospective, Multicenter, Double- Blind, Randomized Trial. J Urol. 2014 Dec;192(6):1743-9. doi: 10.1016/j.juro.2014.07.008. Epub 2014 Jul 18. PMID:25046622 499. Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health- related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014 Apr 4;14:74. doi: 10.1186/1471-2377-14-74.PMID: 24708598 500. Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT: Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014 Jul;46(7):1269-75. doi: 10.1007/s11255-014-0669-2. Epub 2014 Mar 5. PMID: 24595602 501. Chancellor MB, Levanovich P, Rajaganapathy BR, Vereecke AJ: Optimal management of overactive bladder: medication vs Botox vs INterstim vs Urgent PC. Business of Urology 1: 7-12, 2014. Chancellor 30 of 108 502. Burks J, Chancellor MB, Bates D, Denys P, MacDiarmid S, Nitti V, Globe D, Signori M, Hudgens S, Odderson I, Panicker J, Perrin Ross A: Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. International Journal of MS Care, 15: 182-192. 503. Chancellor, M. B., Diokno, A.: CURE-UAB: shedding light on the underactive bladder syndrome. Int Urol Nephrol, 46 Suppl 1: S1, 2014; PMID: 25238887 504. Valente, S., DuBeau, C., Chancellor, D.D., Okonski, J., Vereecke, A., Doo, F., Lajiness, M., Diokno, A., Chancellor, M.B: Epidemiology and demographics of the underactive bladder: a cross-sectional survey. Int Urol Nephrol, 46 Suppl 1: S7-10, 2014; PMID: 25238889 505. Chancellor, M. B.: The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol, 46 Suppl 1: S23-27, 2014; PMID: 25238891 506. Griebling, T. L., DuBeau, C. E., Kuchel, G.A., Wilde, M.H., Lajiness, M., Tomoe, H., Diokno, A., Vereecke, A., Chancellor, M.B.: Defining and advancing education and conservative therapies of underactive bladder. Int Urol Nephrol, 46 Suppl 1: S29-34, 2014; PMID: 25238892 507. Smith, P.P., Tyagi, P., Kuchel, G.A. Pore, S., Chermansky, C.J., Chancellor, M.B., Yoshimura, N., Levanovich, P.: Advanced therapeutic directions to treat the underactive bladder. Int Urol Nephrol, 46 Suppl 1: S35-44, 2014 508. Tyagi, P., Smith, P. P., Kuchel, G. A. de Groat, W.C., Birder, L.A., Chermansky, C.J., Adam, R.M., Tse, V., Chancellor, M.B., Yoshimura, N.: Pathophysiology and animal modeling of underactive bladder. Int Urol Nephrol, 46 Suppl 1: S11-21, 2014; PMID: 25238893 509. Levanovich PE, Diokno A, Hasenau DL, Lajiness M, Pruchnic R, Chancellor MB: Intradetrusor injection of adult muscle‑ derived cells for the treatment of underactive bladder: pilot study. Int Urol Nephrol, 47:465-467, 2015; PMID: 25663053 510. Yoshikawa S, Kawamorita N, Oguchi T, Funahashi Y, Tyagi P, Chancellor MB, Yoshimura N. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience. 2015 Jan 22;284:422-9. doi: 10.1016/j.neuroscience.2014.08.064. Epub 2014 Oct 15.PMID: 25445197

511. Kantor D, Chancellor MB, Snell CW, Henney Iii HR, Rabinowicz AL. Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.Postgrad Med. 2015 Feb;127(2):218-22. doi: 10.1080/00325481.2015.1000229. Epub 2015 Jan 6.PMID: 25560174

512. Wang HJ, Tyagi P, Chuang YC, Yoshimura N, Huang CC, Chancellor MB. Pharmacologic and Molecular Characterization of Underactive Bladder Induced by Lumbar Canal Stenosis. Urology. 2015; 85:1284-1290. PMID: 25770729

513. Miyazato M, Kitta T, Kaiho Y, Oshiro T, Saito S, Chancellor MB, de Groat WC, Yoshimura N. Effects of Duloxetine, a Norepinephrine and Serotonin Reuptake Inhibitor, on the Urethral Continence Reflex and Bladder Activity in Rats with Cerebral Infarction. J Urol. 2015; 194:842-847. PMID: 25804088

514. Rajaganapathy BR, Chancellor MB, Nirmal J, Dang L, Tyagi P. Bladder uptake of liposomes after intravesical administration occurs by endocytosis. PLoS One. 2015; Mar 26;10(3):e0122766. doi: 10.1371/journal.pone.0122766. eCollection 2015. PMID: 25811468

515. Rajaganapathy BR, Janicki JJ, Levanovich P, Tyagi P, Hafron J, Chancellor MB, Krueger S, Marples B. Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation. J Urol. 2015 194: 578-584. PMID: 25839382

516. Chartier-Kastler E, Rovner E, Hepp Z, Khalaf K, Ni Q, Chancellor M. Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2015; Apr 6. doi: 10.1002/nau.22757. PMID: 25846869 517. Chancellor M, Versi E, Dvergsten C, Toler S. Clinical efficacy and tolerability of the nicotinic channel modulator dexmecamylamine in subjects with overactive bladder. J Urol. 2015; 194:1329-1335. PMID: 26073872 518. Martins da Silva C, Chancellor MB, Smith CP, Cruz F: Use of botulinum toxin for genitourinary conditions: What is the evidence? Toxicon. 2015 Dec 1;107(Pt A):141-7. doi: 10.1016/j.toxicon.2015.07.333. Epub 2015 Jul 31.PMID: 26235907 519. Liu HT, Chen SH, Chancellor MB, Kuo HC: Presence of cleaved synaptosomal-associated protein-25 and decrease of purinergic receptors P2X3 in the bladder urothelium influence efficacy of botulinum toxin treatment for Chancellor 31 of 108 overactive bladder syndrome. PLoS One. 2015 Aug 4;10(8):e0134803. doi: 10.1371/journal.pone.0134803. eCollection 2015.PMID: 26241848 520. Mori K, Noguchi M, Tobu S, Sato F, Mimata H, Tyagi P, Chancellor MB, Yoshimura N: Age-related changes in bladder function with altered angiotensin II receptor mechanisms in rats. Neurourol Urodyn. 2015 Aug 7. doi: 10.1002/nau.22849. [Epub ahead of print] PMID: 26250880 521. Dave CN, Chaus F, Chancellor MB, Lajness M, Peters KM: Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. Int Urol Nephrol. 2015 Oct;47(10):1679-81. doi: 10.1007/s11255-015-1098-6. Epub 2015 Sep 7. PMID:26347076 522. Chuang YC, Plata M, Lamb LE, Chancellor MB: Underactive bladder in older adults. Clin Geriatr Med. 2015 Nov;31(4):523-33. doi: 10.1016/j.cger.2015.06.002. Epub 2015 Jul 26. Review. PMID:26476113 523. Janicki JJ, Gruber MA, Chancellor MB: Intravesical liposome drug delivery and IC/BPS. Transl Androl Urol 2015; 4:572-578. PMID: 524. Vereeck A, Chancellor MB: Buliding momentum toward underactive bladder research and education. INt Urol Nephrol 2915. 47:1593-1594, PMID: 525. Ogawa T, Ishizuka O, Ueda T, Tyagi P, Chancellor MB, Yoshimura N. Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS). Expert Opin Emerg Drugs. 2015 Dec;20(4):555-70. doi: 10.1517/14728214.2015.1105216. Epub 2015 Nov 4. PMID: 26535808 526. Zwaans BM, Chancellor MB, Lamb LE. Modeling and treatment of radiation cystitis. Urology. 2015 Nov 10. pii: S0090-4295(15)01048-1. doi: 10.1016/j.urology.2015.11.001. [Epub ahead of print] Review. PMID:26571081 527. Kitta T, Chancellor MB, de Groat WC, Shinohara N, Yoshimura N. Role of the anterior cingulate cortex in the control of micturition reflex in a rat model of Parkinson's disease. J Urol. 2015 Nov 25. pii: S0022-5347(15)05309- 4. doi: 10.1016/j.juro.2015.11.039. PMID:26626223 528. Kashyap M, Yoshimura N, Smith PP, Chancellor M, Tyagi P. Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation. Bladder (San Franc). 2015;2(2). pii: e15. Epub 2015 Jul 17. PMID: 26709376 529. Tyagi P, Kashyap M, Yoshimura N, Chancellor M, Chermansky CJ: Past, Present, and Future of Chemodenervation With Botulinum Toxin in the Treatment of OAB. J Urol. 2016 Nov 18. pii: S0022- 5347(16)31796-7. doi: 10.1016/j.juro.2016.11.092. PMID:27871929 530. Nickel JC, Gorin MA, Alan W P, Loeb S, Ellen S, Chancellor MB, Assimos DG, Brawer MK, Brucker BM: Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA. Rev Urol. 2016;18(3):159-173. PMID: 27833468 531. Kashyap M, Pore S, Chancellor M, Yoshimura N, Tyagi P: Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor. Life Sci. 2016 Dec 15;167:98-104. doi: 10.1016/j.lfs.2016.10.025. PMID: 27789288 532. Lamb LE, Bartolone SN, Kutluay SB, Robledo D, Porras A, Plata M, Chancellor MB: Reply to the letter: Urine based molecular diagnosis of Zika virus by Viroj Wiwanitkit. Int Urol Nephrol. 2016 Dec;48(12):2025. PMID: 27687554 533. Zwaans BM, Nicolai HG, Chancellor MB, Lamb LE: Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis. Rev Urol. 2016;18(2):57-65. doi: 10.3909/riu0700. PMID: 27601964 534. Lamb LE, Bartolone SN, Kutluay SB, Robledo D, Porras A, Plata M, Chancellor MB: Advantage of urine based molecular diagnosis of Zika virus. Int Urol Nephrol. 2016 Dec;48(12):1961-1966. Review. PMID: 27567913 535. Faraj K, Doo F, Boura J, Vereecke A, Chancellor MB: A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms. Int Urol Nephrol. 2016 Nov;48(11):1797-1802. PMID: 27473156 536. Tyagi P, Tyagi V, Qu X, Chuang YC, Kuo HC, Chancellor M: Elevated CXC chemokines in urine noninvasively discriminate OAB from UTI. Am J Physiol Renal Physiol. 2016 Sep 1;311(3):F548-54. doi: 10.1152/ajprenal.00213.2016. PMID: 27335375 537. Honda M, Yoshimura N, Kawamoto B, Hikita K, Muraoka K, Shimizu S, Saito M, Chancellor MB, Takenaka A: Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats. Int Urol Nephrol. 2016 Sep;48(9):1407-12. doi: 10.1007/s11255-016-1329-5. PMID: 27256398 538. Chancellor MB, Yehoshua A, Waweru C, Globe D, Cheng IN, Campbell KL, Joshi M, Pulicharam R: Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): Chancellor 32 of 108 results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study. Int Urol Nephrol. 2016 Jul;48(7):1029-36. doi: 10.1007/s11255-016-1277-0. PMID: 27032397 539. Yehoshua A, Chancellor M, Vasavada S, Malone DC, Armstrong EP, Joshi M, Campbell K, Pulicharam R: Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics. J Manag Care Spec Pharm. 2016 Apr;22(4):406-13. doi: 10.18553/jmcp.2016.22.4.406. PMID: 27023694 540. Janicki JJ, Chancellor MB, Kaufman J, Gruber MA, Chancellor DD: Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction. Toxins (Basel). 2016 Mar 18;8(3). pii: E81. doi: 10.3390/toxins8030081. Review. PMID: 26999210 541. Jhang JF, Birder LA, Chancellor MB, Kuo HC: Patient characteristics for different therapeutic strategies in the management ketamine cystitis. Neurourol Urodyn. 2016 Mar 21. doi: 10.1002/nau.22996. PMID: 26998599 542. Smith CP, Chancellor MB: Botulinum Toxin to Treat Neurogenic Bladder. Semin Neurol. 2016 Feb;36(1):5-9. doi: 10.1055/s-0035-1571216. PMID:26866490 543. Honda M, Hikita K, Kawamoto B, Muraoka K, Shimizu S, Saito M, Sejima T, Chancellor MB, Yoshimura N, Takenaka A: Spinal glycine transporter-1 inhibition influences the micturition reflex in urethane-anesthetized rats. Int Urol Nephrol. 2016 Mar;48(3):349-54. doi: 10.1007/s11255-015-1148-0. PMID: 26843416 544. Kawamorita N, Yoshikawa S, Kashyap M, Tyagi P, Arai Y, Chancellor MB, Yoshimura N: 545. Liposome Based Intravesical Therapy Targeting Nerve Growth Factor Ameliorates Bladder Hypersensitivity in Rats with Experimental Colitis. J Urol. 2016 Jun;195(6):1920-6. doi: 10.1016/j.juro.2015.12.090. PMID: 26780168 546. Kitta T, Chancellor MB, de Groat WC, Shinohara N, Yoshimura N: Role of the Anterior Cingulate Cortex in the Control of Micturition Reflex in a Rat Model of Parkinson's Disease. J Urol. 2016;195(5):1613-20. doi: 10.1016/j.juro.2015.11.039. PMID:26626223 547. Chermansky CJ, Chancellor MB: Use of Botulinum Toxin in Urologic Diseases. Urology. 2016 May;91:21-32. doi: 10.1016/j.urology.2015.12.049. Review. PMID:26777748 548. Zwaans BM, Chancellor MB, Lamb LE: Modeling and Treatment of Radiation Cystitis. Urology. 2016 Feb;88:14-21. doi: 10.1016/j.urology.2015.11.001. Review. PMID:26571081 549. Mori K, Noguchi M, Tobu S, Sato F, Mimata H, Tyagi P, Chancellor MB, Yoshimura N: Age-related changes in bladder function with altered angiotensin II receptor mechanisms in rats. Neurourol Urodyn. 2016 Nov;35(8):908- 913. doi: 10.1002/nau.22849. PMID:26250880 550. Chartier-Kastler E, Rovner E, Hepp Z, Khalaf K, Ni Q, Chancellor M: Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 Jun;35(5):595-600. doi: 10.1002/nau.22757. PMID: 25846869 551. Pradeep Tyagi, Mahendra Kashyap, Naoki Yoshimura, Michael Chancellor, Christopher J. Chermansky: Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder. J Urology 982–990, 2017. DOI: http://dx.doi.org/10.1016/j.juro.2016.11.092. PMID: 27871929. 553. Dewulf K, Abraham N, Lamb LE, Griebling TL, Yoshimura N, Tyagi P, Veerecke A, Bartolone SN, Zwaans BMM, De Ridder D, Diokno A, Chancellor MB: Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB). Int Urol Nephrol. 2017; 49:777-785. doi: 10.1007/s11255-017-1549-3. PMID: 28233085 554. Chancellor MB: OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence. J Urol. 2017 Feb;197(2S):S224-S225. doi: 10.1016/j.juro.2016.11.077. Epub 2016 Dec 20. No abstract available. PMID: 28010976 555. Jhang JF, Birder LA, Chancellor MB, Kuo HC.: Patient characteristics for different therapeutic strategies in the management ketamine cystitis. Neurourol Urodyn. 2017 Mar;36(3):687-691. doi: 10.1002/nau.22996. Epub 2016 Mar 21.PMID: 26998599 559. Chancellor MB: Editorial Comment. Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls. J Urol. 2017 Jun;197(6):1495. doi: 10.1016/j.juro.2017.01.090. Epub 2017 Mar 17. PMID: 28322192. 560. Majima T, Tyagi P, Dogishi K, Kashyap M, Funahashi Y, Gotoh M, Chancellor MB, Yoshimura N: Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide. Hum Gene Ther. 2017; 28:598-609. doi: 10.1089/hum.2016.121. PMID: 28446032 Chancellor 33 of 108 561. Zwaans BM, Krueger S, Bartolone SN, Chancellor MB, Marples B, Lamb LE.: Modeling of chronic radiation- induced cystitis in mice. Adv Radiat Oncol. 2016 Oct-Dec;1(4):333-343. doi: 10.1016/j.adro.2016.07.004. Epub 2016 Aug 1. PMID: 28217761 562. Chuang YC, Tyagi P, Wang HJ, Huang CC, Lin CC, Chancellor MB. Urodynamic and molecular characteristics of detrusor underactivity in a rat cryoinjury model and effects of low energy shock wave therapy. Neurourol Urodyn. 2018 Feb;37(2):708-715. doi: 10.1002/nau.23381. Epub 2017 Aug 2. PMID: 28767169 563. Lamb LE, Janicki JJ, Bartolone SN, Peters KM, Chancellor MB.: Development of an interstitial cystitis risk score for bladder permeability. PLoS One. 2017 Oct 31;12(10):e0185686. doi: 10.1371/journal.pone.0185686. eCollection 2017. PMID: 29088231 564. Chancellor MB, Bartolone SN, Veerecke A, Lamb LE. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study. J Urol. 2018 May;199(5):1344-1350. doi: 10.1016/j.juro.2017.09.167. Epub 2017 Dec 7. PMID: 29225061 565. Chancellor MB, Watanabe T Making a Case for NOT Prescribing Antimuscarinic Drugs to Treat Overactive Bladder in Older Adults. J Urol. 2018 Oct 6. pii: S0022-5347(18)43968-7. doi: 10.1016/j.juro.2018.09.061. [Epub ahead of print] No abstract available. PMID: 30300633 566. Bartolone SN, Tree MO, Conway MJ, Chancellor MB, Lamb LE. Reverse Transcription-Loop-mediated Isothermal Amplification (RT-LAMP) Assay for Zika Virus and Housekeeping Genes in Urine, Serum, and Mosquito Samples. J Vis Exp. 2018 Sep 14;(139). doi: 10.3791/58436. PMID: 30272674 567. Zwaans BMM, Lamb LE, Bartolone S, Nicolai HE, Chancellor MB, Klaudia SW. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. Int Urol Nephrol. 2018 Oct;50(10):1745-1751. doi: 10.1007/s11255-018-1970-2. Epub 2018 Aug 21. Review. PMID: 30132277 568. Zwaans BMM, Bartolone SN, Chancellor MB, Nicolai HE, Lamb LE. Altered Angiogenic Growth Factors in Urine of Prostate Cancer Survivors With Radiation History and Radiation Cystitis. Urology. 2018 Oct;120:180-186. doi: 10.1016/j.urology.2018.07.025. Epub 2018 Jul 29. PMID: 30059715 569. Wu MP, Luo HL, Weng SF, Ho CH, Chancellor MB, Chuang YC. Risk of Urinary Tract Carcinoma among Subjects with Bladder Pain Syndrome/Interstitial Cystitis: A Nationwide Population-Based Study. Biomed Res Int. 2018 Jun 28;2018:7495081. doi: 10.1155/2018/7495081. eCollection 2018. PMID: 30050942 570. Chancellor MB, Bartolone SN, DeVries EM, Diokno AC, Gibbons M, Jankowski R, Lamb LE, Pruchnic R, Thor K, Dmochowski R. New technology assessment and current and upcoming therapies for underactive bladder. Neurourol Urodyn. 2018 Nov;37(8):2932-2937. doi: 10.1002/nau.23738. Epub 2018 Jun 28. PMID: 29953660 571. Ogawa T, Ishizuka O, Ueda T, Tyagi P, Chancellor MB, Yoshimura N. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play. Expert Rev Clin Pharmacol. 2018 May;11(5):495-505. doi: 10.1080/17512433.2018.1457435. Epub 2018 Apr 9. Review. PMID: 29575959 572. Lamb LE, Bartolone SN, Tree MO, Conway MJ, Rossignol J, Smith CP, Chancellor MB. Rapid Detection of Zika Virus in Urine Samples and Infected Mosquitos by Reverse Transcription-Loop-Mediated Isothermal Amplification. Sci Rep. 2018 Feb 28;8(1):3803. doi: 10.1038/s41598-018-22102-5. PMID: 29491389 573. Tyagi P, Moon CH, Janicki J, Kaufman J, Chancellor M, Yoshimura N, Chermansky C. Recent advances in imaging and understanding interstitial cystitis. F1000Res. 2018 Nov 9;7. pii: F1000 Faculty Rev-1771. doi: 10.12688/f1000research.16096.1. eCollection 2018. Review. PMID: 30473772 574. Jankowski RJ, Tu LM, Carlson C, Robert M, Carlson K, Quinlan D, Eisenhardt A, Chen M, Snyder S, Pruchnic R, Chancellor M, Dmochowski R, Kaufman MR, Carr L. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence. Int Urol Nephrol. 2018 Dec;50(12):2153-2165. doi: 10.1007/s11255-018-2005-8. Epub 2018 Oct 15. PMID: 30324580 575. Valença MP, da Silva Filho JC, Santos ICRV, Almeida Calado A, Chancellor DD, Chancellor MB, de Aguiar Cavalcanti G.Translation, cross-cultural adaptation and validation of the underactive bladder questionnaire to portuguese. Int Urol Nephrol. 2019 May 27. doi: 10.1007/s11255-019-02176-4. PMID: 31134507 576. Chuang YC, Tyagi P, Luo HL, Lee WC, Wang HJ, Huang CC, Chancellor MB. Long-term functional change of cryoinjury-induced detrusor underactivity and effects of extracorporeal shock wave therapy in a rat model. Int Urol Nephrol. 2019 Apr;51(4):617-626. doi: 10.1007/s11255-019-02095-4. Epub 2019 Feb 22. PMID: 30796726 Chancellor 34 of 108 577. Chancellor MB, Watanabe T. Making a Case for Not Prescribing Antimuscarinic Drugs to Treat Overactive Bladder in Older Adults. J Urol. 2019 Apr;201(4):676-677. doi: 10.1016/j.juro.2018.09.061. PMID: 30300633

BOOKS AUTHOR and JOURNALS EDITOR

1. Neuro-Urology and its Role in Urologic Disease: Part I. eds. Blaivas, J.G. and Chancellor, M.B., Problems in Urology, W, B, Saunders, 1992. 2. Neuro-Urology and its Role in Urologic Disease: Part II. eds. Blaivas, J.G. and Chancellor, M.B., Problems in Urology, W, B, Saunders, 1993. 3. Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. eds. Chancellor, M.B. and Blaivas, J.G. Butterworth Heinemann, Stoneham, MA. 1995. 4. Chancellor, M.B.: Bladder Management. In: Topics in Spinal Cord Injury Rehabilitation. Volume 1, Number 5. Aspen Publisher, Frederick, MD., 1996. 5. Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA., 1996. 6. Urge Incontinence; Pathophysiology and Management. eds. Appell, R.A. and Chancellor, M.B., Contemporary Urology Supplement, Medical Economics Company, NY, NY, March, 1999. 7. Challenges in the Treatment of Urinary Incontinence and Overactive Bladder. Review in Urology Supplement, Ed. Chancellor, M.B., Vol 3, 2001. 8. Strategies for the Treatment of Overactive Bladder and Urinary Incontinence. Review in Urology Supplement, Eds. Nitti, V.W., Chancellor, M.B., Vol 4, 2002. 9. The Impact of Overactive Bladder on the Urology Practice, Urology Times Supplement, Eds: Chancellor, M.B. and Peters, K.M.., 31 (Supple 1) 2003. 10. Continence for People Living with Multiple Sclerosis, O'Leary, M. and Chancellor, M.B.; National Multiple Sclerosis and NAFC Education, 2004. 11. Overactive Bladder; Guest Editor Chancellor, M.B., Urology Clinics of North America, 33: 433-549, 2006. Elsevier, Saunders, Philadelphia, PA. 12. Atlas of Urodynamics, 2nd Edition. Blaivas, J.G., Chancellor, M.B., Verhaaren, M., Weiss, J., Blackwell Publishing, Boston, MA., 2007. 13. Continence for People Living with Multiple Sclerosis, O'Leary, M. and Chancellor, M.B.; National Multiple Sclerosis and NAFC Education, 2nd edition, 2009. 14. Yoshimura, N., Chuang, Y.C., Kim, J.C., Chancellor, M.B. Editors: Pan Pacific Continence Society Special Supplement Issue, Lower Urinary Tract Symptoms, 1(Supp 1): 1-104, 2009. 15. Chancellor, M.B., Smith, C.P.: Botulinum Toxin in Urology, 2011, Springers, http://www.springer.com/medicine/urology/book/978-3-642-03579-1?changeHeader 16. Chancellor, MB: Optimizing outcomes in multiple sclerosis: delaying disease progression and aggressively managing acute symptoms. http://neurorehabresource.org/compendium_Resource_Tools.php 17. Guest Editors: Chancellor, M.B., Diokno, A.C.: Frontier in Urology; The Underactive Bladder. Int Urol Nephrol, Supplemental Issue Vol. 46, Suppl 1, S1-46, 2014. 18. Chancellor M.B., Diokno, A.C.: The Underactive Bladder, Springer, 2006. http://www.springer.com/us/book/9783319236865

BOOK CHAPTERS, MONOGRAPHS, and REVIEW PAPERS

1. Blaivas, J.G. and Chancellor, M.B.: Treatment of Complicated Stress Urinary Incontinence, Seminar in Urology, 7:103-116, 1989. 2. Chancellor, M.B., Kaplan, S.A. and Blaivas, J.G.: Detrusor External Sphincter Dyssynergia in Neurobiology of Incontinence. John Wiley & Sons Ltd (Ciba Foundation Symposium 151), Sussex, UK, pp. 195-206, 1990. 3. Chancellor, M.B. and McGuire, E.J.: Urology Injuries, in Oral and Maxillofacial Trauma, eds. Fonseca, R.J., Walker, R.V., W.B. Saunders Company, pp. 189-199,1990. 4. Chancellor, M.B., Blaivas, J.G.: Injury to the Genitourinary Tract Associated with Pelvic and Sacral Fractures and Their Management, in Surgical Disorders of the Sacrum. ed. Doty, J.R., Rengachary, S.S., Thieme Medical Publishers, New York, NY, 1991. Chancellor 35 of 108 5. Blaivas, J.G. and Chancellor, M.B.: Transurethral Incision of the Prostate: An Alternative to Prostatectomy, in Controversies and Advances in the Diagnosis and Treatment of BPH. Guest Editor Lepor, H., Problems in Urology, J.B. Lippincott Co., 5:412-418, 1991. 6. Chancellor, M.B., Blaivas, J.G.: Incontinence Associated with Neurologic Disorders, Comprehensive Therapy, 17: 37-43, 1991. 7. Chancellor, M.B.: Urinary Sphincter Prosthesis. Current Surgical Techniques in Urology. Medical Publications, Inc., Wilmington, DE. 4 (5), 1991. 8. Gray, J. and Chancellor, M.B.: Understanding Intermittent Catheterization: All You Need to Know. Department of Health, State of New York, 1991. 9. Chancellor, M.B., Blaivas, J.G.: Video-Cystometry and Urethral Pressure Profile Studies, in: Coloproctology and the Pelvic Floor 2nd Edition. ed. Henry M.M., Swash, M., Butterworths, London, UK, pp. 226-243, 1992. 10. Sotolongo, J.R., Chancellor, M.B: Parkinson's disease, Problems in Urology, 7:54-67, 1993. 11. Chancellor, M.B., Blaivas, J.G.: Unstable Bladder and Anatomic Defects, in Gynecologic and Obstetric Urology, third edition. Bushsbaum, H.J. and Schmidt, J.D. editors, W.B. Saunders, 1992, pp. 371-400. 12. Blaivas, J.G., Chancellor, M.B.: Detrusor Instability and Incontinence: Cystodistention, Denervation of Bladder, and Augmentation Cystoplasty. Chapter 6a, 6b, and 6c in Urogynecologic Surgery, Hurt, J.R. editor, Aspen Publishers, Inc., Gaithersburg Maryland, 1992, pp. 107-128. 13. Chancellor, M.B.: Urinary Flow Curve Patterns and Their Prognostic Value in Males over the Age of 50 Years (Editorial Comments). Neurourology & Urodynamics, 11:480-481, 1992. 14. Chancellor, M.B., Blaivas, J.G.: Urodynamics Evaluation in Neuro-Urology. Problems in Urology, J.B. Lippencott Company, Philadelphia, 6:604-621, 1992. 15. Chancellor, M.B., Shenot, P.J., McGinnis, D.E.: Lyme Disease is a Urologic Dilemma Too. Contemporary Urology, 4:18-27, 1992. 16. Chancellor, M.B., Kiilholma, P.: Urodynamic Evaluation of Patients Following Spinal Cord Injury. Seminars in Urology, 10:83-94, 1992. 17. Abdill, C.K., Chancellor, M.B., Tice, M.: Understanding Intermittent Catheterization. Thomas Jefferson University Health Services. 1992. 18. Chancellor, M.B., Blaivas, J.G.: Urinary Dysfunction in Multiple Sclerosis. Problems in Urology, J.B. Lippencott Company, Philadelphia, 7:15-34, 1993. 19. Chancellor, M.B., Gomella, L.G.: Recurrent Incontinence, Letter to Editor. Contemporary OB/GYN, February 1993, Page 111-112. 20. Chancellor, M.B.: Urodynamic Evaluation in Neurogenic Bladder, Physical Medicine and Rehabilitation Clinic of North America. eds. Stover, S.L., Lloyd, L.K., 4:273-298, 1993. 21. Chancellor, M.B.: Muscle Wrap Restores Bladder Function. Urology Times, October 1993. 22. Chancellor, M.B., Gomella, L.G.: Transurethral Contact Laser External Sphincterotomy. Clinical Procedures Review #22, Surgical Laser Technologies, May 1993. 23. Karasick, S., Chancellor, M.B.: Balloons, Stents Offer Alternatives to Sphincterotomy. Diagnostic Imagery, June 29-30, 1993. 24. Chancellor, M.B., Blaivas, J.G.: Physiology of the Lower Urinary Tract in Female Urology (eds) Kurch, E.D., McGuire, E.J. J. B. Lippincott, pp. 39-58, 1994. 25. Rivas, D.A., Chancellor, M.B., Blaivas, J.G.: Interstitial Cystitis, Current Status of Diagnosis and Management. Advances in Urology, (Ed) McGuire, E.J., Vol. 7:229-265, 1994. 26. Rivas, D.A., Chancellor, M.B: Chapter 1: Neuro-Urologic Anatomy. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA. pp. 3-8, 1995. 27. Chancellor, M.B., Blaivas, J.G.: Chapter 2: Neurophysiology of Micturition. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 9-24, 1995. 28. Blaivas, J.G., Chancellor, M.B.: Chapter 3: Classification of Neurogenic Bladder Disease. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 25-32, 1995. 29. Rivas, D.A., Chancellor, M.B., Blaivas, J.G.: Chapter 4: Sexual Dysfunction and Infertility. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 33-45, 1995. Chancellor 36 of 108 30. Chancellor, M.B., Blaivas, J.G.: Chapter 5: Urological Symptoms of Neurologic Diseases.In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 49-54, 1995. 31. Blaivas, J.G., Chancellor, M.B.: Chapter 6: Neuro-Urological Examination. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 55-62, 1995. 32. Chancellor, M.B., Blaivas, J.G.: Chapter 7: Urodynamic Evaluation in Neuro-Urology. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B.and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 63-74, 1995. 33. Chancellor, M.B., Mandel, S., Manion, R.: Chapter 8: Electromyography in Neuro-Urology. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B.and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 75-84,1995. 34. Chancellor, M.B., Mandel, S., Manion, R.: Chapter 9: Advance Electromyography Techniques in Neuro-Urology. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 85-96, 1995. 35. Chancellor, M.B., Blaivas, J.G.: Chapter 10: Spinal Cord Injury. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, 99-118, 1995. 36. Blaivas, J.G., Chancellor, M.B: Chapter 11: Cerebrovascular Accident and Other Intracranial Lesions. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 199-126, 1995. 37. Chancellor, M.B., Blaivas, J.G.: Chapter 12: Multiple Sclerosis. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 127-138, 1995. 38. Blaivas, J.G., Chancellor, M.B.: Chapter 13: Parkinson Disease. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 139-148, 1995. 39. Chancellor, M.B., Blaivas, J.G.: Chapter 14: Diabetic Neurogenic Bladder. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 149-154, 1995. 40. Blaivas, J.G., Chancellor, M.B.: Chapter 15: Cauda Equina and Peripheral Nerve Injury. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 155-164, 1995. 41. Rivas, D.A., Chancellor, M.B.: Chapter 16: Intervertebral Disc Disease. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 165-170, 1995. 42. Chancellor, M.B., Rivas, D.A.: Chapter 17: Autonomic Nervous System Dysfunction. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 171-178, 1995. 43. Chancellor, M.B., Blaivas, J.G.: Chapter 18: Infections Neurological Diseases. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 179-186, 1995. 44. Blaivas, J.G., Chancellor, M.B.: Chapter 19: Non-Traumatic Spinal Cord Diseases. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 187-193, 1995. 45. Chancellor, M.B., Rivas, D.A.: Chapter 20: Myelodysplasia.In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 195-204, 1995. 46. Blaivas, J.G., Chancellor, M.B.: Chapter 21: Sacral Agenesis and Dysraphism.In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 205-210, 1995. 47. Blaivas, J.G., Chancellor, M.B.: Chapter 22: Enuresis and Voiding Dysfunction in Children. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 211-218, 1995. Chancellor 37 of 108 48. Chancellor, M.B., Blaivas, J.G.: Chapter 23: Cerebral Palsy.In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 219-223, 1995. 49. Chancellor, M.B., Blaivas, J.G.: Chapter 24: Benign Prostatic Hyperplasia. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 227-238, 1995. 50. Blaivas, J.G., Chancellor, M.B: Chapter 25: Urinary Retention and Dysfunctional Voiding. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 239-246, 1995. 51. Chancellor, M.B., Blaivas, J.G.: Chapter 26: Urologic Cancer with Neurologic Sequela. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 247-250, 1995. 52. Blaivas, J.G., Chancellor, M.B.: Chapter 27: Female Urology and Pelvic Floor Dysfunction. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, .M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 251-258, 1995. 53. Chancellor, M.B., Blaivas, J.G.: Chapter 28: Urinary Incontinence and Neurological Implication. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 259-274, 1995. 54. Blaivas, J.G., Chancellor, M.B: Chapter 29: Urinary Tract Infection and Neurogenic Bladder. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 275-281, 1995. 55. Blaivas, J.G., Chancellor, M.B.: Chapter 30: Pharmacology of Neuro-Urology. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 285-292, 1995. 56. Chancellor, M.B., Blaivas, J.G.: Chapter 31: Alternative Therapeutic Modalities. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 293-298, 1995. 57. Blaivas, J.G., Chancellor, M.B.: Chapter 32: Catheterization Management. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 299-308, 1995. 58. Chancellor, M.B., Blaivas, J.G.: Chapter 33: Management of Sphincter Dyssynergia. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 309-324, 1995. 59. Blaivas, J.G., Chancellor, M.B.: Chapter 34: Surgery for Neuro-Urologic Diseases. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 325-340, 1995. 60. Chancellor, M.B., Blaivas, J.G.: Chapter 35: Neuromodulation. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B. and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 341-350, 1995. 61. Chancellor, M.B., Blaivas, J.G.: Chapter 36: Electrical Stimulation for Micturition. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B.and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 351-363, 1995. 62. Chancellor, M.B.: Appendix A: Understanding Intermittent Catheterization-Patient Education. In: Practical Neuro- Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B.and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 365-367, 1995. 63. Chancellor, M.B.: Appendix B:: Neurologic Drugs With Urologic Effects. In: Practical Neuro-Urology: Genitourinary Complications in Neurologic Disease. Chancellor, M.B.and Blaivas, J.G., eds. Butterworth Heinemann, Stoneham, MA, pp. 3368-370, 1995. 64. Rivas, D.A., Chancellor, M.B.: Benign Prostatic Hyperplasia. Conn's Current Therapy, pp. 627-633, 1995. 65. Chancellor, M.B. and Blaivas, J.G.: Urological and Sexual Procedures in Multiple Sclerosis. In: Clinical Neuroscience: Multiple Sclerosis, ed Poser C.M., Butterworth Heinemann, Stoneham, MA. 2:196-201, 1995. 66. Chancellor, M.B., Rivas, D.A.: Current Management of Detrusor Sphincter Dyssynergia in Advances in Urology, Eds. McGuire, E.J., Mosby-Year Book, Chicago, IL, PP.291-324, 1995. 67. Chancellor, M.B., Rivas, D.A: Voiding Dysfunction Due to Spinal Cord Injury. AUA Update Series, Lesson 35, Volume XIV, 1995. American Urological Association, Inc., Office of Education, Houston, TX. Chancellor 38 of 108 68. Chancellor, M.B., Rivas, D.A., Keeley, F.X., Lofti, M.A., Gomella, L.G.: Similarity of the American Urological Association Symptom Index Among Men with Benign Prostatic Hyperplasia (BPH), Urethral Obstruction Not Due to BPH, and Detrusor Hyperreflexia Without Outlet Obstruction. Dear Colleague, Care & Cure Communication, Zurich, Switzerland. Vol 1, 1995. 69. Newman, L, Chancellor, M.B.: Sphincter Stent Offers Spinal Cord-Injured Men Options. Urology Times, July 1995, pg 6. 70. Chancellor, M.B., Blaivas, J.G.: Chapter 1: Introduction Overview. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.3-8, 1996. 71. Blaivas, J.G., Chancellor, M.B.: Chapter 2: Pre-urodynamic Evaluation. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.9-18, 1996. 72. Chancellor, M.B., Blaivas, J.G.: Chapter 3: Deciding on the Right Urodynamic Equipment. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.19-30, 1996. 73. Blaivas, J.G., Chancellor, M.B.: Chapter 4: Cystometrogram. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.31-47, 1996. 74. Rivas, D.A., Chancellor, M.B.: Chapter 5: Uroflowmetry. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.48-59, 1996. 75. Blaivas, J.G., Chancellor, M.B.: Chapter 7: Urethral Pressure Measurements. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.77-86, 1996. 76. Chancellor, M.B., Blaivas, J.G.: Chapter 8: Synchronous Pressure-flow and Video-urodynamics. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.88-104, 1996. 77. Blaivas, J.G., Chancellor, M.B.: Chapter 12: Normal and Abnormal Physiology of Micturition. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.149-159, 1996. 78. Chancellor, M.B., Blaivas, J.G.: Chapter 13: Spinal Cord Injury. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.160-174, 1996. 79. Blaivas, J.G., Chancellor, M.B.: Chapter 14: Cerebrovascular Accident, Parkinson Disease, and Other Intracranial Diseases. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.174-182, 1996. 80. Chancellor, M.B., Blaivas, J.G.: Chapter 15: Multiple Sclerosis and Diabetic Neurogenic Bladder. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.183-191, 1996. 81. Blaivas, J.G., Chancellor, M.B.: Chapter 16: Cauda Equina, Infectious, and Other Spinal Diseases. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.192-204, 1996. 82. Chancellor, M.B., Blaivas, J.G.: Chapter 17: Classification of Stress Incontinence. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.205-207, 1996. 83. Blaivas, J.G., Chancellor, M.B.: Chapter 19: Mixed Incontinence and Interseptal Cystitis. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.214-226, 1996. 84. Chancellor, M.B., Blaivas, J.G.: Chapter 20: Benign Prostatic Hyperplasia, Bladder Neck Obstruction, and Prostatitis. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.227-239, 1996. 85. Blaivas, J.G., Chancellor, M.B.: Chapter 21: Post-prostatectomy Incontinence. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.240-250, 1996. 86. Chancellor, M.B., Blaivas, J.G.: Chapter 23: Geriatric Urodynamics. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.271-282, 1996. 87. Rivas, D.A., Chancellor, M.B.: Chapter 24: Urodynamics in Urinary Tract Reconstruction. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.283-290, 1996. 88. Chancellor, M.B.: Appendix A: Urodynamic Diagnosis and Procedure Codes. In: Atlas of Urodynamics. eds. Blaivas, J.G. and Chancellor, M.B. Williams and Wilkins, Philadelphia, PA. Pp.291-294, 1996. 89. Chancellor, M.B., Rivas, D.A., Janknegt, R.A.: Gracilis Urethromyoplasty: A Novel Autologous Urinary Sphincter. Current Surgical Techniques in Urology. Volume 9, Issue 1. Medical Publications, Inc., Wilmington, DE. 1996. 90. Chancellor, M.B.: Better Ways to Control Urination in SCI Patient. In, Contemporary Rehabilitation, Reich, G.B. ed., Thomas Jefferson University Hospital Press, 1996. 91. Chancellor, M.B.: Forward. In: Topics in Spinal Cord Injury Rehabilitation. Chancellor, M.B., ed., Aspen Publisher, 1(5): vii-viii, 1996. 92. Chancellor, M.B., Rivas, D.A.: Neuromodulation and Neurostimulation in Urology. In: Topics in Spinal Cord Injury Rehabilitation. Chancellor, M.B., ed., Aspen Publisher, 1(5): 18-35, 1996. 93. Rivas, M.D., Abdill, C.K. Chancellor, M.B.: Current Management of Detrusor Sphincter Dyssynergia. In: Topics in Spinal Cord Injury Rehabilitation. Chancellor, M.B., ed., Aspen Publisher, 1(5):1-17, 1996. Chancellor 39 of 108 94. Rivas, D.A., Chancellor, M.B.: Male and Female Sexual Dysfunction. In: Topics in Spinal Cord Injury Rehabilitation. Chancellor, M.B., ed., Aspen Publisher, 1(5):55-64, 1996. 95. Watanabe, T., Rivas, D.A., Chancellor, M.B.: Neurogenic Bladder Dysfunction. In: Evaluation and Treatment of Urinary Incontinence. Blaivas, J.G., ed., Igaku-Shoin, Inc., New York, NY, pp.148-167, 1996. 96. Chancellor, M.B.: Evaluation and Outcome. In: The Health of Women with Physical Disabilities: Setting a Research Agenda for the 90's. Krotoski D.M., Nosek, M., Turk, M. eds. Brooks Publishing Company, Baltimore, MD, Chapter 24, 309-332, 1996. 97. Chancellor, M.B.: Leg Muscle May Stand up to Refractory Incontinence. Urology Times, December, 1996. 98. Chancellor, M.B., Rivas, D.A., Manon-Espaillant, R., Mandel, S.: Evaluation of neurogenic bladder dysfunction and disability. Disability, 6: 1-17, 1997. 99. Rivas, D.A., Chancellor, M.B.: Management of Erectile Dysfunction. In. Sexual Function in People with Disability and Chronic Illness. Ed. Sipski, M.L., Alexander, C.J., Aspen Publication, Gaitherburg, MD, 429-464, 1997. 100. Watanabe, T., Chancellor, M.B., Rivas, D.A.: Chapter 13: Neurogenic Voiding Dysfunction. In. Practical Urodynamics. Nitti, V.W. ed. W.B. Saunders, Philadelphia, PA, pp.142-155, 1998. 101. Mandel, S., Manon, J., Rivas, D.A., Chancellor, M.B.: Urology. In. Hospital Consultation Neurology, ed. Samuels, M.A., Butterworth, Boston, MA, 597-616, 1998. 102. Chancellor, M.B.: Parkinson’s disease. Continuum, Lifelong Learning in Neurology, 4: 81-89, 1998. 103. Chancellor, M.B.: Transverse myelitis. Continuum, Lifelong Learning in Neurology, 4: 103-105, 1998. 104. Chancellor, M.B.: Spina bifida and related disorders. Continuum, Lifelong Learning in Neurology, 4:111-115, 1998. 105. Chancellor, M.B.: Lumbosacral disc disease. Continuum, Lifelong Learning in Neurology, 4: 105-107, 1998. 106. Chancellor, M.B.: Guillain-Barre disease. Continuum, Lifelong Learning in Neurology, 4: 109-110, 1998. 107. Chancellor, M.B.: Other neuropathics. Continuum, Lifelong Learning in Neurology, 4: 110-111, 1998. 108. Chancellor, M.B.: New pharmacological therapy for the overactive bladder. AUA News, 3(6): 4-5, 1998. 109. Chancellor, M.B., Rivas, D.A.: Complications related to sphincter stent used for the management of detrusor sphincter dyssynergia. In. Stenting the Urological System. Ed. Yachia, O, Isis Medical Media, 1998. 110. Chancellor, M.B., Diokno, A.C., Ouslander, J.G.: Treatment options for urinary incontinence. Patient Care, March, pp. 11-16, 1999. 111. Chancellor, M.B., Liu, J.B.: Lower Urinary Tract. In: Endoluminal Ultrasound. Goldberg, B.B., ed. Martin Dunitz, Publishers, 1999. 112. Chancellor, M.B.: Managing the urge incontinent bladder: Competent therapies help restore quality of life. Contemporary Urology, March: 7-13, 1999. 113. Chancellor, M.B.: Urinary incontinence: New treatment options. Consultations in Primary Care 39:S15-S19, 1999. 114. Voduske, D.B., Bemelmans, B., Chancellor, M.B., Coates, K. van Kerrebroeck, P., Opsomer, R.J., Schmidt, R., Swash, M.: Clinical Neurophysiology. In: Incontinence, W.H.O. 1st International Consultantion in Incontinence. eds. Abrams, P., Khoury, S., Wein, A., Plymbridge Distributors Ltd, Plymouth, UK, 157-199, 1999. 115. Barrett, D.M., Abol-Enein, H., Castro-Diaz, D., Hohenfellner, M., Stohrer, M.W., Tanagho, E.A., Elliott, D.S., Chancellor, M.B., Madersbacher, H., Stein, R.: Surgery for the Neuropathic Patient. In: Incontinence, W.H.O. 1st International Consultantion in Incontinence. eds. Abrams, P., Khoury, S., Wein, A., Plymbridge Distributors Ltd, Plymouth, UK, 813-836, 1999. 116. Partin, A.W. and Chancellor, M.B.: Best of the AUA annual meeting. Rev. in Urology, 1:124-144, 1999. 117. Chancellor, M.B., Andersson, K.E., Abrams, P.: New pharmacological therapy for the overactive bladder. AUA News, 4(6): 4-7, 1999. 118. Wein, A.J., Chancellor, M.B., Andersson, K.E., Abrams, P., Payne, C.K.: Evaluating clinical relevance in overactive bladder. Oxford Institute, Newtown, PA, pp. 1-38, 1999. 119. Lavelle, J.P., Yokoyama, T., Chancellor, M.B.: How best to treat detrusor instability in patients with stress incontinence. Contemporary Urology, May: 28-47, 2000. 120. Smith, C.P., Chancellor, M.B.: Neurourology. In Fast Facts-Urology Highlights 1999-2000, ed. Shah, J., Heath Press Limited, Oxford, UK, pp.65-74, 2000. 121. Jung, S.Y., Chancellor, M.B., Lyme Disease, Urologic Considerations. In: The 5-Minute Urology Consult, Ed Gomella, L.G., Lippincott Williams & Wilkins, pp. 328-329, Philadelphia, PA, 2000. 122. Teahan, S.J., Lavelle, J.P., Chancellor, M.B., Myasthenia Gravis, Urologic Considerations. In: The 5-Minute Urology Consult, Ed Gomella, L.G., Lippincott Williams & Wilkins, pp356-357, Philadelphia, PA, 2000. 123. Chancellor, M.B.: Stem cells examined as treatment for incontinence. Urology Times, September, 2000. Chancellor 40 of 108 124. Rivas, D.A., Chancellor, M.B.: Radiology of Specific Neuromuscular Diseases Affecting the Urinary Tract: Diseases of the Brain, Spinal Cord, and Peripheral Nervous System. In: Clinical Urography, 2nd ed. Pollack, H., McClennan B.L., W.B. Saunders, 2367-2394, 2000. 125. Jung, S.Y., Chancellor, M.B.: Upper and Lower Motor Neuron Diseases. In: Textbook of Female Urology and Urogynecology, ed. Cardozo, L., Staskin, D., Isis Medical Media, Oxford, United Kingdom, 2001. 126. Lavelle, J.P., Phelan, M.W., Teahan, S., Chancellor, M.B.: Office Urodynamics, In Office Urology, ed. Kursh E.D., Humana Press, Totowa, NJ, 407-416, 2000. 127. Chancellor, M.B.: Best of the AUA Annual Meeting. Rev. Urology, 2:142-143, 2000. 128. Chancellor, M.B.: First-line therapy for stress incontinence, Rev. Urology, 2:229-230, 2001. 129. Chancellor, M.B.: Investigational of two potential interstitial cystitis treatments. Interstitial Cystitis Update, December 6-7, 2000. 130. Smith, C.P., Chancellor, M.B.: Neurourology. In Fast Facts-Urology Highlights 2000-2001, ed. Shah, J., Heath Press Limited, Oxford, UK, 69-80, 2001. 131. Chancellor, M.B.: Artificial urinary sphincter; expanded indications and results, AUA News, 3-4, January 2001. 132. Chancellor, M.B.: What is best sling material? Review in Urology, 3:28-29, 2001. 133. Chancellor, M.B.: RTX, gene therpay hold future promise for treating IC. Urology Times, February, 34, 2001. 134. Chancellor, M.B.: Can we rebuild the lower urinary tract with stem cell tissue engineering. Best of the AUA Annual Meeting. Rev. Urology, 3:193-206, 2001. 135. Leng, W.W., Chancellor, M.B.: Comparison of incontinence risk after radical prostatectomy versus hysterectomy. Rev. Urology, 3:156-159, 2001. 136. Yoshimura, N., Chancellor, M.B.: Interstitial cystitis and bladder research: progress and future directions. Rev. Urology, 3:146-152, 2001. 137. Chancellor, M.B.: Fix for leaky bladder, NewScientist Archive. June 9, 2001. 138. Chancellor, M.B.: Future trends in the treatment of urinary incontinence. Review in Urology Supplement, 3:S27- S34, 2001. 139. Chancellor, M.B.: Overactive bladder versus stress incontinence; Progressive Farmer, September, 34-25, 2001. 140. Chancellor, M.B.: Stem cells to treat incontinence. AUA Daily News, April 3, 2001. 141. Chancellor, M.B.: Urinary incontinence; state-of-the-art., AUA Daily News, April 4, 2001. 142. Jung, S.Y., Chancellor, M.B.: Neurogenic disorders. In: Textbook of Female Urology and Uogynaecology, eds. Staskin, D., Cardozo, L. Isis Medical Media, London, UK, 837-855.2001. 143. Chancellor, M.B.: Lovely-but useless: Chain cystourethrography. Consultantions in Primary care, 41:1503, 2001. 144. Appell, R., Chancellor, M.B.: Product Monograph, Oxybutynin Chloride Extended-Release Tablet. ALZA, 2001. Fraser, M.O., Lavelle, J.P., Sacks, M.S., Chancellor, M.B.: The future of bladder control – Intravesical drug delivery, a pinch of pepper, and gene therapy. Rev. Urol., 4: 1-11, 2002 2002. 145. Cannon, T.W., Chancellor, M.B.: Review of neurogenic voiding dysfunction. CNS News, March: 7-12, 2002. 146. Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Botulinum toxin: Poisoning the spastic bladder and urethra. Rev. Urol., 4:61-68, 2002. 147. Chancellor, M.B., Leng, W.W.: Hypotheses on how sacral nerve stimulation neuromodulation works for the treatment of detrsuor overactivity and urinary retention. Textbook of Sacral Nerve Stimulation. Chapter 3; 17-28, 2002. 148. Chancellor, M.B.: Overactive bladder among neurological patients. Neurology Reviews, in press, 2002. 149. Chancellor, M.B.: New frontiers in the treatment of overactive bladder and incontinence. in: Strategies for the Treatment of Overactive Bladder and Urinary Incontinence. Review in Urology Supplement, Eds. Nitti, V.W., Chancellor, M.B., Vol 4, S50-56, 2002. 150. Chancellor, M.B., Yoshimura, N.: Vol. 2, Part V. Physiology and pharmacology of the bladder and urethra. In Campbells Urology 8th edition. Edtior: Walsh, P.C., Pp.831-886. 2002. 151. NIDDK Report of Bladder Research Progress Review Group: Chancellor, M.B., Weiss, R. eds; Chapter 10: Urologic Problems in Diabetes Mellitus. Pg 133-146, 2002. 152. Chancellor, M.B.: Botulinum toxin update, ICA Update, Sept. /October: 8-9, 2002. 153. Smith, C.P., Somogyi, G.T., Chancellor, M.B.: Eemerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Current Urology Reports; 3:382-387, 2002 154. Chancellor, M.B.: Botulinum toxin A to treat overactive bladder. Best of the AUA Annual Meeting. Rev. Urology, 4:122-140, 2002. 155. Kim, J., Chancellor, M.B.: New approaches to the treatment of overactive bladder: Rev. Urology, 5: 59-60, 2003. 156. Smith, C.P., Chancellor, M.B.: Botulinum shows promise for voding dysfunction, Urology Times, November, 2002. Chancellor 41 of 108 157. Chancellor, M.B.: A new wrinkle for botox. Prevention, January, 2003. 158. Kim, Y.T., Chancellor, M.B.: Use of desmopressin in the elderly, Reviews in Urology, 6:43-49, 2003. 159. Chermansky C.J., Chancellor, M.B.: Increasing awareness and improving the care of urinary incontinence. Meeting Review. Rev. Urology, 5:22-25, 2003. 160. Chancellor, M.B.: Best of 2003 AUA Annual Meeting. 5:1565-181, 2003. 161. Kwon, D.D., Chancellor, M.B.: The estrogen controversay, Rev. Urology, 5:131-132, 2003. 162. O'Leary, M.; Chancellor, M.B.; Multiple Sclerosis and Bladder Health; NAFC Quarterly Newsletter; 21: 1-2, 2003. 163. Cannon, T.W.; Chancellor, M.B.: Pharmacotherapy for stress urinary incontinence. Rev. Urology 56:135-141, 2003. 164. Yoshimura, N., Chancellor, M.B.: Neurophysiology of lower urinary tract function and dysfunction. Rev. Urology 2003 (Supple 8): S3-S10, 165. Cannon, T.W., Howden, N., Xavier, M., Chancellor, M.B.: Advances in the treatment of pelvic floor dysfunction. Rev. Urology, 5:235-240, 2003. 166. Chancellor, M.B.: Botox for bladder problems. Renal & Urology News. 3: (March), 2003. 167. Leng, W.W., Chancellor, M.B.: Recognition and treatment of bladder outlet obstruction after sling surgery. Rev. Urology, 6:29-33, 2004. 168. Rivas, D.A., Chancellor, M.B.: Complications related to Urolume sphincter stent used for the management of detrusor-sphincter dyssyenrgia. In: Sphincter stent. In The Urinary Sphincter. Eds., Corcos, J., Chapter 67: 507-513, Martin DUnitz, NY, NY, 2004. 169. Yoshimura, N., Chancellor, M.B.: Differential disgnosis and treatment of impaired bladder emptying. Rev. Urology 6 (Supple. 1) S24-S31, 2004. 170. Azuma, H., Chancellor, M.B.: Overview of biodegradable urethral stents and treatment of mixed incontinence. Rev. Urology 6:1-2, 2004. 171. Smith, C.P., Blaivas, J., Chancellor, M.B.: Lower urinary tract dysfunciton in the male. In Bourcier, A.P. McGuire, E., Abrams, P. Harcourt Health Science. In press, 2004. 172. Lu, S-H., Chancellor, M.B.: Chapter 44: Systemic pharmacological treatment. In Neurogenic Bladder, eds Corcos, J., Schick, E., Martin Dunitz, London, UK, 2004. 173. Chermansky, C., Huard, J., Chancellor, M.B.: Gene therapy using muscle-derived stem cells. Adult Stem cells, Edtior: K. Turksen, Humana Press, Totowa, NJ, pp. 51-66, 2004. 174. Chancellor, M.B., Yoshimura, N.: Neurophysiology of stress urinary incontinence. Rev. Urology 6 (Supple. 3) S19- S28, 2004. 175. Jankowski, R., Pruchnic, R., Hiles, M., Chancellor, M.B.: Advances toward tissue engineering for the treatment of stress urinary incontinence. Rev. Urology 6: 51-57, 2004. 176. Kamo, I., Chancellor, M.B.: Treatment of mixed incontinence. Rev. Urol., 6:166-167, 2004. 177. Prantil, R., Chancellor, M.B.: Pharmacotherapy of stress urinary incontinence. Business Briefing, in press, 2005. 178. Chancellor, M.B.: (Editorial) Dulxoetine in stress urinary incontinence. Drugs, in press, 2005. 179. Chancellor, M.B: Pathophysiological of urgency as rationale for treatment. Urology Times, Supplement August 2004. 180. Chancellor, M.B.: Chapter 12: Pathophysiology of the areflexic bladder. In Neurogenic Bladder, eds Corcos, J., Schick, E., 2004. 181. Prantil, R., Chancellor, M.B.: Recent advances in the treatment of stress urinary incontinence. Business Briefing North American Pharmacotherapy, 2:106-110, 2004. 182. Sweeney, D.D., Chancellor, M.B.: Treatment of stress urinary incontinence with duloxetine hydrochloride, Reviews in Urology, 7:81-86, 2005. 183. de Miguel, D., Chancellor, M.B.: Urinary acidity and pain in interstitial cystitis. Reviews in Urology, 7:112,-113, 2005. 184. Wein, A.J., Dmochowski, R.R., Andersson, K-E, Chancellor, M.B., Staskin, D.R.: The new science of the urothelium and data reconciliation in OAB. Urology Time CME Supplement. Dec. 2005. 185. Yoshimura, N. and Chancellor, M.B.: Physiology and pharmacology of the bladder and urethra. In Campbells Urology 9th edition. Edtiors: Wein, A.j., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. Pp. 1922-1972, 2007. 186. Chancellor, M.B.: Urological applications, in: A Multispeciality Guide to the Use of Botulinum Neurotoxins, Neurotoxin Institute. Pp 98-114, 2006 187. Chancellor, MB, Ginsburg, D., Siegel, S.: Experts debate between two treatment options for refractory detrusor overactivity. AUA Daily News, May 2007. Chancellor 42 of 108 188. Tyagi, P., Chancellor, M.C., Drug Delivery and Intravesical Instillation. Editded by Kreder, K., Dmochowski, R.: Overactive Bladder. Informa Helathcare, London, 2007, pp115-125. 189. Botox better than expected for BPH, Renal & Urology News, 6:1-8, July, 2007. 190. Chancellor, M.B.: Recalcitrant urinary frequency and urgency. In Female Urology, eds, Goldman, H.B., Vasavada, S.P., Humana Press, Totowa, NJ, pp375-377, 2007. 191. de Miguel, F., Chancellor, M.B.: Somatic cell therapy for urinary incontinence. In Cell Therapy, eds Garcia-Olmo, D., Garcia-Verdugo J.M., Alemany, J., Gutierrez-Fuentes, J.A., McGraw Hill, Madrid, Spain, pp. 403-414, 2008. 192. Chuang, Y.C., Chancellor, M.B: Treatment of painful bladder and pelvic organ prolapse. Reviews in Urology, 2008. 193. Tyagi, P., Chancellor, M.B.: Drug delivery and intravesical instillation. in Diagnosis and Management of the Overactive Bladder, eds., Kreder, K.J, Dmochowski, R.R., Taylor & Francis, Medical Book, London, UK, 2008. 194. Chuang, Y.C., Chancellor, M.B.: Application of botulinum toxin in the prostate. Chapter 22, 273-282, in Botulinum Toxin, Therapeutic Clinical Practice and Science. ed: Jankovic, J, Saunders/Elsevier, Philadelphia, 2009. 195. Chancellor, M.B., Somogyi, G.T., Smith, C.P.: Mechanism of botulinum toxin in the lower urinary tract. Chapter 19, 231-239, in Botulinum Toxin, Therapeutic Clinical Practice and Science. ed: Jankovic, J, Saunders/Elsevier, Philadelphia, 2009. 196. Chuang, Y.C., Kuo, H.C., Chancellor, M.B.: Bladder botulinum toxin, Lower Urinary Tract Symptoms, 1(Supp 1):22-25, 2009. 197. Furuta, A., Naruoka, T., Suzuki, Y., Egawa, S., Erickson, V., Chancellor, M.B., Yoshimura, N.: Alpha-2 adrenoreceptor as a new target for stress urinary incontinence, Lower Urinary Tract Symptoms, 1(Supp 1):26-29, 2009. 198. Kato, R., Bennett, N.E., Kim, J.H., Nelson, J.B., Glorioso, J.C., Chancellor, M.B., Yoshimura, N.: Gene therapy for neurogenic erectile dysfunction, Lower Urinary Tract Symptoms, 1(Supp 1):44-47, 2009. 199. Kim, D.K., Yoshimura, N., Tyagi, P, Chancellor, M.B.: Role of sarco/endoplasmic reticulum calcium ATPase in lower urinary tract smooth muscles, Lower Urinary Tract Symptoms, 1(Supp 1):50-53, 2009. 200. Kim, Y.T., Chancellor, M.B., Tyagi, P., Yoshimura, N., Masuda, H., Kim, D.K, Kwon, D.D., Chuang, Y.C.: Localized effects of antimuscarinics in the bladder, Lower Urinary Tract Symptoms, 1(Supp 1):56-59, 2009. 201. Kuo, H.C., Liu, H.T., Guan, E., Chancellor, M.B.: Novel biomarkers for diagnosis and therapeutic assessment of overactive bladder: urinary nerve growth factor and detrusor wall thickness, Lower Urinary Tract Symptoms, 1(Supp 1):59-62, 2009. 202. Lu, S.H., Chancellor, M.B., Pruchnic, R., Jankowski, R., Lee, J.Y., Yoshimura, N., Yokoyama, T.: Muscle-derived stem cell therapy for stress urinary incontinence, Lower Urinary Tract Symptoms, 1(Supp 1):62-64, 2009. 203. Ogawa, H., Chancellor, M.B., Nose, H., Watanabe, Y., Yokoyama, T., Sasaki, K., Watanabe, T., Kumon, H.: Noninvasive ivdeourodyanmics using transperineal Doppler ultrasonography, Lower Urinary Tract Symptoms, 1(Supp 1):80-84, 2009. 204. Torimoto, K., Sasaki, K., Matsuyoshi, H., Matsumoto, Y., Hirao, Y., Chancellor, M.B., Yoshimura, N.: Lower urinary tract: diabetes mellitus-focused on recent experimental results, Lower Urinary Tract Symptoms, 1(Supp 1):87-90, 2009. 205. Tyagi, P., Chuang, Y.C., Yoshimura, N., Kaufman, J., Chancellor, M.B.: Bladder instillation of liposomes for bladder coating and drug delivery platform, Lower Urinary Tract Symptoms, 1(Supp 1):90-94, 2009. 206. Wang, C.C., Nagatomi, J., Toosi, K.K., Yoshimura, N., Sacks, M.S., Chancellor, M.B.: Biomechanics of diabetic bladders, Lower Urinary Tract Symptoms, 1(Supp 1):94-98, 2009. 207. Chancellor, M.B.: Cardozo and Staskin (eds) Textbook of Female Urology and Urogyencology 3E., in press, 2011. 208. Yoshimura, N. and Chancellor, M.B.: Physiology and pharmacology of the bladder and urethra. In Campbells Urology 10th edition. Editors: Wein, A.j., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. 2011. 209. Brawer MK, Loeb S, Partin AW, Nirmal J, Chancellor MB, Nickel JC, Rajfer J, Shapiro E, Roehrborn CG. Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC. Rev Urol. 2011;13(3):151-72. 210. Smith CP and Chancellor MB: Botulinumtoxin in urology. Urology Times supplement, December 2012. 211. Watanabe T, Chancellor MB. Pelvic surgeons caught in the meshes of the law. Rev Urol. 2012;14(1-2):35-6. 212. Homma Y, Kakizaki H, Smith JA Jr, Namiki S, Arai Y, Tomita Y, Uzzo R, Tsuchiya N, Takahashi M, Ichikawa T, Quek ML, Uemura H, Mizokami A, Kakizaki H,Steers WD, Gotoh M, Ogawa T, Chancellor MB, Yamamoto S, Takahashi S, Ichihara K. The 7th American Urological Association and the Japanese Urological Association international affiliate society meeting.Int J Urol. 2012 Apr;19(4):374-85. doi: 10.1111/j.1442-2042.2012.02984.x. 213. Chancellor MB, Ginzberg DA: OAB: Current and emerging therapies for optimal individualized treatment. Renal & Urology News: Sept, 2013 Chancellor 43 of 108 214. AUA News: Voiding dysfunction and female urology AUA 2013 Annual Meeting Highlights. October 2013. 215. AUA News: Underactive Bladder: a Bigger Nuisance than Overactive Bladder. Vol 19; Issue 11, November 2014. 216. Chancellor MB, Ginsberg DA, Nitti VW: Shared decision making in managing idiopathic and neurogenic OAB. Renal and Urology News, September 2014. 217. Vereecke A, Chancellor D, Levanovich P, Chancellor MB: Experts meet to advance underactive bladder research priorities. AUA News, 2014. 218. O’Leary M, Okonski J, Chancellor MB: A Patient’s Guide to Underactive Bladder. Booklet from the Underactive Bladder Foundation, 2015 www.underactivebladder.org 219. AUA News: AUA 2017 Annual Meeting Highlights, Female Urology/Voiding Dysfunction, Course #0081C 2017.

AUDIO, VIDEOTAPES AND ELECTRONIC EDUCATION

1. Urological Dysfunction in Multiple Sclerosis, Delaware Valley Regional M.S. Center Audiotape. April, 1991. 2. Sexual Dysfunction in Multiple Sclerosis, Delaware Valley Regional M.S. Center Audiotape. April, 1991. 3. Colpopoiesis A.M. Davydov. Makinen, J., Hirvonen, T., Davydov, S., Kiilholma, P., Chancellor, M.B., Filmer, B. Videotape, 1991 Annual Meeting of the American Urological Association. Washington, D.C., May 11-14, 1992. 4. Transurethral Laser Vaporization of the External Sphincter. Liberman, S.N., Chancellor, M.B., Gomella, L.G., Cowan, B., Perkash, I. Videotape, 1993 Annual Meeting of the American Urological Association. San Antonio, TX, May 16-20, 1993. 5. Video Conference Moderator, Current Advances in the Treatment of Intrinsic Sphincter Deficiency. New York, NY, November 20, 1993. 6. Diagnosis and Treatment of Voiding Disturbances in Spinal Cord Injury. Chancellor, M.B., American Urological Association Consultant Urologist Audiotape Project. July 5, 1994. 7. Haarala, M., Kiilholma, P., Makinen, J., Polvi, H., Meltomaa, S., Chancellor., M.B.: Endoscopic Colpofixation Using Fibrin Sealant. Videotape Annual Meeting of the AUA., Orlando, Fl., May 4-9, 1996. J. Urol., 155: 301A, 1996. 8. Detrusor Sphincter Dyssynergia, Medical Outlook for Urologist Audiotape. Vol. 10, No. 2, 1996. The Cortlandt Group Inc., 500 Executive Blvd., Ossining, NY 10562. 9. Chancellor, M.B., Rivas, D.A.: Urinary Incontinence. Williams & Wilkins' World Wide Web Medical School Education. 1996. 10. Rivas, D.A., Chancellor, M.B.: Benign Prostatic Hyperplasia. Williams & Wilkins' World Wide Web Medical School Education. 1996. 11. Evaluation of Voiding Dysfunction and Incontinence. AUA Comprehensive Urology Review Videotape. Tape 2 of 13, CME Conference Video, Inc. 3000 Crawford Place, Suite 100, Mt. Laurel, NJ 08054, 1997. 12. National Teleconfrence Course Director on Sphincter Stent Treatment of Detrusor-Sphincter Dyssynergia. July and August, 1999. 13. Neurourology Knowledge Center Advising Board 1998-present www.urologynet.org. 14. Chancellor, M.B.: New approaches to bladder control: tissue engineering, gene therapy, and a pinch of pepper. Americas Doctor live internet chat. January 5, 2000 www.americansdoctor.com 15. Advisory Board of Urology Network’s Knowledge Center, 2000-present www.neurourology.net 16. Quest for Continence Audiotape; British Urological Surgeon Meeting Symposium, July 2000. 17. National Teleconfrence Course Director on Sphincter Stent Treatment of Detrusor-Sphincter Dyssynergia. October, 2000. 18. Myoplasty for postprostatectomy incontinence. Audio-Digest Urology, Vol 25: Issue 06, June 2002. 19. Chancellor, M.B.: Advanced drug delivery systems and future treatments for overactive bladder. Currect and future approaches to treating urinary incontinence. CD-ROM, 2001. 20. Chancellor, M.B.: Review of book “Urinary Sphincter” Dood’y On-Line Review. www.doody.com, 2001. 21. Urinary Incontinence, WAMC, The Health Show, July 5, 2001 22. Treatment of voiding dysfunction into the next decade. Audio-Digest Urology, Vol 25: Issue 05, May 2002. 23. OABExpert.com Advisory Board. 2002-present 24. Contributor: NIH Bladder Research Progress Review Group Report http://www.niddk.nih.gov/fund/other/brprg_book.pdf 25. Contributor: World Health Organization: CV-ROM Book: Incontinence. 26. Neurotoxin Institute Website Faculty, 2002-Present Chancellor 44 of 108 27. Section; online CME course: Overactive bladder, interstitial cystitis and urinary tract infection, Dot Com Advisors, 2003-Present. 28. CD-ROM CME Course: Challenges in the Detection and Diagnosis of Bladder Dysfunction, Med Reviews, 2004. 29. The state of urinary incontinence in women. CD-ROM, Review in Urology, March 2004. 30. Bridiging the gap in the management of overactive bladder. CD-ROM, Academy for Healthcare Education, 2004. 31. Understanding the relationship between the mechanism of incontinence and treatment strategies. http://accelmed.webex.com, 2004. 32. Prauresis, UrologyHealth.org, AUA information web site, www.urologyhealth.org, 2005. 33. Academic specialist vitual advisory board, Astellas/GSK, 2005. 34. Botulinum toxin bladder injection technique for voiding dysfunctions. DVD, Neurotoxin Institute, 2005 http://www.neurotoxininstitute.org/ 35. 2006 Webcast Program Director: CURE-IC Hope and Awareness for Interstitial Cystitis. http://mediasite.cidde.pitt.edu 36. CME DVD Moderator: Potential Therapeutic Application of Botulinum Toxin in Overactive Blader Neurotoxin Institute, 2006 http://www.neurotoxininstitute.org/ 37. O’Leary, M., Heyman, R., Erickson, J., Chancellor, M.B.: Premature ejaculation and MS: A Review, Consortium of MS Centers, http://www.mscare.org, June 2007 38. Overactive Bladder, UrologyHealth.org, AUA information web site, www.urologyhealth.org, 2008. 39. Chancellor, M.B.: Research points to expanding role of botulinum toxin in several urologic procedures, Urology Times, 2009. http://license.icopyright.net/user/viewFreeUse.act?fuid-NTg0NjU0Mw%3D%3D 40. Chancellor, M.B.: Part II: Current Treatment Options for Neurogenic Bladder Dysfunction. www.renalandurologynews.com JULY 2012 Renal & Urology News 41. Chancellor, M.B.: MyCME: Neurogenic Overactive Bladder: Assessment and Management Strategies to Optimize Patient Outcomes 2012 http://www.mycme.com/neurogenic-overactive-bladder-assessment-and-management- strategies-to-optimize-patient-outcomes/activity/1064/ 42. Stragegies to Improve Adherence and Clinical Management of Overactive Bladder. http://vimeo.com/64032045, http://vimeo.com/64032576, http://vimeo.com/64032977, 2013 43. MyCME.com http://www.mycme.com/oab-current-and-emerging-therapies-for-optimal-individualized- treatment/activity/1514 44. 2014 Renal & Urology News: http://www.renalandurologynews.com/shared-decision-making-in-managing- idiopathic-and-neurogenic-oab/article/369434/ 45. 2014 myCME: http://www.mycme.com/shared-decision-making-in-managing-idiopathic-and-neurogenic- oab/activity/1987/ 46. https://www.bottomlinepublications.com/content/article/health-a-healing/the-other-bladder-problem 47. UroToday: CURE-UAB, 2019 48. Beaumont Clinical Research Day LinkIn story https://www.linkedin.com/in/michael-chancellor-a687847/detail/recent- activity/posts/ 2019

PROFESSIONAL ACTIVITIES

• Instructional Course Faculty, American Spinal Injury Association 18th Annual Scientific Meeting: Urological Care in Spinal Cord Injury, Toronto, Canada, May 8, 1992. • Urodynamics Evaluation • Experimental Methods in Neuro-Urology • Urology Committee, American Spinal Injury Association, 1992-Present. • Subcommittee on Sexual Dysfunction and Infertility, American Spinal Injury Association, 1992-Present. • Program Committee, American Urogynecologic Society and Urodynamic Society Combined Annual Meeting, 1993. • Program Committee, American Spinal Injury Association Annual Meeting, 1993-Present. • Postgraduate Course Faculty, American Urological Association Office of Education: Spinal Cord Injury, Washington, DC, May 12, 1992 • Urodynamics Technique • Bladder Dysfunctional Patterns • Intraurethral Stents for Neurogenic Bladder Chancellor 45 of 108 • Neurostimulation in Urology • Postgraduate Course Faculty, American Urological Association Office of Education: Spinal Cord Injury, San Antonio, Texas, May 12, 1993. • Moderator, Video Conference Current Advances in the Treatment of Intrinsic Sphincter Deficiency, New York, NY, and November 29, 1993. • Instructional Course Faculty, American Spinal Injury Association 18th Annual Scientific Meeting: Management of Stones in Spinal Cord Injury, Philadelphia, PA, and April 26, 1994: Epidemiology and Pathophysiology of Stone Disease. • Invited Faculty, "Rehabilitation of Women with Disability, 1994", National Institute of Health Consensus and Research Planning Conference, Washington, D.C., May 9-11, 1994. • Postgraduate Course Faculty, American Urological Association Office of Education, "Spinal Cord Injury", San Francisco, CA, May 17, 1994. • Moderator, "Detrusor Sphincter Dyssynergia-Sphincterotomy" Session of the 1994 Annual Urodynamic Society Program, San Francisco, CA, May 14, 1994. • Moderator, "Prosthetic Urethral Stents" Session of the 1994 Annual Biomedical Engineering Forum, San Francisco, CA, May 18, 1994. • Invited Visiting Professor, Department of Obstetric and Gynecology, Turku University, Finland, May 27-June 1, 1994. • Invited Visiting Professor, Department of Urology, Tempera University, Finland, June 1-3, 1994. • Moderator, Poster Session: Female Urology: Nonsurgical Management, American Urological Association Annual Meeting, Las Vegas, NV, April 23-28, 1995. • Moderator, General Session: Urological Issues, American Spinal Injury Association Annual Meeting, Orlando FL, May 1-3, 1995. • Invited Faculty, "Symposium and Public Forum: Urinary Incontinence" Delaware Health and Social Services, Dover, DE, June 16, 1995. • Keynote Speaker and Advance Urodynamics Workshop Moderator, Canadian Urodynamic Professional Tenth Annual Meeting, Ottawa, Canada, June 18, 1995. • Invited Faculty and Hands on Workshop Moderator, "Urodynamic", American Urological Association Office of Education" Houston, TX, July 22-23, 1995. • Invited Faculty and Hands on Workshop Moderator, "Urodynamic", American Urological Association Office of Education" Houston, TX, December 2-3, 1995. • Invited Faculty, “Urology, State of the Art Symposium”, NYU Medical Center, New York, NY, December 14-16, 1995. • Neurogenic Voiding Dysfunction • Case Presentations- Neurogenic Voiding Dysfunction • Medical and Surgical Treatment of Neurogenic Voiding Dysfunction • Invited Faculty, “Urinary Incontinence, 7th Annual Urology Symposium”, Memorial Regional Hospital, Hollywood, FL, February 2-4, 1996. • Augmentation Cystoplasty Including Auto-augmentation • Urethral Sphincter Reconstruction and Sacral Spinous Suspension for Pelvic Prolapse • Interstitial Cystitis • Keynote Speaker, Japan Urological Association Annual Meeting, “UroLume-The European and North American Long Term Experience with BPH, Stricture and DESD”. Okayama, Japan, April 5, 1996. • Chairperson and Speaker, “State of the Art in Neuro-Urology Neurostimulation and Neuromodulation” Urology Instructional Course, American Spinal Injury Association 22 nd Annual Meeting, Seattle, WA, April 23, 1996. • Moderator, Poster Session: Bladder Dysfunction-Research and Clinical, American Urological Association Annual Meeting, Orlando, FL, May 4-9, 1996. • Keynote Speaker, Michigan Urological Society, “Neuromodualation and Neurostimulation for Voiding Dysfunction: State of the Art”. Royal Oak, MI, January 8, 1997. • Invited Visiting Professor, Department of Urology Residency Program, William Beaumont Hospital, Royal Oak, MI, January 7-8, 1997. • Program Committee, Urodynamics Society’s Annual Meeting, 1997. • Keynote Speaker, Pittsburgh Urological Association, “Update on Incontinence from Leak Point Pressure to New Treatments”. Pittsburgh, PA February 17, 1997. Chancellor 46 of 108 • Invited Faculty "Urodynamic" Course, American Urological Association Office of Education, Houston, TX, and March 1-2, 1997. • Urodynamics of Spinal Cord Injury; Acute; Late; Monitoring Outcome • Obstructive Uropathy Related to BPH; Flow/Pressure Flows/Video Studies • Bladder-Related Incontinence • Moderator, General Session, Urodynamic Society Annual Meeting. New Orleans, LA, April 12, 1997. • Keynote Speaker, 8th AUA Highlight Meeting, “Neuromodulation for Voiding Dysfunction: State of the Art”, New Orleans, LA, April 15, 1997. • Keynote Speaker, Second Annual Korean Urodynamic Society Annual Meeting, “Diagnosis and Management of the Neurogenic Bladder”, Seoul, Korea, May 24, 1997. • Visiting Professor and Speaker, Dong-A University, “Update on Neurourology and Urinary Incontinence”, Pusan, Korea, May 26, 1997. • Visiting Professor and Speaker, Ewha Woman’s University, “Update on Basic Urology Research in Neurourology and Urinary Incontinence”, Seoul, Korea, May 27, 1997. • Invited Faculty “Physiology and Medical Management of the Neurogenic Bladder” 29th Annual Wound, Ostomy and Continence Conference, Nashville, TN June 8-12, 1997. • Invited Faculty, Symposium: Detrusor Sphincter Dyssynergia. American Paraplegia Society 1997 Annual Meeting, “Urolume stent versus external sphincterotomy in SCI patient”. Las Vegas NV, September 2-4, 1997, J. Spinal Cord Med., 20:465-466, 1997. • Invited Faculty, 1997 Thomas Jefferson University Urology Symposium. Bladder Outlet Obstruction, Avalon, NJ, September 6, 1997. • Invited Faculty, Symposium: A Proactive Approach to Urological Problems in Spinal Cord Injury, Rehabilitation Institute of Chicago, Chicago, IL, September, 11-12, 1997. • Pathophysiology of Neurogenic Bladder and Sexual Dysfunction • Urodynamic Evaluation and Pharmacologic Management of Neurogenic Bladder Dysfunction • Invited Faculty, Symposium: Neurostimuation and modulation. 4 Th International Congress of the Dutch Urological Association. “Electrically Stimulated Rectus-flap for Retention”, November 5-7, 1997. • Invited Faculty, Symposium: Advanced Surgical Techniques/Endosocpy, BPH & Voiding Dysfunction. “Urodynamic & Incontinence”, San Francisco, CA, October 24, 1997. • Pfizer Visiting Professor, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, November, 20-22, 1997 • Urinary Incontinence and Urodynamics, Division of Urology Grand Round • Principals of Treatment of Neurogenic Bladder, Division of Urology Teaching Conference • Update on Management of Neurogenic Urinary Incontinence, Physical Medicine and Rehabilitation Grand Rounds • Experimental Results with Dynamic Bladder Neck and Bladder Myoplasty, Division of Plastic Surgery Grand Rounds • Clinical Applications of Electrically Stimulated Skeletal Muscle for Assistance of the Non-Functioning Urinary Sphincter and Bladder, Surgery Grand Round • Invited Faculty: Interstim Sacral Nerve Stimulation Incontinence Control Therapy Course, Minneapolis, MN, March 27-28, 1998 • Principles of Innervation and Neuromodulation • Test Stimulation Laboratory Mentor • Sacral Nerve Stimulation Programming Laboratory Mentor • Symposium Director: Treatment of Urinary Incontinence: State of the Art 1998, Pittsburgh, PA, May 9, 1998. Co- Directors: Sandra Engberg, PhD, CRNP, M. Joan McDowell, PhD, CRNP, FAAN • Urodynamic Evaluation of Incontinence • Faculty, American Urological Association and American Board of Urology: Female Urology Committee Affairs, May 31, 1998. • Course Faculty: “Gene Therapy for Voiding Dysfunction”, Biotechnology Forum, American Urological Association 93rd Annual Meeting, San Diego, June 1, 1998. • World Health Organization, 1st International Consultation on Incontinence Preparatory Meeting. Deputy Chairman, Clinical Neurophysiology Subcommittee, San Diego, CA, June 1, 1998 Chancellor 47 of 108 • Course Director: “New Pharmacological Therapy for the Overactive Bladder”, American Urological Association 93rd Annual Meeting Post Graduate Course, San Diego, June 1, 1998. Also Lecture: • Intravesical Capsaicin Therapy • Consultant: National Multiple Sclerosis Society Bladder Management Guideline Development Panel, 1998. • World Health Organization, 1st International Consultation on Incontinence. Monaco, June 28-July 1, 1998 • Deputy Chairman, Clinical Neurophysiology Subcommittee • Consultant: Surgery for the Neuropathic Patient Subcommittee • Invited Visiting Professor, Department of Urology, University of Rochester, July 21, 22, 1998. • Intravesical C-fiber Neurotoxin Therapy • New Pharmacologic Therapy for Urinary Incontinence • Invited faculty “New treatment options of urge incontinence”. Annual Meeting of American Association of Family Practice, San Francisco, CA, September 16, 1998. • Invited faculty, Treatment of urinary incontinence. 18th Annual Conference on Aging Cambria-Somerset Council for Education of Health Professionals, Champion, PA, September 18, 1998. • Invited faculty, International Conference on the Pelvic Floor, Montreal, Canada, and September 23-27, 1998. • Supraspinal control of perineal muscles • Consequences of vesicourethral dyssynergia • Visiting Professor, Department of Urology, University of Syracuse, Syracuse, New York, October 7-8, 1998. • New therapies for the overactive bladder • Spicing up the way we treat voiding dysfunction; from capsaicin to gene therapy • Visiting Professor, Department of Urology, University of Nebraska and Nebraska Urological Association, Omaha, NE, October 9-10, 1998. • Urinary incontinence and overactive bladder • New therapy of voiding dysfunction; from capsaicin to gene therapy • Visiting Professor, State of the Art in bladder management. Department of Urology, University of Buffalo, Buffalo, New York, October 13-14, 1998. • Reviewer, Annual Meeting of the American Urological Association Program Abstract, 1998-Present • Invited Faculty: Interstim Sacral Nerve Stimulation Incontinence Control Therapy Course, Memphis, TN, January 22- 23, 1999 • Principles of Innervation and Neuromodulation • Test Stimulation Laboratory Mentor • Sacral Nerve Stimulation Programming Laboratory Mentor • Visiting Professor, University of Alabama School of Medicine, Birmingham, Alabama, February 11-12, 1999. • State of the Art in Incontinence Management. Department of Urology and Alabama Urological Society • New Therapy for the Neurogenic Bladder: From capsaicin to Gene Therapy; Department of Physical Medicine and Rehabilitation Grand Round • American Urological Association Ad Hoc Committee to Develop Urology Research Priorities at NIH, 1999. • Visiting Professor, Albany Medical College, Albany, New York, February, 26-27, 1999. • Urodynamic Evaluation of Incontinence • New Therapies on the Horizon for Urinary Incontinence • Invited Faculty: Advances in Urology; The Cleveland Clinic Foundation 29th Urological Postgraduate Symposium, Cleveland, OH, March 25-27, 1999 • Intractable Instability Electrical Stimulation • Urethral Stenting in Urology: Stricture, BPH, and DSD • Spinal Cord Injury Neurogenic Bladder • Course Director: “Advances in Treating Overactive Bladder; Speaking About the Silent Symptom”, American College of Physician and American Society of Internal Medicine 1999 Annual Meeting Symposium, New Orleans, LA April 22, 1999. Also Lecture: • Urinary Incontinence: The Silent Symptom • AUA Satellite Symposium: New Perspective on Incontinence, Dallas, TX April 30, 1999. • Clinical Results in Overactive Bladder • Society of Urodynamics and Female Urology 20th Annual Meeting Symposium Moderator: Point-Counterpoint: Non Surgical Management of Urinary Incontinence, Dallas, TX May 1, 1999. Chancellor 48 of 108 • Course Director: “New Pharmacological Therapy for the Overactive Bladder”, American Urological Association 94rd Annual Meeting Post Graduate Course, Dallas, TX, May 2, 1999. Also Lecture: • Intravesical Capsaicin and Resiniferatoxin Therapy • American Urological Association 94th Annual Meeting: Point-Counterpoint: Collagen injection in post-radical prostatectomy incontinence. Moderator, Dallas, TX May 5, 1999. • U.S. Geriatric and Long-Term Care Congress, Orlando, FL June 26, 1999. • Developing and Incontinence Treatment Plan • 2nd Overactive Bladder Consensus Meeting, London, UK, July 4, 1999. • Intravesical Treatment • 29th International Continence Society Annual Meeting, Denver, CO August 23-26, 1999 • State of the Art Lecture: Drug Therapy for Incontinence and Future Possibilities • Workshop Director: Advances in Drug Therapies and Delivery Systems • Satellite Symposium: Overactive Bladder in the 21th Century • Satellite Symposium: Sacral Nerve Stimulation Mechanism of Action • Visiting Professor, Sapporo Department of Urology, September 21-22, 1999. • Keynote Speaker, Japan Urodynamic Society September 23-25, 1999. • Visiting Professor, Division of Urologic Surgery, University of Arizona, Tuson, AZ, October, 21-22, 1999. • State of the Art in Urinary Incontinence • Faculty, NIDDK Genitourinary Tissue Engineering Workshop, Washington DC, November 4, 1999. • Myoblast Therapy for Incontinence • Faculty, University of Pittsburgh and Carnegie Mellon University Workshop: The Science of Cell and Tissue Engineering”. January 7, 2000. • Visiting Professor, Department Urology, SUNY Downstate and Long Island College Hospital, New York, NY, February 27-28, 2000. • Urinary Incontinence; Urodynamic Evaluation and Treatment Options • American Urological Association 95rd Annual Meeting, and Society of Neurourology and Female Urology Annual Meeting Atlanta, GA, May 1-4, 2000. • AUA Post Graduate Course Director: “New Pharmacological Therapy for the Overactive Bladder”, • AUA Course Lecture: Intravesical Therapy and Drug Delivery • AUA Podium Session Moderator • AUA and SUFU abstract reviewer • Course Director: “Bladder Inflammation and Pain”, University of Pittsburgh NIH Training Grant Symposium. Pittsburgh PA, May 26, 2000. • Invited Faculty, British Association Urologic Surgeons 2000 Annual Meeting, Birmingham, UK, June 20-21, 2000: • Keynote Speaker: New Approaches to Bladder Control • Moderator of Podium Session on Urinary Incontinence • Northeaster Section AUA Annual Meeting, Pittsburgh, PA, September, 14-17, 2000. • Executive Board of Director • Abstract Reviewer • Podium Session Moderator: Urinary Incontinence • Invited Faculty, 10th National Meeting of the Interstitial Cystitis Association and NIH, Minneapolis, MN, October 20- 22, 2000: • Keynote Speaker: Intravesical Peppers and Gene Therapy for IC • Moderator of Podium Session on Genetic Links in Interstitial Cystitis • Visiting Professor, Division of Urology, University of North Carolina, Chapel Hill, NC, December 6-7, 2000: • Urology Grand Round: Surgical therapy of stress incontinence • Triangle Urological Society: Quest for continence; intravesical peppers to gene therapy • Visiting Professor, Department of Urology, University of California San Francisco, San Francisco, CA, December 13- 14, 2000: • Urology Grand Round: Quest for continence • Operating room demonstration of botulinum toxin injection • Visiting Professor, Department of Urology, University of Indiana, India polis, IN, February 23-24, 2001: • Urology Grand Round: Neurourology Chancellor 49 of 108 • Indiana Urological Society; State of the art in incontinence • Invited Faculty, Female Pelvic Medicine and Reconstructive Surgery Symposium, University of Colorado, Breckenridge, CO, March 15-17, 2001: • Standardization of Diagnosis for Treatment Strategy • Treatment of Urge Incontinence • Invited Faculty, National Institute of Diabetes and Digestive and Kidney Disease’s Bladder Research Progress Review Group (Bladder Research PRG) 2001: • Committee Chairman: Diabetes Research Planning Meeting, February 21, 2001 • Committee Chairman: Diabetes Research, July 20-22, 2001 • American Urological Association 96rd Annual Meeting, and Society of Neurourology and Female Urology (SUFU) Annual Meeting Los Angeles, CA, June 2-7, 2001. • Invited AUA Keynote Speaker "New Therapy of the Overactive Bladder" • AUA Post Graduate Course Director: “New Pharmacological Therapy for the Overactive Bladder”, • AUA Course Lecture: "Intravesical Therapy and Drug Delivery" • Society of Basic Urologic Research Invited Speaker "Gene Therapy for Bladder Dysfunction" • AUA and SUFU abstract reviewer • World Health Organization, 2st International Consultation on Incontinence. Paris, France, July 1-4, 2001 • Faculty, Conservative Therapy on Neurogenic Bladder Committee • 23rd Annual Congress of the Urological Association of the Republic of China. Kaohsiung, Taiwan, August 24-27, 2001. • Keynote Speaker: Urinary incontinence, present and future therapy • Conference Podium Session Moderator • Visiting Professor Kaohsiung University • Visiting Professor Veterans General Hospital, Taipei, Taiwan • Visiting Professor, Medical College of Ohio and Northwestern Ohio Urological Association. Toledo, OH, October 17- 18, 2001. • State of the art treatment of the overactive bladder • Case studies in voiding dysfunction and incontinence • Invited Faculty, State of the Art Symposium, NYU Medical Center, New York, NY, and December 6-8, 2001. • Treatment of incontinence and voiding dysfunction • Slings and myoplasty • Visiting Faculty, University of California San Francisco Annual Symposium, San Francisco, CA, February 26-28, 2002: • Overactive bladder; State-of-the art • Sling operation in men and women • Artificial urinary sphincter; technique and outcome • Optimizing the Management of Overactive Bladder and Urinary Incontinence; MedReviews Round Table. New York, March 5-6, 2002: • Co-Chairman • Chapter: New Frontiers in the Treatment of the Overactive Bladder and Incontinence. • Invited Speaker; American College of Obstetricians and Gynecologists Annual Meeting May 6, 2002. • New approaches for the treatment of overactive bladder • AUA and SUFU abstract reviewer American Urological Association 96rd Annual Meeting, and Society of Neurourology and Female Urology (SUFU) Annual Meeting, Orlando, FL May 25-30, 2002. • Invited SUFU Keynote Speaker: New pharmacological therapies in the treatment of the neurogenic bladder • Aging in American Press Conference: Effect of diabetes and incontinence in aging • Meet the Expert Press Release: Voiding dysfunction and innovation in treatment • Moderator: Late Breaking Podium Session: BPH; Urodynamics; Female Urology • AUA and SUFU abstract reviewer • Faculty and Invited Speaker; American Society of Gene Therapy (ASGT) workshop on herpes virus vector for gene transfer, Annual Meeting, June 5-9, 2002. • Faculty: Bladder Management. Consortium for Spinal Cord Medicine Clinical Practice Guidelines (CPGs) Paralyzed Veterans of American, 2002-Present. Chancellor 50 of 108 • Symposium Chairman: Frontiers of Rehabilitation Research, Pittsburgh PA, September 19, 2002 • Program Director of program jointly sponsored by CURE-SCI, (HD39768) and NIH Model SCI Center • Speaker: Center of Urology Research Excellence – Spinal Cord Injury Mission, Organization, and Research • Visiting Professor, University of Rochester, Rochester, NY, October, 15-16, 2002: • Overactive bladder; State-of-the art • Basic research in neurourology • Co-Chairman, University of Pittsburgh Mini-Medical School, October 22, 2002. • Frontiers of Bladder Research • Symposium Faculty: University of Toronto Annual Urology Update. November, 1-3, 2002. • Review of New Pharmacologic Agents • Botulinum Toxin Injection and Intravesical Peppers • Summit Conference and Interdisciplinary Effort for Neurotoxin Comprehensive Education (SCIENCE), San Juan, Puerto Rico, December 5-8, 2002. • Urologic Applications of Neurotoxin • Chairman, Program Committee, 2nd Annual Retreat of McGowan Institute of Regenerative Medicine, March 2003. • Keynote Speaker: Tissue Engineering of the Urinary Tract. Biomedical Engineering Society Annual Meeting, University of Pittsburgh, April 4, 2003. • Course Faculty, Frontiers in Human Embryonic Stem Cell Training Course; Pittsburgh Development Center, April 28-May 15, 2003 • American Urological Association 97rd Annual Meeting, Chicago, IL, April 26, May 1, 2003. • Invited Speaker: The Future of Sexual Medicine "Effect of neural trauma on end organ structure and function" • Press Program: Meet the Expert: Treating Erectile Dysfunction • AUA Rally for Research NIH Campaign • Poster Session Moderator: Neurogenic Bladder • AUA abstract reviewer • Northeaster Section AUA Annual Meeting, Halifax, Canada, September 14-17, 2003. • Scientific Program Committee • Abstract Reviewer • Northeastern Section Research Council • NIH/Interstitial Cystitis Association: Research Insights into Interstitial Cystitis: A Basic Clinical and Science Symposium: October 30-November 1, 2003, Washington DC. • Program Committee • Podium Moderator • Invited speaker: Botulinum toxin application to bladder muscle and interstitial cystitis • Invited speaker: Vanilloid therapies - RTX and capsaicin • Program Committee, 3nd Annual Retreat of McGowan Institute of Regenerative Medicine, February 23-24, 2004. • 2003 Annual Meeting of the International Continence Society, Florence, Italy, October 30-November 1, 2003. Moderator: posters session • Invited Faculty: Botulinum Toxin Application in Urology; CDC IBRCC Meeting, Atlanta, GA, November 5-7, 2003. • Visiting Professor, Mayo Clinic al, Jacksonville, FL, November 24-25, 2003. • Faculty, University of Pittsburgh Mini-Medical School, October, 2003: Erectile Dysfunction with Aging • NIDDK Complications of Diabetes Symposium: December 2-5, 2003, Washington DC. • Program Committee • Podium Moderator • Bladder Research Section Chairman • Visiting Faculty, Wright State University Department of Gynecology, Dayton, OH, and February 24-25, 2004. • What is really new in overactive bladder • Neurophysiology of stress urinary incontinence • American Urological Association 98rd Annual Meeting, San Francisco, CA, May 5-9, 2004. • Podium Program Moderator: Treatment of Refractory Overactive Bladder • Podium Speaker: Botulinum Toxin for Refractory Overactive Bladder • Invited Faculty: AUA Research Forum: Muscle stem cell for urologic tissue engineering Chancellor 51 of 108 • Invited Faculty: Pathophysiology of urgency and Rational for treatment, AUA CME Course: Bladder Urgency: Understanding and Therapy • Invited Speaker: Muscle progenitor cell injection for stress incontinence. Engineering and Urology Society, 2004 Program • Invited Faculty: Pathophysiology of urgency, AUA CME Symposium: Bridging the Gap in Overactive Bladder • Co-Director: AUA CME Course: New Treatment of Overactive Bladder • Abstract Reviewer • Roland R. Cross, Jr., Visiting Professorship in Urology, Loyola University, Chicago, IL, May 20-21, 2004. • What is really interesting in overactive bladder • Neurophysiology of stress urinary incontinence • Invited Faculty, Current Concepts in Men’s Health 2004, Albany Medical College, and August 13-15, 2004. • New concepts and treatment for stress urinary incontinence • Pharmacologic management of incontinence • Visiting Speaker, Raleigh County Medical Society, Beckley, WV, September 29-30, 2004. • Role of Primary Care Physicians in Gaining Bladder Control, Society Monthly Meeting • Pharmacologic management of incontinence, Raleigh County Hospital Grand Round • Visiting Professor, State University of New York, Upstate Medical University, Syracuse, NY October 6-7, 2004. • Betty and Melbourne Lent Visiting Professor, University at Buffalo, October 7-8, 2004. • Center of Urologic Research Excellence-Spinal Cord Injury Annual Meeting: The State of Urinary Incontinence in Women, Pittsburgh, PA., November 9, 2004. • Invited Faculty: Pathophysiolgy of OAB. PROAB 2004; Philadelphia, PA, December 11, 2004. • Invited Keynote Speaker: Tissue Engineering in Urology. Annual meeting of the Japan Urology Association, Tokyo, Japan April 14-17, 2005. • American Urological Association 99th Annual Meeting, San Antonio, TX, May 5-9, 2005. • Poster Program Moderator: Neurogenic and Nonneurogenic Bladder • AUA Research Counsel Meeting • AUA Reimbursement Consultant • Invited Faculty: Pathophysiology of urgency and Rational for treatment, AUA CME Symposium • Invited Faculty: Botulinum toxin for OAB, AUA CME Course • Invited Faculty: Correlation of OAB and BPH, AUA CME Symposium • Director: AUA CME Course: A Fresh Start in OAB: Expanding the Direction of Clinical Evaluations • Abstract Reviewer • Invited Keynote Speaker, Annual Spain Congress of Urology, San Sebastian, June 4-7, 2005. • Pharmacology of stress urinary incontinence • Investigational translation in urology research • Botulinum toxin for refractory OAB • International Continence Society 35th Annual Meeting, Montreal, Canada, August 29-Sept 2, 2005. • Chairman, Interactive workshop on botulinum toxin in urology • Chairman, State-of-the-Art Podium Session • Invited Faculty: The New Science of OAB ICS Satellite Symposium • Chairman: CURE-SCI Neurourology Research Symposium. American Paraplegic Society 2005 Annual Conference, Las Vegas, Sept 6-8, 2005. • Center for urologic research excellence in SCI: Neurourology clinical trials • Invited Faculty, West Virginia University Annual Urology Retreat, Sept. 16-17, 2005. • Clinical update on botulinum toxin • Receptor physiology for bladder function • Invited Speaker: Botulinum Toxin in Urology, University of Toronto Urology Symposium, Toronto, Canada, Oct. 22- 23, 2005. • Use of botulinum toxin in neurogenic overactive bladder • Use of botulinum toxin in interstitial cystitis • Invited Speaker: Translational Research in SCI Related Urological Issues. American Academy of Physical Medicine and Rehabilitation Annual Meeting, Philadelphia, PA, October 27-30, 2005. Chancellor 52 of 108 • Invited Speaker: Adult Stem Cells: Achievements and Vision for the Future, 5th Annual Scientific Retreat, McGowan Institute of Regenerative Medicine, Pittsburgh, PA, March 6-7, 2006. • Invited Speaker: Raising the Bar in the Management of OAB, Pri-Med Institute, Durham, NC, March17, 2006. • CME Program Director: Hope and Awareness for Interstitial Cystitis. March 22, 2006, University of Pittsburgh Medical Center, Pittsburgh, PA • Visiting Professor: Long Island Jewish Health System, Long Island, NY, March 23, 2006, • American Urological Association 100th Annual Meeting, Atlanta, GA, May 20-25, 2006. • Invited Faculty: Diagnosis and Treatment of LUTS in Men: Antimuscarinic Therapy, AUA CME Symposium • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results? • Invited Speaker: Gene Therapy Approaches for Erectile Dysfunction. Society of Basic Urology Research 2006 Meeting • Abstract Reviewer • Guest Faculty: Lower Urinary Tract Dysfunction, AUA/Japanese Urological Association Joint Program • Botulinum Toxin: A Revolutionary Approach for Treating Lower Urinary Tract Dysfunction. Taiwanese Continence Society. Taipei, Taiwan, June 18-19, 2006 • Keynote speaker: My experience with Botulinum toxin at Pittsburgh from bedside to bench top and back • Moderator of round table discussion • Lecture: Mechanism of action of botulinum toxin in the lower urinary tract • Visiting Professorship in Urology, University of Kansas, Kansas City, Kansas, Sept 29-30, 2006. • How are OAB medications similar and different • Stem cell therapy for stress urinary incontinence • Invited Grand Round Lecture in Urology, Washington University, St. Louis, MO, October 4, 2006. • 2006 NIH/Interstitial Cystitis Association: Frontiers in Painful Bladder Syndrome and Interstitial Cystitis. October 26- 27, 2006, Washington DC. • Program Committee • Podium Chairman: New Consideration in PBS/IC Treatments • Invited speaker: Novel therapies for PBS/IC • Program Director: The Role of Botulinum Toxin in Urologyy, UPMC CME Course, Seattle, WA, November 17-18, 2006 • Keynote Speaker, The Novel Management of Overactive Bladder • Kaohsiung, Taiwan, Dec 8, 2006 • Taichung, Taiwan, Dec 9, 2006 • Taipei, Taiwan, Dec 10, 2006 • International Conference on Neurotoxins (ICON 2006), Miami, Fl., Nov 29-Dec 2, 2006 • Program Steering Committee • Speaker: Intravesical vanilloid therapies: capsaicin and resiniferatoxin • Director, NIH Center for Urologic Research Excellence-Spinal Cord Injury (CURE-SCI) 5th Annual Retreat, March 9, 2007. • Expert Advisory Committee: Screening, treatment and management of IC/PBS: A medical education program for health care providers and their patients, April, 2007. • Visiting Professor, Department of Urology, Johns Hopkins, University, April 17-18, 2007. • American Urological Association 101th Annual Meeting, Anaheim CA, May 19-24, 2007. • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Plenary Program: Point-Counterpoint: Refractory Detrusor Overactivity: What’s Next? • Lunch with the Expert, May 22, 2007 • Invited Speaker: Voiding Dysfunction: Botulinum Toxin for Refractory Incontinence. First Annual Program of the Society of Korean Urological Association Meeting • Abstract Reviewer • Podium Session Moderator: Pelvic Floor Prolapse • Panelist: Lower Urinary Tract Dysfunction, AUA/Japanese Urological Association Joint Program • Center for Urological Regional Entrepreneurship Booth Guest Speaker Chancellor 53 of 108 • Guest Faculty: Reconstructive Urology and Tissue Engineering, Society International Urology, Paris, France, September 2-5, 2007. • Keynote Speaker: 14th Annual Meeting of the Japan Neurogenic Bladder Society, Fukushima, Japan, October 3-6, 2007. • Muscle stem cell tissue engineering • New aspects of OAB • Symposium Faculty: NIDDK Technology in Urology and Nephrology, San Francisco, CA, November 16, 2007. • 2008 Winter Meeting of the Society for Urodynamics & Female Urology, Miami, FL., Feb. 28-March 2, 2008. • Guest Speaker: Pathophysiology of OAB: A new understanding • Guest Speaker: Therapeutic receptor targets for the bladder and urethra • Invited Speaker: Stress urinary incontinence: From animal modeling to Stem cell therapy. Department of OB/GYN Grand Round, SUNY Upstate Medical University at Syracuse. April 18, 2008. • Invited Faculty: Workshop on Clinical Research.: Muscle stem cell tissue engineering for urinary incontinence. First Midwest Conference on Stem Cell Biology, Troy, MI, May 9-11, 2008. • American Urological Association 102th Annual Meeting, Orlando, FL, May 17-22, 2008. • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • Podium Session Moderator: Urodynamics, Incontinence, Female Urology • Panelist: Lower Urinary Tract Dysfunction, AUA/Japanese Urological Association Joint Program • Invited Faculty: Sensation Investigation: Advancing Methods of Measuring Bladder Sensation in OAB. • Program Director: The Role of Botulinum Toxin in Urologyy, CME Course by the William Beaumont Hospital, Dearborn, MI, June 14, 2008 • Invited Faculty, 4th International Consultation on Incontinence. World Health Organization, Paris France July 5-8, 2008 • Conference Director: 3rd Pan-Pacific Continence Society Satellite Symposium, September 26-27, 2008. • Liposome and Chet’s Web of Influence • Ten Years Single Surgeon Experience with Botulinum Toxin • Invited speaker: Festschrift in Honor of Edward McGuire: Muscle derived stem cell therapy: bench top to bedside development. Ann Arbor, October 24-25, 2008. • Invited Faculty: NIDDK New Research Directions in Urinary Incontinence Symposium. Washington DC, January 7- 9, 2009. • Spinal cord injury • Muscle derived stem cell for stress urinary incontinence • Keynote Speaker: Muscle Stem Cells for Stress Urinary Incontinence. Michigan Urological Society, Livonia, Michigan, January 21, 2009. • 2009 Winter Meeting of the Society for Urodynamics & Female Urology, Las Vegas, NV, February 25-28, 2009. Guest Speaker: Update on stem cell research for stress urinary incontinence • The American Urological Association Lecture: Botulinum Toxin for the Lower Urinary Tract-Past, Present and Future, 24th Annual European Association of Urology Congress, March 19, 2009 Stockholm, Sweden. • 97th Japan Urological Association Annual Meeting, Okayama, Japan, April 16-19, 2009 • State-of-the-Art Lecture: Stem cell therapy: bench top to bedside development. • Symposium Faculty: Current Status and Future Prospects of Neurourology • Seminar: Pathophysiology of OAB • American Urological Association 103th Annual Meeting, Chicago, IL, April 24-28, 2009. • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • Panelist: Urine Inflammatory Biomarkers for the Diagnosis of OAB, AUA and Japanese Urological Association 4th Joint Meeting • Program Moderator: Society for Urodynamics and Female Urology Annual Meeting • Guest Speaker: OAB State-of-the-Art; Society for Urodynamics and Female Urology Annual Meeting • Invited speaker: Botulinum toxin in the urinary tract. Society of Urologic Nursing Association (SUNA), September 8, 2009. Detroit, MI. Chancellor 54 of 108 • First International Symposium on Bladder Neuro-restoration and Nerve Rerouting, September 11-12, 2009, Detroit, MI • Program Co-Chair • Hands On Workshop Coordinator • Speaker: Neurotoxin and Pharmaconeuromodulation • Invited speaker: Physiology of bladder and urethra. Wayne State University Urology Grand Round, September 23, 2009, Detroit, MI. • 39th Annual Meeting of International Continence Society, September 29-October 3, 2009, San Francisco, CA • Workshop faculty: Potential urinary biomarker for assessment of detrusor overactivity • Symposium faculty: Neuromodulation vs. neurotoxins • Abstract selection reviewer • Podium session moderator • 2009 Global Chinese OAB Expert Meeting, Society of International Urology, Oct 31-Nov 2, 2009, Shanghai, China • Chairman of symposium • Speaker: A new treatment approach to OAB • Visiting Professor, Department of Urology, Tottori University, Yonago, Japan, December 8-10, 2009 • Winter Meeting of the Society for Urodynamics & Female Urology, St. Petersburg, FL., Feb. 23-27, 2010 Invited Speaker: Muscle Derived Stem Cells • American Urological Association 104th Annual Meeting, San Francisco, May 29-June 3, 2010. • 0551C Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • Guest Speaker: Geriatric Urological Society Annual Meeting: Aging Underactive Bladder. • Invited Keynote Lecturer: Sphincter Regeneration with Muscle Stem Cells: Cell Therapy Discovery Science to Clinical Trials. 2010 Joint International Continence Society and International Urogynecology Meeting, Toronto CA, August, 25, 2010. • Invited Keynote Speaker: Asia Pacific Overactive Bladder Meetings, Taiwan, September, 24-26, 2010. • Mechanism of action of BoNT-A in lower urinary tract dysfunction • Translational science in diabetic cystopathy • Invited Lecturer: Bridging the Abyss Between Academic Research and Biotech Startup, Winter Meeting of the Society for Urodynamics & Female Urology, Phoenix AZ., March 1-4, 2011 • Invited Faculty: Advances in Management of OAB, European Association of Urology, Vienna March 18-22, 2011. • Invited Faculty: White House Startup America: Reducing Barriers Roundtable, April 26, 2011. • American Urological Association 105th Annual Meeting, Washington DC, May 14-19, 2011. • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • Capital Hill Urological Advocates • Lunch and Learn Faculty: Case Discussions in Female Urology and Voiding Dysfunction • Course Director: Refractory idiopathic and neurogenic detrusor overactivity • Invited faculty; Whitehouse Startup USA, United States Government Executive Branch 2011 • Invited Keynote Speaker World Congress of Endourology, Kyoto Japan Nov 29-Dec3, 2011 • Keynote talk: Battling incontinence with stem cells • Invited faculty: Satellite LUTS meeting: Botulinum toxin in urology • Keynote speaker: 25th Annual Meeting Japanese Society of Endourology: Stem cell therapy for lower urinary tract dysfunction • American Urological Association 106th Annual Meeting, Atlanta, GA, May 19-24, 2012. • Program Director: CME Conference: Neurogenic Overactive Bladder Assessment and Management Strategies to Optimize Patient Outcomes. • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • State of the Art Lecture: Clinical development of muscle stem cells for SUI treatment, 7th AUA/JUA International Affiliate Society Meeting • Moderator Poster Session: Urodynamics/Incontinence/Female Urology Chancellor 55 of 108 • C Dayton Riddle Distinguished Lecturer Clemson University Biomedical Engineering Innovation Campus; Aug 9, 2012 • Toxin 2012; International Nurotoxin Association. Miami, December 5-8, 2012 • Steering committee • Keynote Speaker: Botulinum toxin in urology • Workshop Director: Technique of botulinum toxin in gastroenterology and urology • Invited Faculty: Novel Therapies IC/BPS; Joint Meeting of the 3rd International Consultation on Interstitial Cystitis Japan and the ESSIC Annual Meeting 2013; Kyoto Japan March 21-23, 2013 • Future Research and Treatment of Urothelial Dysfunction. Taiwan Continence Society, Taipei, Taiwan, March 24, 2013 • Masters Lecture on Lowery Urinary Tract; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan March 28, 2013 • American Urological Association 107th Annual Meeting, San Diego, CA, May 3-8, 2013. • State-of-the-Art Lecture: Bladder Underactivity and Urinary Retention in Older Adults. Geriatric Urology Society (GUS) • Program Director: CME Conference: OAB Optimize Patient Outcomes. • Keynote Speaker: Botox Update. American College of Osteopathic Surgeons (ACOS) Urology Program • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Abstract Reviewer • Program Director: Botox for Overactive Bladder Product Theater • Kyorin Pharmaceutical English Presentation School • Invited Faculty: Neuromodulation Symposium, Detroit, MI, September 20-21, 2013 • Invited Faculty “Stem Cell Research in Urinary Tract”: 22nd Annual Symposium on Molecular Pathology, Detroit, MI, September 25, 2013 st • Congress Director: CURE-UAB 1 International Congress of Urologic Research and Education on Aging Underactive Bladder, NIH Washington DC February 20-21, 2014 • Introduction and Housekeeping: Ananias Diokno, MD & Michael Chancellor, MD • Summary of day and announcements: Ananias Diokno, MD and Michael B. Chancellor, MD • Novel therapies including stem cell and gene therapy: Michael Chancellor, MD • Group discussion & closing statement: Michael Chancellor, MD • Society for Urodynamics & Female Urology, Miami, FL 25-30, 2014 • Lifetime Achievement Award Blaivas Lecture • Diokno-Lapides Essay Contest Director • Consensus Panel on 3rd Line OAB Therapies • Panel: Pathological Conditions Leading to the Underactive Bladder • Visiting Professor; Neurophysiologic basis for voiding function/dysfunction. Lunds University, Sweden, May 8-9, 2014. • American Urological Association 108th Annual Meeting, Orlando, FL, May 16-20, 2014. • Plenary Critical Discussion: Underactive Bladder and Chronic Urinary Retention in Older Adults • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Science of Female Pelvic Health Faculty: The Underactive Bladder • Abstract Reviewer • Program Director: CME Conference: Share Decision Making in Management of Idiopathic and Neurogenic OAB. • State-of-the-Art Lecture: Underactive Bladder in Older Adults. Geriatric Urology Society (GUS) • Indian American Urological Association: Management of Refractory OAB • 2014 Society of Columbia Urologia, Cartagena Aug 14-18, 2014 • Keynote speaker: Detrusor underactivity • State of art Tissue Engineering and Regenerative Urology • Symposium Pfizer: Detrusor overactivity • Point-Counter Point: Management of idiopathic OAB: Case for botulinum toxin • Visiting Professor University los Andes: Regenerative medicine, August 11, 2014 Chancellor 56 of 108 • 21st Annual Meeting of the Japan Neurogenic Bladder: Okayama September 18-20, 2014. • Keynote lecture: Future prospective • Pfizer seminar: strategy for underactive bladder • International Continence Society Workshop, Concept of drug delivery across urothelium Rio De Janeiro, October 20, 2014. • Quebec Urological Association Annual Meeting. Montreal, Canada, Nov 9-10, 2014 • Keynote speaker: Future prospective in voiding dysfunction • Plenary: Future in incontinence • Toxin 2015; Lisbon, Portugal, January 14-17, 2015 • Course Director: Botulinum Toxin in Urologic Conditions (Which Conditions, Which Evidence?) • Cracking the Code of Refractory OAB Symposium Faculty, European Association of Urology, Madrid Spain, March 22, 2015 • American Urological Association 2016h Annual Meeting, New Orleans • Plenary Critical Discussion: Underactive Bladder and Chronic Urinary Retention in Older Adults • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • NIH Basic Science Symposium Faculty: Advance Therapeutic Directions to Treat the Underactive Bladder • Abstract Reviewer • Press Conference Moderator • Diokno-Lapides Award Ceremony Master of Ceremony • Plenary Crossfire: Controversies in Urology: L Neuromodultion vs Botulinum Toxin • Hands-on Neuromodulation, Detroit, MI, Sept. 25-26, 2015 • Neuromodulation with Botulinum Toxin • Breakout Session: Botulinum Toxin Injection • Taiwan Urological Association, Hualien, Taiwan, Aug 21-22, 2015 • Liposome as bladder lotion for IC/BPS • Future Treatment of Underactive Bladder • Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. (DCCT/EDIC) Research Group NIDDK, Baltimore, MD, November 18-19, 2015 • Congress Director: 2nd International Congress on Underactive Bladder: CURE-UAB 2.0, December Funding NIA, NIDDK, Aikens Neurourology Research, Denver, CO, December 2-3, 2015 • Society for Urodynamics & Female Urology, New Orleans, February 23-27, 2016 • Diokno-Lapides Essay Contest Director • Panel: Treatment of Underactive Bladder • FDA advisory panel on nocturia drug assessment, October, 2016 • Toxin 2017; Madrid, Spain 18-21, 2017 • Course Director: Botulinum Toxin in Urologic Conditions (Which Conditions, Which Evidence?) • Organizing Committee • Congress Director: CURE-UAB 3rd International Congress of Urologic Research and Education on Aging Underactive Bladder, NIH Washington DCMarch 9-10, 2017 • American Urological Association 2017 Annual Meeting, Boston, MA May 2017 • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Diokno-Lapides Award Ceremony Master of Ceremony • Abstract reviewer • Moderator at Geriatric Urology Society Annual Meeting • Press Conference on Zika Virus Urine Detection Research • Keynote Speaker: New Paradigm in OAB Treatment, Meixco Urology Congress, Mexico city, July 30, 2017 • Hands-on Neuromodulation, Detroit, MI, Sept. 22-23, 2017 • Neuromodulation with Botulinum Toxin • Breakout Session: Botulinum Toxin Injection • Taiwan Continence Society, Taichung, Taiwan September 30 – October 2, 2017 • Keynote Speaker: The International CURE-UAB initiative • Special Lecture: Cystitis in Cancer Survivors: The Unmet Need of Hemorrhagic Radiation Cystitis • 69th Annual Meeting of West Japan Urology Assocation, Oita, Japan November 9-12, 2017 Chancellor 57 of 108 • KeyNote Lecture: Regnerative Medicine for Stress Incontinence and Underactive Bladder • NIH Individualizing Urinary Incontinence Treatment Meeting, Washington DC, February 1-2, 2018 • Invited Faculty: Bench to Bedside Development of a Treatment for Urinary Incontinence • Global Coalition on Aging; Washington DC, February 20, 2018 • Invited Faculty: Overactive Bladder and Aging • Society for Urodynamics & Female Urology, Austin, TX, March 1, 2018 • Faculty: The Patholophysiology and Future of Underactive Bladder • Moderator: Diokno-Lapides Essay Contest Award • Japan Urological Association, Kyoto, Japan April 18-20, 2018 • Keynote Speaker: The International CURE-UAB Initiative • American Urological Association 2018h Annual Meeting, San Francisco, CA May 2018 • Program Director: AUA CME Course: Botulinum Toxin: Why Use, How to Do it, What Are the Results • Speaker: Geriatric Urology Society • Abstract Reviewer • Diokno-Lapides Award Ceremony Master of Ceremony • NorthEast American Urological Association 2018h Annual Meeting, Toronto, Oct, 11 2018 • Invited Keynote Speaker: The Atonic Detrusor and its Rehabilitation • Toxin 2019; Copenhagen January 16-19, 2019 • Course Director: Botulinum Toxin in Urologic Conditions (Which Conditions, Which Evidence?) • Organizing Committee

FELLOWS and STUDENTS TRAINING

• Qualifying Written Examination Committee, American Board of Urology, 1994-1998. • Oral Certifying Examination Committee, American Board of Urology, 1998-2001. • Faculty, University of Pittsburgh Course on Ethics in Medicine, 2000-2003. • Urology Director, Uroygnecology Fellowship Program, Dept. of Gynecology, University of Pittsburgh School of Medicine, 2001-2007. • Urology Director, Spinal Cord Injury Fellowship Program, Dept. of Physical and Rehabilitation Medicine, University of Pittsburgh School of Medicine, 2001-2007. • Director of Research: Female Pelvic Medicine and Reconstructive Surgery Fellowship Program 2012- Present • Mentor: Canadian Urological Assocation Scholarship Foundation for Lysanne Campeau MD, McGill University, 2018-2020 • Mentor: AUA Urology Scientific Mentoring and Training Program (USMART) Academy: Vijay Samineni, PhD, Washington University

NIH Physician Scientist and American Foundation of Urologic Disease Research Mentor: Rivas, David A., M.D. 1993-1995 Present: Medical Director; Glaxo Smith Klein, Philadelphia, PA T. Ernesto Figueroa, M.D. 1996-1997 Present: Associate Professor of Urology, Thomas Jefferson University, Philadelphia, PA John Lavelle, M.D. 1998-2000 Present: Assistant Professor of Urology, University of North Carolina, Chapel Hill, NC Christopher P. Smith, M.D. 2000-2002 Present: Assistant Professor, Baylor University, Houston, TX Tracy W. Cannon, M.D. 2001-2003 Present: Clinical Associate Assistant Professor, University of Pittsburgh Christopher Chermansky, M.D. 2002-2004 Chancellor 58 of 108 Present: NIH K12 Physician Scientist Fellow in Neurourology and Female Urology Brandon S. Minnery, Ph.D. 2003-2004 American Foundation for Urologic Disease Research Scholar: Muscle derived stem cells as treatment for nerve injury induced erectile dysfunction Leng, Wendy, M.D. 2002-2007 Present: Assistant Professor in Urology; NIH K23 Physician Scientist Fellow in Neurourology and Female Urology (DK062726) Nirmal Jayabalan, Ph.D. 2012-2013 American Foundation for Urologic Disease Research Scholar: Functional Role of Organic Cation Transporters in Bladder Physiology and Pharmacology Bharathi Raja Rajaganapathy, Ph.D. 2013-2014 American Foundation for Urologic Disease Research Scholar: Radiation Cystitis Bernadette Zwaas, Ph.D. 2015-Current American Foundation for Urologic Disease Research Scholar: Radiation Cystitis Lysanne Campeau, M.D. 2015-2020 Urology Care Foundation Rising Star Research Award The Effect of Cannabinoid Receptor Modulation on Voiding Dysfunction Associated with Metabolic Syndrome

Ph.D. Doctoral Dissertation Examiner, Sponsor and Postdoctoral Mentor: Watanabe, Toyohiko, M.D., Ph.D., Okayama, Japan 1995-1997 Bladder and Urethomyoplasty for Neurourology Present: Assistant Professor of Urology, Okayama Medical College, Okayama, Japan Dirk DeRidder, M.D., Ph.D. Leuven, Belgium 1997-1999 Urological Dysfunction in Multiple Sclerosis Patients University of Leuven School of Medicine, Belgium Mervi Haarala, M.D., Ph.D., Turku, Finland 1997-1999 Interstitial Cystitis; Studies on Infection and Autoimmunity as Etiological Factors University of Turku School of Medicine, Turku, Finland Ozawa, Hideo, M.D., Ph.D., Okayama, Japan 1997-1998 Non-invasive Doppler based pressure-flow urodynamics Present: Associate Professor of Urology, Medical College of Okayama, Okayama, Japan Yokoyama, Teruhiko, M.D., Ph.D., Okayama, Japan 1998-2000 Muscle Stem Cell Tissue Engineering for Incontinence David Smith, Ph.D., Pittsburgh, PA 1999-2001 Department of Bioengineering, University of Pittsburgh, Ph.D. Candidacy Committee Sasaki, Katsumi, M.D., Ph.D. Okayama University, Japan 2000-2002 Herpes simplex virus gene therapy for diabetes Present: Assistant Professor of Urology, Medical College of Okayama, Okayama, Japan D. Gloeckner, Claire, Ph.D., Pittsburgh, PA 2000-2002 Department of Bioengineering, University of Pittsburgh, Ph.D. Candidacy Committee Ronald Jankowski Ph.D., Pittsburgh, PA 2001-2003 Department of Bioengineering, University of Pittsburgh, Ph.D. Candidacy Committee Jiro Nagatomi, Ph.D., Ressling Institute 2001-2003 Christopher Reeeve Spinal Cord Foundation Scholar Present: Assistant Professor of Bioengineering, University of Pittsburgh Jun Nishiguchi, M.D., Ph.D., Okayama University, Japan 2002-2004 IPD Sappirin for Bladder Pain Present: Neurourology Fellow and Ph.D. Candidate, University of Pittsburgh Pradeep Tyagi, Ph.D., Pittsburgh, PA 2002-2005 School of Pharmacy; Institute of Pharmacogenomic, University of Pittsburgh, Present: Chief Scientifc Offier, lipella Pharmaceutical, Inc. Kevin Toosi, M.D., Pittsburgh, PA 2003-2005 Department of Bioengineering, University of Pittsburgh, Chancellor 59 of 108 NIDDK T32 Fellow Candidacy Committee Rachelle L. Prantil, M.S., Pittsburgh, PA 2003-2007 School of Bioengineering; University of Pittsburgh, CATER Fellow; Ph.D. Candidacy Committee F31 EB004738 $36,664 Present: Research Scientist, Pfizer, Cambridge, MA Christian Coyle, Ph.D.Pittsburgh, PA 2005-2007 Department of Urology, University of Pittsburgh, NIDDK T32 Fellow Brian Phillips, Ph.D.Pittsburgh, PA 2005-2007 Department of Urology, University of Pittsburgh, NIDDK T32 Fellow Aron Parekh Ph.D., Pittsburgh, PA 2006-2008 School of Bioengineering; University of Pittsburgh, Present: Research postdoc, Vanderbilt University, Nashville, TN Donna J. Haworth, M.S., Pittsburgh, PA 2006-2008 School of Bioengineering; University of Pittsburgh,

Neuro-Urology and Female Urology Fellowship/Research Mentor: Pentti J. Kiilholma, M.D., Ph.D., Turku, Finland 1991-1992 Present: Associate Professor of Gynecology, Director of Urogyencology Programs, University of Turku School of Medicine, Turku, Finland Watanabe, Toyohiko, M.D., Ph.D., Okayama, Japan 1995-1997 Present: Assistant Professor of Urology, Okayama Medical College, Okayama, Japan Hui-Lung Tai, M.D., Changlua, Taiwan 1996 Present: Assistant Professor of Urology, Changlua Medical College, Changlua, Taiwan Sean Tirney, M.D., Urology Residency Research, Pittsburgh 1997 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Suk Jung Young, M.D., Seoul, South Korea 1997-1998 Present: Assistant Professor of Urology, Catholic University, Seoul, South Korea Julio Barros, M.D., Cordoba, Argentina 1998 Present: Assistant Professor of Urology, Sanatorio Allende University, Cordoba, Argentina Duk-Yoon, Kim, M.D., Taegu, South Korea 1998-1999 Present: Assistant Professor of Urology,Taegu Catholic University, South Korea Ali Atai, M.D., Ankeria, Turkey 1999 Present: Assistant Professor of Urology, Ankeria University, Turkey Ciaran Brady, MB, BCh, BAO 1999 Present: Urology Resident, London Urologic Institute, London, UK Emmanuel Chartier-Kastler, M.D., Ph.D. 1999 Present: Assistant Professor of Urology, Praicien Hospitalo-Universitaire, Paris, France Phelan, Michael, M.D., Urology Residency Research, Pittsburgh 1999 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Franks, Michael, M.D., Urology Residency Research, Pittsburgh 1999-2000 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Yao-Chi Chuang, M.D., Kaohsiung, Taiwan 1999-2000 Present: Lecturer, National Yang-Ming University, Taiwan Seung-June Oh, M.D., Seoul, Korea 2000 Present: Assistant Professor of Urology, Seoul National University Hospital, Korea Ji Youl Lee, M.D., Catholic University, Seoul, South Korea 2000-2001 Present: Assistant Professor, Catholic University, Seoul, South Korea Steven Chuang, M.D., Urology Residency Research, Pittsburgh 2000-2001 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Henry Lu, Shing-Hwa, M.D., Ph.D., Veterans General Hospital, Taipei Taiwan 2000-2002 Present: Assistant Professor, National Yang-Ming University, Taiwan Jang Hwan Kim, M.D., Seoul, South Korea 2001-2004 Present: Neuro-urology and Female Urology Fellow Bennett, Nelson, III, M.D., Urology Residency Research, Pittsburgh 2002 Chancellor 60 of 108 Present: Infertility Fellow, Cornell Univeristy, NY, NY Dong Deuk Kwon, M.D., Seoul, South Korea 2002-2004 Present: Neurourology Fellow, University of Pittsburgh, Pittsburgh, PA Raj Patel, M.D., Urology Residency Research, Pittsburgh 2003 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Robert Stein, M.D., Urology Residency Research, Pittsburgh 2003 Present: Urology Resident, University of Pittsburgh, Pittsburgh, PA Yong Tae Kim, M.D., Seoul, South Korea 2003-2005 Present: Neurourology Fellow, University of Pittsburgh, Pittsburgh, PA Irma Usiene, M.D. Muscle stem cell tissue engineering 2003-2005 Present: Medicine Resident Shachi Tyagi, M.D., India 2003-2006 Present: Internal Medicine Resident, William Beaumont Hospital Catherine Thomas, Ph.D.: Postdoc fellow in Neurourology research 2004-2007 Present: Research Associate Yoshikatsu Nojiri, M.D., National Center for Geriatrics and Gerontology, Japan 2004 Present: Instructor Japan National Center for Geriatrics and Gerontology Erik Wang, M.D., National University of Taiwan, Taiwan 2004-2005 Present: Assistant Professor Taiwan Danielle Sweeney, MD: Molecular biology of bladder thermoreceptors 2005 Present: Urology resident, University of Pittsburgh Dae Kyung Kim, M.D., Seoul, Korea: Tissue engineering in urology 2005-2007 Present: Chairman, Department of Urology Erin Gibbons, MD: Bladder cancer and bladder thermoreceptors 2006 Present: Urology resident, University of Pittsburgh Shelby Morrisore, MD: Green tea extract on bladder and penile inflammation 2006 Present: Urology resident, University of Pittsburgh Mathew Hayes, MD: CB1 and CB2 receptors in the urinary tract 2007 Present: Urology resident, University of Pittsburgh Masuda Honda, MD, PhD, Glutamate pharmacology of bladder and urethra 2006-2007 Present: Assistant Professor of Urology, Tottori University, Tottori, Japan Marc Smaldone, MD: Botulinum toxin in in the urinary tract 2007 Present: Urology resident, University of Pittsburgh Akira Furuta, MD, PhD, Urethral sphincter stem cell and pharmacology 2005-2007 Present, Assistant Professor of Urology, Jikei University, Tokyo, Japan Bruce Jacobs, MD: Interstitial cystitis proteinomic 2008 Present: Urology resident, University of Pittsburgh Vikas Tyagi, M.D., AIMS India 2008-2011 Present: Urology Resident, India Dmitriy Nikolavsky, MD: Urine nerve growth factor 2008 Present: Urology resident, William Beaumont Hospital Joseph Mashni, MD: Interstitial cystitis proteinomic 2009 Present: Urology resident, William Beaumont Hospital Don Bui, MD: Overactive bladder proteinomic 2009 Present: Urology resident, William Beaumont Hospital Jayabalan Nirmal, Ph.D., AIMS India 2011-2013 Present: Assistant Professor Department of Pharmaceutical Sciences, Dr. H.S. Gour University, India Bharathi Raja Rajaganapathy, Ph.D. Anna University, India 2013-2015 Present: Faculty India

Career Advisor and Medical Student Research Fellowship Mentor Carol E. Mattes, PhD, M1 1997 Human inducible nitric oxide synthase as gene therapy for erectile dysfunction Present: Matched in Internal Medicine, George-Washington University Frank Nezu, M3-M4 1997 Chancellor 61 of 108 The effect of glutamate antagonists on detrusor-sphincter dyssynergia in SCI rats Present: Matched in Urology Residency, Thomas Jefferson University, Philadelphia, PA Tammy Dennis, M3-M4 1997 Treatment of cylophosphamide cystitis with nitric oxide synthase inhibitor and NK3 Present: Matched in Gynecology Residency, Tulan University, New Orleans, LA Bennett, Nelson, M3-M4 1998 Diabetic bladder afferent neuron function and NGF gene therapy Present: Urology Residency, University of Pittsburgh Brian McNeal, M3-M4 2000 Botulinum toxin injection into the urethra to treat bladder outlet obstruction Present: Loyola University, Department of Urology Kenneth Rodriguez, University of Pittsburgh Minority Premedical Research 2001 Immunohistoloyg of botulinum toxin treatment of overactive bladder Present: Applying to Medical School Sophie Fletcher, M3-M4 2001-2002 Rat model of stress urinary incontinence and tissue engineering Present: University of Virginia, Department of Urology Tatum V. Tarin, M3-M4 2002-2003 Human derived muscle stem cell for incontinence Present: Urology Resident at Stanford Deidra Conway, M3-M4 2002-2003 Model of Stress Urinary Incontinence in Rat Present: OBGYN Resident at NYU Macrina Xavir, Univ. Pittsburgh Honor’s College 2002-2004 Female Sexual Dysfunction and Neurogenic Bladder Present: Premedical Student Carla Linsenbigler, NUR, Nurse Research Practicum 2003 Bladder Botulinum Toxin Clinical Study Present: Nurse Anesthesia Mark Perlmutter, M3-M4 2003-2004 Residency and Career Advisor Present: NYU Urology Residency Ankur Patel, Premed Student 2003-200-5 Overactive Bladder and Female Sexual Dysfunction Present: University of Pittsburgh Undergraduate Student Hugh Perkin, M3-M4 2004-2005 Muscle Derived Cell Immunogenicity Present: Urology Resident USC Michell Jo Simmers, M3-M4 2004-2005 Overactive Bladder and Female Sexual Dysfunction Present: Urology Resident John’s Hopkin University Vincent Hsieh, M3-M4 2005-2006 Comparative Intravesical Drug Therapies for Interstitial Cystitis Present: Residency Candidate Chancellor 62 of 108 Ratna Gannabathi, B.S., Premed Student 2005-2006 Intravesical Liposome Development for Interstitial Cystitis Present: University of Pittsburgh Undergraduate Student Sara Valenta, M.D. M4 University of Massachusetts 2013-2014 Underactive Bladder Epidemiology Present: Resident Peter Levanovich, B.S., 2013-2015 Proteinomic and Radiation Cystitis Present: Ph.D. Student, Wayne State University Florance Doo, M.D., Medical Student 2013-2017 CAPSTONE MENTOR Present: Oakland University William Beaumont School of Medicine Kassem Faraj, M.D., Medical Student 2013-2017 CAPSTONE MENTOR Present: Oakland University William Beaumont School of Medicine

EDITORIAL RESPONSIBILITIES

EDITORIAL BOARD: 1. Associate Section Editor: Techniques in Urology, 1994-2001 2. Sectional Editor, Neurourology & Urodynamics Journal, 1994-Present 3. Associate Editor, Reviews in Urology, 1998-present 4. Consulting Editor, Brazilian Journal of Urology, 2000-Present 5. British Journal of Urology, International, 2001-2003 6. Board Member, Consultations in Primary Care, 2001-Present 7. Journal of Andrology, 2003-Present 8. InfoMed on Female Urology, 2003-Present 9. Asia Journal of Andrology, 2004-Present 10. International J. Impotence Research: Journal of Sexual Medicine, 2004-Present 11. Neurotoxin Institute Steering Committee, http://www.neurotoxininstitute.com 2005-Present 12. Current Bladder Dysfunction Reports, 2006-Present 13. Tzu Chi Medical Journal, 2007-Present 14. Lower Urinary Tract Symptoms (LUTS); 2009-Present 15. International Urology &Nephrology, 2012-Present 16. Director: The Diokno-Lapides Urology Contest 2013-Present 17. Editorial board: Scientific Report, 2017-Present

REVIEWER: 1. Neurourology & Urodynamics Journal, 1989-Present 2. Ostomy and Wound Management Journal, 1989-Present 3. The Journal of Urology and Investigation Urology, 1993-Present 4. UROLOGY, 1993-Present 5. Igaku-Shoin Medical Publishers, 1993-Present 6. Consultant Editor, Human Sexuality Computer Network, Clinical Communication, Inc. Hutchin Hill Road, Shady, NY 12409, 1993-Present 7. Journal of Rehabilitation Research and Development, 1995-Present 8. Paraplegia, 1995-Present 9. THE LANCET, 1997-Present 10. American Journal of Physiology, 1997-Present 11. International Urogynecology Journal and Pelvic Floor Dysfunction, 1997-Present 12. Southern Medical Journal, 1997-Present 13. AUA Annual Meeting Program Abstract Review Committee, 1998-Present 14. Society for Urodynamics & Female Urology Annual Meeting Program Abstract Review, 2000 15. Brazilian Journal of Urology, 2000-Present Chancellor 63 of 108 16. Interstitial Cystitis Association Grant Review, 2000 17. National Kidney and Urologic Diseases Information Clearing house, 2000-Present 18. Medical Letters, 2000-Present 19. Current Opinion in Investigational Drugs, 2001-Present 20. British Journal of Urology, International, 2000-Present 21. Journal of Pelvic Surgery, 2001-Present 22. Clinical Therapeutics, 2001-Present 23. New England Journal of Medicine, 2003-Present 24. AUA Urology Health.Org, 2003-Present 25. Expert Opinion on Pharmacotherapy, 2003-Present 26. Nitric Oxide: Biology and Chemistry, 2003-Present 27. Gene Therapy, 2003-Present 28. Journal of Endourology, 2003-Present 29. Molecular Therapy, 2004-Present 30. International Journal of Impotence Research, 2004-Present 31. Human Gene Therapy, 2004-Present 32. Neuroscience Letters, 2004-Present 33. Women’s Health in Primary Care, 2004-Present 34. Tissue Engineering, 2004-Present 35. Nature Clinical Practice Urology, 2004-Present 36. BMC Complementary and Alternative Medicine, 2005-Present 37. Consortium of Spinal Cord Medicine Clinical Practice Guidelines, 2005-2006. 38. Nature Biotechnology, 2005-Present 39. Allergan Scientific Resource Center Advisor, 2005-Present 40. European Urology, 2005-Present 41. Journal of Andrology, 2005-Present 42. Neurotoxicity Research, 2006-Present 43. Drugs, 2006-Present 44. International Urology and Nephrology, 2006-Present 45. Biomaterial, 2007-Present 46. Regenerative Medicine, 2007-Present 47. Canadian Journal of Urology, 2007-Present 48. Cell Transplantation, 2007-Present 49. Human Reproduction, 2008-Present 50. Expert Opinion on Therapeutic Patent, 2008-Present 51. Medical Science Monitor; 2008-Present 52. Annals, Academy of Medicine, Singapore, 2009-Present 53. Advances in Urology, 2010-Present 54. European Association of Urology Annual Meeting abstract reviewer; 2010-Present 55. Society of International Urology Annual Meeting abstract reviewer; 2010-Present 56. AUA Guideline: Overactive Bladder, 2012 57. Urology Foundation AFUD Research Scholar Application Review Nov 18, 2013 58. BioMed Research International, 2013-Present

GRANT REVIEW RESPONSIBILITIES

1. Small Business Innovation Research, The National Institute of Diabetes and Digestive and Kidney Diseases, 1990 2. Merit Grants, Department of Veterans Affairs, 1992-Present 3. National Institute of Disability and Rehabilitation Research, 1992-Present 4. American Paraplegic Society Research Grants, 1993-Present 5. Spinal Cord Research Foundation, 1997-Present 6. Interstitial Cystitis Center Special Emphasis Review Panel, ZDK1 GRB7, The National Institute of Diabetes and Digestive and Kidney Diseases, 1997 7. Office of Special Education and Rehabilitative Services, 1997 8. Austrian Science Fund Grant Review, 1998 Chancellor 64 of 108 9. Veterans Administration Merit Medical Research Services, 1998 10. NIDDK Training Grant Reviewer, 1999 11. Interstitial Cystitis Association Grant Review, 2000 12. SCOR Review NIH-NIAMS, 2002 13. University of Pittsburgh Office of Technology Transfer Invention Disclosure Review, 2002-Present 14. Research in Aging, 2003 15. Urology Special Emphasis Panel (SEP) NIDDK, 2003 16. Pfizer/AUA Visiting Professorship in Urology; Academic Review Board, 2003-2007 17. NIH ZRG Reviewer 2004 18. NIH MERIT Award Reviewer R32-DK049030, 2005 19. NIH ZRG1 RUS-B (06) December 15, 2005 20. STOPPED due to CV length

RESEARCH and GRANTS NIH SPONSOR 1. RO1HD30522, Comparison of Sphincter Prosthesis and Sphincterotomy, National Center of Medical Rehabilitation Research at the National Institute of Child Health and Human Development, Principal Investigator, 20%, 1993- 1997. 2. RO1DK49524, Capsaicin in Interstitial Cystitis and Vulvovestibulitis, National Institute of Health, Principal Investigator at Thomas Jefferson University Center, 10%, 1994-1997. 3. RT Center Grant for Spain Rehabilitation Center, University of Alabama School of Medicine, Consultant, 1999- 2004. 4. Spinal Cord Injury and Bladder Cancer Detection, NICHD Small Grants Program, (P.I.: Getzenberg, R., Pittsburgh Cancer Institute), Co-investigator, 5%, 1997-1999. 5. RO1 DK 55387-01: Muscle cells mediated gene therapy for incontinence. NIDDK, Principal Investigator, 35% total costs $190,190 year one (10/1/98-9/30/2002: total costs $769,864). 6. T32 DK 07774 (Post-doctoral) Training Grants: Urologic research training program for physicians and scientists. NIDDK, Principal Investigator, 10%, total costs $28,201 year one (31/99-2/28/2004: total costs $266,065). 7. K12 DK 02656 (Physician Scientist) Training Grants: Urologic research training program for physicians and scientists. NIDDK, Principal Investigator, 10%, total costs $92,610 year one (31/99-2/28/2004: total costs $704,825). 8. RO1, Plasticity at Synapses in the Lower Urinary Tract, NIH, (P.I.: Somogyi, G., Department of Pharmacology), Co-investigator, 5%, 1997-2002. 9. RO1 DK55045-01: Diabetic bladder afferent neuron function and NGF gene therapy. NIDDK, Principal Investigator, 25%, total costs $150,669 year one (7/1/02-6/30/2006: total costs $1,176,547). 10. UO1 DK56225-01: Pittsburgh incontinence collaborative treatment program. NIDDK/NICHD, Principal Investigator, 30%, total costs $238,387 year one (7/1/00-6/30/2005: total costs $1,236,620). 11. UO1 HD39768-01: Pittsburgh collaborative reconstructive pelvic surgery program, NICHD, Co-Principal Investigator, 18%, total costs $292,287 year one (7/1/01-6/30/2006: total costs $1,730,838). 12. PO1 NICHD [PO1 HD39768-01]: Collaborative Urologic Research in Spinal Cord Injury. Program Director and Principal Investigator, 30% total costs $902,692 year one (9/01/01-08/31/2006: total costs $4,704,162). 13. R21 NS43660: Lower Urinary tract dysfunction in Parkinson's disease. NINDS. P.I.: Yoshimura, Naoki; Role: Co- Investigator, 9% effort, total cost yr1 $182,794. (2/1/02-1/31/04 total cost %366,452). 14. RO1 DK 55387-05: Muscle cells mediated gene therapy for incontinence. (Competitive Renew led) NIDDK, Principal Investigator, 20% total costs $250,000 year one (10/1/02-9/30/2007: total costs $1,500,000). 15. RO1 DK 066138: Proteomic characterization of IC bladder. NIDDK, PI: Pradeep Tyagi; Co-invest Igor 4.80%; Total Cost: $280,215 year one (09/30/03-07/31/2007). 16. RO1 AR049398: Functional tissue engineering for stress incontinence. Principal Investigator, 7.80% total costs $268,605 year one (05/01/03-04/30/2007). 17. T32 DK 07774-06 (Post-doctoral) Training Grants: Urologic research training program for physicians and scientists. NIDDK, Pending; Priority Score 140; Principal Investigator, 10%, total costs $28,201 year one (03/01/2004-2/28/2009: total costs $266,065). 18. RO1 DK068556; Advance Drug Delivery for Bladder Dysfunction. 12/1/03-11/30/07 $225,000 direct costs year 1; $1,125,000 direct costs total project; Co-investigator - 10% effort Chancellor 65 of 108 19. R01 DK068557; Afferent modulation in bladder dysfunction. Co-investigator 8.3%; Total cost $ 184,500/year (01/01/04-12/31/07) 20. R21 DK066095: Bladder pain gene therapy with pro-opiomelanocortin cDNA. Consultant; Total cost $100,000/year (9/30/03-8/31/05) 21. R01 DK067226: Neurophysiology and biomechanics of urethra in SUI. Co-investigator 12%; Total cost $235,000/year (04/01/04-03/31/09) Scholarly works on accepts 21 entries for grants. 22. RO1 DK057267(Yoshimura) 4/1/05-3/31/10, 1.2 cal month, NIH/NIDDK, $225,000, Afferent Plasticity Underlying Urethral and Pelvic Pain 23. P01 DK044935 (P.I.: Glorioso/Yoshimura); 4/01/06-3/31/11; 0.6 cal months NIH/NIDDK; $200,000, Gene Therapy for Bladder Pain 24. R21 HL006318 (P.I.: David Vorp) 12/01-/6-11/30/08; 0.6 cal months; Bioengineered urethral augmentation. $275,000 entire grant. 25. R42 DK074286 (P.I. Pradeep Tyagi): 09/01-/6-/8/31/07; 3 cal months. Intravesical liposome treatment for interstitial cystitis. $100,000. 26. RO1 DK083323 (P.I. Michael Chancellor). 06/15/2010-05/31/2013 2.4 cal months. Intravesical liposome drug delivery to treat interstitial cystitis. $807,002. 27. Stopped due to CV length

OTHER SPONSORS 1. Neuro-urodynamic Evaluation of Multiple Sclerosis, The National Multiple Sclerosis Foundation, Columbia University, New York, NY, Co-investigator, 10%, 1989-1992. 2. Imaging and Assessment of Urethral Wall Collagen Injection in the Pig Model, C.R. Bard, Inc. Principal Investigator, 10%, 1990-1991. 3. DDAVP in the Management of Neurogenic Bladder in MS, The National Multiple Sclerosis Foundation, Columbia University, New York, NY, Co-investigator, 10%, 1990-1992. 4. Transurethral Urolume Wallstent Sphincter Clinical Application, American Medical Systems, Jefferson Medical College, Principal Investigator, 5%, 1990-1996. 5. A Phase II Dose Finding Placebo-controlled Study of Four Dose Levels of YM-617 in Patients with Symptomatic Benign Prostatic Hyperplasia, Oxford Pharmaceutical Services, Clifton, NJ Co-investigator, 10%, 1990-1991. 6. Double Blind Randomized Placebo Controlled, Dose Ranging Study of Adamantine in Symptomatic Patients With Benign Prostatic Hyperplasia, Berlex Laboratory, Wayne, NJ, Co-investigator, 5%, 1990-1993. 7. Transurethral Urolume Wallstent Prostate Clinical Application, American Medical Systems, 8. Jefferson Medical College, Principal Investigator, 5%, 1991-1996. 9. Bladder Physiology and Functional recovery Following Experimental Spinal Trauma, Nemours Research Foundation, Alfred I. duPont Institute, Principal Investigator, 10%, 1991-1995. 10. Transurethral Urolume Wallstent Urethral Stricture Clinical Application, American Medical Systems, Jefferson Medical College, Principal Investigator, 5%, 1992-1996. 11. Roberts Pharmaceutical Corporation, "A Double-Blind Evaluation of Midodrine and Placebo in Female Patients With Stress Urinary Incontinence, Principal Investigator, 5%, 1992. 12. Prospective Evaluation of Terazosin in Spinal Cord Injured Men, Abbott Pharmaceutical Research Grant, Principal Investigator, 5%, 1992-1994. 13. Spermatogenesis Following SCI: Quantitative and Dynamic assessment in the Rat Model. Spinal Cord Research Foundation, Co-Investigator, 5%, 1993-1994. 14. Bladder Physiology and Function Recovery After Experimental Spinal Trauma, 15. American Foundation of Urologic Disease, Co-Investigator, 5%, 1993-1994. 16. Bladder Physiology and Function Recovery after Experimental Spinal Trauma, American Foundation of Urologic Disease, Co-Investigator, 5%, 1994-1995. 17. Gastric Augmentation and Metabolic Alterations After Experimental Spinal Trauma, Nemours Research Foundation, Alfred I. duPont Institute, Co-Investigator, 5%, 1994-1996. 18. Urodynamic Effect of Madalazam, Nemours Research Foundation, Alfred I. duPont Institute, Co-Investigator, 5%, 1995-1996. 19. Phase I Urodynamic Methodology Study. Zeneca, Principle Investigator, 5%, 1995-1996. 20. Dynamic bladder Myoplasty. Medtronic, Principal Investigator, 5%, 1995-Present. 21. Dynamic Gracilis Urethral Myoplasty. Medtronic, Principal Investigator, 5%, 1995-Present. 22. Molecular Analysis of Normal Bladder and Interstitial Cystitis, Dean's Overage Research Program, Thomas Jefferson University, Principle investigator, 5%, 1995-1996. Chancellor 66 of 108 23. Intravesical Capsaicin for Treatment of Hyperreflexic Bladder. American Paraplegic Society Seed Grant, Principal Investigator, 5%, 1995-1996. 24. Evaluation of the Safety and Efficacy of the Sacral Nerve Stimulation System for the Treatment of Urinary Incontinence or Dysfunctional Voiding Patterns. Medtronic, Principal Investigator, 5%, 1994-Present. 25. Prospective Randomized Study of Sphincter Stent Prosthesis and Sphincterotomy, American Medical Systems, Pfizer, Principal Investigator, 5%, 1995-1997. 26. Molecular Analysis of Neurogenic Lower Urinary Tract Dysfunction, American Foundation of Urologic Disease Award, Co-Investigator, 5%, 1996-1997. 27. Molecular Analysis of Neurogenic Lower Urinary Tract Dysfunction, Nemours Research Foundation, Alfred I. duPont Institute, Co-Investigator, 5%, 1997-1999. 28. Human inducible nitric oxide synthase as gene therapy for erectile dysfunction. American Foundation for Aging Research, Preceptor, 1997, $3,500. 29. Gene therapy for impotence with human inducible nitric oxide synthase. American Foundation for Urological Disease, Preceptor, 1997, $2,000. 30. Nitric oxide synthase gene therapy using virus and plasmid vectors for erectile dysfunction. The Order of the Eastern Star, Preceptor, 1997, $700. 31. Effect of nitric oxide synthase gene therapy on the urinary tract. University of Pittsburgh School of Medicine Summer Research Scholarship, Preceptor, 1997, $2,000. 32. Myoblast Urethral Myoplasty and Gene Therapy for Stress Urinary Incontinence. Pittsburgh Tissue Engineering Initiative (PTEI) Development Fund, $49,968, Principal Investigator, 1997-1999. 33. American Foundation for Urologic Disease AUA Traveling Fellowship, $2,500, John Lavelle, MD, Mentor, May 29- June 4, 1998. 34. Dose escalation study with tolterodine in patients with overactive bladder. A single-blind study in patients with symptoms of overactive bladder including urinary urgency and frequency with or without urge incontinence, Pharmacia & Upjohn, Inc., Principal Investigator, 1997-1999. IRB# 990619, $71,785. 35. A dose escalating, single-blind, placebo-controlled clinical trial evaluating the safety, tolerance and effects of resiniferatoxin (RTX), Afferon Inc., [RTX-102] Principal Investigator, 1997-Present. IRB# 970708, $47,064. 36. Clinical efficacy and tolerability/safety of tolterodine prolonged release capsules and tolterodine immediate release tablets vs placebo. A randomized, double-blind, placebo-controlled, multinational study in patients with symptoms of overactive bladder, Pharmacia & Upjohn, Inc.,Principal Investigator, 1998-1999. IRB# 981233, $75,805. 37. Long-term safety and efficacy of tolterodine prolonged release capsules. An open-label, uncontrolled, multinational study in patients with symptoms of overactive bladder, Pharmacia & Upjohn, Inc., Principal Investigator, 1999- present. IRB# 990619, $32,377. 38. A randomized, double-blind, placebo-controlled, fixed-dose study to evaluate the safety and efficacy of LU 25-109 in the treatment of adult patients with overactive bladder, Forrest Laboratories, Inc., Principal Investigator, 2000-present, IRB# 991072, $64,386. 39. A randomized, parallel-group, double-blind, placebo-controlled clinical trial evaluating the safety, tolerance and effects of RTX (resiniferatoxin) on overactive bladder in patients with detrusor hyperreflexia, Afferon Inc., [RTX- 108] Principal Investigator, 2000-present. 40. IRB# 000105, $26,719. 41. Gene Therapy for Interstitial Cystitis Using Nonreplicating Herpes Simplex Virus-Human Preproenkephalin. Fishbein Family IC Foundation and Interstitial Cystitis Association Research Fund, Principal Investigator, 7/1/2000 – 6/30/2001, Direct $75,000. 42. 95th American Foundation for Urologic Disease AUA Traveling Fellowship, $2,500, Christopher Smith, MD., Mentor, April 30-May 4, 2000. 43. A Possible Bladder Site of Action of Doxazosin in BPH. International Cardura Competitive Research Awards Program, Principal Investigator, 7/1/2000 – 6/30/2001, Direct $15,000. 44. Muscle Cell Mediated Therapy for Stress Urinary Incontinence. Pittsburgh Tissue Engineering Initiative (PTEI) Development Fund, $49,968, Principal Investigator, 7/1/2000 – 6/30/2001, Direct $50,000. 45. Urodynamics in Spinal Cord Injury Patients Following Treatment with Ditropan XL (Oxybutynin Chloride), Alza Corporation, Principal Investigator, 2000-present, IRB# 000660, $45,000. 46. Primary Treatment with Ditropan XL (Oxybutynin Chloride) in Multiple Sclerosis Patients, Alza Corporation, Principal Investigator, 2000-present, IRB#000922, $45,000. 47. Effects of Botulinum toxin on multiple sclerosis and spinal cord injury neurogenic bladder. Spinal Cord Research Foundation, Principal Investigator, 1/1/02-12/31/03. Direct $149, 010. Chancellor 67 of 108 48. Botulinum toxin: investigation on afferent nerve inhibitory effects in animal model of interstitial cystitis. Fishbein Family IC Research Foundation and Interstitial Cystitis Association Research Fund, Principal Investigator, 1/1/2002 – 12/31/2003, Direct $50,000. 49. Intravesical liposome and advanced drug delivery for interstitial cystitis. Fishbein Family IC Research Foundation and Interstitial Cystitis Association Research Fund, Principal Investigator, 1/1/2002 – 12/31/2003, Direct $25,000. 50. Muscle stem cell translational research. Cook-Myosite, Inc., 7/1/02-6/30/03, Direct: $100,000. 51. Fishbein Family Award for Center of Urology Research Excellence – Interstitial Cystitis (CURE-IC), Principal Investigator, 7/1/02-6/30/03, Total: $100,000. 52. Development of a novel biaxial mechanical bioreactor for MDSC tissue engineering applications. Nagatomi, J., Chancellor, M.B., Sacks, M.S., McGowan Institute of Regenerative Medicine Graduate Student Award, Co- investigator 2002, $35,000. 53. Muscle stem cell sponsored research. Cook-Myosite, Inc., 7/1/03-6/30/04, Direct: $96,000. 54. Education in Female Bladder and Sexual Dysfunction, Pfizer, $26,000; 2003. 55. Investigation of the Cellular, Molecular and Biomechanical Alterations in the Urinary Bladder Following Spinal Cord Injury; Spinal Cord Research Foundation (Paralyzed Veterans of America); 10/03 – 9/05; $148,846; PI: Jiro Nagatomi, PhD; Co-Investigator. 56. Efficacy and Safety of Duloxetine Compared with Placebo in Subjects with Symptoms of Bladder Overactivity due to Pure Detrusor Instability or Sensory Urgency, IRB# 010558, Eli Lilly [F1J-MC-SBBL] Principal Investigator, 2002- 2003 $76,100. 57. Botulinum toxin: investigation on afferent nerve inhibitory effects in animal model of interstitial cystitis. Fishbein Family IC Research Foundation and Interstitial Cystitis Association Research Fund, Principal Investigator, 1/1/2002 – 12/31/2003, Direct $50,000. 58. CATER; Cellular Approaches to Tissue Engineering and Gegeneration Program Training Grant; Rachelle Prantil, 11/2003-8/2004. 59. Long-Term Monitoring of Safety in Subjects Treated with Duloxetine for Bladder Overactivity, IRB# 030105, Eli Lilly [F1J-MC-SBBX] Principal Investigator, 2003 – present, $20,000 60. Fishbein Family Award for Center of Urology Research Excellence – Interstitial Cystitis (CURE-IC), Principal Investigator, 7/1/03-6/30/04, Total: $100,000. 61. A Double-Blind, Placebo-Controlled Study of Urinary Frequency and Urgency Using Trospium Chloride, 20 mg Tablets, Twice Daily, for 12 Weeks Followed by a 6-Month, Open-Label Treatment Phase in Patients with Overactive Bladder, IRB#0307002, Indevus Pharmaceuticals, Inc. [IP631-005] Principal Investigator, 2003-present, $35,000. 62. A 12-week, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the efficacy of Darifenacin 15mg Once Daily (OD) on increase in warning time, the time from first sensation of urgency to voiding, in subjects with overactive bladder (OAB) IRB# 0404002 Novartis Pharmaceuticals. Principal Investigator, 2003-2004, $45,000 63. An Open-Label Multicenter Study to Assess the Efficacy and Safety of Daily Oral Administration of 5 and 10mg Vesicare (Solifenacin Succinate) in Subjects Who Wish to Switch From Detrol LA (Tolterodine Tartrate Extended Release) for the Treatment of Overactive Bladder Symptoms. Yamanouchi. Principal Investigator, IRB# 0409099, 2003-2004, $33,000. 64. Muscle stem cell sponsored research. Cook-Myosite, Inc., 7/1/04-6/30/05, Direct: $96,000. 65. The Role of Botulinum Toxin in Urology, CME Course, Pittsburgh, PA, April 9, 2005. $23,500. 66. The Role of Botulinum Toxin in Urology, CME Course, Los Angeles, CA, April 30, 2005. $30,000. 67. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of AZD7371 in Patients 18 – 70 Years of Age with Symptoms of Overactive Bladder. Astra Zeneca. Principal Investigator. IRB#0412003, 2004-2005 $24,000. 68. A Phase 1, Randomized, Placebo-Controlled, Crossover, Target Validation Study of CP-122,721 In Subjects with Neurogenic Detrusor Overactivity. Pfizer Inc. IRB# 0408123, 2004-present $100,000. 69. A Pilot Study to Determine the Gene Expression Profile of Bladder Tissue from Patients with Overactive Bladder (OAB). GlaxoSmithKline. Principal Investigator. IRB #0504051 2005-2006 $85,000. 70. 12-week, randomized, open-label, parallel-group, multicenter study to evaluate the efficacy, safety and tolerability of Enablex (darifenacin) (with voluntary uptitration from 7.5 mg o.d. to 15 mg o.d. at week 2) alone or in combination with Behavioral Modification Program for symptoms of overactive bladder. Novartis Pharmaceuticals. IRB # Principal Investigator.$31,000. 2005-2006 Chancellor 68 of 108 71. A Phase 2, 8-week, Multi-center, Randomized Double-Blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy, Tolerability and Safety of [S, S] – Reboxetine (PNU-165442G) for Stress Urinary Incontinence in Women. Pfizer Inc. IRB# Prinicpal Investigator. 2005-2006 72. Fishbein Family Award for Center of Urology Research Excellence – Interstitial Cystitis (CURE-IC), Principal Investigator, 7/1/04-6/30/05, Total: $100,000. 73. Juanita Gregg Foundation for Interstitial Cystitis Research, Principal Investigator, 7/1/05-6/30/06, Total: $25,000. 74. Fishbein Family Award for Center of Urology Research Excellence – Interstitial Cystitis (CURE-IC), Principal Investigator, 7/1/05-6/30/06, Total: $100,000. 75. A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose- Response Study of the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Urge Incontinence, Allergan, Principal Investigator $339,548, 2006-2008 76. A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Repeat Treatment with Two Dose Levels of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with BOTOX in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity, Allergan, Principal Investigator. $308,860 2006-2008 77. Heinze Foundation Center for Urological Regional Entrepreneurship (Heinz CURE) $100,000, 2006-2007. 78. IND study of Autologous Muscle Derived Cells for Stress Urinary Incontinence, Cook MyoSite, Co-Investigator, 2008-Present 79. Extension study: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Repeat Treatment with Two Dose Levels of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with BOTOX in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity, Allergan, Principal Investigator. 2009-Present, 80. Urine Biomarkers for OAB. 2009 OAB-LUTS Competitive Grants, Pfizer Inc, $75,000, 2009-2010 81. Urine Inflammatory Biomaerks for Differential Diagnosis of OAB from IC/PBS. Oakland University-Beaumont Mulitdisciplinary Research Award. $5,000, 2009-2010 82. Inflammation associated with Neuromodulation in IC/PBS. Society of Female Urology and Urodynamics Research Grant, $40,000, 2010-2011 83. Multivariate Chemokines-based Model for Discrimination of OAB from UTI. 2010 OAB-LUTS Competitive Grants, Pfizer Inc, $75,000, 2010-2011 84. Investigation into the mechanistic link between obesity and overactive bladder. Oakland University-Beaumont Mulitdisciplinary Research Award. $5,000, 2011-2012 85. Stopped due to CV length

ABSTRACTS

1. Chancellor, M.B., McHugh, T.A., Dorr, R.P. and Van Appledorn, C.A.: Transrectal Prostate Ultrasonography before Transurethral Prostatectomy, Its Value in Screening for Stage A Cancer. J. Urol., 137:241A, 1987. 2. Chancellor, M.B., Bennett, C.J., Sonda, L.P. and Konnak, J.W.: Effectiveness of Yohimbine in the Treatment of Erectile Impotency - Retrospective Analysis. J. Urol., 137:310A, 1987. 3. Chancellor, M.B. and Konnak, J.W.: Comparison of Ileocecal Intussusception and Simple Ileal Lumen Reduction as a Continence Mechanism in a Dog Model Ileocecal Reservoir. J. Urol., 139:311A, 1988. 4. Chancellor, M.B., Griffiths, D.J., Kaplan, S.A., and Blaivas, J.G.: Bladder Outlet Obstruction and Impaired Detrusor Contractility: A Blind Comparison of the Video-urodynamics Diagnosis Versus the Diagnosis Based on a Detrusor Contractility Parameter (WF), a Urethral Resistance Parameter (URA), and a Sustained/Fade Index (SFI). Neurourology & Urodynamics, 9:209-211, 1990. 5. Chancellor, M.B., Kaplan, S.A., Schuessler, G.B. and Blaivas, J.B.: The Cholinergic and Purinergic Components of Detrusor Contractility in Rabbit Whole Bladder Model. J.Urol. 143:378A, 1990. 6. Kaplan, S.A., Brown, W.C., Chancellor, M.B., Schuessler, G.B. and Blaivas, J.G.: Parameters of Detrusor Contractility in an In- Vitro Rabbit Whole Bladder Model. J. Urol., 143:371A, 1990. 7. Chancellor, M.B., Otter, M.W., Kaplan, S.A. and Blaivas, J.G.: A New Method of Measuring Uroflow in the Rat Bladder. International Continence Society, Aarhus Denmark, October, 1990. 8. Kaplan, S.A., Chancellor, M.B., Schuessler, G.B. and Blaivas, J.G.: The Effect of Bethanechol and Atropine on the Contractility Parameters Power, Work, and Wf in an In-vitro Rabbit Whole Bladder Model. International Continence Society, Aarhus Denmark, October, 1990. Chancellor 69 of 108 9. Kaplan, S.A., Chancellor, M.B. and Blaivas, J.G.: A Urodynamic Evaluation of Bladder and Sphincter Behavior in Patients with Spinal Cord Lesions. J. Urol., 143:135A, 1990. 10. Bhattacharyya, A.K., Chancellor, M.B.: Simultaneous Cystometrogram and External Urethral Sphincter Electromyogram in Evaluation of Neurogenic Bladder. American Congress of Rehabilitation Medicine and American Academy of Physical Medicine and Rehabilitation, 1990. 11. Chancellor, M.B., Hills, E., Schwartz, M., Hirsch, I.H.: Treatment of Erectile Dysfunction in Males with Spinal Cord Injury Using the Vacuum Construction Device (VDC). 1991 Annual Meeting of the American Spinal Injury Association, Seattle WA, April 8-10, 1991. 12. Hirsch, I.H., Christinzio, J., Bagley, D.H., Chancellor, M.B, Staas, W.E.: Treatment of erectile dysfunction of spinal cord injured men with prostaglandin E-1 dosage considerations, safety, and efficacy. 1991 Annual Meeting of American Spinal Cord Injury Association, Seattle, Washington, April 8-10, 1991. 13. Chancellor, M.B., Shenot, P.J., Hirsch, I.H., Blaivas, J.G., Bhansali, L.D., Kaplan, S.A., Benach, J.J., Freemont-Smith, M.: Bladder Infection by the Lyme Spirochaete. J. Urol. 145:235A, 1991. 14. Kaplan, A., Blaivas, J.G., Chancellor, M.B., Brown, W.C.: Mechanical Indices of Detrusor Contractility in Male and Female Rabbit Bladders. J. Urol. 145:308A, 1991. 15. Kaplan, S.A., Blaivas, J.G., Chancellor, M.B., Griffiths, D.G.: The Effect of Pharmacologic and Electrical Stimulation on Power, Work and WF. J. Urol. 145:385A, 1991. 16. Kiilholma, P., Chancellor, M.B., and Hirsch, I.H.: Complications of Periurethral Teflon Injection. 1991 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Bermuda, October 13-16, 1991. 17. McGinnis, D.E., Chancellor, M.B., Shenot, P.J., Kiilholma, P., Hirsch, I.H., and Data, V.M.: Bladder Dysfunction in Lyme Disease. 1991 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Bermuda, October 13-16, 1991. 18. Chancellor, M.B., Hirsch, I.H., Kiilholma, P.J.: DDAVP in the Management of Nocturia in Multiple Sclerosis. 1991 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Bermuda, October 13-16, 1991. 19. Chancellor, M.B. Hirsch, I.H., Bagley, D.H.: Initial Northern American Experience with the Urinary Sphincter Stent. 1991 International Meeting of the Society for Minimally Invasive Therapy, Boston, MA, November 12, 1991. 20. Chancellor, M.B., Hirsch, I.H., Bagley, D. H.: Flexible Cystoscopy during Urodynamics of Spinal Cord Injured Patients. 1991 International Meeting of the Society for Minimally Invasive Therapy, Boston, MA, November 12, 1991. 21. Chancellor, M.B., Erhard, M.J., Abdill, C.K., Goodman, C., Hirsch, I.H., Staas, W.E.: Prospective Evaluation of External Sphincter Balloon Dilatation and Prosthesis Placement as Alternatives to External Sphincterotomy. J. Am. Paraplegia Society. 15:102, 1992. 22. Chancellor, M.B., Erhard, M.J., Hill, K., Hirsch, I.H., Staas, W.E.: Prospective Open-label Evaluation of Terazosin in the Treatment of Autonomic Dysreflexia. 1992 Annual Meeting of the American Spinal Injury Association. Toronto, Canada, May 8- 10, 1992. J. Am. Paraplegia Society. 15:106, 1992. 23. Erhard, M.J., Strup, S., Chancellor, M.B.: Bladder Augmentation Using the Stomach in Spinal Cord Injured Patients with Impaired Renal Function. 1992 Annual Meeting of the American Spinal Injury Association. Toronto, Canada, May 8-10, 1992. J. Am. Paraplegia Society. 15:141, 1992. 24. Erhard, M.J., Chancellor, M.B., Abdill, C.K., Hirsch, I.H., Bagley, D.H.: Flexible Cystoscopy During Urodynamics of Spinal Cord Injured Patients. 1992 Annual Meeting of the American Spinal Injury Association. Toronto, Canada, May 8-10, 1992. J. Am. Paraplegia Society, 15:133, 1992. 25. Baliga, A., Chancellor, M.B., Freedman, D.O., Hill, K.: Ethical Issues in the Management of Impotence with Penile Injection in Spinal Cord Injury. J. Am. Paraplegia Society, 15:95, 1992. 26. Chancellor, M.B., Kiilholma, P., Hirsch, I.H., Filmer, R.B., Salzman, S.K.: Bladder Physiology in Experimental Rat Spinal Trauma: 1: Spinal Injury Model. J. Urology, 147:312A, 1992. 27. Chancellor, M.B., Erhard, M.J., Abdill, C.K., Goodman, C., Hirsch, I.H., Staas, W.E.: Prospective Comparison of External Balloon Dilatation and Prosthesis Placement with External Sphincterotomy in Spinal Cord Injured Men. J. Urology, 147:400A, 1992. 28. Erhard, M.J., Chancellor, M.B., Kiilholma, P., Hill, K., Harton, S., Staas, W.E.: Prospective Open-label Treatment of Autonomic Dysreflexia. J. Urology, 147:270A, 1992. 29. Strup, S., Chancellor, M.B., Erhard, M.J., Abdill, C.K., Kiilholma, P., Staas, W.E.: Application of Prostate Balloon Dilator for External Sphincterotomy. J. Urology, 147:439A, 1992. 30. Erhard, M.J., Chancellor, M.B., Abdill, C.K., Kiilholma, P., Hirsch, I.H., Staas, W.E.: Membranous Urethral Prosthesis for Neurogenic Bladder. J. Urology, 147:439A, 1992. 31. Kiilholma, P., Chancellor, M.B., Makinen, J., Pitkanen, Y., Hirvonen, T.: Modified Burch Colposuspension: Two Year Follow- up Study in 186 Patients. J. Urology, 147:278A, 1992. 32. Abdill, C.K. and Chancellor, M.B.: Transurethral Placement of External Sphincter Wire Mesh Stent for Neurogenic Bladder. American Association of Spinal Cord Injury Nursing, September, 1992. 33. Kiilholma, P., Pitkanen, Y., Makinen, J., Chancellor, M.B., Varpula, M.: Comparison of Ultrasound and Urodynamic Examinations in the Evaluation of Female Urinary Incontinence. Annual Meeting of the International Continence Society, Halifax, Canada, September 1-4, 1992. Chancellor 70 of 108 34. Chancellor, M.B., Karasick, S., Abdill, C.K., Hirsch, I.H., Staas, W.: Assessment of Alternative Therapies to External Sphincterotomy: Sphincter Prosthesis Placement and Balloon Dilatation. Annual Meeting of the International Continence Society, Halifax, Canada, September, 1992. Neurourology & Urodynamics, 11:331, 1992. 35. Chancellor, M.B., Huang, B., Kiilholma, P., Hirsch, I.H.: Micturition Pattern in Experimental Rat Spinal Trauma. Annual Meeting of the International Continence Society, Halifax, Canada, September 1-4, 1992. 36. Chancellor, M.B., Karasick, S., Hirsch, I.H.: Transurethral Balloon Dilatation of the External Urinary Sphincter: Effectiveness in Spinal Cord Injured Men with Detrusor Sphincter Dyssynergia. 78th Scientific Assembly and Annual Meeting of RSNA, November 29th to December 4, 1992, Chicago, IL. 37. Chancellor, M.B., Karasick, S., Liu, J.B., Goldberg, B.B.: Intraurethral Wire Mesh Prosthesis Placement in the External Urinary Sphincter: A New Treatment for Detrusor Sphincter Dyssynergia. 78th Scientific Assembly and Annual Meeting of RSNA, November 29th to December 4, 1992, Chicago, IL. 38. Chancellor, M.B., Ackman, D., Appell, R.A., Binard, J., Boon, T.B., Roehrborn, C.G., Chetner, M.P., Thorndyke, W.C., Defalco, A., Mayo, M., Gajewski, J., Green, B., Bennett, J., Foote, J., Juma, S., Linsenmeyer, T., McMillan, R., Stone, A., Vasquez, A.: Multicenter Trials of Urolume Wallstent Prosthesis for the Urinary Sphincter in Spinal Cord Injured Men. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA.. 39. Erhard, M.J., Chancellor, M.B., Rivas, D., Kiilholma, P.: Pubovaginal Sling for the Treatment of Destroyed Female Urethra Secondary to Long-term Foley. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 40. Chancellor, M.B., Rivas, D.A., Huang, B., Hirsch, I.H., Filmer R.B., Salzman, S.K.: Micturition Patterns After Experimental Rat Model Spinal Cord Injury. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 41. Chancellor, M.B., Liberman, S., Rivas, D.A., Moore, J.: Autogenous Fat Injection in the Treatment of Vesicoureteral Reflux in Spinal Cord Injury: Preliminary Report. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 42. Erhard, M.J., Chancellor, M.B., Rivas, D.A., Staas, W.: Evaluation of Terazosin for the Treatment of Voiding Dysfunction In Spinal Cord Injury (SCI). ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 43. Chancellor, M.B., Ackman, D., Appell, R.A., Binard, J., Boon, T.B., Roehrborn, C.G., Chetner, M.P., Thorndyke, W.C., Defalco, A., Mayo, M., Gajewski, J., Green, B., Bennett, J., Foote, J., Juma, S., Linsenmeyer, T., McMillan, R., Stone, A., Vasquez, A.: Multicenter Trial in North America of Urolume Urinary Sphincter Prosthesis. AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 44. Kiilholma, P., Virtanen, H., Makinen, J., Tenho, T., Pitkanen, Y. Hirvonen, T.: Prospective Evaluation of Urinary Symptoms before and 1 Year after Abdominal Hysterectomy. AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 45. Perkash, I., Cowan, B., Gomella, L.G., Liberman, S.N, Chancellor, M.B.: Use of Contact N:d YAG Laser for Ablation of the External Urethral Sphincter. AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 46. Hirsch, I.H., Chancellor, M.B., Huang, B., Salzman, S.K., Evenson, D.: Spermatogenesis Following Experimental Spinal Cord Injury (SCI). AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 47. Hirsch, I.H., Chancellor, M.B., Sedor, J., Byrne, D. S.: Male Reproductive Rehabilitation: Adjunctive Diagnostic and Therapeutic Techniques. AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 48. Hirsch, I.H., Chancellor, M.B., Kulp, D., Sedor, J.: Enhanced Fertility in Spinal Cord Injured Men Following External Sphincter Reduction Procedures: AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 49. Chancellor, M.B., Karasick, S.: Assessment of Sphincter Prosthesis Placement as Alternative to External Sphincterotomy. Society of Uroradiology - Postgraduate Course, Naples, FL, January, 9, 1993. 50. Rivas, D.A., Chancellor, M.B., Huang, B., Salzman, S.K.: Autonomic Dysreflexia in a Rat Model Spinal Cord Injury and the Effect of Pharmacologic Agents. Urodynamics Society, San Antonio, TX, May 15, 1993. 51. Huang, B., Rivas, D.A., Chancellor, M.B.: Autonomic Dysreflexia in a Rat Model Spinal Cord Injury (SCI) and the Effect of Pharmacologic Agents. American Paraplegia Society, 16:276, 1993. 52. Rivas, D.A., Moore, J., Chancellor, M.B.: Complications of Vacuum Constriction Device for Treatment of Erectile Dysfunction in Spinal Cord Injury (SCI) Men. American Paraplegia Society, 16:250, 1993. 53. Chancellor, M.B., Rivas, D.A., Acosta, R., Erhard, M.J., Salzman, S.K.: Detrusor-Myoplasty: Skeletal Muscle Wrap of the Urinary Bladder and Function Neuromuscular Electrical Stimulation. American Paraplegia Society, 16:273, 1993. 54. Abdill, C.K., Rivas, D.A., Chancellor, M.B.: Urodynamic Evaluation of Spinal Cord Injured Patients Using a Flexible Cystoscopy. American Association of Spinal Cord Injury Nurses, 1993. 55. Hirsch, I.H., Chancellor, M.B., Sedor, J., Byrne, D.S., Staas, W.E.: Male Reproductive Rehabilitation: Adjunctive Diagnostic and Therapeutic Techniques. The American Fertility Society, October 9-14, 1993. 56. Hirsch I.H., Chancellor, M.B., Huang, B., Salzman, S.K., Evenson, D.: Spermatogenesis Following Experimental Spinal Cord Injury (SCI). The American Fertility Society, October 9-14, 1993. 57. Chancellor, M.B., Rivas, D.A., Karasick, S., Liu, J.B., Alexander, D.A., Merton D.A., Goldberg, B.B.: Endoluminal Ultrasound Evaluation of Urethral Diverticulum and Periurethral Mass. 1993 Annual Meeting of the American Uro-Gynecologic Society, San Antonio, TX, October 30 to November 2, 1993. 58. Chancellor, M.B., Rivas, D.A., Kiilholma, P.J.: The Application of the New American Urological Association Symptom Index for Women with Voiding Symptoms. 1993 Annual Meeting of the American Uro-Gynecologic Society, San Antonio, TX, October 30 to November 2, 1993. Chancellor 71 of 108 59. Rivas, D.A., Erhard, M.J., Kiilholma, P.J., Chancellor, M.B.: Functional Urethral Closure with Pubovaginal Sling for Destroyed Female Urethra After Long-term Foley Catheterization. 1993 Annual Meeting of the American Uro-Gynecologic Society, San Antonio, TX, October 30 to November 2, 1993. 60. Chancellor, M.B., Karasick, S., Abdill, C.K., Hirsch, I.H., Staas, W.E.: Assessment of Alternative Therapies to External Sphincterotomy: Sphincter Prosthesis Placement and Balloon Dilatation. Society of Uroradiology - Postgraduate Course, Naples, FL, January 1993. 61. Karasick, S., Chancellor, M.B.: Augmentation Cystoplasty with Stomach: Initial Experience in Three Patients with impaired Renal Function. Society of Uroradiology - Postgraduate Course, Laguna Niguel, CA, January 10, 1994. 62. Keeley, F.X., Chancellor, M.B., Rivas, D.A., Acosta, R., Erhard, M.J., Salzman, S.K.: Detrusor-Myoplasty: Skeletal Muscle Wrap of the Urinary Bladder; Animal and Clinical Experience. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 63. Chancellor, M.B., Rivas, D.A.: DDAVP in the Urological Management of the Difficult Neurogenic Bladder in SCI. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 64. Erhard, M.J., Liberman, S., Rivas, D.A., Karasick, S., Keeley, F.X., Chancellor, M.B.: Cutaneous Ileocystostomy (Bladder Chimney) for the Treatment of the End-Stage Neurogenic Bladder. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 65. Chancellor, M.B., Rivas, D.A., Panzer, D.E., Hirsch, I.H., Staas, W.E: Topical Minoxidil Therapy for Erectile Dysfunction in Upper and Lower Motor Neuron Spinal Cord Injury. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 66. Rivas, D.A., Chancellor, M.B., Erhard, M.J., Huang, B., Hirsch, I.H., Salzman, S.K.: Comparison of Erectile Response to the Intracorporal, Topical and Intraurethral Application of Vasoactive Substances in the Rat Model of Spinal Cord Injury. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 67. Sood, O., Chancellor, M.B., Rivas, D.A., Karasick, S., Abdill, C.K., Staas, W.E., Bennett, C., Perkash, I.: Three Year Follow-up of the Urinary Sphincter Stent for the Treatment of Sphincter Dyssynergia in Spinal Cord Injury Patients. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 68. Weiss, D., Chancellor, M.B., Rivas, D.A., Staas, W.E., Fried G.W.: Correlation of Bladder Function After Spinal Cord Injury with Initial Perianal Pinprick Testing. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 69. Hirsch, I.H., Shenot, P.J., Huang, B., Salzman, S.K., Rivas, D.A., Chancellor, M.B.: Spermatogenesis in the Rodent Model Following Spinal Cord Injury (SCI). 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 70. Hirsch, I.H., Chancellor, M.B., Shenot, P.J., Rivas, D.A., Staas, W.E.: Enhanced Fertility in Spinal Cord Injured Men Following External Sphincter Reduction Procedure. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 71. Hirsch, I.H., Shenot, P.J., Chancellor, M.B., Staas, W.E.: Simplified and Objective Assessment of Spermatogenesis in SCI Men by Flow Cytometry Analysis (FCA). 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 25 - 27, 1994. 72. Hirsch, I.H., Chancellor, M.B., Rivas, D.A., Sedor, J., Shupp-Byrne, D.: Male Reproductive Rehabilitation: Adjunctive Diagnostic and Therapeutic Techniques. Annual Meeting of the American Society of Andrology, Springfield, IL, March 4-7, 1994. 73. Das, A.K., Chancellor, M.B., Rivas, D.A., Liu, J.B., Alexander, A., Karasick, S., Goldberg, B.: Endoluminal Ultrasound Evaluation of Urethral Diverticulum and Periurethral Mass. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:476A, 1994. 74. Chancellor, M.B., Rivas, D.A., Karasick, Steven, Abdill, C.K.: Three Year Follow-Up of the Urinary Sphincter Stent in Spinal Cord Injured Men. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:271A, 1994. 75. Shenot, P., Rivas, D.A., Kalman, D.D., Staas, W.E., Chancellor, M.B.: Latex Allergy Manifested in Urological Surgery and Care of Adult Spinal Cord Injured Patients. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:272A, 1994. 76. Erhard, M.J., Libermen, S., Rivas, D.A., Keeley, F.X., Karasick, S., Chancellor, M.B.: Cutaneous Ileocystostomy (bladder chimney) for the Treatment of the End-Stage Neurogenic Bladder. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:511A, 1994. 77. Rivas, D.A., Chancellor, M.B., Erhard, M.J., Huang, B., Hirsch, I.H., Salzman, S.K.: Comparison of Erectile Response to Intraurethral, Topical, and Intracorporal Pharmacotherapy in the Rat Model of Spinal Cord Injury. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:495A, 1994. 78. Keeley, F.X., Chancellor, M.B., Lotfi, A., Gomella, L.G., Rivas, D.A.: Similarity of the American Urological Association Symptom Index Among Men with Benign Prostate Hyperplasia (BPH), Urethral Obstruction not Due to BPH and Detrusor Instability Without Bladder Outlet Obstruction. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:297A, 1994. 79. Huang, B., Rivas, D.A., Chancellor, M.B.: Comparison of the American Urological Association Symptom Index between Women and Men. 1994 Annual Meeting of the American Urological Association, San Francisco, CA. J. Urol., 151:313A, 1994. Chancellor 72 of 108 80. Chancellor, M.B., Rivas, D.A.: DDAVP in the Symptomatic Management of Voiding Symptoms in Men with Benign Prostatic Hyperplasia. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:507A, 1994. 81. Shenot, P.J., Rivas, D.A., Mandel, S., Schwartzman, R.J., Chancellor, M.B.: Urological Manifestations of Reflex Sympathetic Dystrophy versus Interstitial Cystitis. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, J. Urol., 151:282A, 1994. 82. Das, A., Rivas, D.A., Karasick, S. and Chancellor, M.B.: Cutaneous Ileocystostomy (Bladder Chimney) in End-stage Neurogenic Bladder. 1994 Annual Meeting of the American Paraplegia Society, Las Vegas September 6-8, 1994. 83. Rivas, D.A., Chancellor, M.B., Huang, B., Hirsch, I.H., Salzman, S.K.: Comparison of Erectile Response to Intraurethral, Topical, and Intracorporal Pharmacotherapy in the Rat Model of Spinal Cord Injury. 1994 Annual Meeting of the American Paraplegia Society, Las Vegas September 6-8, 1994. 84. Weiss, D., Chancellor, M.B., Rivas, D.A., and Fried G.W.: Spinal Cord Injury and Bladder Recovery. 1994 Annual Meeting of the American Paraplegia Society, Las Vegas September 6-8, 1994. 85. Huang, B., Rivas, D.A., Salzman, S.K. and Chancellor, M.B.: In-Vivo Whole Bladder Spinal Cord Injury Response to Anticholinergic Agent. 1994 Annual Meeting of the American Paraplegia Society, Las Vegas September 6-8, 1994. 86. Strup, S., Rivas, D.A., Liu J.B., Bagley, D., Goldberg, B. Chancellor, M.B.: Endoluminal Ultrasonographic and Histological Evaluation of Periurethral Collagen Injection. Injection. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22-25, 1994. 87. Das A.K., Rivas, D.A., Chancellor, M.B. Liu J.B., Goldberg, B. Alexander, A.A.: Endoluminal Ultrasound Examination of the Male and Female Urethras. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22-25, 1994. 88. Hirsch, I.H., Huang, B. Chancellor, M.B., Rivas, D.A. and Salzman, S.K.: Rodent Spermatogenesis Following Experimental Spinal Cord Injury: Assessment by Duel Parameter Flow Cystometry Analysis. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22-25, 1994. 89. Rivas, D.A., Chancellor, M.B., Huang, B., Hirsch, I.H. and Salzman, S.K.: Comparison of the Erectile Response to the Topical and Urethral Application of Minoxidil in the Rat Model of Spinal Cord Injury to that of the Clinical Response to Topical Minoxidil in SCI Men. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22-25, 1994. 90. Das, A.K., Sedor, J.F., Byrne, D.S., Chancellor, M.B., Rivas, D.A. and Hirsch, I.H.: Male Reproductive Rehabilitation: Adjunctive Diagnostic and Therapeutic Techniques. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22-25, 1994. 91. Liu, J.B., Alexander, A.A., Chancellor, M.B., Merton, D.A., Rivas, D.A., Goldberg, B.B.: Endoluminal Urethral Ultrasound: Clinical Applications. Radiology, 193(P):168, 1994. 92. Chancellor, M.B., Rivas, D.A., Staas, W.E., Bennett, C.J., FInocchiaro, M.V., Razi, S., Bennett, J.K., Green, B.G., Foote, J.E., Killorian, R.W.: Management of Sphincter Dyssynergia in SCI Men with Indwelling Catheter Using the Sphincter Stent Prosthesis. Annual Meeting of the American Spinal Injury Association, Orlando, FL, May 1-3, 1995. 93. Chancellor, M.B., Rivas, D.A., Huang, B., Figerosa, S., Bergoise, I., Salzman, S.K.: Bladder Rupture after Bladder Augmentation and Myomotomy: Effect on Intstinal Segment and Detrusor-Myoplasty. Annual Meeting of the American Spinal Injury Association, Orlando, FL, May 1-3, 1995. 94. Chancellor, M.B., Rivas, D.A., Huang, B., Figerosa, S., Bergoise, I., Salzman, S.K.: Gracilis Muscle Dynamic Urethral Sphicter Myoplasty: Rat Model Experience. Annual Meeting of the American Spinal Injury Association, Orlando, FL, May 1-3, 1995. 95. Rivas, D.A., Chancellor, M.B., Hirsch, I.H., Bennett, C.J., FInocchiaro, M.V., Razi, S., Bennett, J.K., Green, B.G., Foote, J.E., Killorian, R.W., Jma, S., Lindseymeyer, T., Lloyd, K.: Epidemiology of Current Treatment for Sexual Dysfunction in Spinal Cord Injured Men in the Model Spinal Cord Injury Centers. Annual Meeting of the American Spinal Injury Association, Orlando, FL, May 1-3, 1995. 96. Rivas, D.A., Chancellor, M.B., McHugh, K.M., Salzman, S.K.: Bladder Smooth Muscle Gene Expression in Spinal Cord Injury: Potential Early Marker of Long-term Bladder Function and Risks. Annual Meeting of the American Spinal Injury Association, Orlando, FL, May 1-3, 1995. 97. Flood, H.D., Chancellor, M.B., Fraser, M.O., Erdman, S., de Groat, W.C.: Effect of Acute Intravesical Instillation of Capsaicin on Substance P Containing Nerves in Rat Bladder. Research Symposium on Interstitial Cystitis. NIH January 9-11, 1995. 98. Shupp Byrne, D.E. McCue, P., Sedor, J., Mulholland, M., Rivas, DA., deGroat, W.C., Flood, H.D., Chancellor, M.B.: Accute Effect of Intravesical Instillation of Capsaicin on Bladder Mucin/Glycoaminoglycan Layer in Control and Spinal Cord Injured (SCI) Rats. Research Symposium on Interstitial Cystitis. NIH January 9-11, 1995. 99. Rivas, D.A., McHugh, K.M., Chancellor, M.B., McCue, P, Salzman, S.K.: A Molecular Marker for the Development of Interstitial Cystitis in a Rat Model: Isoactin Gene Expression. Research Symposium on Interstitial Cystitis. NIH January 9-11, 1995. 100. Shupp Byrne, D.E., McCue, P., Sedor, J., Mulholland, M., Rivas, D.A., deGroat, W.C., Flood, J.D., Chancellor, M.B.: Acute Effect of Intravesical Capsaicin on Bladder Mucin/Glycosaminoglycan Layer in Control and Spinal Cord Injured Rats. J. Urology, 153:263A, 1995. 101. Rivas, D.A., Chancellor, M.B., McHugh, K.M. and Salzman, S.K.: Isoactin Gene Expression in the Rat Model Spinal Cord Injury: A Potential Early Marker of Long-term Bladder Function and Risks. J. Urology, 153:264A, 1995. Chancellor 73 of 108 102. Huang, B., Chancellor, M.B., Rivas, D.A., Figueroa, T.E., Salzman, S.K. and Bourgeois, I: Effect of Myomyotomy, Intestinal Augmentation, and Detrusor-Myoplasty on Bladder Rupture Pressure in a Rat Model of Bladder Augmentation. J. Urology, 153:304A, 1995. 103. Staas, W.E., Rivas, D.A., Gomella, L.G. and Chancellor, M.B.: Contact Nd: YAG Laser Ablation of the External Urinary Sphincter in Spinal Cord Injured Men with Detrusor Sphincter Dyssynergia. J. Urology, 153:336A, 1995. 104. Chancellor, M.B., Rivas, D.A., Staas, W.E., et al.,: Replacement of the Indwelling Catheter with the Sphincter Stent Prosthesis in the Management of Sphincter Dyssynergia in SCI Men. J. Urology, 153:336A, 1995. 105. Kiilholma, P.J., Haarala, M., Makinen, J., Polvi, H. and Chancellor, M.B.: Sutureless Laparoscopic Bladder Suspension Using Fibrin Sealant. J. Urology, 153:356A, 1995. 106. The North American Urolume Study Group: Multiple Urolume Endourethral Prostheses for the Treatment of Recurrent Bulbar Urethral Strictures: Result of the North American Urolume Trial. J. Urology, 153:373A, 1995. 107. The North American Urolume Study Group: The North American Experience with the Urolume Endourethral Prostheses as a Treatment for BPH: Three-year Results. J. Urology, 153:436A, 1995. 108. Rivas, D.A., Chancellor, M.B., Hirsch, I.H., et al.,: Epidemiology of Current Treatment for Sexual Dysfunction in Spinal Cord Injured Men in the Model Spinal Cord Injury Centers. J. Spinal Cord Medicine, 18:142, 1995. 109. Chancellor, M.B., Rivas, D.A., Huang, B., Figuoera, S, Beougeois, I., Salzman, S.K.: Bladder Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience. J. Spinal Cord Medicine, 18:151, 1995. 110. Fabrizio, M.D., Chancellor, M.B., Rivas, D.A., Richard, D.A.: The Role of Renal Scintigraphy in Spinal Cord Injured Patients with Presumed Urosepsis. 1995 Annual Meeting of the American Paraplegia Society, Las Vegas, Sept. 7-9, 1995. 111. Shenot, P.J., Chancellor, M.B., Rivas, D.A.: Latex Allergy Related to Bladder Management in Spinal Cord Injury Patients. 1995 Annual Meeting of the American Paraplegia Society, Las Vegas, Sept. 7-9, 1995. 112. McHugh, K.M., Rivas, D.A., Salzman, S.K., Fabrizio, M.D., Chancellor, M.B.: Bladder Smooth Muscle Isoactin Gene in the Rat Model of Spinal Cord Injury. 1995 Annual Meeting of the American Paraplegia Society, Las Vegas, Sept. 7-9, 1995. 113. Shenot, P.J., Chancellor, M.B., Byrne, D.E., Rivas, D.A., Fabrizio, M.D., deGroat, W.C., Flood, H.C.: Intravesical Capsaicin Effect on Bladder Mucosa in Control and Spinal Cord Injured Rats. 1995 Annual Meeting of the American Paraplegia Society, Las Vegas, Sept. 7-9, 1995. 114. Watanabe, T., Rivas, D.A., Huang, B., Figueroa, T.E., Chancellor, M.B.: Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience. 53rd Annual Meeting of the Mid-Atlantic Section AUA, Bermuda, Sept. 17-20, 1995. 115. Rivas, D.A., Chancellor, M.B., McCue, P., McHugh, K.M.: A Molecular Marker for the Development of Interstitial Cystitis in a Rat Model: Isoactin Gene Expression. 53rd Annual Meeting of the Mid-Atlantic Section AUA, Bermuda, Sept. 17-20, 1995. 116. Chancellor, M.B., Rivas, D.A., Watanabe, T., Bennett, J.K., Green, B.G., Foote, J.E., Killorin, R.W., MacMillan R.: Reversible Clinical Outcome after Sphincter Stent Removal. J. Spinal Cord Med., 19:146, 1996. 117. Rivas, D.A., McHugh, K.M., Shenot, P.S., Watanabe, T., Shupp-Byrne, D., McCue, P., Salzman, S.K., Chancellor, M.B.: Bladder Smooth Muscle Isoactin Gene Expression in the Rat Model Spinal Cord Injury. J. Spinal Cord Med., 19:126, 1996. 118. Rivas, D.A., King, S., Abdill, C.K., Shenot, P.S., Watanabe, T., Chancellor, M.B.: Effect of Urinary Tract Reconstruction in Neurologically Impaired Women. J. Spinal Cord Med., 19:141, 1996. 119. Rivas, D.A., Chancellor, M.B., Shenot, P.S., Figuero, T.E., Watanabe, T., Crewalk, J.A.: Gracilis Urethromyoplasty-The Creation of a New Autologous Urinary Sphincter in Neurologically Impaired Patients. J. Spinal Cord Med., 19:161, 1996. 120. Figueroa, T.E., Chancellor, M.B., Rivas, D.A., Huang, B.: Effect of Midazolam on Bladder Physiology. First International Bladder Symposium, Boston, MA., March 28-31, 1996. 121. Figueroa, T.E., Chancellor, M.B., Rivas, D.A., Huang, B.: Effect of Bladder Augmentation on Urodynamic Parameters and Homeostatic Balance in the Rat. First International Bladder Symposium, Boston, MA., March 28-31, 1996. 122. Fitzpatrick. K., Fabrizio, M.D., Rivas, D.A., Chancellor, M.B.: The Role of Renal Scintigraphy in Spinal Cord Injury (SCI) Patients with Presumed Urosepsis. J. Urol., 155: 434A, 1996. 123. Shenot, P.S., Rivas, D.A., McHugh, K.M., Hong, R., Watanabe, T., Shupp-Byrne, D., McCue, P., Salzman, S.K., Chancellor, M.B.: Analysis of Bladder Smooth Muscle Isoactin Expression in Interstitial Cystitis Using a Semi-Quantitative PCR Assay. J. Urol., 155: 441A, 1996. 124. Watanabe, T., Chancellor, M.B., Rivas, D.A., Shenot, Pl., Crewalk, J.A., Figueroa, T.E., Bourgeois, I.: Gracilis Urethromyoplasty-The Creation of A New Autologous Urinary Sphincter in Neurologically Impaired Patients. J. Urol., 155: 591A, 1996. 125. Sedor, J.F., Chancellor, M.B., Rivas, D.A., Shupp-Byrne, D., Hong, R., deGroat, W.C., Flood, H.D.: Intravesical Capsaicin in Neurologic Impaired Patients with Detrusor Hyperreflexia. J. Urol., 155: 592A, 1996. 126. Chancellor, M.B., Rivas, D.A., Shenot, P.J., Bennett, C., Finocciaro, M.V., Razi, S., Bennett, J.K., Green, B.G., Foote, J.E., Killorin, R.W.: Prospective Randomized Multicenter Study of Sphincter Stent Versus External Sphincterotomy in SCI Patients. J. Urol., 155: 594A, 1996. 127. Rivas, D.A., McHugh, K.M., Shenot, P.S., Watanabe, T., Shupp-Byrne, D., McCue, P., Salzman, S.K., Chancellor, M.B.: Bladder Smooth Muscle Isoactin Gene Expression in the Rat Model Spinal Cord Injury. J. Urol., 155:597A, 1996. 128. Rivas, D.A., Chancellor, M.B., Watanabe, T., Shenot, P.J., Crewalk, J.A.: Effect of urinary tract reconstruction in neurologically impaired women. 96th International Continence Society Meeting, Athens, Greece, August 27-30, 1996. 129. Rivas, D.A., Chancellor, M.B., Frabrizio, M.D., Fitzpatrick, K: The role of renal scintigraphy in spinal cord injury (SCI) patients whit presumed urosepsis. 96th International Continence Society Meeting, Athens, Greece, August 27-30, 1996. Chancellor 74 of 108 130. Rivas, D.A., Chancellor, M.B., Watanabe, T., Shenot, P.J., Figueroa, T.E.: Gracilis urethromyoplasty-the creation of a new autologous urinary sphincter in neurologically impaired patients. 96th International Continence Society Meeting, Athens, Greece, August 27-30, 1996. 131. Chancellor, M.B., Watanabe, T., Sedor, J.F., Shupp-Byrne, D., Hong, R., Rivas, D.A.: Intravesical capsaicin in neurologically impaired patients with detrusor hyperreflexia. American Paraplegia Society 1996 Annual Meeting, J. Spinal Cord Med., 19:294- 295, 1996. 132. Watanabe, T., Chancellor, M.B., Rivas, D.A.: Gracilis urethromyoplasty - An autologous urinary sphincter in neurologically impaired patients.. American Paraplegia Society 1996 Annual Meeting, J. Spinal Cord Med., 19:294, 1996. 133. Fitzptrick, K.K., Chancellor, M.B., Watanabe, T., Crewalk, J.A., King, S., Rivas, D.A.: Continuous versus conventional urodynamic studies in spinal cord injured patients. American Paraplegia Society 1996 Annual Meeting, J. Spinal Cord Med., 19:294, 1996. 134. Watanabe, T., Rivas, D.A., Crewalk, J.A., Shenot, P.A., Chancellor, M.B.: Effect of urinary tract reconstruction in neurologically impaired women. American Paraplegia Society 1996 Annual Meeting, J. Spinal Cord Med., 19:280, 1996. 135. Figueroa, T.E., Chancellor, M.B., Rivas, D.A., Huang, B.: Effect of midazolam on bladder physiology. American Academy of Pediatrics 1996 Annual Meeting, Boston, MA., October 26, 1996. 136. Fitzpatrick, K.J., Chancellor, M.B., Watanabe, T., Crewalk, J.A., Rivas, D.A.: Continuous versus conventional urodynamic studies in spinal cord injured patients. 1996 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA October Oct. 27-30, 1996. 137. Watanabe, T., Rivas, D.A., Crewalk, J.A., Shenot, P.J., Chancellor, M.B.: Effect of urinary tract reconstruction in neurologically impaired women. 1996 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA October Oct. 27-30, 1996. 138. Rivas, D.A., Chancellor, M.B., Watanabe, T., Shenot, P.J., Figueroa, T.E.: Methyprednisolone and mianserin improve recovery of bladder function after spinal cord injury in the rat model. Annual Meeting of the ASIA, Houston TX, March 24-26, 1997, J. Spinal Cord Med., 20:157, 1997. 139. Rivas, D.A., Chancellor, M.B., Huang, B., Figueroa, T.E.: The effect of myomyotomy, intestinal augmentation, and detrusor- myoplasty on bladder rupture pressure in a rat model of bladder augmentation. Annual Meeting of the ASIA, Houston TX, March 24-26, 1997, J. Spinal Cord Med., 20:157, 1997. 140. Rivas, D.A., Chancellor, M.B., Fitzpatrick, K.K., Crewalk, J.A., Troy, D. P.J., Figueroa, T.E.: Continuous versus conventional urodynamic studies in spinal cord injured patients. Annual Meeting of the ASIA, Houston TX, March 24-26, 1997, J. Spinal Cord Med., 20:149, 1997. 141. Chancellor, M.B., Rivas, D.A., Hong, R., Crewalk, J.A., Troy, D., Bourgeois, I.: Electrically stimulated skeletal muscle urinary neosphincter for stress urinary incontinence. Annual Meeting of the ASIA, Houston TX, March 24-26, 1997, J. Spinal Cord Med., 20:166, 1997. 142. Chancellor, M.B., Rivas, D.A., Staas, W.E.,, Sedor, J., Jordan, M., deGroat, W.C.: Intravesical capsaicin for neurogenic bladder dysfunction. Annual Meeting of the ASIA, Houston TX, March 24-26, 1997, J. Spinal Cord Med., 20:165, 1997. 143. Sedor, J.F., Shupp-Byrne, D., McCue, P., Rivas, D.A., Chancellor, M.B., deGroat, W.C., Fraser, M.O., Jordan, M.L.: Effects of ethanol and oil vehicles for intravesical capsaicin treatment. 1997 Annual AUA Meeting, J. Urol., 157:83A, 1997. 144. Rivas, D.A., Watanabe, T., Shenot, P.J., Huang, B., Figueroa, T.E., Chancellor, M.B.: Methyprednisolone and mianserin improve recovery of bladder function after spinal cord injury in the rat model. 1997 Annual AUA Meeting, J. Urol., 157:82A, 1997. 145. Fitzpatrick, K.K., Shenot, P.J., Rivas, D.A., Ozawa, H., Kumon, H., Watanabe, T., Chancellor, M.B.: Continuous versus conventional urodynamic studies in spinal cord injury: correlation of autonomic dysreflexia and rectal contractions with detrusor hyperreflexia. 1997 Annual AUA Meeting, J. Urol., 157:101A, 1997. 146. Chiura, A., Shupp-Byrne, D., Sedor, J.F., Rivas, D.A, Mulholland, S.G., Chancellor, M.B.: What is the major source of GP51 glycoprotein? Study of urine GP51 in control and post cystectomy patients. 1997 Annual AUA Meeting, J. Urol., 157:129A, 1997. 147. Flood, H., Shupp-Byrne, D., Rivas, D.A, McCue, P., Sedor, J., Crewalk, J.A., Chancellor, M.B., deGroat, W.C., Fraser, M.O., Fagerli, J., Smith, D.A., Chatlos, L., Jordan, M.L.: Intravesical capsaicin for interstitial cystitis. 1997 Annual AUA Meeting, J. Urol., 157:254A, 1997. 148. Laine, M., Kiilholma, P., Makinen, J., Chancellor, M.B.: Long-term results of Burch colposuspension.. 1997 Annual AUA Meeting, J. Urol., 157:265A, 1997. 149. Schmidt, R.A., Gajewski, J., Houssana, M., Chancellor, M.B.: Management of refractory urge frequency syndromes using an implantable neuroprosthesis: a North American muticenter study. 1997 Annual AUA Meeting, J. Urol., 157:319A, 1997. 150. Rivas, D.A, Hong, R., Watanabe, T., Crewalk, J.A., Troy, D., Bourgeois, I., Chancellor, M.B.: An autologous skeletal muscle urinary neosphincter (gracilis urethromyoplasty) for the treatment of incontinence in neurologically impaired patients. 1997 Annual AUA Meeting, J. Urol., 157:318A, 1997. 151. Das. A., Shupp-Byrne, D., Rivas, D.A., Sedor, J., Crewalk, J.A., Flood, H., Jordan, M.A., deGroat, W.C., Fraser, M.O., Fagerli, J., Chatlos, L., Smith, D.A., Chancellor, M.B.: Intravesical capsaicin for neurogenic bladder dysfunction. 1997 Annual AUA Meeting, J. Urol., 157:352A, 1997. 152. Watanabe, T., Vaccaro, A.R., Shenot, P.J., Rivas, D.A, Kumon, H., Ozawa, H., Chancellor, M.B.: High incidence of occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal injuries. 1997 Annual AUA Meeting, J. Urol., 157:352A, 1997. Chancellor 75 of 108 153. Fraser, M.O., Liu, J.S., Flood, H.D., Chancellor, M.B., de Groat, W.C.: Dissociation of urethral smooth and striated muscle behavior after SCI. American Paraplegia Society, 1997 Annual Meeting, J. Spinal Cord Med., 20:448, 1997. 154. Shenot, P.J., Chancellor, M.B., Rivas, D.A., Huang, B., Figeroa, T.E., Bourpoise, I., Salzman, S.K.: The effect of intestinal segment chosen and detrusor-myoplasty on bladder repture pressure after intestinal bladder augmentation and autoaugmentation. American Paraplegia Society, 1997 Annual Meeting, J. Spinal Cord Med., 20:448-449, 1997. 155. Rivas, D.A., Watanabe, T., Shenot, P.J., Figeroa, T.E., Chancellor, M.B.: Methyprednisolone and mianserin improve recovery of bladder function after spinal cord injury in the rat model. American Paraplegia Society 1997 Annual Meeting, J. Spinal Cord Med., 20:450, 1997. 156. Somogyi, G.T., Zernova G.V., Yoshiyama, M., Chancellor, M.B., de Groat W.C.: Muscarininc facilitation of transmitter release in bladder strips from control and rats with SCI. American Paraplegia Society, 1997 Annual Meeting, J. Spinal Cord Med., 20:451, 1997. 157. Fagerli, J., Fraser, M.O., de Groat, W.C., Chancellor, M.B., Smith, D., Jordan, M.J.: Intravesical capsaicin for the treatment of interstitial cystitis. 1997 Annual Meeting of the North-Eastern Section of the American Urological Association. October, 1997. 158. DeRidder, D., Chancellor, M.B., Engberg, S.: Towards a quantification of the effect of pelvic floor reeducation by frequency analysis of the pelvic floor EMG signal. 4th International Congress of the Dutch Urological Association. November 5-7, 1997. 159. Chancellor, M.B., Fraser, M.O., Jung, S.Y., Ozawa, J., Yoshiyama, M., Yokoyama, O, de Groat, W.C.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. NIDDK Research Workshop: Issues and Opportunities in Urinary Incontinence. January 23-24, Bethesda, MD, 1998. 160. Karasick, S., Rivas, D.A., Shenot, P.J., Trabulsi, E.J., Chancellor, M.B.: Cystodefecography: an effective tool for delineating pelvic floor weakness. NIDDK Research Workshop: Issues and Opportunities in Urinary Incontinence. January 23-24, Bethesda, MD, 1998. 161. Rivas, D.A., Figeroa, T.E., McHugh, K.M., Rajan, R., Shenot, P.J., Shupp, D., Trabulsi, E.J., Chancellor, M.B.: Bladder smooth muscle isoactin gene expression in the rat model of spinal cord injury. NIDDK Research Workshop: Issues and Opportunities in Urinary Incontinence. January 23-24, Bethesda, MD, 1998. 162. Rivas, D.A, Sedor, J., Shupp-Byrne, D., McCure, P., Shenot, P.., Chancellor, M.B., de Groat, W., Fraser, W., Jordan, W.: Effect of ethanol and oil vehicles for intravesical capsaicin treatment. Annual Meeting of the ASIA, Cleveland, OH, April 20-22, 1998, J. Spinal Cord Med. 21:157, 1998. 163. Shenot, P., Shupp-Byrne, D., Rivas, D.A., Chancellor, M.B., Huang, B., Figueroa, T.: Effect of bladder augmentation on urodynamic parameters and homeostatic balance in the rat model of spinal cord injury. Annual Meeting of the ASIA, Cleveland, OH, April 20-22, 1998, J. Spinal Cord Med. 21:165, 1998. 164. Somogyi, G.T., Rivas, D.A., Figueroa, T., Shenot, P.J., Yoshiyama, M., Ozawa, H., de Groat, W.C. and Chancellor, M.B.: Change in neurotransmitter release and neurally evoked contractions in bladders of spinal cord transected and blunt spinal cord injured rats. Annual Meeting of the ASIA, Cleveland, OH, April 20-22, 1998, J. Spinal Cord Med. 21:170, 1998. 165. Rivas, D.A, Figueroa, T., McHugh, K., Rajan, R., Shenot, P., Chancellor, M.B.: Bladder smooth muscle isoactin gene expression in the rat model of spinal cord injury. Annual Meeting of the ASIA, Cleveland, OH, April 20-22, 1998, J. Spinal Cord Med. 21:165, 1998. 166. Ozawa, H., Kumon, H., Yokoyama, T., Watanabe, T., Chancellor, M.B.: The development of non-invasive pressure-flow video- urodynamics using Doppler ultrasonograph. Urodynamic Society’s 19th Annual Meeting, San Diego, CA, May 30, 1998. 167. Jung, S.Y., Fraser, M.O., Ozawa, H., Yokoyama, O., Yoshiyama, M., de Groat, W.C., Chancellor, M.B.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. Urodynamic Society’s 19th Annual Meeting, San Diego, CA, May 30, 1998. 168. Chancellor, M.B., Tirney, S., Huard, J., Mattes, C.E., Watanabe, T., Ozawa, H., Jung, S.Y., Yoshimura, N., de Groat, W.C.: Myoblast periurethral injection for the treatment of stress urinary incontinence. Urodynamic Society’s 19th Annual Meeting, San Diego, CA, May 30, 1998. 169. Gajewski, J.B. and Chancellor, M.B.: Removal of the UroLume endoprosthesis: experience of the North American Study Group for detrusor sphincter dyssynergia application. Urodynamic Society’s 19th Annual Meeting, San Diego, CA, May 30, 1998. 170. Huard, J., Tirney, S., Huard, J., Mattes, C.E., Ozawa, H., Jung, S.Y., Watanabe, T., Birder, L.A., Kanai, A.J., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Myoblast into the bladder wall: a possible method of modulating detrusor contractility and cell- mediated gene therapy for bladder dysfunction. 1998 Annual AUA Meeting, J. Urol., 159:16A, 1998. 171. Fraser, M.O., Chancellor, M.B., Ozawa, H., Jung, S.Y., de Groat, W.C.: The effect of NMDA glutamatergic antagoinist MK801 on the urethral smooth muscle and striated muscle function. 1998 Annual AUA Meeting, J. Urol., 159:20A, 1998. 172. Fraser, M.O., Jung, S.Y., Ozawa, H., Tirney, S., Mattes, C.E., Yoshimura, N., Huard, J., Simmons, R.L., de Groat, W.C., Chancellor, M.B.: Intraurethral nitric oxide donor relaxes the urethral smooth muscle. 1998 Annual AUA Meeting, J. Urol., 159:23A, 1998. 173. Chancellor, M.B., Vivas, C.A, Bennett, C.J., Simoneau, A., FInocchiaro, M.V., Klein, C., Bennett, J.K., Green, B.G., Foote, J.E., Killorian, R.W., Martin, S.h., Crewalk, J.A., Rivas, D.A.: Sphincter Stent Versus External Sphincterotomy in Spinal Cord Injured Men; Prospective Randomized Multicenter Trial, 1998 Annual AUA Meeting, J. Urol., 159:80A, 1998. 174. Gajewski, J.B. and Chancellor, M.B.: Removal of the UroLume endoprosthesis: experience of the North American Study Group for detrusor sphincter dyssynergia application. 1998 Annual AUA Meeting, J. Urol., 159:82A, 1998. Chancellor 76 of 108 175. Rivas, D.A, Figueroa, T., McHugh, K., Rajan, R., Shenot, P., Chancellor, M.B.: Bladder smooth muscle isoactin gene expression in relation to detrusor leak point pressure in the spinal cord injured rat model. 1998 Annual AUA Meeting, J. Urol., 159:82A, 1998. 176. Yokoyama, O., Fraser, M., Jung, S.Y., Yoshiyama, M., de Groat, W.C., Chancellor, M.B.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. 1998 Annual AUA Meeting, J. Urol., 159:82A, 1998. 177. Shenot, P., Rivas, D.A., Shupp-Byrne, D., Rajan, R., Chancellor, M.B., Figueroa, T.: Bladder smooth muscle isoactin gene expression after augmentation cystoplasty in the rat model of spinal cord injury. 1998 Annual AUA Meeting, J. Urol., 159:83A, 1998. 178. Huard, J. Tirney, S., Huard, J., Mattes, C.E., Watanabe, T., Ozawa, H., Yoshimura, N., Moreno, J., Birder, L.A., Kanai, A.J., de Groat, W.C., Tzeng, E., Kibbe, M., Hierholzer, C., Geller, D.A., Simmons, R.L., Billiar, T.R., Chancellor, M.B.: Nitric oxide synthase (NOS) gene therapy for erectile dysfunction: comparison between plasmid, adenovirus, and adenovirus transduced myoblast vectors. 1998 Annual AUA Meeting, J. Urol., 159:90A, 1998. 179. Birder, L.A., Kanai, A.J., Tirney, S., Huard, J., Mattes, C.E., Ozawa, H., Jung, S.Y., Tzeng, E., Kibbe, M., Hierholzer, C., Simmons, R.L., Billiar, T.R., de Groat, W.C., Chancellor, M.B.: Direct measurement of basal nitric oxide release with a porphyrinic microsensor following inducible nitric oxide synthase gene therapy. 1998 Annual AUA Meeting, J. Urol., 159:95A, 1998. 180. Somogyi, G.T., Ozawa, H., Jung, S.Y., de Groat, W.C., Chancellor, M.B.: Release of norepinephrine (NE) from rat prostate after hypogastric nerve stimulation in vivo: a microdialysis study. 1998 Annual AUA Meeting, J. Urol., 159:107A, 1998. 181. Chancellor, M.B., Ozawa, H., Watanabe, H., Kumon, H., Yokoyama, T.: Non-invasive velocity-flow video-urodynamics using Doppler ultrasonograph: from concept to clinical application. 1998 Annual AUA Meeting, J. Urol., 159:120A, 1998. 182. Jung, S.Y., Kalff, J.C., de Groat, W.C., Chancellor, M.B., Bauer, A.J.: Lipopolysaccharide (LPS) causes inflammation of the detrusor muscle and suppresses muscle contractility. 1998 Annual AUA Meeting, J. Urol., 159:310A, 1998. 183. Tirney, S., Huard, J., Mattes, C.E., Ozawa, H., Jung, S.Y., Watanabe, T., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Myoblast periurethral injection for the treatment of stress urinary incontinence. 1998 Annual AUA Meeting, J. Urol., 159:327A, 1998. 184. Gajewski, J.B. and Chancellor, M.B.: Removal of the UroLume endoprosthesis: experience of the North American Study Group for detrusor sphincter dyssynergia application. Canadian Urological Association Annual Meeting, Halifax, Nova Scotia, June 21- 24, 1998. 185. Gajewski, J.B., Schmidt, R.A, can Kerrebroeck, P.E.V, Siegel, S.W., Hassouna, M.M., Elhilali, A.A.B., Nijeholt, L., Chancellor, M.B., Jonas, U., Jankenegt, R.A., Fall, M., Catanzaro, F., Fowler, C., Oleson, K.A: Sacral root stimulation to manage urge urinary incontinence. Canadian Urological Association Annual Meeting, Halifax, Nova Scotia, June 21-24, 1998. 186. Fraser, M.O., Yoshiyama, M., Chancellor, M.B., Zhou, L.M., Nielsen, R.T.: Intrathecal conantokins inhibit striated sphincter at doses sparing bladder contractions. American Paraplegia Society, 44th Annual Conference, Las Vegas, Nevada, September 8-10, 1998. 187. Somogyi, G.T., Zernova, G., Yoshiyama, M., Rivas, D.A., de Groat, W.C., Chancellor, M.B.: Plasticity of Ach release in the rat urinary bladder of chronic spinal cord transected and spinal cord injury rats. American Paraplegia Society, 44th Annual Conference, Las Vegas, Nevada, September 8-10, 1998. 188. Tierney, S., Huard, J., Chancellor, M.B.: Human inducible nitric oxide synthase gene therapy for erectile dysfunction. American Paraplegia Society, 44th Annual Conference, Las Vegas, Nevada, September 8-10, 1998. 189. Yoshiyama, M., Chancellor, M.B.: Improvements in micturition by glutamate antagonist(s) in rats with SCI. American Paraplegia Society, 44th Annual Conference, Las Vegas, Nevada, 1998. 190. Shenot, P.J., Chancellor, M.B., Rivas, D.A.: Contact Nd-Yag laser external sphincterotomy in spinal cord injured men with detrusor sphincter dyssynergia. Mid-Atlantic Section American Urological Association, 56th Annual Meeting, Palm Beach, Florida, October 4-7, 1998. 191. Rivas, D.A., Shenot, P.J., McHugh, K., Chancellor, M.B., Figueroa, T.E.: Bladder smooth muscle isoactin gene expression in the rat model of spinal cord injury. Mid-Atlantic Section American Urological Association, 56th Annual Meeting, Palm Beach, Florida, October 4-7, 1998. 192. Shenot, P.J., Figueroa, T.E., Epple, A., Chancellor, M.B., Rivas, D.A.: Effects of bladder augmentation on urodynamic parameters and homeostatic balance in the rat model of spinal cord injury. Mid-Atlantic American Urological Association, 56th Annual Meeting, Palm Beach, Florida, October 4-7, 1998. 193. Chancellor, M.B., Ozawa, H., Goins, W.F., Glorioso, J.C., Araki, I., deGroat, W.C., Yoshimura, N.: Nerve growth factor (NGF) expression in the rat bladder and dorsal root ganglion neurons using herpes simplex virus (HSV) vectors. Society for Neuroscience, San Diego, CA, October 10, 1998. 194. Chancellor, M.B., Goins, W., DeGroat, W.C., Glorioso, J.C., Yoshimura, N.: Nerve growth factor (NGF) gene therapy using herpes simplex virus (HSV) vectors for diabetic dysfunction. Northeastern Section of the American Urological Association, 50th Annual Meeting, Toronto, Canada, October 18-21, 1998. 195. Chancellor, M.B., Lavelle, J.P., Erickson, J. R.: Dose escalation study with Tolterodine in patients with overactive bladder. Northeastern Section of the American Urological Association, 50th Annual Meeting, Toronto, Canada, October 18-21, 1998. Chancellor 77 of 108 196. Rivas, D.A., Shenot, P., Kim, D.Y., Fraser, M.O., Erickson, J.R., de Groat, W.C., Chancellor, M.B.: Intravesical resiniateratoxin (RTX) treatment of detrusor hyperreflexia; results of prospective double-blind mutlicenter trial. Urodynamic Society’s 20th Annual Meeting, Dallas, TX May 1, 1999. 197. Ozawa, H., Chancellor, M.B., Kumon, H., Yu, Y.B., Yoshimura, N., de Groat, W.C.: Intravescial nitric oxide donor treatment of cyclophosphamide-induced cystitis. Urodynamic Society’s 20th Annual Meeting, Dallas, TX May 1, 1999. 198. Lavelle, J.P., Yoshiyama, M., Doty, D.A., Meyers, S.A., Chancellor, M.B. Zeidel, M.: Capsaicin antagonizes elevated urothelial permeability induced by pelvic nerve stimulation of rat bladder. Urodynamic Society’s 20th Annual Meeting, Dallas, TX May 1, 1999. 199. Jung, S.Y., Schwarz, N.T., Chancellor, M.B., Bauer, A.J.: Cyclooxygenases (COX-1 and COX-2) Mediate the Bacterial Toxin fMLP Induced Contraction of the Rabbit Detrusor. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:7, 1999. 200. Lavelle, J.P., Yoshiyama, M., Doty, D.A., Meyers, S.A., Chancellor, M.B. Zeidel, M., de Groat, W.C.: Capsaicin antagonizes elevated urothelial permeability iin rat bladder induced by pelvic nerve stimulation. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:25, 1999. 201. Yoshimura, N., Bennett, N. Jr., Yokoyama, T., de Groat, W.C., Chancellor, M.B.: Bladder hyperactivity and hyperexcitability of bladder afferent neuros following chronic instillation of nerve growth factor in the rat. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:39, 1999. 202. Pezzone, M.A., Fraser, M.O., VanBibber, M.M., de Groat, W.C., Chancellor, M.B.: The discovery of the pacemaker cells of the urinary tract. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:41, 1999. 203. Somogyi, G., Chancellor, M.B., Yokoyama, T., Yoshimura, N., de Groat, W.C., Huard, J.: A precise, localized bladder injury model to investigate the effect of myoblast injection on bladder contractility. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:43, 1999. 204. Yoshiyama, M., Kim, D.Y., Fraser, M.O., Erickson, J.R., de Groat, W.C., Lavelle, J., Chancellor, M.B.: Intravesical resiniferatoxin (RTX) in control and spinal cord transected rats during transurethral or isolated cystometrogram and urethral perfusion. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:44, 1999. 205. Yoshiyama, M., Fraser, M.O., Chancellor, M.B., de Groat, W.C., Zhou, L.M., Nielsen, J.S., Layer, R,T., McCabe, R.T.: Conatokins discriminate between glutamatergic receptors that regulate parasympathetic and somatic pathways controlling lower urinary tract function. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:46, 1999. 206. Fraser, M.O., Chancellor, M.B., de Groat, W.C., Zhou, L.M., Nielsen, J.S., Layer, R,T., McCabe, R.T.: Local injection of conopeptide MI inhibits striated muscle of external urethral sphincter in a dose dependent fashion. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:47, 1999. 207. Sacks, M.S., Chancellor, M.B., de Groat, W.C., Francis X. Schneck, F.X., Block, N.: 3D in-vivo surface curvature of the human bladder. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:49, 1999. 208. Kim, D.Y., Hawranko, A.A., Fraser, M.O., Yoshiyama, M., Chancellor, M.B., de Groat, W.C.: Modulation of the micturition reflex in rats by stimulation of purinergic receptors in the lumbosacral spinal cord. 1999 Annual Meeting of the AUA, J. Urol., 161:49, 1999. 209. Huard, J., Yokoyama, T., Tirney, S., Mattes, C.E., Ozawa, H., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Differentiation of primary myoblast injection into the lower urinary tract: creation of detrusor cellular myomyoplasty. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:66, 1999. 210. Ozawa, H., Kumon, H., Watanabe, T., Chancellor, M.B., Yokoyama, T.: Evaluation of bladder outlet obstruction using non- invasive doppler ultrasound urodynamics. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:78, 1999. 211. Chancellor, M.B., Goins, W.F., Yoshimura, N., Yokoyama, T., Fraser, M.O., Bennett, N. Jr., de Groat, W.C., Glorioso, J.C.: Bladder gene therapy with nerve growth factor (NGF) using herpes simplex virus (HSV) vectors. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:253, 1999. 212. Diokno, A.C., Chancellor, M.B., Mitcheson, H.D., Zadra, J., Linet, O.I., McNeice, R.: Tolterodine (Detrol) improves incontinence and nocturia in urologist based study. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:256, 1999. 213. Chancellor, M.B., Sathyan, G., Gupta, S.K.: Spit study to compare different formulations of oxybutynin. 1999 Annual Meeting of the AUA, J. Urol., 161:256, 1999. 214. Yoshimura, N., Yokoyama, T., Fraser, M.O., Ozawa, H., Bennett, N. Jr., Goins, W., Glorioso, J.C., de Groat, W.C., Chancellor, M.B.: Nerve Growth Factor (NGF) Gene Therapy Using Replication Defective Herpes Simplex Virus (HSV) Vectors for Diabetic Bladder Dsyfunction. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:274, 1999. 215. Rivas, D.A., Shenot, P., Kim, D.Y., Fraser, M.O., Erickson, J.R., de Groat, W.C., Chancellor, M.B.: Intravesical resiniferatoxin (RTX) treatment of detrusor hyperreflexia; results of prospective double-blind mutlicenter trial. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:276, 1999. 216. Ozawa, H., Chancellor, M.B., Kumon, H., Yu, Y.B., Yoshimura, N., de Groat, W.C.: Intravescial nitric oxide donor treatment of cyclophosphamide-induced cystitis. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:277, 1999. 217. Yokoyama, T., Fraser, M.O., Tirney, S., Mattes, C.E., Watanabe, T., Ozawa, H., Yoshimura, N., de Groat, W.C. Billiar, T.R., Huard, J., Chancellor, M.B.: Gene therapy as a potential treatment for BPH: injection of myoblast-adenovirus transfected with human inducible notric oxide synthase (iNOS) into the proximal urethra. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:305, 1999. Chancellor 78 of 108 218. Yokoyama, T., Chancellor, M.B., Watanabe, T., Ozawa, H., Yoshimura, N., de Groat, W.C. Qu, Z., Huard, J.: Primary myoblasts injection into the urethra and bladder wall: a potential treatment of stress urinary incontinence and impaired detrusor contractility: long-term survival without significant cytotoxicity. 1999 Annual Meeting of the American Urological Association, J. Urol., 161:307, 1999. 219. Goins, W., Chancllor, M.B., Yoshimura, N., Yokoyama, T., Phelan, W., Fraser, M.O., de Groat, W.C., Glorioso, J.C.: HSV vector-mediated NGF therapy for diabetic bladder dsyfunction. 2nd Annual Meeting of the American Society of Gene Therapy Washington, D.C., June 9-13, 1999. 220. Ishiura, Y., Yoshimura, N., Yokoyama, T., Phelan, W., Fraser, M.O., Goins, W., de Groat, W.C., Glorioso, J.C., Chancellor, M.B.; NGF gene therapy using HSV vector for diabetic bladder dsyfunction. 29th Annual Meeting International Continence Society, Neurourol & Uroydnam 18:269-270, 1999. 221. Chancellor, M.B., Sathyan, G., Gupta, S.K.: Effect of ketoconazole on the pharmacokinetics of oxybutynin: comparision between an extended release oxybutynin and conventional oxybutynin. 29th Annual Meeting International Continence Society, Neurourol & Uroydnam 18:374-375, 1999. 222. Mitcheson, H.D., Chancellor, M.B., Zadra, J., Diokno, A.C.: Flexible dose study with tolterodine in patients with overactive bladder confirms efficacy and safety of tolterodine. 29th Annual Meeting International Continence Society, Neurourol & Uroydnam 18:381-382, 1999. 223. Ishiura, Y., Yokoyama, O. Namiki, M. Chancellor, M.B., de Groat, W.C.: Central muscarinic mechanisms regulating voiding in rats. 29th Annual Meeting International Continence Society, Neurourol & Uroydnam 18:351-352, 1999. 224. Siegel, S., Chancellor, M.B., Dijkema, H., et al.: Improvement in quality of life: Sacral nerve stimulation for urinary urgency- frequency. 29th Annual Meeting International Continence Society, Neurourol & Uroydnam 18:378-379, 1999. 225. Yokoyama, T., Huard, J., Watanabe, T., Ozawa, H., Yoshimura, N., de Groat, W.C., Qu, Z., Chancellor, M.B., McHugh, K.: Differentiation of primary myoblast injection into the lower urinary tract; Detrusor cellular myoplasty. APS, 45th Annual Conference, J. SCI., 22: 324, 1999. 226. Yu, Y., Ozawa, H., Chancellor, M.B., Kumon, H., Yoshimura, N., de Groat, W.C.: Intravesical nitric oxide donor treatment of cyclophosphamide-induced cystitis. APS, 45th Annual Conference, J. SCI., 22: 324, 1999. 227. Phelan, M., Yoshimura, N., Yokoyama, T., Fraser, M.O., Ozawa, H., Bennett, N.E., Goins, W.F., Glorioso, J.C., de Groat, W.C., Chancellor, M.B.: Nerve growth factor (NGF) Gene therapy for diabetic bladder dysfunction. APS, 45th Annual Conference, J. SCI., 22: 3242 1999. 228. Kim, D.Y., Fraser, M.O., Kim, M.Y., Lavelle, J., Yokoyama, T., Erickson, J.R., de Groat, W.C., Chancellor, M.B.: C-fiber afferent in the human and rat urinary tract and effects of resiniferatoxin. APS, 45th Annual Conference, J. SCI., 22: 353, 1999. 229. Fraser, M.O., Chancellor, M.B., de Groat, W.C.: Local injection of conopeptide MI inhibits external urethral sphincter in a dose dependent fashion. APS, 45th Annual Conference, J. SCI., 22: 323, 1999. 230. Lavelle, J.P., Yoshiyamam, M., Doty, D.A., Meyers, S.A., Chancellor, M.B., Zeidel, M.L., de Groat, W.C.: Elevated urothelial permeability induced by nerve stimulation antagonized by capsaicin. APS, 45th Annual Conference, J. SCI., 22: 324, 1999. 231. Atan, A., Konety, B.R., Chancellor, M.B.: Ileovesicostomy bladder reconstruction for neurogenic bladder. APS, 45th Annual Conference, J. SCI., 22: 335, 1999. 232. Shenot, P.J., Lee, D., Chancellor, M.B., Rivas, D.A.: Laser sphincterotomy in spinal cord injured men with detrusor-external sphincter dyssynergia. APS, 45th Annual Conference, J. SCI., 22: 337, 1999. 233. Rivas, D.A., Shenot, P.J., Green, B., Fraser, M.O., de Groat, W.C., Chancellor, M.B.: Intravesical resiniferatoxin (RTX) treatment of detrusor hyperreflexia: results of randomzied, placebo-controlled, multicenter trial. APS, 45th Annual Conference, J. SCI., 22: 317, 1999. 234. Phelan, M., Somogyi, G.T., Yokoyama, T., Fraser, M.O., de Groat, W.C., Chancellor, M.B.: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. APS, 45th Annual Conference, J. SCI., 22: 354, 1999. 235. Yokoyama, T., Chancellor, M.B., oshimura, N., de Groat, W.C., Qu, Z., Huard, J.: Long-term survival and differentiation of primary myoblasts injection into the urethra and bladder as a treatment of stress urinary incontinence and impaired detrusor contractility. Northeastern Section AUA 51th Annual Meeting, November 1-4, 1999. 236. Konety, B.R., Phelan, W.P., O’Donnell, W.F., Antiles, L., Chancellor, M.B.: Urolume stent placement for the treatment of post- brachytherapy bladder outlet obstruction. Northeastern Section AUA 51th Annual Meeting, November 1-4, 1999. 237. Phelan, M.W., Goins, W.F., Yoshimura, N., Ozawa, H., Yokoyama, T., Bennett, N., de Groat, W.C., Glorioso, J., Yu, Y.B., Chancellor, M.B.: Rat diabetic cystophaty involves bladder c-fiber damage which may be prevented through NGF gene therapy. Northeastern Section AUA 51th Annual Meeting, November 1-4, 1999. 238. Franks, Michael, Zyczynski, Halina, Capelle, Susan, Moalli, Pam, Sagan, Elizabeth, Chancellor, Michael: Clinical outcome and cost comparison with the pubovaginal sling procedure using autologous fascia versus cadaveric dermalpatch. 2000 Annual Meeting of the AUA, J. Urol., 163:1, 2000. 239. Yokoyama, Teruhiko, Somogyi, George,, Qui, Zhuqing, Pruchnic, Ryan,Yoshimura, Naoki, De Groat, William C. , Huard, Johnny, Chancellor, Michael B.: Muscle derived stem cells (MDC) Injected into the bladder wall can improve detrusor contractility. 2000 Annual Meeting of the AUA, J. Urol., 163:39, 2000. 240. Franks, Michael E., Somogyi, George T., Phelan, Michael W., Fraser, Matthew, Yokoyama, Teruhiko, Gnosh, Rudrani, De Groat, William C., Chancellor, Michael B.: Botulinum toxin injection into the bladder wall decreases Acetylcholine (ACH) and Chancellor 79 of 108 norepinephrine (NE) release; potential treatment for the overactive bladder. 2000 Annual Meeting of the AUA, J. Urol., 163:42, 2000. 241. Yokoyama, Teruhiko, Huard, Johnny, Zhuqing Qu, Pruchnic, Ryan, Yoshimura, Naoki, De Groat, William C. , Chancellor, Michael B.: Muscle derived stem cells mediated ex-vivo gene transfer to the lower urinary tract; comparison of viral vectors. 2000 Annual Meeting of the AUA, J. Urol., 163:42, 2000. 242. Brady, Ciaran M., Fowler, Clare J., Fraser, Matthew, Beckel, Jonathan M., De Groat, William C., Chancellor, Michael B.: The effects of intravesical tinyatoxin (TNX) in normal female rats during transurethral cystometrogram. 2000 Annual Meeting of the AUA, J. Urol., 163:46, 2000. 243. Franks, Michael, Yoshimura, Naoki, Yokoyama, Teruhiko, Goins, William F., Fraser, Matthew, De Groat, William C. , Glorioso, Joseph C., Chancellor, Michael B.:Gene therapy for urogenital pain; proof of concept with herpes simplex virus expressing prepronkephalin (HSV-PPE). 2000 Annual Meeting of the AUA, J. Urol., 163:59, 2000. 244. Chancellor, Michael B., Yokoyama, Teruhiko, Rajiv Dhir, Zhuqing Qu, Fraser, Matt, Hirome Kumon, Yoshimura, Naoki, De Groat, William C.Huard, Johnny: Comparison of autologous muscle derived stem cell versus bovine collagen injection as treatment of stress urinary incontinence. 2000 Annual Meeting of the AUA, J. Urol., 163:75, 2000. 245. Fraser, Matthew, De Groat, William C., Chancellor, Michael B.: Creation of a new stess incontinence model in the rat by using vertical tilt table and surgical or pharmacological manipulation of internal and external sphincter activity with measurement of leak point pressure (LPP). 2000 Annual Meeting of the AUA, J. Urol., 163:76, 2000. 246. Konety, Badrinath, Somogyi, George; Atan, Ali; Muindi, Josephia; Chancellor, Michael B., Getzenberg, Robert H.: Evaluation of intra-prostatic metabolism of vitamin D using a novel microdialysis technique. 2000 Annual Meeting of the AUA, J. Urol., 163:213, 2000. 247. Yokoyama, Teruhiko, Huard, Johnny, Zhuqing Qu, Pruchnic, Ryan, Yoshimura, Naoki, Hirome Kumon, De Groat, William C, Chancellor, Michael B.: Injection of autologous primary muscle derived stem cells (MDC) into the lower urinary tract. 2000 Annual Meeting of the AUA, J. Urol., 163:227, 2000. 248. Chancellor, Michael B.: Toterodine: selectivity for the bladder over effects on visual accommodation. 2000 Annual Meeting of the AUA, J. Urol., 163:229, 2000. 249. Phelan, Michael, Somogyi, George T., Yokoyama, Teruhiko, Fraser, Matthew, De Groat, William C. , Chancellor, Michael B.: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. 2000 Annual Meeting of the AUA, J. Urol., 163:244, 2000. 250. Rivas, David A., Shenot, Patrick J., Green, Bruce, Kennelly, Michael, Erickson, Janet, De Groat, William C. Chancellor, Michael B.: Intravesical Resiniferatoxin (RTX) improves bladder capacity and decreases incontinence for refractory detrusor hyperreflexia (DH): A multicenter blinded, randomized, placebo-controlled trial. 2000 Annual Meeting of the AUA, J. Urol., 163:244, 2000. 251. Phelan, Michael W., Yoshimura, Naoki, Goins, William F., Yokoyama, Teruhiko, Fraser, Matthew, Ozawa, Hideo, Franks, Michael, De Groat, William C. Glorioso, Joseph, Yongbei Yu, Chancellor, Michael B.: Nerve growth factor (NGF) gene therapy improves Rat diabetic cystopathy, but does not increase pain sensation. 2000 Annual Meeting of the AUA, J. Urol., 163:245, 2000. 252. Gloeckner, Claire, Sacks, Michael S., Chancellor, M.B., Somogyi, G.T., de Groat, W.C.: Changes in biaxial mechanical properties in the rat urinary bladder wall due to spinal cord injury. 2000 Annual Meeting of the AUA, J. Urol., 163:248, 2000. 253. Ozawa, Hideo, Watanabe, Toyohiko, Sasaki, Katsumi, Watanabe, Yuichi, Kumon, Hiromi, Yokoyama, Teruhiko, Chancellor, Michael B.: Evaluation of bladder outlet obstruction using doppler ultrasonogrpahy. 2000 Annual Meeting of the AUA, J. Urol., 163:266, 2000 254. Chartier-Kastler, Emmanuel J., Denys, Pierre, Chancellor, Michael B.,Haertig, Alain, Bussel, Bernard, François Richard: Urodynamic Monitoring During Percutaneous Sacral Nerve Neurostimulation in Patients with Neurogenic Detrusor Hyperreflexia. 2000 Annual Meeting of the AUA, J. Urol., 163:267, 2000. 255. Phelan, M.W., Goins, W.F., Yoshimura, N., Ozawa, H., Yokoyama, T., Bennett, N., de Groat, W.C., Glorioso, J., Yu, Y.B., Chancellor, M.B.: Rat diabetic cystopathy involves bladder c-fiber damage which may be prevented through NGF gene therapy. Northeastern Section AUA, 51st 256. Annual Meeting, November 1-4, 1999. 257. Chancellor, Michael B., Phelan, Michael W., Yoshimura, Naoki, Goins, William F., Yokoyama, Teruhiko, Fraser, Matthew, Ozawa, Hideo, Franks, Michael, De Groat, William C. , Glorioso, Joseph: Nerve growth factor (NGF) gene therapy improves rat diabetic cystopathy, but does not increase pain sensation. 3rd [2000] Annual Meeting of the American Society of Gene Therapy Denver, CO, June 1-4, 2000. 258. Yokoyama, Teruhiko, Somogyi, George,, Qui, Zhuqing, Pruchnic, Ryan,Yoshimura, Naoki, De Groat, William C. , Huard, Johnny, Chancellor, Michael B.: Muscle derived stem cells injection into the bladder and urethra. 3rd [2000] Annual Meeting of the American Society of Gene Therapy Denver, CO, June 1-4, 2000. 259. Gleckner, D.C., Sacks, M.S., Fraser, M.O., Chancellor, M.B., Somogyi, G.T., de Groat, W.C.: Active biaxial mechanical response of the urinary bladder wall. Biomedical Engineering Society, June 27- July 1 , 2001. 260. Getzenberg, R.H., Brenes, G., Sholder, A., Chancellor, M.B., Konety, B.R., Blader cancer detection in individuals with spinal cord injury. American Spinal Cord Injury Association 26th Annual Conference, J. SCI., 23: 5-6, 2000. 261. Green, G. Bennett, J., Foote, J., Rivas, D.A., Shenot, P.J., Fraser, M.O., de Groat, W.C., Chancellor, M.B.: Intravesical resiniferatoxin (RTX) treatment of detrusor hyperreflexia: results of randomzied, placebo-controlled, multicenter trial. American Spinal Cord Injury Association 26th Annual Conference, J. SCI., 23: 7, 2000. Chancellor 80 of 108 262. Smith, C.P., Yokoyama, T., Somogyi, G.T., Qui, Z., Pruchnic, R., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: Muscle derived stem cells injected into the baldder wall can improve detrsuro contractility. APS, 46th Annual Conference, J. SCI., 23: 189-190. 2000. 263. Katsumi, S., Yoshimura, N., Goins, W. Franks, M.E., Sasaki, K., Goss, J., Yokoyama, T., Fraser, M.O., Seki, S., Fink, J., Glorioso, J., de Groat, W.C., Chancellor, M.B.: Nerve growth factor gene therapy improves rat diabetic cystophaty, but does not increase pain sensation. APS, 46th Annual Conference, J. SCI., 23: 209 2000. 264. Chuang, Y.C., Fraser, M.O., Beckel, J.M., Kimn, D.Y., Yu, Y.B., Chancellor, M.B., de Groat, W.C.: Effect of intravesical resiniferatoxin on the vesicovascular reflex (VV-R) in rats; a possible way to treat autonomic dysreflexia. APS, 46th Annual Conference, J. SCI., 23: 208-209 2000. 265. Franks, M.E., Somogyi, G.T., Phelan, M.W., Fraser, M.O., Yokoyama, T., Gnosh, R., de Groat, W.C., Chancellor, M.B.: Botox injection into the bladder wall decreases acetycholine (ACH) and noreepinephrine (NE) release. APS, 46th Annual Conference, J. SCI., 23: 208, 2000. 266. Yoshimura, N., Franks, M.E., Sasaki, K., Goins, W.F., Goss, J., Yokoyama, T., Fraser, M.O., Seki, S., Fink, J., Glorioso, J., de Groat, W.C., Chancellor, M.B.: Gene therapy of bladder pain with HSV expressing preproenkephalin. NIH/ICA Annual Meeting, Oct 20-22, 2000. 267. Yoshimura, N., Saki, SK, Ericson, V., Erickson K., Kassotakis, L., Novakovic, S., Fraser, M.O., Chancellor, M.B., de Groat, W.C.: Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): A possible new treatment of bladder pain. NIH/ICA Annual Meeting, Oct 20-22, 2000. 268. Fraser, M.O., Chunag, Y.C., Lavelle, J.P., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride. NIH/ICA Annual Meeting, Oct 20-22, 2000. 269. Fraser, M.O., Chunag, Y.C., Kim, D.Y., Brady, C.M., Beckel, J.M., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation. NIH/ICA Annual Meeting, Oct 20-22, 2000. 270. Somogyi, G.T., Ghosh, R., Chancellor, M.B., de Groat, W.C.: Effect of the ganglionic agonist tetramethylammonium in the human urinary bladder. Neuroscience 2000. 271. Chartier-Kastler, E.J., Bosch, R., Perrigot, M., Chancellor, M.B., Richard, J., Denys, P.: Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. 94th Congress France Urology. Paris November 15-19, 2000. 272. Chartier-Kastler, E.J., Thomas, L., Bussel, B., Chancellor, M.B., Richard, F., Denys, P.: A urethral stent for the treatment of detrusor-straited sphincter dyssynergia. 94th Congress France Urology. Paris November 15-19, 2000. 273. Yokoyama, T., Pruchnic, R., Qu., Z., Yoshimura, N., de Groat, W.C., Chancellor, M.B., Huard, J.: Autologous muscle based gene therapy and tissue engineering to improve stress urinary incontinence and impaired detrusor contractility. 3rd Biennial Meeting of the Tissue Engineering Society, November, 30-December, 33, 2000. Orlando, FL. 274. Smith, C.P. Yokoyama, T., Pruchnic, R., Dhir, R., Qu., Z., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: Persistence and survival of autologous muscle derived cells versus boine collagen as possible treatment of stress urinary incontinence. 3rd Biennial Meeting of the Tissue Engineering Society, November, 30-December, 33, 2000. Orlando, FL. 275. Sand, P.K., Chancellor, M.B., Sathyan, G., Gupta, S.: Effect of controlled-release oxybutynin and tolterodine on salivary output. American Society of Urogynecology; Int. Urogyn. J. 12 [supp]; S27, 2001. 276. Chuang, Y.C., Fraser, M.O., Lavelle, J.P., Yoshimura, N., de Groat, W., Chancellor, M.B.: A reliable, nondestructive animal model for interstitial cystitis: intravesical low dose protamine sulfate combined with physiological concentrations of potassium chloride. Urodynamic Society 2001 Annual Meeting, Neurourol & Urodynam, 20: 331-332, 2001. 277. Yoshimura, N., Franks, M.E., Sasaki, K., Seki, S., Yokoyama, T., Fink, D., Goss, J., Goins, W.F., de Groat, W.C., Chancellor, M.B.: Gene therapy for interstitial cystitis pain with recombinant herpes simplex virus expressing preproenkephalin (HSV-ENK). Urodynamic Society 2001 Annual Meeting, Neurourol & Urodynam, 20: 333-333, 2001. 278. Sasaki, K., Yoshimura, N., Phelan, M.W., Seki, S., Goins, W.F., Glorioso, J., de Groat, W., Chancellor, M.B.: Nerve Growth Factor (NGF) Gene Therapy Mediated by HSV Reverses Bladder Dysfunction and the Decline in NGF Expression in L6-S1 Afferent Neurons in Diabetic Rats. Urodynamic Society 2001 Annual Meeting, Neurourol & Urodynam, 20: 352-353, 2001. 279. Chung, S.Y., Huard, J., Yokoyama, T., Pruchnic, R., Smith, C., Qu, Z., Yoshimura, N., Somogyi, G., de Groat, W., Chancellor, M.: Muscle based gene therapy and tissue engineering for urological dysfunction. 2001 AUA Annual Meeting, J. Urol., 165:33- 34A, 2001. 280. Pruchnic, R., Chancellor, M.B., Lee, J.Y., Chung, S.Y., Smith, C.P., Fraser, M.O., Yokoyama, T., Au, Z., Yoshimura, N., de Groat, W.C., Huard, J.: A population of muscle derived cells exhibit stem cell properties and may offer an alternative treatment for urological dysfunction. 2001 AUA Annual Meeting, J. Urol., 165:37A, 2001. 281. Franks, M.E., Sasaki, L. Yokoyama, T., Fraser, M.O., Yoshimura, N., Fink, D., Goss, J., Goins, W.F., de Groat, W.C., Chancellor, M.B.: Gene therapy of visceral bladder pain with recombinant herpes simplex virus expressing preproenkephalin. 2001 AUA Annual Meeting, J. Urol., 165:66A, 2001. 282. Phelan, M., Fraser, M.O., Yokoyama, T., Smith, C.P., Lee, J.Y., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: The vertical tilt table and intravesical pressure clamp: New animal models for the study of continence mechanisms and detrusor hyperreflexia. 2001 AUA Annual Meeting, J. Urol., 165:102, 2001. Chancellor 81 of 108 283. Chung, S.Y., Franks, M.E., Zyczynski, H., Moalli, P., Chancellor, Michael, M.B.: Technique of combined stress urinary incontinence and cystocele repair using a single piece of cadavaeric dermal allograft. . 2001 AUA Annual Meeting, J. Urol., 165:199, 2001. 284. Boone, T.B., Appell, R.A., Lopez, M.A., Diokno, A.C., Chancellor, M.B., Wein, A.J., Parsons, C.L.: Pharmacokinetic evaluation of intravesical oxybutynin: bolus and continuous delivery. . 2001 AUA Annual Meeting, J. Urol., 165:252, 2001. 285. Franks, M.E., Sasaki, K., Yokoyama, T., Goins, W.F., Glorioso, J.C., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Inhibitory effects of preproenkephalin gene therapy mediated by herpes simplex virus vectors on bladder hyperactivity induced by intravesical capsaicin. 2001 AUA Annual Meeting, J. Urol., 165:249-300A, 2001 286. Seki, S., Sasaki, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N., Nishizawa, O.: Suppression of nerve growth factor in bladder afferent pathways reduces detrusor hyperreflexia in spinal cord injured rats. 2001 AUA Annual Meeting, J. Urol., 165:274A, 2001. 287. Fraser, M.O., Dally, K.E., Adhikari, R., Kiraly, H.H., de Groat, W.C., Chancellor, M.B.: Dramatic reduction in spinal cord injury effects on lower urinary tract function with concomitant bilateral pudendal nerve transection in the rat. 2001 AUA Annual Meeting, J. Urol., 165:276A, 2001. 288. Smith, C.P., Franks, M.E., Phelan, M.W., McNeil, B., Ghosh, R., Somogyi, G.T., Chancellor, M.B.: BOTULINUM TOXIN INJECTION IN THE URETHRA CAUSES SMOOTH MUSCLE RELAXATION; A NOVEL POTENTIAL TREATMENT OF BPH AND BLADDER NECK OBSTRUCTION. 2001 AUA Annual Meeting, J. Urol., 165:37A, 2001. 289. Fraser, M.O., Chuang, Y.C., Kim, D.Y., Brady, C.M., Beckel, J.M., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder hyperreflexia. 2001 AUA Annual Meeting, J. Urol., 165:69A, 2001. 290. Lee, J.Y., Fraser, M.O., Qu, Z., Pruchnic, R., Smith, C.P., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: New functional sphincter formation after allergenic muscle derived stem cells (MDSC) injection into the denervated rat urethral sphincter. 2001 AUA Annual Meeting, J. Urol., 165:251A, 2001. 291. Lee, J.Y., Fraser, M.O., Qu, Z., Pruchnic, R., Smith, C.P., Yoshimura, N., de Groat, W.C., Huard, J., Chancellor, M.B.: Effect of collagen and muscle derived stem cells (MDSC) injection on leak point pressure in denervated female rat urethral sphincter. 2001 AUA Annual Meeting, J. Urol., 165:76A, 2001. 292. Sasaki, K., Yoshimura, N., Phelan, M.W., Seki, S., Goins, W.F., Glorioso, J.C., de Groat, W.C., Chancellor, M.B.:NERVE GROWTH FACTOR (NGF) GENE THERAPY MEDIATED BY HERPES SIMPLEX VIRUS (HSV) VECTORS REVERSES BLADDER DYSFUNCTION AND THE DECLINE IN NGF EXPRESSION IN L6-S1 AFFERENT NEURONS IN DIABETIC RATS. 2001 AUA Annual Meeting, J. Urol., 165:274A, 2001. 293. Smith, C.P., Fraser, M.O., Ghosh, R., de Groat, W.C., Somogyi, G.T., Chancellor, M.B.: THE EFFECT OF INTRAPERITONEAL BOTULINUM TOXIN INJECTION ON CYSTOMETROGRAM, LEAK POINT PRESSURE AND BLADDER MUSCLE STRIP CONTRACTILITY. 2001 AUA Annual Meeting, J. Urol., 165:277A, 2001. 294. McNeil, B., Smith, C.P., Frank, M., Fraser, M.O., de Groat, W.C., Chancellor, M.B., Somogyi, G.T.: EFFECT OF BOTULINUM TOXIN A ON URETHRAL NEUROTRANSMITTER RELEASE: IMPLICATONS ON SOMATIC/AUTOONOMIC NERVE TRANSMISSION. 2001 AUA Annual Meeting, J. Urol., 165:299A, 2001. 295. Gloeckner, D.C., Sacks, M.S., Fraser, M.P., Chancellor, M.B., Somogyi, G.T., de Groat, W.C.: Active biaxial mechanical response of the urinary bladder wall. ASME Bioengineering Conference, June 30, 2001. 296. Lee, Y.C, Chung, Y.C., Somogyi, G.T., Ghosh, R., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Standardization of fast twitch contractile properties in male rat external urethral sphincter using spiral, transverse and circular muscle strip orientations. International Continence Society 2001, Annual Meeing, Seoul, Korea, Neurourology & Uroydnam. 20:440-441, 2001. 297. D. C. Gloeckner and M.S. Sacks, “3D fiber architecture of the urinary bladder wall,” Presented at the Fall BMES meeting, October 4-7, 2001, Durham, NC., Published in pg. S-33, vol. 29, supplement 1, Annals of Biomedical Engineering, 2001. 298. D.C. Gloeckner, M.S. Sacks, M.O. Fraser, M.B. Chancellor, G.T. Somogyi, W.C. de Groat, “Active biaxial mechanical response of the urinary bladder wall,” ASME BED Vol. 50, pp. 773-774, 2001 299. Chancellor, M.B., O'Leary, M., Erickson, J.R., Smith, J.P., Chung, S.Y.: Early efficacy with high dose oxybutynin XL in spinal cord injured patients. International Continence Society 2001, Annual Meeting, Seoul, Korea, September, 2001. 300. Chung, S.Y., Franks, M.E., Chancellor, M.: Treatment for combined stress urinary incontinence and cystocele using a single piece of cadavaeric dermal allograft. International Continence Society 2001, Annual Meeting, Seoul, Korea, September, 2001. 301. Chancellor, M.B., O'Leary, M., Erickson, J.R., Smith, J.P., Chung, S.Y.: Clinical outcome and tolerability of controlled release oxybutynin on the catheterization or voiding frequency in multiple sclerosis patients with neurogenic bladder. International Continence Society 2001, Annual Meeting, Seoul, Korea, September, 2001. 302. Fraser, M.O., Smith, C.P., de Groat, W.C., Chancellor, M.B.: Neuromuscular blockade and leak point pressure in SCI rats. APS, 47th Annual Conference, J. SCI., 24: 195, 2001. 303. Sasaki, K., Franks, M.E., Goins, W.F., Glorioso, J.C., de Groat, W.C., Chancellor, M.B., Yoshimura, N.: Preproenkephalin gene therapy for overactive bladder in rats. APS, 47th Annual Conference, J. SCI., 24: 206, 2001. 304. Lu, S-H., Yamagata, T., Atsuki, K., Smith, C.P., Sun, L., Chancellor, M.B., Yoshimura, N., de Groat, W.C.: Effects of KW-7158 on detrusor activity and vesicovascular reflex in rats. APS, 47th Annual Conference, J. SCI., 24: 206-207, 2001. 305. Seki, S., Sasaki, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Nerve growth factor and bladder hyperreflexia in spinal cord injury. APS, 47th Annual Conference, J. SCI., 24: 207, 2001. Chancellor 82 of 108 306. Cannon, T.W., O’Leary, M., Erickson, J.R., Smith, C.P., Camp, J., McDermott, C., Horton, J. Chancellor, M.B.: Early efficacy with high-dose oxybutynin XL in patients with SCI. APS, 47th Annual Conference, J. SCI., 24: 207-208, 2001. 307. Pruchnic, R., Huard, J., Yokoyama, T., Smith, C.P., Zhuging, Q., Somogyi, G., de Groat, W.C., Chancellor, M.B.: Stem cell gene therapy and tissue engineering for neurogenic bladder reinnervation. APS, 47th Annual Conference, J. SCI., 24: 208, 2001. 308. Sasaki K., Yoshimura, N., Goins, W., Glorioso, J., Chancellor, M.B.: Herpes simplex virus (HSV) vector-mediated nerve growth factor (NGF) expression reverses bladder dysfunction and the decline in NGF expression in L6-S1 afferent neurons in diabetic rats. American Society of Gene Therapy. Molecular Therapy; 3:S125, 2001. 309. Yoshimura, N., Franks, M., Sasaki, K., Goss, J., Goins, W., Fink , D., Glorioso, J., Chancellor: Gene therapy for interstitial cystitis (IC) and visceral pain using recombinant herpes simplex virus (HSV) vector expressing preproenkephalin (PPE). American Society of Gene Therapy. Molecular Therapy; 3:S124-S125, 2001. 310. Fraser, M.O., Chuang, Y.C., Kim, C.M., Brady, C.M., Beckel, J.M., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: Intravesical ultrapotent vanilloid receptor agonist: acute effects on animal models of bladder irritation. Interstitial Cystitis Association Annual Meeting, Urology, 57 (Supp 6A):111-112, 2001. 311. Fraser, M.O., Chuang, Y.C., Lavelle, J.P., Yoshimura, N., de Groat, W.C., Chancellor, M.B.: A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride. Interstitial Cystitis Association Annual Meeting, Urology, 57 (Supp 6A):112, 2001. 312. Chancellor, M.B.: RTX and Gene therapy. Interstitial Cystitis Association Annual Meeting, Urology, 57 (Supp 6A):106-107, 2001 313. Yao-Chi C., Jang K., Kazumasa T., Huang, L., De Groat, W., Chancellor, M., Fraser, M: Intravesical liposomes as non-toxic delivery vehicles for hydrophobic drugs: proof of concept with capsaicin. 2002 100th Annual Meeting AUA, J. Urol., 167: 41A, 2002. 314. Pruchnic, R., Huard, J., Yokoyama, T., Ji L., Yong L., Chancellor, M.: The use of skeletal muscle derived cells offers a more effective and long-term treatment option for urinary incontinence than conventional methods. 2002 100th Annual Meeting AUA, J. Urol., 167:33A, 2002. 315. Smith, C., Fraser, M., Lorand, B., deGroat,W., Chancellor, M., Somogyi, G: Botulinum toxin A inhibits afferent nerve evoked bladder strip contractions. 2002 100th Annual Meeting AUA, J. Urol., 167:41A, 2002. 316. Kazumasa T., Jang,K., Cannon, T., Fletcher, S., Dally, K., Xavier,M., de Groat, W., Chancellor, M., Fraser, M.: Dramatic alterations in the relationship between intravesical pressure and the micturition reflex following afferent sensitization .2002 100th Annual Meeting AUA, J. Urol., 167:38A, 2002. 317. Somogyi, G., Chancellor, M., de Groat, W.: Analysis of the inhibitory effect of doxazosin on bladder alpha-1 adrenoceptors. 2002 100th Annual Meeting AUA, J. Urol., 167: 41A, 2002. 318. Cannon, T., Fletcher, S., Lu, S., Xavier,M., de Groat, W., Chancellor, M., Fraser, M.: Leak point pressure testing after sis sling placement in a rat model of stress urinary incontinence. 2002 100th Annual Meeting AUA, J. Urol., 167: Late breaking abstract, 2002. 319. Lu, S., Chung, S., Sellaro, T., Gloeckner,D., Sacks,M., Huard, J., de Groat, W., Chermansky, C., Chancellor, M.: Could muscle- derived stem cells make small intestinal submucosa more compliant for bladder reconstitution? 2002 100th Annual Meeting AUA, J. Urol., 167:58A, 2002. 320. Chuang, Y., Teruhiko, Y., Huang, L., de Groat, W., Yoshimura, N., Chancellor, M., Fraser, M.: Intravesical liposome administration : A novel treatment for hyperactive bladder in the rat. 2002 100th Annual Meeting AUA, J. Urol., 167:66A, 2002. 321. Lu, S., de Groat, W., Somogyi, G., Huard, J., Pruchnic, R., Chancellor, M.: Contractile activity of muscle-derived stem cells incorporated into small intestinal submucosa scaffolds. 2002 100th Annual Meeting AUA, J. Urol., 167:106A, 2002. 322. Lee,J., Cannon, T., Pruchnic, R., Fraser, M., Huard, J., Chancellor, M.: The effect of periurethral muscle derived stem cell injection on leak point pressure in a female rat model of stress urinary incontinence. 2002 100th Annual Meeting AUA, J. Urol., 67:198A, 2002. 323. Lee,J., Cannon, T., Pruchnic, R., Fraser, M., Smith,C., Somogyi, G., de Groat, W., Huard, J., Chancellor, M.: Improved sphincter contractility after allogenic muscle derived stem cell injection into the denervated rat urethral sphincter. 2002 100th Annual Meeting AUA, J. Urol., 167:201A, 2002. 324. Cannon, T., Fletcher,S., Xavier,M., Torimoto,K., Damaser,M., de Groat, W., Chancellor, M., Fraser, M.: Dramatic effects of simulated birth trauma on leak point pressure using the vertical tilt table/intravesical pressure clamp method. 2002 100th Annual Meeting AUA, J. Urol., 167:201A, 2002. 325. Kim,J., Katsumi,S., Yoshimura, N., Goins,W.,Glorioso, J., Nelson, J., de Groat,W., Chancellor, M.: Herpes simplex virus mediated gene therapy for neurogenic erectile dysfunction: proof of concept for afferent and efferent neuron transfection. 2002 100th Annual Meeting AUA, J. Urol., 167:234A, 2002. 326. Lu, S., Tsuyoshi, Y., Atsuki, K., Sun, K., Smith, C., Yoshimura, N., Chancellor, M., de Groat, W.: Effect of KW-7158, a novel putative afferent nerve inhibitor, on bladder and vesico-vascular reflexes in rats with normal and irritated bladders. 2002 100th Annual Meeting AUA, J. Urol., 167:247A, 2002. 327. Prantil, R., Jankowski, R., Torimoto, K., Dally, K., Huard, J., de Groat, W., Yoshimura, N., Chancellor, M., Vorp, D., Fraser, M.: Dramatic effects of diabetes mellitus on urethral biomechanics: Implications for diabetic cystopathy. 2002 100th Annual Meeting AUA, J. Urol., 167:248A, 2002. Chancellor 83 of 108 328. Kazumasa, T.,Yoshiyama,M., Vorp,D., de Groat, W., Yoshimura,N., Chancellor, M., Fraser, M.: Dramatic effects of diabetes mellitus on in vivo urethral function: Implications for understanding the pathogenesis of diabetic cystopathy. 2002 100th Annual Meeting AUA, J. Urol., 67:248A, 2002. 329. Chancellor, M., Smith, C.: One surgeon’s experience in 50 patients with botulinum toxin injection into the bladder and urethra. 2002 100th Annual Meeting AUA, J. Urol., 167:249A, 2002. 330. O`Leary, M., Erickson, J., Smith, C., Chancellor, M.:Botulinum toxin urethral sphincter injection restores spontaneous micturition in multiple sclerosis women. 2002 100th Annual Meeting AUA, J. Urol., 167: 273A, 2002. 331. Kim,J., Torimoto,K., de Groat, W., Yoshimura, N., Chancellor, M., Fraser, M.: Prophylactic treatment of urinary tract damage and dysfunction following spinal cord injury. 2002 100th Annual Meeting AUA, J. Urol., 167:277A, 2002. 332. Lu, S., Fraser, M., Chancellor, M., Lushen, S., de Groat, W.: Evaluation of voiding dysfunction and purinergic mechanism in awake long-term spinal cord injured rats: Comparison of metabolism cage and cystometrogram measurements. 2002 100th Annual Meeting AUA, J. Urol., 167:276A, 2002. 333. Sasaki, K., Chancellor, M., Phelan, M.,Yokoyama, T., Fraser, M., Satoshi S., de Groat, W., Yoshimura, N.: The correlation between bladder dysfunction and decreased nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia in diabetic rats. 2002 100th Annual Meeting AUA, J. Urol., 167:277A, 2002. 334. Satoshi S,, Sasaki, K., Fraser, M., Chancellor, M., de Groat, W., Osamu N., Yoshimura, N.: Suppression of nerve growth factor (NGF) in bladder afferent pathways reduces detrusor hyperreflexia and detrusor sphincter dyssynergia in spinal cord injured rats. 2002 100th Annual Meeting AUA, J. Urol., 167:274A, 2002. 335. O’Leary, M., Erickson, J., Smith, C., Cannon, T., McDermott, C., Horton, J., Leng, W., Chancellor, M.: Dose titration and tolerability versus efficacy of oxybutynin controlled release in neurogenic bladder patients. 2002 Society of Female Urology and Neurourology Annual Meeting, Orlando, May 24, 2002. 336. Lu, S., de Groat, W., Somogyi, G., Huard, J., Pruchnic, R., Chancellor, M.: Contractile activity of muscle-derived stem cells incorporated into small intestinal submucosa scaffolds. 2002 Society of Female Urology and Neurourology Annual Meeting, Orlando, May 24, 2002. 337. Ji Youl L., Cannon, T., Pruchnic, R., Fraser, M., Huard, J., Chancellor, M.: The effect of periurethral muscle derived stem cell injection on leak point pressure in a female rat model of stress urinary incontinence. 2002 Society of Female Urology and Neurourology Annual Meeting, Orlando, May 24, 2002. 338. Sasaki, K., Chancellor, M., Phelan, M., Yokoyama, T., Fraser, M., Satoshi S., de Groat,W., Yoshimura, N.: The correlation between bladder dysfunction and decreased nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia in diabetic rats. 2002 Society of Female Urology and Neurourology Annual Meeting, Orlando, May 24, 2002. 339. Yoshimura, N., Sasaki, K., Kim, J., Franks, M., Goss, J., Goins, W., Fink , D., Glorioso, J., Chancellor, M.: In vivo gene therapy fo urinary bladder pain using replication-defective herpes simplex virus (HSV) vector expressing preproenkephalin (PPE). 5th Annual Meeting of American Society of Gene Therapy. Molecular Therapy; 56:S247, 2002. 340. Kim, J., Sasaki, K., Yoshimura, N., Huang, S., Wolfe, D., Goins, W., Nelson, J., de Groat, W.C., Glorioso,J., Chancellor, M.: The feasibility of herpes simplex virus mediated gene therapy for neuorgneic erectile dysfunction. 5th Annual Meeting of American Society of Gene Therapy. Molecular Therapy; 56:S253, 2002. 341. Yoshimura, N., Sasaki, K., Kim, J., Franks, M., Goss, J., Goins, W., Fink, D., Glorioso, J., Chancellor, M.: Ex vivo gene transfer using skeletal muscle derived cells offering a long-term treatment option for urinary incontinence. 5th Annual Meeting of American Society of Gene Therapy. Molecular Therapy; 56:S366, 2002. 342. Gloeckner, D., Chancellor, M., Sacks, M.: Material classification of biaxial mechanical data. World Congress of Biomechanics, August, Calgary Canada, 2002. 343. Lee, J., Loo, W., Lee, S., Chancellor, M.: Leak point pressure comparison after bovin collagen and muscle derived stem cell injection into denervated external urethral sphincter in female rat. International Continence Society 27th Annual Meeing, Praque, Czech Republic, August 21-24, 2002. 344. Chermansky, C., Chancellor, M.: Contractility of small intestinal submucosa and muscle-derived stem cells. APS, 48th Annual Conference, J. SCI., 2002. 345. Chermansky, C., Chancellor, M.: Muscle-derived stem cells improve bladder compliance for small intestinal submucosa. APS, 48th Annual Conference, J. SCI., 2002. 346. Cessna, W., O'Leary, M., Erickson, J., Cannon, T., Leng, W., Chancellor, M.: Dose titration and tolerability of oxybutynin controlled release in patients with Parkinson's disease, multiple sclerosis, and spinal cord injury. Northeastern Section of AUA 54th Annual Meeting, Quebec, Canada, Sept. 26-29, 2002. 347. Gloeckner, D., Chancellor, M., Sacks, M.: Material classification of biaxial mechanical data. ASME International Mechanical Engineering Congress, November 17-22, New Orleans, LU, 2002. 348. Smith, C., Rocha, J., Boone, T., Chancellor, M., de Groat, W., Somogyi, G.: ATP and glutamate release in the spinal cord during increased bladder afferent activity. Neuroscience 32nd Annual Meeting, Orlando, Fl., November 2-7, 2002. 349. Seki, S., Erickson, K., Sasaki, K., Sugaya, K., Chancellor, M., de Groat, W., Yoshimura, N.: Effect of intrathecal substance P- saporin conjugate on baldder hyperactivity induced by intravesical capsaicin. Neuroscience 32nd Annual Meeting, Orlando, Fl., November 2-7, 2002. 350. Lu, S-H., Fraser, M., Chancellor, M., Cheng, C-L., de Groat, W.: Voiding dysfunction and purinergic mechanisms in awake chronic spinal cord injured rats. Neuroscience 32nd Annual Meeting, Orlando, Fl., November 2-7, 2002. Chancellor 84 of 108 351. Nagatomi, J., Evanuik, K., Gloeckner, D.C., Torimoto, K., Getzenberg, R.H., Chancellor, M.B., Sacks, M.S.: Spinal cord injury induces early chagnes in uriary bladder wall composition. Society for Basic Urology Research Fall 2002 Meeting, Tucson, AZ, December 5-8, 2002. 352. Gloeckner, D., Nagatomi, J., Chancellor, M., Sacks, M.: New method to quantify changes in bladder components after diseases. Society for Basic Urology Research Fall 2002 Meeting, Tucson, AZ, December 5-8, 2002. 353. Nagatomi, J., Gloeckner, D., Chancellor, M., Sacks, M.: Passive-state viscoelastic properties of normal vs. neurogenic bladder wall tissue. 2003 Summer Bioengineering Conference, June 25-29, 2003. 354. Horton, J., Getzenberg, R., Sacks, M., Dhir, R., Yoshimura, N., Heyman, R., Brenes, G., Borello-France, D., de Groat, E.C., Chancellor, M.: Center of urologic research excellence in SCI (CURE-SCI): a model for research integration. ASIA 2003 Annual Meeting, J SCI Medicine: 26, S46-47, 2003. 355. Kim, J., Bennett, N., Seki, S., Yoshimura, N., Nelson, J., Morris, S., Chancellor, M.: Arginase inhibitor affects the urogenital system through manipulation of the nitric oxide (NO) pathway. 2003 101th Annual Meeting AUA, J. Urol., 169:47A, 2003. 356. Chuang, Y., Chou, A., Yang, L., Yu, T., Hsien, K., Chancellor, M.: Gene therapy of bladder pain with gene gun particle encodign pro-opiomelanocortin (POMC) cDNA. 2003 101th Annual Meeting AUA, J. Urol., 169:64A, 2003. 357. Nishiguchi, J., Chancellor, M., Sasaki, K., Kim, J., Franks, M., Goss, J., Goins, W., Fink, D., Glorioso, J., Yoshimura, N.: Gene therapy of urinary bladder pain using replication-defective herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). 2003 101th Annual Meeting AUA, J. Urol., 169:47-48A, 2003. 358. Kamo, I., Torimoto, K., Chancellor, M., de Groat, W., Yoshimura, N.: Urethral closure mechanisms under sneeze-induced stress condition in rats - a new animal model for evaluation of stress urinary incontinence. 2003 101th Annual Meeting AUA, J. Urol., 169:94A, 2003. 359. Tarin, T., Chermansky, C., Kwon, D., Cannon, T., Huard, J., Chancellor, M.: Periurethral muscle derived stem cell injections increase leak point pressure in a rat model of intrinsic sphincteric deficiency. 2003 101th Annual Meeting AUA, J. Urol., 169:94A, 2003. 360. Lu, S., Cannon, T., Chermansky, C., Pruchnic, R., Somogyi, G., Sacks, M., de Groat, W., Huard, J., Chancellor, M.: Muscle- derived stem cells seeded acellular scaffolds improves compliance and develop calcium dependent contractile activity that is modulated by nicotinic receptors. 2003 101th Annual Meeting AUA, J. Urol., 169:100-101A, 2003. 361. Kamo, I., Cannon, T., Chancellor, M., de Groat, W., Yoshimura, N.: Active urethral closure mechanisms under sneeze-induced stress condition is impaired in a rat model of birth trauma. 2003 101th Annual Meeting AUA, J. Urol., 169:270A, 2003. 362. Kim, J., Bennett, N., Sasaki, K., Yoshimura, N., Wolfe, D., Goins, W., Nelson, J., de Groat, W., Glorioso, J., Chancellor, M.: Neurotrophic factor gene therapy: potential cure for post radical prostatectomy erectile dysfunction. 2003 101th Annual Meeting AUA, J. Urol., 169:303-304A, 2003. 363. Bennette, N., Kim, J., Yoshimura, N., Wolfe, D., Goins, W., Nelson, J., Glorioso, J., de Groat, W., Chancellor, M.: Dramatic improvement of erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. 2003 101th Annual Meeting AUA, J. Urol., 169:304A, 2003. 364. Tyagi, P., Chancellor, M., Yoshimura, N., Kim, J., Bennett, N., Huang, L.: Proof of concept of using the bio-bolistic gene transfer (Gene gun) to the rat penis. 2003 101th Annual Meeting AUA, J. Urol., 169:307A, 2003. 365. Kim, J., Bennett, N., Yoshimura, N., Chermansky, C., Kwon, D., Tarin, T., Nelson, J., de Groat, W., Qu-Petersen, Z., Huard, J., Chancellor, M.: Neurorecovery and improved erectile function using muscle derived stem cells (MDSC) in a model of post- radical prostatectomy erectile dysfunction. 2003 101th Annual Meeting AUA, J. Urol., 169:323A, 2003. 366. Cannon, T., Conway, D., Lu, S., Xavier, M., Fraser, M., Chermansky, C., de Groat, W., Huard, J., Chancellor, M.: Leak point pressure testing after tissue engineered sling placement in a model of stress urinary incontinence. 2003 101th Annual Meeting AUA, J. Urol., 169: 352A, 2003. 367. Lu, S., Qu-Petersen, Z., Peng, H., Cannon, T., Huard, J., de Groat, W., Chancellor, M.: Demonstration of acetylcholine receptor expression in a muscle-derived stem cells incorporated into acellular scaffolds. 2003 101th Annual Meeting AUA, J. Urol., 169:353A, 2003. 368. Chancellor, M., O'Leary, M., Erickson, J., Cannon, T., Chermansky, C., Leng, W., Smith, C.: Successful use of bladder botulinum toxin injection to treat refractory overactive bladder. 2003 101th Annual Meeting AUA, J. Urol., 169:353A, 2003. 369. Seki, S., Kuno, S., Torimoto, K., Nishizawa, O., de Groat, W., Chancellor, M., Yoshimura, N.: Dopaminergic D1 mechanisms underlying lower urinary tract dysfunctions in rats with Parkinsonism induced by unilateral 6-Hydroxy-dopamine injection. 2003 101th Annual Meeting AUA, J. Urol., 169: 368A, 2003. 370. Rocha, J., Smith, C., Chancellor, M., de Groat, W., Boone, T., Somogyi, G.: Changes in spinal cord transmitter release patterns during volume or noxious evoked bladder afferent activity. 2003 101th Annual Meeting AUA, J. Urol., 169: 372A, 2003. 371. Torimoto, J., Fraser, M., Chancellor, M., de Groat, W., Yoshimura, N.: A-adrenoceptor-mediated urehtral instability in diabetic rats. 2003 101th Annual Meeting AUA, J. Urol., 169: 372A, 2003. 372. Torimoto, K., Fraser, M., Chancellor, M., de Groat, W., Yoshimura, N.: The therapeutic effects of oral administration of L- arginine on urethral dysfunction in diabetic rats. 2003 101th Annual Meeting AUA, J. Urol., 169: 372A, 2003. 373. Prantil, R., Jankowski, R., Torimoto, J., Fraser, M., de Groat, W., Yoshimura, N., Chancellor, M., Vorp, D.: Effects of diabetes mellitus on urehtral biomechanics in the passsive state. 2003 101th Annual Meeting AUA, J. Urol., 169: 372-373A, 2003. 374. Cannon, T., Xavier, M., O'Leary, M., Chermansky, C., Erickson, J., Leng, W., Chancellor, M.: Correlation of bladder and sexual function in women with neurological disabilities. 2003 101th Annual Meeting AUA, J. Urol., 169: 374A, 2003. Chancellor 85 of 108 375. Conway, D., Kamo, I., Yoshimura, N., Chancellor, M., Cannon, T.: Comparison of leak point pressure methods in a animal model of stress urinary incontinence. 2003 101th Annual Meeting AUA, J. Urol., 169:402A, 2003. 376. Smith, C., Chancellor, M., de Groat, W., Boone, T., Somogyi, G.: Botulinum toxin: A new twist on "A" vs "D". 2003 101th Annual Meeting AUA, J. Urol., 169:38A, 2003. 377. Jankowski, R., Prantil, R., Vorp, D., Fraser, M., Huard, J., Torimoto, J., de Groat, W., Chancellor, M.: Evaluation of regional rat urehtral function usign a novel whole-mounted system. 2003 101th Annual Meeting AUA, J. Urol., 169:38-39A, 2003. 378. Torimoto, J., Kim, J., Seki, S., de Groat, W., Yoshimura, N., Chancellor, M.: The effect of resiniferatoxin on detrusor sphincter dyssynergia in chronic spinal cord injured rats. 2003 101th Annual Meeting AUA, J. Urol., 169:40-41A, 2003. 379. Nishiguchi, J., Sasaki, K., Seki, S., Chancellor, M., Erickson, J., de Groat, W., Yoshimura, N.: Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder hyperactivity induced by bladder irritation. 2003 101th Annual Meeting AUA, J. Urol., 169:42A, 2003. 380. Smith, C., Radziszewski, P., Borkowski, A., Chancellor, M.: Botulinum toxin A improves voiding and pain symptoms in patients with interstitial cystitis. A case series. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 381. Nishiguchi, J., Sasaki, K., Seki, S., Chancellor, M., Erickson, J., de Groat, W., Yoshimura, N.: Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder hyperactivity induced by bladder irritation. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 382. Smith, C., Rocha, J., Boone, T., Chancellor, M., de Groat, W., Somogyi, G.: Changes in spinal cord transmitter release patterns during volume or noxious evoked bladder afferent activity. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 383. Smith, C., Boone, T., Chancellor, M., de Groat, W., Somogyi, G.: Effect of stimulation intensity and botulinum toxin isoform on rat bladder strips contractions. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 384. Torimoto, J., Chancellor, M., de Groat, W., Yoshimura, N.: Urethral dysfunction induced by upregulation of A-adrenoceptor mechansims in diabetic rats. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 385. Lu, S., Cannon, T., Chermansky, C., Pruchnic, R., Somogyi, G., Sacks, M., de Groat, W., Huard, J., Chancellor, M.: Muscle- derived stem cells seeded acellular scaffolds improves compliance and develop calcium dependent contractile activity that is modulated by nicotinic receptors. 2003 Society of Female Urology and Neurourology Annual Meeting, Chicago, April 26, 2002. 386. Yoshimura, N., Sasaki, K., Nishiguchi, J., Kim, J., Goss, J., Gois, W., Fink, D., Glorioso, J., Chancellor, M.: Gene therapy of urinary bladder pain using replication-defective herpes simplex virus vectors expressing preproenkephalin. NIH Research Insigts into Interstitial Cystitis, Washington DC, November, 2003. 387. Nishiguchi, J., Hayashi, Y., de Groat, W., Chancellor, M., Yoshimura, N.: Effects of P2X receptor antagonists on detrusor overactivity by intravesical application of adonosine 5-triphosphate (ATP) under different delivery conditions in rats. NIH Research Insigts into Interstitial Cystitis, Washington DC, November, 2003. 388. Nishiguchi, J., Sasaki, K., Erickson, K., de Groat, W., Chancellor, M., Yoshimura, N.: Effects of isolectin B4-conjugated saporin, a taargeting cytotoxin, on bladder hyperactivity induced by bladder irritation. NIH Research Insigts into Interstitial Cystitis, Washington DC, November, 2003 389. Ogawa, T., Kamo, I., Pflug, B., Nelson, J., Chancellor, M., de Groat, W., Yoshimura, N.: Role of Endothelin ETA receptors in the micturition reflex in rats. NIH Research Insights into Interstitial Cystitis, Washington DC, November, 2003 390. Chermansky, C., Cannon, T., Torimoto, J., Fraser, M., de Groat, W., Chancellor, M.: Producing intrinsic sphincter deficiency in the rat. Electrocauterization. APS, 49th Annual Conference, J. SCI., 2003. 391. Kim, J., Bennett, N., Seki, S., Yoshimura, N., Nelson, J., Morris, S., Chancellor, M.: Arginase inhibitor affects the voiding and erectile process through the nitric oxide (NO) pathway. APS, 49th Annual Conference, J. SCI., 2003. 392. Kwon, D., Chermansky, C., Tarin, T., Cannon, T., Huard, J., Chancellor, M.: Periurethral muscle derived stem cell injections increase leak point pressure. APS, 49th Annual Conference, J. SCI., 2003. 393. Cannon, T., Conway, D., Lu, S., Xavir, M., Fraser, M., Chermansky, C., de Groat, W., Huard, J., Chancellor, M.: Leak point pressure testing after tissue engineering sling placement in a model of stress urinary incontinence. 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:372, 2003. 394. Satoshi, S., Sasaki, K., Igaway, Y., Nishizawa, O., Chancellor, M., de Groat, W., Yoshimura, N: Detrusor overactivity induced by increased levels of nerve growth factor in bladder afferent pathways in rats. 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:375-377, 2003. 395. Lu, S., Qu, Z., Peng, H., Pruchnic, R., Somogyi, G., Cannon, T., Huard, J., de Groat, W., Chancellor, M.: Nicotinic receptors modulated contractile activity and compliance of muscle-derived stem cells incorporated into acellular scaffolds for urethral and bladder reconstruction. 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:388-389,2003 396. Chermansky, C., Tarin, T., Cannon, T., de Groat, W., Huard, J., Chancellor, M.: Intraurethral muscle derived cell injections increase leak point pressure in a rat model of intrinsic deficiency. 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:389- 390, 2003. 397. Kim, J., Seki, S., Torimoto, K., Yoshimura, N., de Groat, W., Morris, S., Chancellor, M.: The effect of arginase inhibitors on the lower urinary tract 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:209-210,2003 398. Torimoto, K., Fraser, M., de Groat, W., Chancellor, M., Yoshimura, N.: Nitrengic and adrenergic mechanisms inducing diabetic urethral dysfunction in rats. 2003 ICS Meeting, Florence, Italy, Neuro & Urodynam 22:765-77,2003. Chancellor 86 of 108 399. Nagatomi, J., Chancellor, M., Sacks, M.: Active biaxial mechanical properties of bladder wall tissue, Presented at the ASME 2003 IMECE, Washington D.C., November 15-21, 2003. Published in the CD of the meeting proceedings. 400. Nagatomi, J. Grashow, J., Attar-Toosi, K., Chancellor, M., Sacks, M.: Relationship between tissue morphology, composition, and biomechanics of the urinary bladder, Presented at the Annual BMES Fall meeting, Nashville, TN, October 1-4, 2003. Published on CD ROM. 401. Horton, J., Getzenberg, R., Sacks, M., Dhir, R., Yoshimura, N., Heyman, R., Brenes, G., Borello-France, D., de Groat, W., Chancellor, M.: Center for Urologic Research Excellence in SCI: A Model for Research Integration,: Journal of Spinal Cord Medicine, Vol. 26, pp. S46, Supp. 1, 2003. 402. Nagatomi, J., Demiguel, F., Torimoto, K., Getzenberg, R., Chancellor, M., Sacks, M.: Molecular determinants to increase bladder compliance in spinal cord injury population: A rat model study, Presented at the AHA National Meeting, New Orleans, LA, November 7-9, 2004. 403. Chappel, C., Jonas, U., Chancellor, M., Ridder, A.: New antimuscarinic agent, solifenacin succinate, reduces urgency episodes in overactive bladder: an analysis of over 3,000 patients. European Association Urology Annual Meeting Vienna, Austria, March 26, 2004. 404. Nagatomi, J., Long, R.J., Zubiate, B., Chancellor, M., Sacks, M.S.: Muscle-derived cell-seeded SIS and a novel biaxial stretch bioreactor for urologic tissue engineering applications. 7th World Biomaterials Congress, Sidney Australia, May 17-21, 2004. 405. Patel, A., Cannon, T., O’Leary, M., Xavier, M., Erickson, J., Leng, W. , Chancellor, M., Borello-Franz, D: Relationship between overactive bladder (OAB) and sexual activity in women. 2004 AUA Meting, J. Urol., 171 (Supple): 88, 2004. 406. Kwon, D., Kim, J., Pruchnic,R., Jankowski, R., Huard, J., Demiguel, F., Yoshimura, N., Kim, J., Chancellor,M.: Comparison of leak point pressure skeletal muscle derived cells versus fibroblast injection into the urethra in model of stress urinary incontinence. 2004 AUA Meting, J. Urol., 171 (Supple): 91-92, 2004. 407. Chuang,Y., Yoshimura, N., Huang, C., Chiang, P., Chancellor, M.: Intravesical Botulinum Toxin A Administration Produces Analgesia Against Acetic Acid Induced Bladder Pain Responses in Rats. 2004 AUA Meting, J. Urol., 171 (Supple): 94, 2004. 408. Nishiguchi, J., Hayashi, Y., Chancellor, M., Erickson, K., De Groat, W., Yoshimura, N.: Role of urothelial barrier function in detrusor overactivity induced by intravesical application of adenosine 5’-triphosphate (ATP) in rats. 2004 AUA Meting, J. Urol., 171 (Supple): 94, 2004. 409. Tyagi, P., Banerjee, R., Basu, S., Chancellor, M., Yoshimura, N., Huang, L.: Intravesical antisense therapeutics against rat beta NGF- exploring in vitro and in vivo potential. 2004 AUA Meting, J. Urol., 171 (Supple): 97-98, 2004. 410. Torimoto, K., Kamo,I., Phillips, S., De Groat, W., Chancellor, M., Yoshimura, N.: Effects of serotonin and noreinephrine reuptake inhibitors on the bladder-to-urethral reflexes (BURs) preventing stress urinary incontinence (SUI). 2004 AUA Meting, J. Urol., 171 (Supple): 130-131, 2004. 12, 14 411. Hitoshi, M., Kazunori K., Chancellor, M., Yoshimura,N.: Cyclopentenone prostaglandin, 15-deoxy-&Delta_upper; -PGJ2, attenuates the development of cyclophosphamide induced cystitis in the rat. 2004 AUA Meting, J. Urol., 171 (Supple): 133-134, 2004. 412. Stein, R., Minnery, B., Xavier, M., Santos, S., Hayashi, S., Futrell, W., Hrebinko, R., Nelson, J., Yoshimura, N., Chancellor, M., De Miguel, F.: Cool and Hot Receptor mRNA in the Rat and Human Genitourinary Tract. 2004 AUA Meting, J. Urol., 171 (Supple): 137, 2004. 413. Yoshimura, N., Izumi, K., Kazumasa, T.,Chancellor, M.: Phasic And Tonic Components Of The Urethral Continence Mechanism. 2004 AUA Meting, J. Urol., 171 (Supple): 137, 2004. 414. Chancellor, M., Smith, C.: A single surgeon’s six-year experience with botulinum toxin injection into the bladder and urethra. 2004 AUA Meting, J. Urol., 171 (Supple): 138, 2004. 415. Seki, S., Erickson, K., Seki, M., Osamu, N.,Chancellor, M., de Groat, W., Yoshimura, N.: Targeting spinal neurokinin 1 receptor- expressing neurons for the treatment of neurogenic detrusor overactivity in spinal cord injury. 2004 AUA Meting, J. Urol., 171 (Supple):142-143, 2004. 416. JunN., Sasaki, K., Satoshi S., Chancellor, M., de Groat, W., Yoshimura, N.: Targeting isolectin B4-biding. C-fiber affernt neurons in dorsal root gangliA for the treatment of neurogenic detrusor overactivity in spinal cord injury. A2004 AUA Meting, J. Urol., 171 (Supple):142, 2004. 417. Hitoshi, M., Kim, J., Teruyuki, O., Kazunori, K., de Groat, W., Chancellor, M., Sidney, M.,Yoshimura, N.: Protective effects of arginase inhibitor on the endothelin-1 induced detrusor overactivity in rats. 2004 AUA Meting, J. Urol., 171 (Supple): 143, 2004. 418. Cannon, T., O’Leary, M., Patel, A., Xavier, M., Erickson, J., Leng, W., Chancellor, M., Borello-Franz,D.: The relationship between sexual function, bladder function, disability level, and quality of life in women with multiple sclerosis (MS). 2004 AUA Meting, J. Urol., 171 (Supple): 237, 2004. 419. Chancellor, M., Yoshimura, N.: Stress Urinary Incontinence Induces Overactive Bladder: A Hypothesis For Treatment. 2004 AUA Meting, J. Urol., 171 (Supple): 325, 2004. 420. YonTae K., Yoshimura, N., Kwon, D., Stein, R., Kim, J., de Miguel, F., Chancellor, M.: New mechanism of action of intravesical antimuscarinic agents. 2004 AUA Meting, J. Urol., 171 (Supple): 327-328, 2004. 421. Kim, Y., Kwon, D., Pruchnic, R., Jankowski, R., Kim, J., Huard, J., de Miguel, F., Yoshimura, N., Chancellor, M.: The use of skeletal muscle derived cells (MDCs) Injection into the penis improves rat model of erectile dysfunction. 2004 AUA Meting, J. Urol., 171 (Supple): 372, 2004. Chancellor 87 of 108 422. Jang H., Yong ,K., Bennett, N., Yoshimura, N., DeMiguel, F., Minnery, B., Wolfe, D., Goins, W., Nelson, J., Glorioso, J., de Groat, W., Chancellor, M.: Glial cell derived neurotrophic factor (GDNF) improves erectile function in a model of post radical prostatectomy erectile dysfunction. 2004 AUA Meting, J. Urol., 171 (Supple): 374, 2004. 423. Minnery, B., Kim, J., Patel, R., Kwon, D., de Miguel, F., de Groat, W., Nelson, J., Yoshimura, N., Huard, J., Chancellor, M.: Muscle-Derived Cells (MDC) Improve Erectile Fuction in a Rat Model of Post-Radical Prostatectomy Erectile Dysfunction. 2004 AUA Meting, J. Urol., 171 (Supple): 375, 2004. 424. Kwon, D., Kim,Y., Kim, J., Pruchnic, R., Jankowski,R., Huard, J., de Miguel, F., Yoshimura, N., deGroat, W., Chancellor, M.: Comparison of urethral contractility following muscle derived cell or fibroblastic cell injection into denervated rat urethral sphincter. 2004 AUA Meting, J. Urol., 171 (Supple): 45, 2004. 425. Prantil, R., Jankowski, R., Kazumasa T., de Groat, W., Chancellor, M., Yoshimura, N., Vorp, D.: Alternations in ex vivo biomechanical and pharmacological properties of the urethral in a rat model of birth trauma induced by vaginal distension. 2004 AUA Meting, J. Urol., 171 (Supple): 456, 2004. 426. Masuda, H., Chancellor, M.B., Kihara, K., de Groat, W.C., Yoshimura, N.: Differential roles of central and peripheral nitric oxide mechanisms in the regulation of lower urinary tract function in the rat. ICS 2004. Neurourolgy Urodynamics, 23:452-453, 2004. 427. Chapple, C., Chancellor, M.B.: Solifenacin reduced urgency episodes in overactive bladder patients with moderate and high micturition frequency at baseline. SIU 27th Congress, Hawaii, October 3-7, 2004. 428. MMP-1 activity of muscle-derived cells seeded onto SIS for urologic tissue engineering. BMES, October, 14, 2004 429. Biaxial mechanical characterization of active bladder wall tissue. BMES, October 14, 2004. 430. Gabapentin for overactive baldder and nocturia after anticholinergic failure. Northeaster Section of the AUA 56th Annual Meeting, Savannah, GA, October 28-30, 2004. 431. Relationship between overactive bladder and sexual activity in women. Northeaster Section of the AUA 56th Annual Meeting, Savannah, GA, October 28-30, 2004. 432. Use of tamsulosin in the treatment of neurogenic bladder dysfunction in women with multiple sclerosis. Northeaster Section of the AUA 56th Annual Meeting, Savannah, GA, October 28-30, 2004. 433. Van Le, Thu-Suong Hayashi, Yukio, Tyagi, Shachi, Yoshimura, Naoki, Chancellor, M.B. deMiguel, Fernando: Identification of nuclear proteins in the chronic cystitic rat model. 2005 AUA annual meeting, J. Urology 173 (Supple): 69, 2005 434. Van Le, Thu-Suong, Hayashi, Yukio, Tyagi, Shachi, Yoshimura, Naoki, Chancellor, Michael B., de Miguel, Fernando: Time- point study of the regulation of nuclear protein SM-22 (Transgelin) in the rat cystitis model. 2005 AUA annual meeting, J. Urology 173 (Supple): 80, 2005 435. Tyagi, Pradeep, Chancellor, Michael B., Yoshimura, Naoki, Huang, Leaf: Intravesical administration of antisense peptide nucleic acid down regulates urothelial NGF expression in rat model of cystitis. 2005 AUA annual meeting, J. Urology 173 (Supple): 147, 2005 436. Ogawa, Teruyuki, Masuda, Hitoshi, Seki, Satoshi,Igawa, Yasuhiko, Nishizawa, Osamu, Nagano, Matsumoto, Chancellor, Michael B. de Groat, William Yoshimura, Naoki: The role of dopaminergic mechanisms in the control of urethral function in rats. 2005 AUA annual meeting, J. Urology 173 (Supple) 154, 2005 437. Thomas, Catherine Tyagi, Shachi, Masuda, Hitoshi, Yoshimura, Naoki, Chancellor, Michael B., de Miguel, Fernando: B- Adrenoceptor Subtype 1, 2, and 3 MRNA are all present in human detrusor muscle and urothelium. 2005 AUA annual meeting, J. Urology 173 (Supple): 165, 2005 438. Hyashi, Yukio, Hamasaki, Sawako, Chancellor, Michael B., Kawatani, Masahito de Groat, William, Yoshimura, Naoki: Activation of protease-activated receptor 2 induces urinary frequency via c-fiber afferent pathways in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 166, 2005 439. Kim, Yong Tae, Yoshimura, Naoki, Masuda, Hitoshi, de Miguel, Fernando, Chancellor Michael B.: Intravesical instillation of human urine concentration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity. 2005 AUA annual meeting, J. Urology 173 (Supple): 542, 2005 440. Masuda, Hitoshi, Hayashi, Yukio, Masuda, Noriyuki, Kihara, Kazunori, Bunkyo-ku, Kim, Yong Tae, Chancellor, Michael B., Yoshimura, Naoki: Roles of bladder muscarinic receptors in the regulation of storage function in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 546, 2005 441. Prantil, Rachelle, Jankowski, Ronald, Haiho, Yasuhiro, Haiho, de Groat, William C., Chancellor, Michael B., Yoshimura, Naoki, Vorp, David: Alterations in ex vivo biomechanical properties and functional properties of the proximal urethra in a rat model of birth trauma induced by vaginal distension. 2005 AUA annual meeting, J. Urology 173 (Supple): 927, 2005 442. Kim, Yong Tae, Usiene, Irmute, Jankowski, Ronald J., Pruchnic, Ryan, Kwon, Dong Deuk, Huard, Johnny, De Miguel, Fernando, Chancellor, Michael B.: Comparison among muscle derived cells (MDC), fibroblasts and combined mdc/fibroblasts urethral injection on leak point pressure in dennervated rat urethral sphincter. 2005 AUA annual meeting, J. Urology 173 (Supple): 929, 2005 443. Nagatomi, Jiro, Demiguel, Fernando, Torimoto, Kazumasa, Getzenberg, Robert H., Chancellor, Michael B., Sacks, Michael: Molecular determinants to increase bladder compliance in spinal cord injury population: A rat model study. 2005 AUA annual meeting, J. Urology 173 (Supple): 1133, 2005 444. Tyagi, Shachi, Van Le, Thu-Suong, Thomas, Catherine A., Masuda, Hitoshi, Stein, Robert J., Yoshimura, Naoki, Chancellor, Michael B., de Miguel, Fernando: Differentiation stage-specific expression patterns of muscarinic receptors 1-5 MRNA in urothelium and detrusor of human bladder. 2005 AUA annual meeting, J. Urology 173 (Supple): 1198, 2005 Chancellor 88 of 108 445. Torimoto, Kazumasa, Nara, Kashihara, Matsuyoshi, Hiroko, Hayashi, Yukio, Masuda, Hitoshi; Matsumoto, Yoshihiro; Mie, Matsusaka; Fujimoto, Kiyohide; Hirao, Yoshihiko; Nara, Kashihara; de Groat, William; Chancellor, Micahel B.; Yoshimura, Naoki: The therapeutic effect of oral administration of L-arginine on bladder dysfunction in diabetic rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 1207, 2005 446. Prantil, Rachelle; Torimoto, Kazumasa; de Groat, William; Chancellor, Michael B.; Yoshimura, Naoki; Vorp, David; Fraser, Matthew: Important changes in the functional smooth muscle properties of the ex-vivo whole mount diabetic rat urethra. 2005 AUA annual meeting, J. Urology 173 (Supple): 1208, 2005 447. Hayashi, Yukio; Torimoto, Kazumasa; Chancellor, Michael B.; de Groat, William C.; Yoshimura, Naoki: Reduced activity of afferent neurons innervating urinary bladder in rats with diabetic cystopathy. 2005 AUA annual meeting, J. Urology 173 (Supple): 1210, 2005 448. Masuda, Hitoshi; Kihara, Kazunori; Chancellor, Micahel B.; Yoshimura, Naoki: Effects of cholineesterase inhibition in spinal and supraspinal neural pathways on micturition reflex in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 1214, 2005 449. Nishiguchi, Jun; Kwon, Dong Deuk; Kaiho, Yasuhiro; de Groat, William; Chancellor, Michael B.; Yoshimura, Naoki; Kumon, Hiromi; Snyder, Peter: Type 4 phosphodiesterase inhibitor-mediated attenuation of uninhibited bladder contractions in rats with partial bladder outlet obstraction. 2005 AUA annual meeting, J. Urology 173 (Supple): 1215, 2005 450. Nishiguchi, Jun; Hayashi, Yukio; Masuda, Hitoshi; Chancellor, Michael B.; de Groat, William C.; Yoshimura, Naoki; Kumon, Hiromi: The ecto-atpase inhibitor, ARL 67156, induces detrusor overactivity by enhancing endogenous ATP activity in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 1221, 2005 451. Masuda, Hitoshi; Kihara, Kazunori; Higaki, Masahide; Chancellor, Michael B.; Yoshimura, Naoki: Effects of intrathecal Cholineesterase inhibitor on bladder overactivity induced by cyclophosphamide and acetic acid. 2005 AUA annual meeting, J. Urology 173 (Supple): 1222, 2005 452. Masuda, Hitoshi; Kihara, Kazumori; Chancellor, Micahel B.; Yoshimura, Naoki: Hydrogen peroxide induces bladder over activity via sensitization of c-fiber afferent pathways through activation of cyclooxygenase in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 1223, 2005 453. Hayashi, Yukio; Kiromoto, Tsukasa; Takimoto, Koichi; Chancellor, Michael B.; Erickso, Kristin; de Groat, William C.; Yoshimura, Naoki: Hyperexcitability of afferent neurons innervating the bladder is associated with reduction in KV1.4 channel expression in rats with chronic cystitis. 2005 AUA annual meeting, J. Urology 173 (Supple): 1224, 2005 454. Kwon, Dong Deuk; Ryu, Soo Bang; Kim, Yong Tae; Pruchnic, Ryan; Huard, Johnny; Yoshimura, Naoki; de Groat, William C.; Chancellor, Michael B.: Improved detrusor contractility and neurorecovery through the use of muscle derived stem cells in a rat model of radical pelvic surgery. 2005 AUA annual meeting, J. Urology 173 (Supple): 1229, 2005 455. Masuda, Hitoshi; Hayashi, Yukio; Chancellor, Michael B.; Kihara, Kazunori; Kim, Yong Tae; de Groat, William C.; Yoshimura, Naoki: Differential roles of peripheral and central nicotinic receptors in the micturition reflex in rats. 2005 AUA annual meeting, J. Urology 173 (Supple): 1234, 2005. 456. J.Nagatomi, M. B. Chancellor, M. S. Sacks, “A new approach for modeling and analyzing the viscoelastic behavior of bladder wall tissue.” Presented at the XXth Congress of the International Society of Biomechanics and 29th Annual Meeting of the American Society of Biomechanics, July 31 - August 5, 2005, Cleveland, OH. Published on CD and available at http://www.isb2005.org/proceedings/ISB05/. 457. K. K. Toosi, J.Nagatomi, M. B. Chancellor, M. S. Sacks, “Time course changes in the mechanical properties of the rat urinary bladder following spinal cord injury.” Presented at the XXth Congress of the International Society of Biomechanics and 29th Annual Meeting of the American Society of Biomechanics, July 31 - August 5, 2005, Cleveland, OH. Published on CD and available at http://www.isb2005.org/proceedings/ISB05/. 458. J. Nagatomi, M. B. Chancellor, M. S. Sacks, “Contribution of the extracellular matrix to the viscoelastic behavior of the urinary bladder,” Presented at the ASME 2005 Summer Bioengineering Conference, Vail, CO, June 22 – 26, 2005. Published on CD “Proceedings of the 2005 Summer Bioengineering Conference Vail Cascade Resort and Spa, Vail, CO.” Abstract #b0233408. 459. K. K. Toosi, J. Nagatomi, M. B. Chancellor, M. S. Sacks, “Changes in the mechanical properties of the rat urinary bladder following long-term spinal cord injury,” Presented at the ASME 2005 Summer Bioengineering Conference, Vail, CO, June 22 – 26, 2005. Published on CD “Proceedings of the 2005 Summer Bioengineering Conference Vail Cascade Resort and Spa, Vail, CO.” Abstract #b0391688. 460. J. Nagatomi, M. Chancellor, M.S. Sacks, “Effects of increased elastin synthesis on the mechanical behaviors of bladder wall tissues, “ Presented at the Society for Biomaterials 30th Annual Meeting, Memphis, TN, April 27-30, 2005. Published on CD “Transactions of the 30th Annual Meeting.” 461. Chuang, Y., Chiang, P., Huang, C., Yoshimura, N., Chancellor, M.B.: Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. International Continence Society 35th Annual Meeting, Montreal, CA, 8/28-9/2, 2005. 462. Fox, K., Chancellor, M.B., Ouslander, J., Cerulli, A., Kahler, K.: A new questionnaire for satisfaction with OAB treatment: Development and content validity of the OAB satisfaction with treatment questionnaire (OAB-SAT-q). International Continence Society 35th Annual Meeting, Montreal, CA, 8/28-9/2, 2005. 463. Chuang, Y., Huang, C., Kang, H., Chiang, P., de Miguel, F., Yoshimura, N., Chancellor, M.B.: Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. International Continence Society 35th Annual Meeting, Montreal, CA, 8/28-9/2, 2005. Chancellor 89 of 108 464. Masuda, H., Chancellor, M.B., Kihara, K, de Groat, W.C., Yoshimura, N.: Evidence for the involvement of spinal endogenous ATP and P2X receptors in detrusor overactivity caused by acetic acid, acrolein or cyclophosphamide. International Continence Society 35th Annual Meeting, Montreal, CA, 8/28-9/2, 2005. 465. Usiene, I., Kim, Y.T., Pruchnic, R., Jankowski, R., Tyagi, S., de Miguel, F., Chancellor, M.B.: Human MDC injection increases leak point pressure in a nude rat model of stress urinary incontinence. Neurourology and Urodynamics, 24:410, 2005. 466. Kaiho, Y., Kamo, I., Sweeney, D., Prantil, R., Vorp, D., de Groat, W., Chancellor, M.B., Yoshimura, N.: Effects of norepinephrine reuptake inhibitor, nisoxetine, on the sneeze-induced urethral continence reflex in rats. Neurourology and Urodynamics, 24:569-570, 2005. 467. Ogawa, T., de Miguel, F., Chancellor, M.B., Tyagi, P., Yoshimura, N.: Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in the rat. Neurourology and Urodynamics, 24:444-445, 2005. 468. Fox, K.M., Chancellor, M.B.: Preference and satisfaction with treatment for constipation: development and validation of new instruments. American College of Gastroenterology 79th Annual Meeting, Honolulu, HA October 30, 2005. 469. Coyle, C., Kato, R., Chancellor, M.B., de Groat, W., De Miguel, F., Yoshimura, N.: Increased Superoxide Formation with simulated low-grade systemic inflammation: Implications for erectile dysfunction in obesity and pre-diabetes. J Urol., 175 (Supplement) 108, 2005. 470. Chuang, Y., DeMiguel, F., Wu, M., Yoshimura, N., Chancellor, M.B.: Intraprostatic capsaicin injection as a novel model for non-bacteria prostatitis. J Urol., 175 (Supplement) 110, 2006. 471. Hayashi, Y., Takimoto, K., Erickson, V., Bacvinskas, S., Chancellor, M.B., de Groat, W., Yoshimura, N.: Adenosine receptors- mediated regulation of micturition reflex in urethane-anesthized rats. J Urol., 175 (Supplement) 178, 2006. 472. Hiragata, S., Ogawa, T., Tyachi, P., De Miguel, F., Chancellor, M.B., de Groat, W., Yoshimura, N.: Effects of IP751, ajulemic acid, on bladder overactivity induced by bladder irritation in the rat. J Urol., 175 (Supplement) 191, 2006. 473. Matsuyoshi, H., Masuda, N., Chancellor, M.B., de Groat, W., Wanaka, A., Yoshimura, N.: Expression of hyperpolarization- activated cyclic nucleotide-gated cation channels in rat dorsal root ganglion neurons innervating urinary bladder. J Urol., 175 (Supplement) 192, 2006 474. Hsieh, V., Ratna,, G., Yoshimura, N., Kaufman, J., Chancellor, M.B., Tyagi, P.: Instillation of liposomes is superior to dmso or pentosan polysulfate in reducing bladder hyperactivity. J Urol., 175 (Supplement) 281, 2006 475. Ganabathi, R., Tyagi, P., De Miguel, F., Tyagi, S., Yoshimura, N., Chancellor, M. B.: Effect of ip-751, ajulemic acid, against acetic acid induced bladder pain responses in rats 24h after intravesical administration. J. Urol., 175 (Supplement) 282, 2006 476. Tyagi, P., Kaufman, J., De Miguel, F., Yoshimura, N., Chancellor, M.B.: Effect of st. john’s wort formulation dp015 against acetic acid induced bladder apin responses in rats. J Urol., 175 (Supplement) 1176, 2006 477. Carr, L., Steele, S., Wagner, D., Pruchnic, R., Jankowski, R., Erickson, J., De Miguel, F., Yoshimura, N., Huard, J., Chancellor, M.B.: muscle derived cell injection technique to optimize the treatment of stress urinary incontinence. J Urol., 175 (Supplement) 1185, 2006 478. Coyle, C., Kato, R., Chancellor, M.B., de Groat, W., De Miguel, F., Yoshimura, N.: Increased production of superoxide in rat penile endothelial cells exposed to interleukin 6: implications for erectile dysfunction in obesity. J. Urol., 175 (Supplement) 1201, 2006 479. Masuda, H., Chancellor, M.B., Kihara, K., de Groat, W., Yoshimura, N.: Inhibitory effects of intrathecal administration of p2y nucleotide receptor agonists, utp and udp, in detrusor overactivity caused by acetic acid and cyclophosphamide. J. Uro., 175 (Supplement) 1266, 2006 480. Thomas, C., Yoshimrua, N., Chancellor, M.B., de Miguel, F.: The effect of VR1antagonist in chronic spinal cord injured rats. 2006 APS meeting. JSCM 29: 465, 2006. 481. Thomas, C., Masuda, H., Marx, S.de Miguel, F., Yoshimura, N., Chancellor, M.B.: The effect of solabegron, a selective Beta 3 agonist, on human bladder strips. 2006 APS meeting. JSCM 29: 466, 2006. 482. Carr, L.K., Furuta, A., Marx, S.A., Thomas, C., Erickson, J., Chancellor, M.B.: The first clinical trial to treat urinary incontinence with muscle-derived cells. 2006 APS meeting. JSCM 29: 466, 2006. 483. Karram, M.M., Chancellor, M.B.: Solifenacin treatment reduces symptoms of overactive bladder in patients with residual urgency on tolterodine treatment: results of the VERSUS study. 2006 AUGS, Oct 19-21, 2006. 484. Chuang, Y., Yoshimura, N., Huang, C., Wu, M., Chiang, P., de Miguel, F., Chancellor, M.B.: Intraprostatic botulinm toxin A administration produces analgesic and anti-inflammatory effects against capsaicin induced prostatitis model in rats. 2006 ICS meeting, Neurourol & Urodynamics, 25:643-644, 2006. 485. Masuda, H., Chancellor, M.B., Kihara, K., de Miguel, F., de Groat, W.C., Yoshimura, N.: Time-dependent changes in nitric oxide synthase isoforms in the spinal cord in a rat model of detrusor overactivity induced by bladder irritation. 2006 ICS meeting, Neurourol & Urodynamics, 25:654-655, 2006. 486. Chuang, Y.C., Yoshimura, N., Huang, C.C., Chiang, P.H., Tyagi, P., Chancellor, M.B.: Intravesical and intraprostatic botulinum toxin A administration in rat models of interstitial cystitis and no-bacteria prostatitis. 2006 NIH/ICA October 26-27, 2006, Washington DC. 487. Chen, X., Tyagi, P., Yoshimura, N., Chancellor, M.B., de Migeul, F.: Biomarker discovery in HCL-induced chronic cystitis rat model. 2006 NIH/ICA October 26-27, 2006, Washington DC. 488. Kim, D.K., Honda, M., Furutra, A., Pruchnic, R., Jankowski, R., Yoshimura, N., Chancellor, M.B.: Expression of sarco- endoplasmic reticulum calcium ATPas 2a in human and rat muscle-derived progenitor cells, 5th Annual NIH CURE-SCI Retreat, Pittsburgh PA, March 9, 2007. Chancellor 90 of 108 489. Carr, L., Steele, D., Steele, S., Wagner, D., Pruchnic, R., Jankowski, R., Erickson, J., Huard, J., Chancellor, M.B.: One year rollow up of autologous muscle derived cell injection to treat stress urinary incontinence. Canidan Urological Assocation, March 14, 2007. 490. Haworth, D., Chew, D., Kim, D.K., Miyazato, M., Yoshimura, N., Chancellor, M.B., Vorp, D.: The effects of culture conditions and implantation on the structural and mechanical characteristics of a tissue engineered urethral wrap. Engineering& Urology Society 2007, May 19, 2007, Anaheim, CA. 491. Long, R.A., Parekh, A., Chancellor, M.B., Sacks, M.S.: An ex vivo model for strain-induced pathologies of the bladder. Engineering& Urology Society 2007, May 19, 2007, Anaheim, CA. 492. Long, R.A., Parekh, A., Chancellor, M.B., Sacks, M.S.: Bladder smooth muscle cell responses to contract guidance and cyclic mechanimcal stretch. Engineering& Urology Society 2007, May 19, 2007, Anaheim, CA. 493. Parekh, A., Long, R.A., Chancellor, M.B., Sacks, M.S.: In vivo expression of TGF-B1 in spinal cord injury bladders and in vitro effects on bladder smooth muscle cell contraction and remodeling. Engineering& Urology Society 2007, May 19, 2007, Anaheim, CA. 494. Chuang, Y-C, Yoshimura, N., Huang, C-C, Chiang, P-H, Tyagi, P., Chancellor, M.B.: Intravesical and intraprostatic botulinum toxin administration in rat models of interstitial cystitis and non-bacterial prostatitis. World Chinese Uroloigcal Society Meeting, Anaheim, CA, May 19, 2007. 495. Chuang, Y-C, Yoshimura, N., Huang, C-C, Chiang, P-H, Chancellor, M.B., Intraprostatic botulinum toxin A injection inhibits COX-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. 2007 AUA Meeting, J. Urology, 277:33, 2007. 496. Honda, M., Kaiho, Y., Miyagawa, I., Tyagi, P., Yoshimura, N., Chancellor, M.B.: Sensory neuron-specific receptor-mediated regulation of micturition reflex in urethane-anesthetized rats. 2007 AUA Meeting, J. Urology, 277:82, 2007. 497. Hiragata, S., Chancellor, M.B., de Groat, W., C., utafova-Yambolieva, V.N., Yoshimura, N.: Effect of B-nicotinamide adenine dinucleotide (B-NAD) on in vivo bladder function in mice. 2007 AUA Meeting, J. Urology, 277:83, 2007. 498. Kato, R., Wolfe, D.P., Coyle, C.H., Huang, S., Wechuck, J.B., Goins, W.F., de Miguel, F., Tsukamoto, T., Nelson, J.B., Chancellor, M.B, Glorioso, J.C., Yoshimura, N.: Herpes simplex virus vector-mediatd delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction of a nerve-sparing radical prostatectomy model. 2007 AUA Meeting, J. Urology, 277:91, 2007. 499. Morrisore, S.N., Coyle, C.H., Philips, B.J., de Groat, W.C., Yoshimura, N., Chancellor, M.B.: Green tea proects bladder cells from hydrogen peroxide-induced inflammation: potential of herbal agents to treat inflammatory bladder disease. 2007 AUA Meeting, J. Urology, 277:100, 2007. 500. Kato, R., Wolfe, D.P., Coyle, C.H., Wechuck, J.B., de Miguel, F., Tsukamot, T., Nelson, J.B., Chancellor, M.B., Glorioso, J.C., Yoshimura, N.: Herpes simplex virus vector-mediated delivery of a penile neurotrophic factor, neurturin, recuses erectile dysfunction following cavernous nerve injury. 2007 AUA Meeting, J. Urology, 277:226, 2007. 501. Kaiho, Y., Nishiguchi, J., Chancellor, M.B., Arai, Y., Snyder, P.B., Yoshimura, N.: Therapuetic effects of type 4 phosphodiesterase inhibitor on detrusor overactivity in rats with bladder outlet obstruction. 2007 AUA Meeting, J. Urology, 277:324, 2007. 502. Masuda, H, Kihara, K., Chancellor, M.B., Yoshimura, N.: The cyclopentenone prostaglandin, 15-deoxy-12,14 PGJ2, attenuates the development of cyclophosphamide induced cystitis. 2007 AUA Meeting, J. Urology, 277:328, 2007. 503. Chuang, Y-C, Kim, D.K., Chang, P-H, Chancellor, M.B.: Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. 2007 AUA Meeting, J. Urology, 277:393, 2007. 504. Carr, L.K., Steele, D., Steele, S., Wagner, D., Pruchnic, R., Jankowski, R.J., Erickson, J., Leng, W.W., Chancellor, M.B.: University of Toronto clinical trail of muscle derived stem cell injection in women with stress urinary incontinence. 2007 AUA Meeting, J. Urology, 277:439, 2007. 505. Prantil, R.L., de Groat, W.C., Haworth, D.J., Jankowski, R.J., Chancellor, M.B., Yoshimura, N.: Contributions of collagen and elastin to urethral biomechanics: correlation of damaged elastin to stress urinary incotinence induced by birth trauma. 2007 AUA Meeting, J. Urology, 277:435, 2007. 506. Kim, D.K., Jankowski, R., Pruchnic, R., Huard, J., Yoshimura, N., Honda, M., Furuta, A., Chancellor, M.B.: The in vitro and in vivo evaluation of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence. 2007 AUA Meeting, J. Urology, 277:481, 2007. 507. Tyagi, P., Chancellor, M.B., Yosimura, N., Juang, L., Kaufman, J.: Activity of different phospholipids in attenuating hyperactivity in bladder irriation. 2007 AUA Meeting, J. Urology, 277:481-482, 2007. 508. Roehrborn, C.G., Kaplan, S.A., Steers, W.D., Chancellor, M.B., Carlsson, M., Bavendam, T., Guan, Z.: Effect of tolerodine extended release and/or tamsulosin on international prostate symptom scores in men with lower urinary tract symptoms including overactive bladder. 2007 AUA Meeting, J. Urology, 277:513, 2007. 509. Chuang, Y-C, Chiang, P-H, Yoshimura, N., Chancellor, M.B.: Efficacy and length of symptom improvement after botulinum toxin type A in jection in BPH patients not correlated with change in prosate volume. 2007 AUA Meeting, J. Urology, 277:610, 2007. 510. Haworth, D., Chew, D., Kim, D.K., Miyazato, M., Yoshimura, N., Chancellor, M.B., Vorp, D.: The effects of culture conditions and implantation on the structural and mechanical characteristics of a tissue engineered urethral wrap. ASME, June 22, 2007. Chancellor 91 of 108 511. Zinner, N., Chancellor, M.B., Nandy, I., Andoh, M., Improved overactive bladder symptoms and patient-reported outcome measures in patients with residual urgency transitioned from tolterodine to solifenacin, including those with high symptom bother. Int Urogyencology J 18:S1, 2007. 512. Morrisore, S.N., Phillips, B.J., Coyle, C.H., Yoshimura, N., Chancellor, M.B.: In vitro proliferative effects og greentea: potential dietary intervention therapy for bladder cancer. NE AUA 2007 annual meeting, Rocheters, Oct 2007. 513. Chancellor, M.B, Aronstein, W.S, Ariely, R., Ebinger, U., Kianifard, F.: The effect of darifenacin on health related quality of life in patients with overactive bladder: results fromt eh ABLE study. SIU Annual mmeting, Paris Sept 2007, Urology 70 (Supplement 3A), 2007. 514. Chuang, Y.C., Chiang, Ph.H, Yoshimura, N., Chancellor, M.B.: Efficacy and duration of symptom improvement after prostate botulinum toxin injection for BPH. SIU Annual mmeting, Paris Sept 2007, Urology 70 (Supplement 3A), 2007. 515. Tyagi, P., Chancellor, M.B., Yoshimura, N., Kaufman, J. Activity of different phospholipids in hyperactivity in bladder irritation. SIU Annual mmeting, Paris Sept 2007, Urology 70 (Supplement 3A), 2007. 516. Hayne, M., Phillips, B., Thomas, C.A., Chancellor, M.B., Yoshimura, N.: Effect of cannabinoids on evoked CGRP release from bladder. SIU Annual mmeting, Paris Sept 2007, Urology 70 (Supplement 3A), 2007. 517. di Miguel, F., Chancellor, M.B., Yoshimura, N., Tyagi, P.: Proteomic characterization of interstitial cystitis/painful bladder syndrome. SIU Annual mmeting, Paris Sept 2007, Urology 70 (Supplement 3A), 2007. 518. Furuta, A., Jankowski, R.J., Pruchnic, R., Honda, M., Kim, D., Yoshimura, N., Chancellor, M.B.: Increased activity of A1- adrenoceptors after human muscle-derived stem cells injection into the denervated rat urethra.. 2007 ICS meeting, Rotterdam, The Netherlands, Neurourol & Urodynamics, 26: 695-696, 2007. 519. Furuta, A., Honda, M., Kim, D., Pruchnic, R., Jankowski, R., Chancellor, M.B., Yoshimura, N.: Bladder overactivity induced by chronic pudendal nerve ligation injury is associated with increased expression of nerve growth factor and activation of A1- adrenoceptors in the rat bladder 2007 ICS meeting, Rotterdam, The Netherlands, Neurourol & Urodynamics, 26: 698-699, 2007. 520. Miyazato, M., Kaiho, Y., Sugaya, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Effects of duloxetine, norepinephrine and serotonin reuptake inhibitor, on the sneeze-induced urethral continence reflex in rats. 2007 ICS meeting, Rotterdam, The Netherlands, Neurourol & Urodynamics, 26: 700-701, 2007. 521. Miyazato, M., Sasatomi, K., Hiragata, S., Sugaya, K., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Suppression of detrusor overactivity and detrusor-sphincter dyssynergia by GABA-receptor activation at the lubosacral spinal cord in spinal cord injury rats. 2007 ICS meeting, Rotterdam, The Netherlands, Neurourol & Urodynamics, 26: 701-702, 2007. 522. Honda, M., Miyaawa, I., Chancellor, M.B., Yoshimura, N.: Diffeential effects of ovariectomy on the continence reflex induced by sneeze and passive intravesical pressure rise in rats. 2008 AUA Meeting, J. Urology, 174 Supp: 532, 2008. 523. Kim, D.K., Yoshimura, N., Chancllor, M.B.: A pilot study of AAV1/ERCA2a gene transfer in the rat stress urinary incontinence model. 2008 AUA Meeting, J. Urology, 174 Supp: 532, 2008. 524. Tyagi, V., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Local activation of cannabinoid CB1 receptors bladder suppresses acetic acd induced bladder irritation. 2008 AUA Meeting, J. Urology, 174 Supp: 540, 2008. 525. Miyazato, M., Kaiho, Y., Sugaya, K., Ogawa, Y., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: The role of serotonergic mechanisms in sneeze-induced urethral continence reflex in rats. 2008 AUA Meeting, J. Urology, 174 Supp: 566, 2008. 526. Furuta, A., Ichiyanagi, N., Matsumoto, Y., Szuki, Y., Egawa, S., Yoshimura, N., Chancellor, M.B.: Role of alpha 2 adrenoceptors and glutamate receptors in the control of external urethral sphincter activity during urethral continence reflex in rats. 2008 AUA Meeting, J. Urology, 174 Supp:513,2008. 527. Furuta, A., Kaiho, Y., Kita, M., Szuki, Y., Egawa, S., Chancellor, M.B., Yoshimura, N.: Nonadrenergic mechanisms in the urethral continence reflex controlling urethral smooth and striated muscle function in rats. 2008 AUA Meeting, J. Urology, 174 Supp:469, 2008. 528. Tyagi, V., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Instillation of selective CB2 agonists protects against bladder irritation. 2008 AUA Meeting, J. Urology, 174 Supp:356, 2008. 529. Honda, M., Miyagawa, I., Chancellor, M.B., Yoshimura, N.: Supraspinal and spinal effects of L-transpyrrolidine-2,4 dicarboxylic acid, an inhibitor of glutamate transporters, on the micturition reflex in urethane-anesthetized rats. 2008 AUA Meeting, J. Urology, 174 Supp:356, 2008. 530. Sasatomi, K., Hiragata, S., Miyazato, M., Chancellor, M.B., Morris, S.M., Yoshimura, N.: Arginase inhibiton suppresses bladder overactivity in rats with chronic spinal cord injury by enhancing NO preoduciton. 2008 AUA Meeting, J. Urology, 174 Supp:355- 356, 2008. 531. Miyazato, M., Sugaya,K., Ogawas, Y. Chancellor, M.B., Goins, W.,F., Goss, J.R., Glorioso, J.C., Yoshimura, N.: Herpes simplex virus vector-mediated delivery of glutamic acid decaboxylase reduces detrusor overactivity in spinal cord injuried rats. 2008 AUA Meeting, J. Urology, 174 Supp:355, 2008. 532. Long, R.A., Parekh, A., Chancellor, M.B., Sacks, M.: Strain-induced tissue remodeling in ex vivo bladder organ culture; implications for regenerative medicine. 2008 AUA Meeting, J. Urology, 174 Supp:354, 2008. 533. Chuang, Huang, C.C., Yoshimura, N., Tyagi, P., Chang, P-H: Intresical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide induced cystitis in rats. 2008 AUA Meeting, J. Urology, 174 Supp:78, 2008. Chancellor 92 of 108 534. Chuang, Huang, C.C., Yoshimura, N., Tyagi, P., Chang, P-H: Effect of botulinum toxin A on SNAP25 level and bladder function in a cyclophospamide induced cystitis model in rats. 2008 AUA Meeting, J. Urology, 174 Supp:61, 2008. 535. Yokoyama, H., Saitoh, C., Miyazato, M., Nishizawa, O., Chancellor, M.B., Goins, W.F., Goss, J.R., Glorioso, J.C., Yoshimura, N.: Effect of different enkephalin treatment on bladder pain. 2008 AUA Meeting, J. Urology, 174 Supp: 60, 2008. 536. Watanabe, J.H., Campbell, J.D., Sullivan, S.D., Chancellor, M.B., Ravelo, A.: Cost Analysis of Overactive Bladder Treatments for Antimuscarinic Refractory Patients. 2008 AUA Meeting, J. Urology, 174 Supp:55-56, 2008. 537. Kim, D.K., Tyagi, P.: Effect of GABAergic system on 8-OH-DPAT-induced facilitation of ejaculation in rats. J. Urology, 174 Supp:336, 2008. 538. Philips, B.J., Smaldone, M.C., Erickson, V.L., Yoshimura, N., Chancellor, M.B., Tyagi, P: Differential Expression of Neurokinin Receptor Subtypes in Urothelium and Detrusor of Human Bladder . J Urology 174 Supp:356, 2008. 539. Tyagi, P., Tyagi, V., Vodovotz, Y., Barclay, D., Yoshimura, N., Chancellor, M.B.: Urine cytokines. William Beaumont Hospitla’s 16th Annual Symposium. Sept. 10-12, 2008 540. Miyazato, M., Sugaya, K., Chancellor, M.B., Goins, W., Goss, J., Glorioso, J., Yoshimura, N: Suppression fo detrusor-sphincter dyssynergia by herpes simplex virus vector-mediated glutamic acid decarboxylase gene delivery in spinal cord injured rats. International Continence Society, 2008. Neurourol & Urodynam 603-604, 2008. 541. Ichiyanagi, N., Furuta, A., Miyazato, M., Chancellor, M.B., Kihara, K., Yoshimura, N.: Inhibitory effects of gabapentin and pregablin on the micturition reflex in rats. International Continence Society, 2008. Neurourol & Urodynam 605-606, 2008. 542. Honda, M., Watanabe, T., Miyagawa, I., Chancellor, M.B., Yoshimura, N.: Somatostatin receptor subtype 4-mediated regulation of micturition reflex in urethane-anesthetized rats. International Continence Society, 2008. Neurourol & Urodynam 625-626, 2008. 543. Chuang, Y.C., Kim, D.K., Chiang, P.H., Chancellor, M.B.: Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. 3rd Pan-Pacific Continence Society, Sept. 26-27, 2008. Kaohsiung, Taiwan. 544. Chuang, Y.C., Yoshimura, N., Huang, C.C., Wu, M., Chiang, P.H., Chancellor, M.B.: Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide induced cystitis in rats. 3rd Pan-Pacific Continence Society, Sept. 26-27, 2008. Kaohsiung, Taiwan. 545. .Furuta, A., Suzuki, Y., Egawa, S. Chancellor, M.B., Yoshimura, N.: Role of adrenoceptors in the control of external urethral sphincter activity under valsalva-like stress conditions in rats.. 3rd Pan-Pacific Continence Society, Sept. 26-27, 2008. Kaohsiung, Taiwan. . 546. Liu, S.H., Yang, A.H., Wei, C.F., Chancellor, M.B., Chen, K.K., Chang, L.S.: How to purify human muscel derived stem cells? 3rd Pan-Pacific Continence Society, Sept. 26-27, 2008. Kaohsiung, Taiwan. 547. Carr., L., Herschorn, S., Birch, C., Murphy, M., Robert, M., Wagner, D., Pruchnic, R., Jankowski, R., Chancellor, M.B.: Safety of autologous muscle-derived cells (AMDCS) as therapy for stress urinary incontinence (SUI) in a randomized, blinded trial. 2009 Annual Meeting of SUFU, Feb 25-28, 2009, Las Vegas, NV 548. Tyagi, P., Nikolavsky, D., Peters, K., Tyagi, V., Barclay, D., Vodovotz, Y., Kuo, H.C., Chancellor, M.B.: Hypothesis driven urine proteomic study on interstitial cystitis/painful bladder syndrome (IC/PBS( patients. 2009 Annual Meeting of SUFU, Feb 25-28, 2009, Las Vegas. 549. Kuo, H.C., Chancellor, M.B.: Comparison of intravesical botulinum toxin A injections plus hydrodistention and hydrodistention alone for treatment of refractory interstitial cystitis.. 2009 AUA Meeting, J. Urology, 181 Supp:17-18, 2009. 550. Yokoyama, H., Saitoh, C., Miyazato, M., Nishizawa, O., Chancellor, M.B., Goins, W.F., Goss, J.R., Glorioso, J.C., Yoshimura, N.: Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nocicption. 2009 AUA Meeting, J. Urology, 181 Supp:20, 2009. 551. Tyagi, P., Nikolavsky, D., Vodovotz, Y., Barclay, D., Tyagi, V., Peters, K.M., Chancellor, M.B.: Urine levels of selected chemokines positively correlate with lower bladder capacity and psychometric scores in IC/PBS patients. 2009 AUA Meeting, J. Urology, 181 Supp:21, 2009. 552. Watanabe, J.H., Campbell, J.D., Ravelo, A., Chancellor, M.B., Kowalski, J., Sullivan, S.D.: Three year cost analysis of sacral neuromodulation, intra-detrusor injection of botulinum toxin type A, and augmentation cystoplasty for overactive bladder with urinary urge incontinence.. 2009 AUA Meeting, J. Urology, 181 Supp:194, 2009. 553. Kaufman, J., Tyagi, P., Chancellor, M.B.: Intravesical liposomal (LP08) instillation protects bladder urothelium from chemical irritation. 2009 AUA Meeting, J. Urology, 181 Supp:539, 2009. 554. Yunoki, T., Naito, S., Chancellor, M.B., Yoshimura, N.: Botulinum neurotoxin-A inhibits L-type voltage-gated Ca current in rat and human detruosr smooth muscles. 2009 AUA Meeting, J. Urology, 181 Supp:540, 2009. 555. Carr, L, K., Herschorn, S., Birch, C., Murphy, M., Robert, M., Jankowski, R.J., Pruchnic, R., Wagner, D., Chancellor, M.B.: Autologous muscle-derived cells as a therapy for stress urinary incontinence: a randomized, blinded, mulit-dose study. 2009 AUA Meeting, J. Urology, 181 Supp:546, 2009. 556. Miyazato, M., Kaiho, Y., Kitta, Ta., Sugaya, K., Saito, S., Chancellor, M.B., de Groat, W.C., Yoshimura, N.: Effect of fluoxetine, a serotonin reuptake inhibitor, on the sneeze-induced continence reflex in rats.. 2009 AUA Meeting, J. Urology, 181 Supp:549, 2009. 557. Kitta, T., Miyazato, M., Honda, M., Chancellor, M.B., Nonormura, K., Yoshimura, N.: Estrogen deficiency causes an early stage altering of urethral responses during sneeze reflex.. 2009 AUA Meeting, J. Urology, 181 Supp:550, 2009. 558. Tyagi, P., Tyagi, V., Witteemer, E., Kuo, H.C., Yoshimura, N., Peters, K.M., Chancellor, M.B.: Expression of ghrelin receptor in bladder points to a new link between obesity and the overactive bladder.. 2009 AUA Meeting, J. Urology, 181 Supp:570, 2009. Chancellor 93 of 108 559. Liu, H.T., Kuo, H.C., Chancellor, M.B.: Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.. 2009 AUA Meeting, J. Urology, 181 Supp:588, 2009. 560. Tyagi, P., Jacobs, B.L., Barcaly, D., Vodovotz, Y., Leng, W.L., Kuo, H.C., Chancellor, M.B.: Urine levels of inflammatory chemokines can be novel biomarkers for the overactive bladder.. 2009 AUA Meeting, J. Urology, 181 Supp:588, 2009. 561. Chuang, Y.C, Tyagi, P., Kuagn, C.C., Wu, M., Yoshimura, N., Kaufman, J. Chancellor, M.B.: Urodynamic and immunohistochemical evaluation of intravesical botuinum toxin A delivery using liposomes.. 2009 AUA Meeting, J. Urology, 181 Supp:589-590, 2009. 562. Chancellor, M.B., Vasavada, S.: The overactive bladder syndrome (OAB) and obesity: evidence of antimuscarinic efficacy regardless of body mass index at baseline. 2009 AUA Meeting, J. Urology, 181 Supp:676, 2009. 563. Nikolavsky, D., Tyagi, P., Tyagi, V., Peters, K., Chancellor, M.B.: Urine proteomic study on interstitial cystitis/IC, painful bladder syndrome (PBS) patients. Beaumont Research Institute Forum, June, 10, 2009. 564. Chancellor, M.B, Oefelein, M., Vasavada, S.: Obesity is associated with a more severe oberactive bladder disease state that is effectively treated with once-daily administration fo trospium chloride extended release. ICS, San Francisco, Sept 29-Oct 3, 2009. 565. .Kuo, H., Liu, H., Chancellor, M.B.: Urinary nerve growth factor is a better biomaerk than detrusor wall thickness for assessment of overactive bladder with incontinence. ICS, San Francisco, Sept 29-Oct 3, 2009. 566. .Chancellor, M.B., Peters, K., Qu, H., Liu, H., Kuo, H., Tyagi, P., Urine chemokine biomarker profile analysis multivariate data analysis suggests low-level inflammation as underlying pathology of the overactive bladder. ICS, San Francisco, Sept 29-Oct 3, 2009. 567. .Furuta, A., Naruoka, T., Suzuki, Y., Egwa, S., Chancellor, M.B., Yoshimura, N.: Urethral compensatory mechanism underlying the recovery of urinary continence after pudendal nerve injury in female rats. ICS, San Francisco, Sept 29-Oct 3, 2009. 568. Kitta, T., Miazato, M., Chancellor, M.B., Nonomura, K., Yoshimura, N.: Alpha2-adrenergic receptor blockade potentiates the effecto fo duloxetine, a norepinephrine and serotonin reuptake inhibitor on sneeze-induced urethral continence reflexes in rats. ICS, San Francisco, Sept 29-Oct 3, 2009. 569. Tyagi, P., Tyagi, V., Peters, K., Witteemer, E., Chuang Y.C, Kuo, H.C., Yoshimura, N., Chancellor, M.B.: Ghrelin-a putatitve mechanistic link between OAB and obesity. SUFU Winter 2010 confernece Poster BS15, St. Petersburg, FL, February 25-27, 2010. 570. Tyagi, V., Sugino, Y., Yoshimura, N., Kaufman, J., Chuang, Y.C., Kuo, H.C., Chancellor, Tyagi, P.: Liposomes facilitate efficient bladder uptake of antisense oligoucleotides. SUFU Winter 2010 confernece Poster BS19, St. Petersburg, FL, February 25-27, 2010. 571. Herschorn, S., Carr, L., Birsch, C., Murphy, M., Robert M., Jankowski, R., Pruchnic, R., Wagner, D., Chancellor, M.B.: Autologous muscle-derived cells as therapy for stress urinary incontinence: a randomized, blinded trial. SUFU Winter 2010 confernece, St. Petersburg, FL, February 25-27, 2010. 572. Chancellor, M.B., Oefelein M., Vasavada, S.: The OAB syndrome and obesity: evidence of antimuscarinic efficacy regarless of body mass index at baseline. SUFU Winter 2010 confernece Poster BS80, St. Petersburg, FL, February 25-27, 2010. 573. 1525 GHRELIN- A PUTATIVE MECHANISTIC LINK BETWEEN OAB AND OBESITY Vikas Tyagi, Pradeep Tyagi, Kenneth Peters, Yao-Chi Chuang, Hann-Chorng Kuo, Naoki Yoshimura, Michael Chancellor The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e588) 574. 1590 DISCRIMINATION OF OAB FROM IC/PBS BY MULTIVARIATE DATA MODELING OF URINARY PROTEINS Pradeep Tyagi, Vikas Tyagi, Don Bui, Harvey Qu, Kenneth Peters, Yao-Chi Chuang, Hann-Chorng Kuo, Naoki Yoshimura, Michael Chancellor The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Pages e614-e615) 575. 1514 CEREBRAL INFARCTION FAILS TO ENHANCE THE SNEEZE-INDUCED CONTINENCE REFLEX AFTER DULOXETINE, A NOREPINEPHRINE AND SEROTONIN REUPTAKE INHIBITOR, IN RATS Minoru Miyazato, Yasuhiro Kaiho, Hideaki Izumi, Naoki Kawamorita, Haruo Nakagawa, Yoichi Arai, Michael Chancellor, William de Groat, Naoki Yoshimura The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e584) 576. 1519 RISK FACTORS OF ADVERSE EVENTS AFTER INTRAVESICAL BOTULINUM TOXIN A INJECTIONS FOR REFRACTORY OVERACTIVE BLADDER SYNDROME Hann-Chorng Kuo, Chia-Yen Chen, Michael Chancellor The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e586) 577. 1020 ALPHA1-ADRENOCEPTOR BLOCKERS IMPROVE URINE STORAGE FUNCTION IN THE SPINAL CORD IN SPINAL CORD INJURED RATS Minoru Miyazato, Katsumi Kadekawa, Kimio Sugaya, Seiichi Saito, Yoichi Arai, Michael Chancellor, William de Groat, Naoki Yoshimura The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e397) 578. 1669 NERVE GROWTH FACTOR LEVELS IN URINE CORRELATE WITH EXPRESSION IN UROTHELIUM BUT NOT SUBUROTHELIUM IN THE BLADDER TISSUES OF OVERACTIVE BLADDER SYNDROME Hsin-Tzu Liu, Yue-Shiung Wang, Michael Chancellor, Hann-Chorng Kuo The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Pages e644- e645) 579. 1626 NON-INVASIVE IMAGING OF NEAR INFRAFRED DYE LABELED LIPOSOMES FACILITATES EVALUATION OF BIORESIDENCE TIME Jonathan Kaufman, Harvey Hensley, Joely Jacobs, Michele Anthony, Vikas Tyagi, Pradeep Tyagi, Michael Chancellor The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e628) 580. 1524 AUTOLOGOUS MUSCLE-DERIVED CELLS AS THERAPY FOR STRESS URINARY INCONTINENCE: A RANDOMIZED, DOSE-RANGING TRIAL Lesley Carr, Sender Herschorn, Colin Birch, Magnus Murphy, Magali Robert, Ronald Jankowski, Ryan Pruchnic, David Wagner, Michael Chancellor The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Pages e587-e588) Chancellor 94 of 108 581. 1034 TIME-DEPENDENT CHANGES IN BLADDER FUNCTION AND PLANTAR SENSITIVITY IN A RAT MODEL OF FIBROMYALGIA INDUCED BY HYDROCHLORIC ACID INJECTION INTO THE GLUTEUS Akira Furuta, Yasuyuki Suzuki, Yusuke Koike, Takehito Naruoka, Nozomu Furuta, Shin Egawa, Michael Chancellor, Naoki Yoshimura The Journal of Urology April 2010 (Vol. 183, Issue 4, Supplement, Page e402) 582. Chuang YC, Tyagi P, Huang CC, Yoshimura N, Wu M, Kaufman J, Chancellor MB: Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide induced overactive bladder. ICS/IUGA, Toronto Canada, August 23-27, 2010. 583. Tyagi P, Tyagi V, Sugino Y, Yoshimura N, Kaufman J, Chancellor MB: Liposome platform for intravesical sequence-specific gene-silencing of NGF in bladder. ICS/IUGA, Toronto Canada, August 23-27, 2010. 584. Tyagi P, Qu, XG, Chancellor, MB, Peters, K: Urine inflammatory biomarers for differential diagnosis of OAB from IC/PBS. Oakland University Beaumotn Hospitals Biomedical Research Symposium, Feb 16, 2011. 585. Tyagi, V., Sugino, Y., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Liposomes assisted bladder uptake of antisense oligonucleotides ameliorate symptoms of detrusor overactivity in rat model. SUFU Winter 2011 conference Phoenix, AZ, March 1-5, 2011. 586. Anthony, M., Chancellor, D., Tyagi, V., Chancellor, M.B., Tyagi, P., Kaufman, J.: Intravesical therapy by liposomes composed of lipds endogenous to urinary tract does not affect serum levels of lipid or its metabolites. SUFU Winter 2011 conference Phoenix, AZ, March 1-5, 2011. 587. Tyagi, V., Qu, H., Peters, K, Chuang, Y.C., Liu, H.T., Kuo, H.C., Yoshimura, N., Tyagi, S., Chancellor, M.B., Tyagi, P.: Age associated changes in urinary proteome of OAB patients. . SUFU Winter 2011 conference Phoenix, AZ, March 1-5, 2011. 588. Tyagi, P., Tyagi, V., Qu, H., Peters, K, Chuang, Y.C., Liu, H.T., Kuo, H.C., Tyagi, P., Chancellor, M.B.: Urine analysis of confirmed UTI patients reveal higher levels of CXC chemokines compared to patients with LUTS but without UTI. SUFU Winter 2011 conference Phoenix, AZ, March 1-5, 2011. 589. Tyagi, V., Sugino, Y., Yoshimura, N., Chancellor, M.B., Tyagi, P.: Liposomes assisted bladder uptake of antisense oligonucleotides ameliorate symptoms of detrusor overactivity in rat model. Abstract 790; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 590. Tyagi, P., Tyagi, V., Qu, H., Peters, K, Chuang, Y.C., Liu, H.T., Kuo, H.C., Tyagi, P., Chancellor, M.B.: Urine analysis of confirmed UTI patients reveal higher levels of CXC chemokines compared to patients with LUTS but without UTI. Abstract 1370; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 591. Chuang, Y.C., Cheng, H.W., Chung, M.S., Lee, W.C., Liu, R.T., Chancellor, M.B.: Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes, Abstract 1506; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 592. Ginsberg, D., Chancellor, M.B, Gousse, A., Keppenne, VA, Sievert, K.D., Thompson, C., Lam, W., Jenkins, B., Haag- Molkenteller, C.: Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. Abstract 1515; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 593. Chancellor, M.B., Chapple, C., Lam, W., Leng, W., Patel, V., Shento., P: OnabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: effects on health-related quality of life. Abstract 1518; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 594. Tyagi, V., Qu, H., Peters, K, Chuang, Y.C., Liu, H.T., Kuo, H.C., Yoshimura, N., Tyagi, S., Chancellor, M.B., Tyagi, P.: Age associated changes in urinary proteome of OAB patients. Abstract 1954; AUA Annual Meeting 2011, Washington DC, May 14- 19, 2011. 595. Peters, K., Biller, D., Carr, L., Chancellor, M.B., Dmochowski, R., Fischer, M., Herschorn, S., Kaufman, M., Nagaraju, P., Sirls, L., Ward. R: Autologous muscle derived cell therapy for the treatment of female stress urinary incontinence: a multicenter experience. Abstract 1340; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 596. Tyagi, P., Araujo, A., Chancellor, M.B., Kupelian, V., McKinlay, J.B., Rosen, R.C.: Obesity, inflammation and overactive bladder: preliminary results from a pilot study of serum liptin and MCP-1 levels in men and women with and without OAB symptoms. Abstract 1153; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 597. Tyagi, V., Chancellor, M.B., Killinger, K., Peters, K., Tyagi, P.: Urinary chemokines as non-invasvie predictors of ulcerative interstitial cystitis. Abstract 806; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 598. Furuta, N., Chancellor, M.B., Egawa, S., Furuta, N., Naruoka, T., Suzuki, Y., Yoshimura, N.: Analysis of transient receptor potential channels related to bladder overactivity induced by pelvic organ cross-sensitization in rats. Abstract 951; AUA Annual Meeting 2011, Washington DC, May 14-19, 2011. 599. Chancellor, M., Sussman, D., Del Popolo, G., Pommerville, P., Shento, P., Globe, D., Lam, W., Chapple, C.: Improvement in health-related quality of life following treatment with onabotulinumtoxinA in patients iwht urinary incontinence due to neurogenic detrusor overactivity. AAMPR 2011 Annual meeting. 600. Kaufman, M., Dmochowski, R., Peters, K., Carr, L., Herschorn, S., Fisher, M., Sirls, L., Biller, D., Chancellor, M.: Safety and potential effectiveness of cook myosite autologous muscle derived cells for treatment of stress urinary incontinence: preliminary results from a dose escalating study. ICS 2011 Annual meeting. 601. Honda, M., Inoue, S., Takenaka, A., Chancellor, M., Yoshimura, N.: Galanin-mediated regulation of micturition reflex in urethane-anesthetized rats. ICS 2011 Annual meeting. 602. STOPPED RECORDING AS CV GETTING TOO LONG BETWEEN 2011 UNTIL 2013 AUA 603. Tyag V, Tyagi P, Nirmal J, Ahmed S, Peter K, Yoshimura N, Chancellor MB: Molecular evidence of the novel HCN2 gene as new diagnostic and treatment for IC/BPS. AUA 2013. Chancellor 95 of 108 604. Chuang YC, Lee WC, Yoshimura N, Huang CC, Chancellor MB: Diabetes mellitus-induced hyposensitive bladder is associated with increased inflammation, apoptosis, expression of EP recpetors, and urine NGF in streptozotocin rat model. AUA 2013 605. Honda M, Inoue S, Hikita K, Muraoka K, Saito M, Sejima T, Takenaka A, Chancellor MB, Yoshimura N: Inhibition of the anandamide transporter inhibits the micturiotn reflex of anesthetized rats. AUA 2013 606. Chancellor MB, Corbell C, Zaharson T, Bramley TJ, Chaudhari S, Globe D: Anticholinergic therapy in pateints with overactive bladder: Patterns of treatment failure and medication use over two years. AUA 2013. 607. Nirmal J, Wolf-Johnston Am, Chancellor MB, Tyagi P, Kaufman J, Anthony M, Birder L: Liposomal treatment offers protection against acrolein-induced urothelial cell damage. AUA 2013. 608. Chancellor MB, Tyagi P, Nirmal J, Bui D, Peters K: Treatment response to neuromodulation in IC/PBS patients accompany decrease in urine chemokines. AUA 2013. 609. Kawamorita N, Kashyap M, Tyagi V, Sugino Y, Chancellor MB, Yoshimrua N, Tyagi P: Downregulation of NGF expression in the bladder by antisense oligonucleotides as new termant of overactive bladder. AUA 2013. 610. Kashyap M, Kawamorita N, Chancellor MB, Yoshimura N, Tyagi P: NGF signaling mediates inflammatory cell responses of bladder to the intravesical insults. AUA 2013. 611. Chuang YC, Chuang MS, Lee WC, Liiu RT, Chancellor MB: Nocturia correlates with bladder and systemic issues and increases mortality in patients with Type 2 diabets. AUA 2013. 612. Tyagi P, Killinger K, McLennan G, Nirmal J, Yoshimura N, Chancellor MB, Peters K: Urine chemokines rflect contribution of bladder in the symptoms of chronic prostatitis. AUA 2013. 613. Dmochowski R, Peters K, Carr L, Rober M, Kaufman M, Herschorn S, Birch C, Kultgen P, Chancellor MB: Autolgous muscle cell mediated therapy for stress urinary incontinence: combined safety & potential efficacy results from two studies. Neurourology & Urodynam 32:554-555, 2013 43rd Annual ICS meeting. 614. Oguchi T, Yokoyama H, Funahashi Y, Yoshikawa S, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Chancellor MB, Tyagi P, Yoshimura N: Inhibiton of bladder hypersensitivity by interfeukin 4 (IL-4) gene therapy using herpes simplex virus (HSV) vectors in rats with cyclophosphamide induced cystitis. Neurourology & Urodynam 32:720780, 2013 43rd Annual ICS meeting. 615. Chartier-Kastler E, Rover E, Chancellor MB, Corbell C, Jin J, Globe D: Sustained improvements in helath-related quality fo life following repeat onabotulinumtoxinA detrusor injections in patients with neurogenic detrusor overactivity: results from tow phase 3 studies. Neurourology & Urodynam 32:763-764, 2013 43rd Annual ICS meeting 616. Honda M, Yoshimura N, Kawamoto B< Inoue S, Kobayashi N, Hikita K, Muraoka K, Saito M, Chancellor MB, Takenaka A: Inhibitory effects of intravesical administration of sensory neuron specific receptor agonist on the micturition reflex in rats. Neurourology & Urodynam 32:834-835, 2013 43rd Annual ICS meeting. 617. Masashi Honda*, Shinji Hirano, Bunya Kawamoto, Shogo Shimizu, Naoto Kobayashi, Katsuya Hikita, Kuniyasu Muraoka, Yonago, Japan, Motoaki Saito, Nankoku, Japan, Takehiro Sejima, Atsushi Takenaka, Yonago, Japan, Michael Chancellor, Royal Oak, MI, Naoki Yoshimura, Pittsburgh, PA. MP1-07: THE ROLE OF SPINAL NEUROPEPTIDE Y Y1 RECEPTORS IN THE CONTROL OF MICTURITION REFLEX IN ANESTHETIZED RATS. AUA Orlando, FL 2014. 618. Yao-Chi Chuang*, Hung-Jen Wang, Kaohsiung, Taiwan, Naoki Yoshimura, Pittsburgh, PA, Michael Chancellor, Royl Oak, MI MP1-15: Functional and Molecular Characteristic of Underactive Bladder Induced by Lumbar Canal Stenosis in Rats. AUA Orlando, FL 2014. 619. Tsuyoshi Yoshizawa*, Pradeep Tyagi, Pittsburgh, PA, Michael B. Chancellor, Royal Oak, MI, Satoru Takahashi, Tokyo, Japan, Naoki Yoshimura, Pittsburgh, PA MP1-17: Therapeutic effects of intravesical application of liposome conjugated with antisense oligonucleotide targeting nerve growth factor on neurogenic detrusor overactivity in rats with spinal cord injury. AUA Orlando, FL 2014. 620. Masashi Honda*, Shinji Hirano, Bunya Kawamoto, Shogo Shimizu, Naoto Kobayashi, Katsuya Hikita, Kuniyasu Muraoka, Yonago, Japan, Motoaki Saito, Nankoku, Japan, Takehiro Sejima, Atsushi Takenaka, Yonago, Japan, Michael Chancellor, Royal Oak, MI, Naoki Yoshimura, Pittsburgh, PA MP17-07: INTRAVESICAL ADMINISTRATION OF SENSORY NEURON- SPECIFIC RECEPTOR AGONIST INHIBITS THE MICTURITION REFLEX OF ANESTHETIZED RATS. AUA Orlando, FL 2014. 621. Naoki Kawamorita*, Satoru Yoshikawa, Pittsburgh, PA, Yoichi Arai, Miyagi, Japan, Pradeep Tyagi, Pittsburgh, PA, Michael Chancellor, Royal Oak, MI, Naoki Yoshimura, Pittsburgh, PA PD9-01: THERAPEUTIC EFFECT OF ANTISENSE OLOGONUCLEOTIDE (OND) TARGETING NERVE GROWTH FACTOR (NGF) ON BLADDER HYPESENSITIVITY IN RAT WITH EXPERIMENTAL COLITIS. AUA Orlando, FL 2014. 622. Yao-Chi Chuang*, Kaohsiung, Taiwan, Jonathan Kaufmann, David Chancellor, Pittsburgh, PA, Michael Chancellor, Royal Oak, MI, Hann-Chorng Kuo, Hualien, Taiwan MP33-02: Prospective Multicenter Double-Blind Placebo-Controlled Trial of the Efficacy and Safety of Liposomal Botulinum Toxin-A Instillation vs. Placebo in Treatment of Patients with Refractory Overactive Bladder. AUA Orlando, FL 2014. 623. Michael Chancellor*, Royal Oak, MI, Riya Pulicharam, I-Ning Cheng, Torrance, CA, Karen Campbell, Catherine Corbell, Manher Joshi, Denise Globe, Irvine, CA MP33-20: ANTICHOLINERGIC CYCLING AND TREATMENT OUTCOMES IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE. AUA Orlando, FL 2014. 624. Minoru Miyazato*, Takuma Oshiro, Ryo Namitome, Seiichi Saito, Okinawa, Japan, Michael Chancellor, Royal Oak, MI, William de Groat, Naoki Yoshimura, Pittsburgh, PA PD11-01: Failure of enhancement of the somatic and sympathetic nerve induced continence reflex after duloxetine, a norepinephrine and serotonin reuptake inhibitor, in rats with cerebral infarction. AUA Orlando, FL 2014. Chancellor 96 of 108 625. Pradeep Tyagi*, Mahendra Kashyap, Pittsburgh, PA, Michael Chancellor, Royal oak, MI, Naoki Yoshimura, Pittsburgh, PA MP76-01: Investigation into Constitutive Expression of Nerve Growth Factor in Bladder By Bladder wall Injection of NGF Antisense 626. Kawamorita N, Yoshikawa S, Tyagi P, Chancellor MB, Yoshimura N: Liposome-based intravesical therapy targeting nerve growth factor (NGF) ameliorates bladder hypersensitivity in rats with experimental colitis. ICS 2014 Abstract 372, Neurouroloyg and Uroydnamc page 829-831, 2014. 627. Okada H, Tyagi P, Kawamorita N, Majima T, Chancellor MB, Yoshimura N: A novel animal model of chronic urotheliual injury and bladder pain hypersensitivity induced by intermittent infusion of protamine sulfate into the bladder in rats: the involvement of prostaglandin E1 and EP1 receptor activation. ICS 2014 Abstract 351, Neurouroloyg and Uroydnamc page 800-801, 2014. 628. Chancellor, MB, Yohoshur A, Campbell K, Joshi M, Pulicharam R: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence. New Orleans, AUA 2015. 629. Rajaganapathy BR, Janicki J, Levanovich P, Tyagi P, Hafron J, Chancellor MB, Krueger S, Marples B: Intrvesical liposomal tacrolimus protects against radiation cystitis induced by 3-D beam targeted bladder radiation. New Orleans, AUA 2015. 630. Ozawa H, Chancellor MB, Nagai K, Kumon H: Non invasive velocity-flow videourodynamics using Doppler ultrasounography detection of periodic detrusor arrest during micturition in men underactive bladder syndrome. New Orleans, AUA 2015. 631. STOPPED RECORDING AS CV GETTING TOO LONG IN 2016 UNTIL RESTART AUA 2017. 632. Bernadette Zwaans, Sarah Bartolone, Heinz Nicholai, Michael Chancellor, Laura Lamb: PD12-11 DECREASED VASCULAR ENDOTHELIAL GROWTH FACTOR IN RADIATION CYSTITIS. The Journal of Urology, Vol. 197, Issue 4, e269–e270 634. Laura Lamb, Joseph Janicki, Sarah Bartolone, Interstitial Cystitis Association, Bernadette Zwaans, Kenneth Peters, Michael Chancellor: MP29-07 DEVELOPMENT OF THE ULCERATIVE INTERSTITIAL CYSTITIS RISK SCORE (ICUS): A URINE-BASED MULTIPLE PROTEIN ASSAY TO PREDICT ULCERATIVE INTERSTITIAL CYSTITIS. The Journal of Urology, Vol. 197, Issue 4, e382 636. Michael Chancellor, Sarah Bartolone, Interstitial Cystitis Association, Joseph Janicki, Bernadette Zwaans, Abdrew Verneecke, Kenneth Peters, Laura Lamb: MP31-04 THE POWER OF CROWDSOURCING: NOVEL METHOD FOR DISCOVERY OF URINE BIOMARKERS. The Journal of Urology, Vol. 197, Issue 4, e399 638. Laura Lamb, Sarah Bartolone, Michael Conway, Maya Tree, Olivia Lossia, Gary Dunbar, Julien Rossignol, Christopher Smith, Michael Chancellor: MP23-03 URINE BASED RAPID MOLECULAR DIAGNOSIS OF ZIKA VIRUS. The Journal of Urology, Vol. 197, Issue 4, e293–e294 640. Lesley Carr, Le Mai Tu, Magali Robert, David Quinlan, Kevin Carlson, Sender Herschorn, Roger Dmochowski, Kenneth Peters, Michael Chancellor: PD50-08 AUTOLOGOUS MUSCLE DERIVED CELLS FOR URINARY SPHINCTER REPAIR FOR RECURRENT OR PERSISTENT STRESS URINARY INCONTINENCE AFTER CONTINENCE The Journal of Urology, Vol. 197, Issue 4, e982 642. Lesley Carr, Le Mai Tu, Magali Robert, David Quinlan, Kevin Carlson, Sender Herschorn, Roger Dmochowski, Ron Jankowski, Michael Chancellor: PNFBA-03 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AUTOLOGOUS MUSCLE DERIVED CELLS FOR URINARY SPHINCTER REPAIR The Journal of Urology, Vol. 197, Issue 4, e609–e610 643. Zwaans B, Bartolone S, Chancellor M, Lamb, L: Decreased endothelial proliferation characterizes the vascular defects in radiation cystitis, AUA 2018 644. Lamb L, Janicki J, Bartolone S, Zwaans Z, Peters K, Chancellor M: Toward personalized medicine for an interstitial cystitis individualized diagnosis using a new bladder inflammation score. AUA 2018.

645. AUA 2019 PD06-09 ASSOCIATION OF URINARY LEAKAGE WITH DECREASED TESTOSTERONE IN OLDER WOMEN: RESULTS FROM THE HEALTH, AGING, AND BODY COMPOSITION STUDY. Joseph J. Janicki*, Richard D. Semba, Michael B. Chancellor, Laura E. Lamb https://doi.org/10.1097/01.JU.0000555230.75742.05

646. AUA 2019 MP47-02 PROTEOMIC ANALYSIS OF INTERSTITIAL CYSTITIS BLADDER SAMPLES OF HUNNER’S LESIONS AND ADJACENT TISSUE REVEALS ALTERATIONS IN UBIQUITINATION PATHWAYS. Sarah N. Bartolone*, Elijah P. Ward, Michael B. Chancellor, Kenneth M. Peters, Laura E. Lamb https://doi.org/10.1097/01.JU.0000556314.69677.4a

647. AUA 2019 MP77-19 DEVELOPMENT OF RADIATION CYSTITIS BIOMARKER: ELEVATED FIBROTIC MARKERS IN URINE OF RADIATION CYSTITIS PATIENTS. Bernadette M.M. Zwaans*, Heinz E. Nicholai, Klaudia Stangel-Wójcikiewicz, Michael B. Chancellor, Laura E. Lamb https://doi.org/10.1097/01.JU.0000557331.48467.97

648. AUA 2019 MP56-20 MASS SPECTROMETRY ANALYSIS OF INTERSTITIAL CYSTITIS BLADDER BIOPSIES REVEALS SIGNIFICANT DIFFERENCES IN INFLAMMATION AND LOSS OF CELLULAR STRUCTURE PATHWAYS IN INTERSTITIAL CYSTITIS WITH HUNNER’S LESIONS SAMPLES. Elijah P. Ward, Sarah N. Bartolone, Michael B. Chancellor, Kenneth M. Peters, Laura E. Lamb* https://doi.org/10.1097/01.JU.0000556635.72503.da

649. AUA 2019 PD31-11 ASSOCIATION OF URINARY LEAKAGE FREQUENCY WITH BIOMARKERS OF SYSTEMIC INFLAMMATION: RESULTS FROM THE HEALTH, AGING, AND BODY COMPOSITION STUDY. Laura E. Lamb*, Ke Song, Richard D. Semba, Robert H. Podolsky, Michael B. Chancellor, https://doi.org/10.1097/01.JU.0000556180.80318.7e Chancellor 97 of 108 650. AUA 2019 LBA-04 INTRADETRUSOR INJECTION OF ADULT MUSCLE-DERIVED CELLS FOR THE TREATMENT OF UNDERACTIVE BLADDER: INTERIM REPORT ON SAFETY AND EFFICACY (NCT02463448). Ananias C. Diokno*, Jason P. Gilleran, Larry T. Sirls, Deborah L. Hasenau, Jennifer E. Bowlus, Evelyn M. Shea, Michael B. Chancellor https://doi.org/10.1097/01.JU.0000557496.18390.2f

INVITED PRESENTATIONS

1. A Comparison of Analgesic Effect of Acupuncture and Transcutaneous Electrical Stimulation in Chronic Pain Patients. Midwest Pain Society Meeting, Minneapolis, MN, May 8, 1982. 2. Haiti, Surgical Experience. Surgical Grand Rounds, University of Michigan Medical Center, Ann Arbor, MI, February 22, 1986. 3. Role of Bone Scan Renal Imaging in Renal Carcinoma. Michigan Branch of American Urological Association Resident's Day Competition, Detroit, MI May 1, 1986. 4. Evaluation and Treatment of Male Impotence. Ambulatory Care Grand Rounds, Veteran's Administration Hospital, Ann Arbor, MI June 30, 1986. 5. Renal and Perirenal Infection. Surgical Grand Rounds, University of Michigan Hospital, Ann Arbor, MI, August 16, 1986. 6. The Value of Prostatic Ultrasound before Transurethral Prostatectomy. Reed M. Nesbit Urological Society Biennial Meeting, Ann Arbor, MI, October 16, 1986. 7. Diagnostic Value of Routine Bone Scintigraphy Renal Imaging in Renal Carcinoma. 60th Annual Meeting of the North Central Section of the American Urological Association. Rancho Mirage, CA, November, 15, 1986. 8. Value of PreProstatectomy Prostate Ultrasound. Michigan Branch of American Urological Association, Ann Arbor, MI, November 15, 1986. 9. Ileocecal Reservoir, a Model of Low Pressure, Continent Urinary Storage. Michigan Branch of the American Urological Association Resident's Day Competition, Detroit, MI, April 29, 1987. 10. Transrectal Prostate Ultrasonography before Transurethral Prostatectomy, Its Value in Screening for Stage A Cancer. 82nd Annual Meeting of the American Urological Association, Anaheim, CA, May 21, 1987. 11. Treatment of Erectile Impotence with Yohimbine: Prospective Double Blind Trial and Review of Experience in 231 Patients. 61st Annual Meeting of the North Central Section of the American Urological Association. Detroit, MI, September, 1987. 12. Ileocecal Reservoir, A Model of Low Pressure, Continent Urinary Storage. 61st Annual Meeting of the North Central Section of the American Urological Association. Detroit, MI, September, 1987. 13. Dog Model of Continent Urinary Diversion. Michigan Branch of the American Urological Association Resident's Day Competition, Ann Arbor, MI, March, 1988. 14. Comparison of Ileocecal Reservoir. 83rd Annual Meeting of the American Urological Association, Boston, MA, June 6, 1988. 15. Evaluation of the Prostate. Family Practice Residency Grand Rounds, Memorial Hospital of Burlington County, Mt. Holly, NJ, August 29, 1988. 16. Urological Care of the Nursing Home Patient. Grand Rounds, Lutheran Home at Moorestown, NJ September 22, 1988. 17. Surgical Treatment of Urinary Incontinence. Department of Operation Room Staff, Memorial Hospital of Burlington County, Mt. Holly, NJ, September 27, 1988. 18. Renal Infections, Pediatric Urology Board Review Course, University of Michigan Medical Center, Ann Arbor, MI, October, 1988. 19. State of the Art; Continent Urinary Diversions. Oncology Grand Rounds, Memorial Hospital of Burlington County, Mt. Holly, NJ, November 1, 1988. 20. Surgical Approaches to Urinary Incontinence. Seminar on Medical and Surgical 21. Approaches to Urinary Incontinence, Memorial Hospital of Burlington County, Mt. Holly, December 7, 1988. 22. Evaluation and Management of Pediatric Neurogenic Bladder. Pediatric Neurology Grand Rounds. Babies Hospital, Columbia-Presbyterian Medical Center, New York, NY, August 28, 1989. 23. The Diagnosis and Treatment of Erectile and Ejaculatory Dysfunction. Medical Grand Rounds, Helen Hayes Hospital, April 4, 1990. 24. Bladder Outlet Obstruction and Impaired Detrusor Contractility: A Blind Comparison of The Video-urodynamic Diagnosis Versus the Diagnosis Based on a Detrusor Contractility Parameter (WF), a Urethral Resistance Parameter (URA), and a Sustained/Fade Index (SFI). Urodynamics Society Annual Meeting, May 12, 1990. 25. The Cholinergic and Purinergic Components of Detrusor Contractility in Rabbit Whole Bladder Model. 85th Annual Meeting of the American Urological Association, May 16, 1990. 26. The Diagnosis and Management of Neurogenic Bladder, Department of Rehabilitation Grand Rounds, Jefferson Medical College, July 20, 1990. 27. A New Method of Measuring Uroflow in the Rat Bladder. International Continence Society, Aarthus, Denmark, September 13, 1990,. Chancellor 98 of 108 28. Neurology and Incontinence: Classifications and Diagnosis. Department of Urology Grand Rounds, Jefferson Medical College, Philadelphia, PA, September 20, 1990 29. Urinary Incontinence. Medical Grand Rounds, Jeff Park Hospital, Philadelphia, PA, September 24, 1990. 30. Bladder Management of the Spinal Cord Injured Patient. Urologic Update for the 90's. Nursing Conference. Thomas Jefferson University Hospital, Philadelphia, PA, October 5, 1990. 31. Management of Nocturia in MS with DDAVP. Reed M. Nesbit, Urological Society. Biennial Meeting, Ann Arbor, MI, October 19, 1990. 32. New Treatment Options of Benign Prostatic Hyperplasia. American Medical Systems, Minnetonka, MN, October 24, 1990. 33. BPH: Diagnosis and New Treatment Options. Visiting Professor Day, Jefferson Medical College, Philadelphia, PA, October 26, 1990. 34. Balloon Dilation of Prostate, 29th Annual Scientific Seminar, Brothman Medical Staff Foundation. Beverly Hills, CA, February 23, 1991. 35. Pharmacological Treatment of BPH, Chief's Conference, Jefferson Medical College, April 24, 1991. 36. Primary Physician's Role in Treatment of Urinary Incontinence. Visiting Professor Lecture, Memorial Hospital of Burlington County, Mt. Holly, N.J., May 16, 1991. 37. Differential Diagnosis and Alternative therapies for BPH. Lancaster County Medical Symposium. Lancaster County, PA., June 20, 1991. 38. Neurogenic Bladder, Philadelphia Spinal Injury Association Meeting, Magee Rehabilitation Hospital, Philadelphia, PA., August 12, 1991. 39. Prostate Stents, Jefferson Fall Symposium, Philadelphia, PA., September 19, 1991. 40. Urodynamics and New Treatments of BPH, Delaware Urological Society, Wilmington, DE., October 2, 1991. 41. DDAVP in the Management of Nocturia in Multiple Sclerosis. 1991 Annual Meeting of the Mid-Atlantic Section of the AUA. Bermuda, October, 16, 1991. 42. Urodynamics and New Treatment Options for Urinary Incontinence. Department of Radiology Grand Rounds, Jefferson Medical College, Philadelphia, PA., December 12, 1991. 43. Urinary Incontinence. Genitourinary Health Science Meeting, Merck, Sharp & Dohme, West Point, PA, February 12, 1992. 44. Urinary Tract Infections and Incontinence. Merck, Sharp & Dohme Clinical Clerkship. Philadelphia, PA, February 28, 1992. 45. Prospective Evaluation of External Sphincter Balloon Dilatation and Prosthesis Placement as Alternatives to External Sphincterotomy. American Spinal Injury Association 1992 Annual Meeting, Toronto, Canada, May 9, 1992. 46. Bladder Physiology in Experimental Rat Spinal Trauma: 1 Spinal Injury Model. American Urological Association 1992 Annual Meeting, Washington, DC, May 11, 1992. 47. Prospective Comparison of External Sphincter Balloon Dilatation and Prosthesis Placement with External Sphincterotomy in Spinal Cord Injured Men. American Urological Association 1992 Annual Meeting, Washington, DC, May 13, 1992. 48. Neuro-Urology and Urodynamics Evaluation. Combined Neurology and Neurosurgery Grand Rounds, Jefferson Medical College, Philadelphia, PA, May 15, 1992. 49. New Perspectives in the Management of Benign Prostatic Hyperplasia. Medical Grand Rounds, Quakertown Community Hospital, Quakertown, PA, June 5, 1992. 50. New Treatments for Benign Prostatic Hyperplasia. Medical Grand Rounds, Bayonne Hospital, Bayonne, NJ, June 19, 1992. 51. Prospective Evaluation of Alternative Treatment Modalities to External Sphincterotomy: External Sphincter Balloon Dilatation and Prosthesis Placement. American Paraplegia Society, September 9, 1992. 52. Micturition Patterns after Spinal Trauma as a Measure of Autonomic Functional Recovery. Jefferson Medical College, Faculty Research Day, Philadelphia, PA, October 14, 1992. 53. Assessment of Alternative Therapies to External Sphincterotomy: Sphincter Prosthesis Placement and Balloon Dilatation. Jefferson Medical College, Faculty Research Day, Philadelphia, PA, October 14, 1992. 54. Micturition Patterns after Spinal Impact Trauma as a Measure of Autonomic Functional Recovery. Tenth Annual Neurotrauma Symposium, Anaheim, CA, October 24-25, 1992. 55. Advances in Management of Benign Prostatic Hyperplasia, Medical Grand Rounds, Lankenau Hospital, Philadelphia, PA, October 28, 1992. 56. Urological Manifestations of Lyme disease. Division of Urology Grand Rounds, University of Michigan, Ann Arbor, MI, November 14, 1992. 57. Management of Benign Prostatic Hyperplasia: A Primary Care Physicians Perspective. Medical Grand Rounds, Coatesville V.A. Medical Center, December 3, 1993. 58. Pharmacological Management of Benign Prostatic Hyperplasia. International Medical Society of Ocean and Cape May County, Avalon, NJ, December 4, 1993. 59. Advances in the Diagnosis and Management of Prostatic Disease and the Role of PSA in Primary Care Practice. Discovery International Symposium, Leola, PA, December 7, 1992. 60. Sexuality in Spinal Cord Injury. Department of Physical and Occupational Therapy, Magee Rehabilitation Hospital, Philadelphia, PA, January 6, 1993. 61. Advances in the Diagnosis and Management of Prostatic Disease and the Role of PSA in Primary Care Practice. Discovery International Symposium, Cherry Hill, NJ, January 11, 1993. Chancellor 99 of 108 62. A Clinical Perspective of Benign Prostatic Hyperplasia, Medical Grand Rounds, Underwood Memorial Hospital, Woodbury, NJ, January 19, 1993. 63. Advances in Evaluation and Pharmacologic Treatment of Benign Prostatic Hyperplasia. Symposium on Medical Problems in a Maturing Population - Endocrine Disorders. Thomas Jefferson University Hospital, Ford Road Campus, Philadelphia, November, 21, 1992. 64. Pharmacotherapy of BPH, Urology Symposium: Current Concepts in the Management of BPH. Lehigh Valley Hospital, Allentown, PA, February 27, 1993. 65. New Therapies of Benign Prostate Hyperplasia. Philadelphia, PA, April 14, 1993. 66. Update on the Diagnosis and Therapies of BPH. Philadelphia, PA, April 24, 1993. 67. Multicenter Trials of UrolumeTM Endourethral WallstentR Prosthesis for the Urinary Sphincter in Spinal Cord Injured Men. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 68. Micturition Patterns after Experimental Rat Model Spinal Cord Injury. ASIA 1993 Annual Meeting, May 10-12, 1993, San Diego, CA. 69. Multicenter Trial in North America of UrolumeTM Urinary Sphincter Prosthesis. AUA 1993 Annual Meeting, May 16-20, 1993, San Antonio, TX. 70. Lapides Essay Contest Grand Prize Winner "Evaluation of Skeletal Muscle Wrap of the Urinary Bladder and Function Neuromuscular Electrical Stimulated Detrusor-Myoplasty". 88th Annual Meeting of the AUA, San Antonio, Texas, May 20, 1993. 71. BPH and Prostate Cancer. Medical Grand Rounds, Geisinger Hospital, Wilkes-Barre, PA, May 26, 1993. 72. Urinary Incontinence. Medical Grand Rounds, Jefferson Medical College, Department of Rehabilitation, Philadelphia, PA June 4, 1993. 73. Detrusor-Myoplasty and Functional Neuromuscular Electrical Stimulation of the Urinary Bladder After Experimental Spinal Trauma. Annual Meeting of the American Paraplegia Society, Las Vegas, NV, September 7, 1993. 74. Endoluminal Ultrasound Evaluation of Urethral Diverticulum and Periurethral Mass. 1993 Annual Meeting of the American Uro-Gynecologic Society, San Antonio, TX, October 30 to November 2, 1993. 75. The Application of the New American Urological Association Symptom Index for Women with Voiding Symptoms. 1993 Annual Meeting of the American Uro-Gynecologic Society, San Antonio, TX, October 30 to November 2, 1993. 76. Female Urology and Periurethral Collagen Injection. Chiefs Conference, Thomas Jefferson University, Philadelphia, PA October 20, 1993. 77. Practical Diagnosis and Care of Urinary Incontinence. Practical Urology for the Primary Care Physician. Thomas Jefferson University, Philadelphia, PA, November 11, 1993. 78. Current Advances in the Treatment of Intrinsic Sphincter Deficiency. ContigenR Implant Conference, New York, NY, November 20, 1993. 79. Medical Management of Obstructive Uropathy. Visiting Professor Lecture, Memorial Hospital of Burlington County, Mount Holly, NJ, January 20, 1994. 80. An Update in the Treatment of Benign Prostatic Hyperplasia. Wilmington Osteopathic Medical Society, Wilmington, DE, March 1, 1994. 81. Urologic Care of Spinal Cord Injury Patients. Department of Rehabilitation Medicine Grand Round, Thomas Jefferson University, Philadelphia, PA, March 25, 1994. 82. Neuro-Urology, Department of Urology Grand Round, Thomas Jefferson University, Philadelphia, PA, March 31, 1994. 83. Epidemiology and Pathophysiology of Stone Disease. American Spinal Injury Association 18th Annual Scientific Meeting: Management of Stones in Spinal Cord Injury, Philadelphia, PA, April 26, 1994 84. DDAVP in the Urological Management of the Difficult Neurogenic Bladder in SCI. 1994 Annual Meeting of the American Spinal Injury Association, Philadelphia, PA, April 27, 1994. 85. Evaluation and Outcome, National Institute of Health Conference on the Health of Women with Physical Disabilities, Bethesda, MD, May 9, 1994. 86. Conservative Management of Benign Prostatic Hyperplasia. Bryn Mawr Hospital Medical Grand Round. May 12, 1994. 87. Use of Urethral Stents in Treatment of Detrusor Sphincter Dyssynergia Session of the 1994 Annual Urodynamic Society Program, San Francisco, CA, May 14, 1994. 88. Three Year Follow-Up of the Urinary Sphincter Stent in Spinal Cord Injured Men. 1994 Annual Meeting of the American Urological Association, San Francisco, CA, May 15, 1994. 89. Sphincterotomy/Stent. Session of the 1994 Annual Urodynamic Society Program, San Francisco, CA, May 16, 1994. 90. Detrusor Sphincter Dyssynergia, Prosthetic Urethral Stents Symposium of the 1994 Annual Biomedical Engineering Forum, San Francisco, CA, May 18, 1994. 91. Clinical and Animal Experience on Detrusor-Myoplasty and Dynamic Myoplasty in Urology. Maastricht, the Netherlands, May 25, 1994. 92. Detrusor Instability. Turku University Department of Obstetrics and Gynecology Grand Round, Turku, Finland, May 30, 1994. 93. Benign Prostatic Hyperplasia: A Clinical Perspective. HIP Rutgers University, New Brunswick, NJ June 22, 1994. 94. Long-term Follow-up of Sphincter Stent Prosthesis in Spinal Cord Injury Patients. 1994 Annual Meeting of the American Paraplegia Society, Las Vegas September 8, 1994. Chancellor 100 of 108 95. Three Year Experience at Thomas Jefferson University with Urinary Prostate and Sphincter Stents. 1994 Annual Meeting of the Mid-Atlantic Section of the American Urological Association. Philadelphia, PA Sept. 22, 1994. 96. New Urologic Perspective in SCI. Urologic Nursing: Preparing for Change, AUAA Delaware Valley Chapter, Philadelphia, PA, Oct. 14, 1994. 97. Go With the Flow: Operative Interventions for Stress Incontinence. Urology: Mainstream Treatment and Management. Philadelphia, PA, Oct. 28, 1994. 98. The Digital rectal Exam, Benign Prostatic Hyperplasia Program, Merck Human Health Division, Philadelphia, PA, Nov. 9, 1994. 99. Intravesical Capsaicin in Neurologic Impaired Patients with Detrusor Hyperreflexia and Autonomic Dysreflexia: Preliminary Study. Research Symposium on Interstitial Cystitis. Washington DC, NIH January 11, 1995. 100. Incontinence in Diabetes. Symposium on Diagnosis and Treatment of genitourinary Disorders in Diabetes. American Diabetes Association and National Institute of Health. San Francisco, CA, March 9-11, 1995. 101. New Treatment of Detrusor Sphincter Dyssynergia. Urology Grand Round, Long Island Jewish Medical Center, NY, March 30, 1995. 102. Management of Sphincter Dyssynergia in SCI Men with Indwelling Catheter Using the Sphincter Stent Prosthesis. American Spinal Injury Association Annual Meeting, Orlando FL, May 1-3, 1995. J. Spinal Cord Medicine, 18:110, 1995. 103. Bladder Rupture after Bladder Augmentation and Myomotomy: Effect of Intestinal Segment and Detrusor Myoplasty. American Spinal Injury Association Annual Meeting, Orlando FL, May 1-3, 1995.J. Spinal Cord Medicine, 18:110, 1995. 104. Pathophysiology of Urinary Incontinence. Symposium and Public Forum: Urinary Incontinence Delaware Health and Social Services, Dover, DE, June 16, 1995. 105. Medical/Surgical Treatment Modalities. Symposium and Public Forum: Urinary Incontinence Delaware Health and Social Services, Dover, DE, June 16, 1995. 106. New Perspective in S.C.I. Canadian Urodynamic Professional Tenth Annual Meeting, Ottawa, Canada, June 18, 1995. 107. Neurogenic Bladder Dysfunction, Urodynamic Course, American Urological Association Office of Education, Houston, TX, July 22-23, 1995. 108. Gracilis Muscle Dynamic Urethral Sphincter Myoplasty: Rat Model Experience. 53 rd Annual Meeting of the Mid-Atlantic Section AUA, Bermuda, Sept. 17-20, 1995. 109. Urology Inservice Examination Preparation, Chief's Conference, Department of Urology, Thomas Jefferson University, Philadelphia, PA September 27, 1995. 110. Clinical Testosterone Replacement. Smith Kline Beecham Clinical Advisor Lecture, Department of Pharmacology, Thomas Jefferson University, December 6, 1995. 111. State of the Art - Urethral Stenting. Urology Grand Round, University of Pennsylvania, December 7, 1995. 112. Neurogenic Voiding Dysfunction. Urology, State of the Art Symposium, NYU Medical Center, New York, NY, December 14, 1995. 113. Case Presentations- Neurogenic Voiding Dysfunction. Urology, State of the Art Symposium, NYU Medical Center, New York, NY, December 14, 1995. 114. Medical and Surgical treatment of Neurogenic Voiding Dysfunction. Urology, State of the Art Symposium, NYU Medical Center, New York, NY, December 14, 1995. 115. Surgical Treatment of Female Urinary Incontinence. Department of Nursing Surgical Staff Grand Round, Thomas Jefferson University Hospital, Philadelphia, PA, January, 25, 1996. 116. Augmentation Cystoplasty Including Auto-augmentation, Urethral Sphincter Reconstruction, Sacral Spinous Suspension for Pelvic Prolapse. Urinary Incontinence, 7th Annual Urology Symposium, Memorial Regional Hospital, Hollywood, FL, February 2-4, 1996. 117. Interstitial Cystitis. Urinary Incontinence, 7th Annual Urology Symposium, Memorial Regional Hospital, Hollywood, FL, February 2-4, 1996. 118. Neurostimulation and Neuromodulation. Female Urology and Neurourolgy Annual Forum, Baltimore, MD, March 7-10, 1996. 119. Dynamic Muscle Use for Bladder and Urethral Rehabilitation. Female Urology and Neurourolgy Annual Forum, Baltimore, MD, March 7-10, 1996. 120. Neurostimulation in Urology, Department of Urology Grand Round, Thomas Jefferson University, Philadelphia, PA, March 21, 1996. 121. Evaluation of Voiding Dysfunction and Incontinence. The AUA Annual Section Seminar Scientific Program. Philadelphia, PA, March 29-31, 1996. 122. UroLume-The European and North American Long Term Experience with BPH, Stricture and DESD. Japan Urological Association Annual Meeting Keynote Address, Okayama, Japan, April 5, 1995. 123. Intravesical Capsaicin in Neurologic Impaired Patients with Detrusor Hyperreflexia, 22 nd Annual Meeting of ASIA, Seattle, WA, April 22-24, 1996. J. Spinal Cord Med., 19:121, 1996. 124. Reversible Clinical Outcome after Sphincter Stent Removal. 22 nd Annual Meeting of ASIA, Seattle, WA, April 22-24, 1996. J. Spinal Cord Med., 19:146, 1996. 125. Prospective Randomized Multicenter Study of Sphincter Stent versus External Sphincterotomy in SCI Patients. 22 nd Annual Meeting of ASIA, Seattle, WA, April 22-24, 1996. J. Spinal Cord Med., 19:140, 1996. 126. Evaluation and Treatment of Benign Prostatic Hyperplasia. Medical Conference, Atlantic City, NJ, June 12, 1996. Chancellor 101 of 108 127. New Insight in the Pathophysiology of Smooth and Skeletal Muscle Urinary Sphincter Function in Stress Urinary Incontinence. Symposium on Potential Therapeutic Targets in the Treatment of Stress Incontinence. Laboraties DEBAT, Paris France, June 24, 1996. 128. Urinary Incontinence, Chief's Conference, Department of Urology, Thomas Jefferson University, Philadelphia, PA September 17, 1996. 129. Neurology, Second Annual Fall Institute, Society of Urologic Nurses Associates. St. Louis, MO, October 4, 1996. 130. Urodynamic Evaluation of the Neuropathic Bladder, Second Annual Fall Institute, Society of Urologic Nurses Associates. St. Louis, MO, October 4, 1996. 131. Dynamic Urethral Myoplasty, Program Investigators Meeting, Bakken Research Center, Maastricht, the Netherlands, October 30-31, 1996. 132. Clinical Neuro-urology Research, Neuropharmacology Grand Round, Department of Pharmacology, University of Pittsburgh, January 6, 1997. 133. Neuromodualation and Neurostimulation for Voiding Dysfunction: State of the Art, Keynote Speaker, Michigan Urological Society, Royal Oak, MI, January 8, 1997. 134. Preparation for the American Board of Urology Examination, Urology Resident Teaching Conference, University of Pittsburgh, January 22, 1997. 135. Terminology of Neurourology and Urinary Incontinence. Urology Resident Teaching Conference, University of Pittsburgh, February 5, 1997. 136. Pelvic Floor Reconstruction and Research, Division of Plastic Surgery Grand Round, University of Pittsburgh, February 5, 1997. 137. Urinary Incontinence, Fourth Year Medical Student Genito-urinary Tract Course, University of Pittsburgh, February 12, 1997. 138. Update on Incontinence; From Leak Point Pressure to New Treatments, Pittsburgh Urological Association Keynote Speaker, Pittsburgh, PA February 17, 1997. 139. Case Studies in Neurourology and Urinary Incontinence. Urology Resident Teaching Conference, University of Pittsburgh, February 19, 1997. 140. Urodynamics of Spinal Cord Injury; Acute; Late; Monitoring Outcome, Invited Faculty. AUA Office of Education, Houston, TX, March 1-2, 1997. 141. Obstructive Uropathy Related to BPH; Flow/Pressure Flows/Video Studies Invited Faculty, AUA Office of Education, Houston, TX, March 1-2, 1997. 142. Bladder-Related Incontinence, AUA Office of Education, Houston, TX, March 1-2, 1997. 143. Advances in Outpatient Investigation of Neurovesical Dysfunction, Society of Urologic Surgery, 43 Annual Meeting of the American College of Surgeons Southwestern Pennsylvania Chapter, Pittsburgh, PA, April 2, 1997. 144. The Evaulation of Autologous Fat Implantation in the Rat Urinary Bladder Submucosa. 18th Annual Urodynamics Society Meeting, New Orleans, LA, April 12, 1997. 145. UroLume Stent versus External Sphincterotomy in SCI Patients: Prospective Randomized Multicenter Study. 1997 Annual Meeting of the American Urological Association, New Orleans, April 16, 1997. J. Urol., 157: 395A, 1997. 146. Update on Bladder Dysfunction, From Videourodynamics to Sphincter Stent. The Rehabilitation Institute. Pittsburgh, PA, May 7, 1997. 147. Treatment of Incontinence after Prostate Cancer Therapy. Pittsburgh Cancer Institute, Pittsburgh, PA, May 21, 1997. 148. Diagnosis and Management of the Neurogenic Bladder, Keynote Speaker, Second Annual Korean Urodynamic Society Annual Meeting, , Seoul, Korea, May 24, 1997. 149. Update on Neurourology and Urinary Incontinence, Dong-A University Hospital Grand Round, Pusan, Korea, May 26, 1997. 150. Update on Basic Urology Research in Neurourology and Urinary Incontinence, Ewha Womans University Hospital Grand Round, Seoul, Korea, May 27, 1997. 151. Urinary Incontinence. Primary Care Grand Rounds, University of Pittsburgh School of Medicine Department of Medicine, UPMC, July 16, 1997. 152. Voiding Dysfunction, Merck Development Training, Philadelphia, PA, September, 5, 1997. 153. Urodynamic & Incontinence. Advanced Surgical Techniques/Endosocpy, BPH & Voiding Dysfunction, Nashville, TN, November, 14, 1997. 154. Mechanisms of Urinary Incontinence, Wyeth-Ayerst Research Urinary Incontinence Expert Panel, October 31, 1997. 155. Anatomy of Urinary Incontinence, Surgical M4 Conference, University of Pittsburgh, February 11, 1998. 156. Urinary Incontinence, Medical Grand Round, University of Pittsburgh Department of Medicine, February 27, 1998. 157. Lower Urinary Tract Trauma, University of Pittsburgh Operating Room Faculty Grand Round, March 4, 1998. 158. Urinary Incontinence, University of Pittsburgh Medical Center, St. Margaret, Medical Grand Round, March 12, 1998. 159. Prostate Cancer and Urinary Incontinence, University of Pittsburgh Medical Center Prostate Support Group Meeting, Pittsburgh, PA, May 20, 1998. 160. Sphincter stent versus external sphincterotomy in spinal cord injured men; prospective randomized multicenter trial”, Urodynamic Society’s 19th Annual Meeting, San Diego, CA, May 30, 1998. 161. Multiple Sclerosis and Urinary Incontinence, Southwest Pennsylvania Multiple Sclerosis Society Meeting, Pittsburgh, PA, June 17, 1998, 162. Urodynamics I & II, Division of Urology Teaching Conference, University of Pittsburgh, August 12,19, 1998. Chancellor 102 of 108 163. Urinary incontinence, Mercy Hospital Medical Grand Rounds, Pittsburgh, PA, August 20, 1998. 164. Sexual and erectile dysfunction. Rehabilitation Medicine Grand Rounds, University of Pittsburgh, September 9, 1998. 165. Current concepts in the management of the overactive bladder. Medical Grand Rounds, Citizens General Hospital, September 29, 1998. 166. New treatment of urinary incontinence, Hershey Medical Society, Hershey, PA, November 4, 1998. 167. Spicing up the ways we treat bladder dysfunction, Department of Urology, George Washington University, Washington, D.C., November 11, 1998. 168. Interstitial cystitis, Womens Health Nurse Practitioner Program, University of Pittsburgh School of Medicine, November 19, 1998. 169. Urinary Incontinence in the Nursing Home. RiverView Towers, Pittsburgh, January 14, 1999. 170. UroLume for detrusor-sphincter dyssynergia. American Medical System's National Meeting, Tampa, Florida, Febr. 2, 1999. 171. Evaluation and treatment of urinary incontinence. Ohio Valley Medical Center, Washington, PA, Febr. 15, 1999. 172. Urinary tract infection. Third Year Medical Student Course, University of Pittsburgh, Febr. 16, 1999. 173. Urinary incontinence, Fourth Year Medical Student Genito-Urinary Tract Course, University of Pittsburgh, Febr., 17, 1999. 174. Practical urodynamics. Pittsburgh Urological Association, Pittsburgh, PA, Feb., 22, 1999. 175. The overactive bladder. Erie Medical Society, Erie, PA, March 10, 1999. 176. New treatment options for overactive bladder, St. Elizabeth Heath Center Medical Grand Round, Youngstown, OH, March 23, 1999. 177. Urinary Incontinence; Evalation and Treatment. Green County Hospital Medical Grand Round. Washington, PA, April 13, 1999. 178. Review of clinical results in overactive bladder. Evaluating Clinical Relevance in Overactive Bladder Symposium, Dallas, TX, April 30, 1999. 179. Urodynamics in spinal cord injury. Rehabilitation Nurses Society of Western Pennsylvania, Jeanneate, PA, May 19, 1999. 180. Primiary physicians' role in urinary incontinence. Wheeling Hospital Medical Grand Round. Wheeling, WV, June 25, 1999. 181. Sacral nerve stimulation for voiding dysfunction. UPMC Operating Room Grand Round, Pittsburgh, PA, July 7, 1999. 182. Update on urinary incontinence. West Virginia Urologic Society, Charleston, WV August 18, 1999. 183. Treatment of overactive bladder; state of art. Binhampton Medical Society, Binhampton, NY, September 2, 1999. 184. Urinary incontinence. Department of Medicine Grand Round, Ohio State University, Columbas, OH, September 9, 1999. 185. Neurogenic bladder management. Harmarville Rehabilitation Hospital Medical Grand Round, Pittsburgh, PA, September 14, 1999. 186. Bladder dysfunction after spinal cord injury. Department of Rehabilitation Medicine Grand Round, University of Pittsburgh, PA, September 16, 1999. 187. Urodynamic evaluation and state of the art treatment of urinary incontinence. Division of Gastroenterology Grand Round, University of Pittsburgh, PA, October, 12, 1999. 188. State of the art treatment of urinary incontinence. Cinncinnate Urology Meeting, Cinncinnate, OH, October, 25, 1999. 189. Urogic issues in spinal cord injury. UPMC Rehabilitation Hospital SCI Center Grand Round, November, 11, 1999. 190. Overactive bladde. Armstrong Medical Society, Brackenridge, PA, January 25, 2000. 191. Urinary incontinence. Asian American Physicians Association of New York, Buffalo, NY, February 26, 2000. 192. Evaluation and management of bladder control problems, The New Jersy Academy of Medicine, Short Hills, NJ, February 29, 2000. 193. Urinary incontinence; evaluation to state-of-the art treatment. Jeannette District Memorial Hospital. Pittsburgh, PA, March 23, 2000. 194. Neurogenic bladder function. First Annual Rex Newton Distinguished Lectureship. Pittsburgh, PA, March 26, 2000. 195. Understanding bladder symptoms: helping patients with overactive bladder. Stark County Medical Society Medical Convention, Canton, OH, April 13, 2000. 196. New Therapies for urinary incontinence; UPMC Passavant Hospital, Pittsburgh, PA, April 25, 2000. 197. Urinary incontinence. Frick Hospital, Frick, PA, April 27, 2000. 198. State of the art in urinary incontinence. Buffalo General Hospital Medical Grand Round, Buffalo, NY, May 24, 2000. 199. Urinary incontinence; evaluation to state-of-the art treatment. Jefferson County Medical Society Medical Convention, Jefferson, PA, June 7, 2000. 200. Update on evaluation and treatment of urinary incontinence. Department of Urology Grand Round, Medical College of Wisconsin, Milwakee, WI, August 3, 2000. 201. Tolterodine: selectivity for the bladder over effects on visual accomodation. XVI FIGO; World Congress of Gynecology and Obstetrics, Washington DC, September, 4, 2000. 202. Neurogenic bladder in spinal cord injury. Rehabilitation Medicine Grand Round, Pittsburgh, PA, October, 18, 2000. 203. New therapies for urinary incontinence in the new millenium, Carnegie Science Center, Pittsburgh, PA, September 23, 2000. 204. Urinary incontinence; from benchtop to bedside. University of Pittsburgh School of Health and Rabilitation Science Grand Round, October, 16, 2000. 205. Neurogenic bladder: evaluation and management, UPMC Rehabilitation Medicine Grand Round, Pittsburgh, PA, October, 18, 2000. Chancellor 103 of 108 206. New therapies for urinary incontinence in the new millenium, VA Hospital of Butler, PA Medical Staff Meeting, Butler, PA, October, 28, 2000. 207. Bioengineering ethics course, School of Engineering, University of Pittsburgh, November 10, 2000. 208. State of the art therapy for urinary incontinence. Pittsburgh Urological Association, Pittsburgh, PA, December 8, 2000. 209. Urinary incontinence, 4th year medical students, University of Pittsburgh School of Medicine, February 14, 2001. 210. Career in urology for medical students, University of Pittsburgh School of Medicine, February 14, 2001. 211. Essential urodynamics, Department of Urology Grand Round, Pittsburgh, PA February 15, 2001. 212. New adanvces in the treatment of neurogenic bladder. Harmonville Rehabilitation Hospital, Pittsburgh, PA March 5, 2001. 213. Pharmacological therapy of incontinence, Magee Women's Hospital Grand Round, Pittsburgh, April 10, 2001. 214. State of the art in therapy of urinary incontinence. Columbus Urological Assocation, Columbus, OH, April 24, 2001. 215. New pharmacological theapy for the overactive baldder. Pennsylvania-ASCP, May 12, 2001. 216. New directions in the management of overactive bladder. Carnegie Museum of Art, Pittsburgh, July 17, 2001. 217. Career in Urology, University of Pittsburgh Academic Enrichment Program, July 19, 2001. 218. Bladder dysfunction in MS. National MS Society: Bridging the gap in MS Care, Pittsburgh, PA, October 5, 2001. 219. Urinary incontinence. Cleveland Clinic Florida Medical Grand Round, Ft. Lauderdale, FL, February 7, 2002. 220. Gene therapy and tissue engineering of the urinary tact. University of Pittsburgh Department of Mechanical Engineering Grand Round, February 15, 2002. 221. Bladder dysfunction in Parkinson’s disease. Western Pennsylvania Parkinson Foundation Grand Round, March 11, 2002. 222. CURE-SCI Grand Round. UPMC, Pittsburgh, PA, March 13, 2002. 223. Stem cell tissue engineering: from the benchtop to the bedside, McGowan Institue for Regenerative Medicine Seminar; Pittsburgh, May 15, 2002. 224. Tissue engineering in urology; Boston Children’s Hospital Urology Research Grand Round, Boston, MA, June 5, 2002. 225. Bladder problems can be controlled, UPMC outreach program, Pittsburgh PA, June 11, 2002. 226. Women with bldder dysfunction: the art of patient management, Baylor College of Medicine CME Seminar, New York, June, 13, 2002. 227. Departments of Urology Grand Round, St. Joe’es Mercy Hospital, Yipsilante, MI, November 20, 2002. 228. Departments of Urology Grand Round, University of Michigan, Ann Arbor, MI, November 21, 2002. 229. Departments of Urology Grand Round, Henry Ford Hospital, Detroit, MI, November, 22, 2002. 230. Departments of Urology Grand Round, Wayne State University, Detroit, MI, November 23, 2002. 231. Pittsburgh Urban Magnet Project: University of Pittsburgh Technology Transfer, January 13, 2003. 232. Bladder dysfunction, Charleston Urology Society, Charleston WV, June 11, 2003. 233. Tissue engineering for incontinence. Pittsburgh Technology Council: CRITA Summer Conference, Pittsburgh, August 1, 2003. 234. State of urinary incontinence in women. National Faculty Conference, Scottsdale, AZ, November 6-9, 2003. 235. Erectile Dyfunction; University of Pittsburgh MiniMed School, October 14, 2003. 236. Female bladder dysfunction: "Love Boat": Greater Pittsburgh public education on female sexual and bladder dysfunction, KDKV-TV, Pittsburgh Gatway Clipper, November 15, 2003; 237. BPH and overactive bladder. Pfizer special emphysis panel, NY, NY, December, 6, 2003. 238. Urinary incontinence, Urology Grand Round, Taipei, Taiwan, December, 26, 2003. 239. Neurogenic Bladder. Urology Grand Round, Kaoishung, Taiwan, December 29, 2003. 240. New understanding of the overactive bladder. Invited speaker, Department of Urology Grand Round, Baylor School of Medicine, Houston, TX, Ferbruary 4, 2004. 241. Physiology of stress urinary incontinence. Department of Urology Grant Round, University of Pittsburgh, PA, Feburary, 11, 2004. 242. Invited speaker on overactive bladder. Cincinnati Urological Society Meeting, Cincinnati, OH, February 25, 2004. 243. Neurogenic bladder, Mercy Hospital Department of PMR Grand Round, Pittsburgh, PA, May 25, 2004. 244. Muscle stem cell tissue engineering: A journey from the benchtop to bedside, University of Pittsburgh CATER Seminar, Sept 3, 2004. 245. STOPPED RECORDING AS CV GETTING TOO LONG IN SEPT. 2004

PATENTS, TRADEMARK and COPYRIGHT

USA 5,370,670: Detrusor Myoplasty and Neuromuscular Electrical Stimulation of the Urinary Bladder Date: 2/6/94. 5,752,978: Detrusor Myoplasty and Neuromuscular Electrical Stimulation. Date: 2/6/94. 6,866,842: Muscle-Derived Cells (MDC) for Treating Muscle-or Bone-Related Injury or Dysfunction. Date: April 30, 1999. 7,063,860 Application of Lipid Vehicles for Drug Delivery. Date: August 13, 2002. 7,115,417 Soft Tissue and Bone Augmentation and Bulking Utilizing Muscle-Derived Progenitor Cells, Composition and Treatments Thereof. Date: March 2005. Chancellor 104 of 108 Muscle-Derived Cells (MDCs) for Promoting and Enhancing Nerve Repair and Regeneration. US Patent Application Serial No.: 10/832,542, Filed April 26, 2004. “Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders" Provisional Attorney's Docket Number: 4999-052467, 2005 Trademark: 78467631: Underactive Bladder (UAB), August 14, 2004 Stopped recording due to time limitation

BIOTECHNOLOGY COMPANY STARTUP

Cook-MyoSite Inc., Founder, Pittsburgh, PA, 2001 Lipella Pharmaceuticals In., Founder, Pittsburgh, PA, 2005

CHARITABLE FOUNDATION

Dato-Chancellor Foundation, 2002-Present

RESEARCH DURING RESIDENCY AND FELLOWSHIP

1. Research in Functional Implication of Liver Cell Heterogeneities. Section of Gastroenterology, 2. University of Michigan Medical Center, MI, 1978. 3. Externship in Anesthesia Chronic Pain Research with Preceptor Dr. S. E. Abrams, Medical College of Wisconsin, WI, 1980-1982. 4. Dog Model Continence Urinary Diversion Preceptor Dr. J. W. Konnak, University of Michigan Medical Center, MI, 1987-1988. 5. Parameters of Detrusor Contractility in Whole Bladder Rabbit and Rat Models, Columbia-Presbyterian Medical Center, New York, NY, 1989-1990 6. The Role of Cholinergic and Purinergic Transmitters in Bladder Function, Columbia-Presbyterian Medical Center, New York, NY, 1989-1990.

COMMITTEES AND ACADEMIC SERVICES

1. Resident's Day Program Committee, 61st Annual Meeting of the American Urological Association, 1987. 2. Urinary Incontinence Task Force Committee, Memorial Hospital of Burlington County, 1988-1989. 3. Judiciary Committee, Burlington County Medical Society, 1989. 4. Chairman, Urinary Incontinence Task Force Memorial Hospital of Burlington County, 1989. 5. Infection Control Committee, Helen Hayes Hospital, 1989-1990. 6. Consultant, Urinary Incontinence Center Memorial Hospital of Burlington County, 1989-1991. 7. Sexuality Program Development Committee, Helen Hayes Hospital, 1989-1990. 8. Radiology Capital Replacement Project, Helen Hayes Hospital, 1990. 9. Administrator of Continuing Medical Education, Department of Urology, Jefferson Medical College, 1990-1996. 10. Monthly medical student lectures, Jefferson Medical College, 1990-1996. 11. Antibiotic Committee, Thomas Jefferson University Hospital, 1991-1996. 12. Regional Spinal Cord Injury Center of the Delaware Valley (RSCIDV), National Rehabilitation 13. Research and Training Center in Spinal Cord Injury, 1992-1996. 14. Clinical Practice Advisory Committee, Jefferson Medical College of Thomas Jefferson University, 1992-1996. 15. Pediatric Urology Education Review Committee, A. I. duPont Institute, 1992-1996. 16. Committee on Surgical Case Review, Thomas Jefferson University Hospital, 1993-1994. 17. Committee on Continuing Medical Education, Jefferson Medical College of Thomas Jefferson University, 1993- 1996. 18. Management of Information Systems Working Group Subcommittee, Thomas Jefferson University, 1995-1996. 19. Faculty, Pittsburgh Tissue Engineering Initiative, 1997-2007. Chancellor 105 of 108 20. Computer Committee, Department of Surgery, University of Pittsburgh School of Medicine, 1997-2001. 21. Teaching of urinary incontinence for Physical Medicine and Rehabilitation and Internal Medicine resident’s 1998- 2007. 22. Career Mentor for Medical Students Going into Urology 1998-2007. 23. Electronic Medical Record Committee, UPMC Health System, 1999-2003. 24. Faculty, Pittsburgh Center for Cell Therapeutics, 2000-2003. 25. American Urological Association Northeaster Section, Executive Board of Directors, 1999-2003. 26. Faculty, Surgical Integrated Life Sciences Course, University of Pittsburgh School of Medicine, 1999-2000. 27. Faculty, UPMC Women’s Rehabilitation Advisory Board, 2000-2007. 28. Faculty, University of Pittsburgh Course on Ethics in Medicine, 2000. 29. Faculty, University of Pittsburgh 3rd year Medical Student Monthly Lecture on Voiding Dysfunction, 2000-2007. 30. NIH (NIDDK and NICHD) USA Urinary Incontinence Treatment Network (UITN) member and Surgical Subcommittee Director, 2000-2007. 31. Department of Bioengineering, University of Pittsburgh. Ph.D. Candidacy Committee. 2000-2007. 32. Reviewer: University of Pittsburgh Office of Technology Management Invention Disclosure Committee, 2000- 2007. 33. American Urological Association Relative Value Scale Committee, 2000-Present. 34. University of Pittsburgh Cancer Institute Limbach Entrepreneurial Center, 2001-2007. 35. Urology Director, Model Spinal Cord Injury Center, University of Pittsburgh School of Medicine, 2001-2007. • Department of Rehabilitation Medicine Resident Rotation in Urology Director • Department of Rehabilitation Medicine SCI Fellow Rotation in Urology Director 36. McGowan Center for Regenerative Medicine (MIRM) Faculty: • Clinical Translation Committee, 2001-Present • Institute Projects & Coordinators, Tissue Engineering Committee, 2001-Present • Search Committee, Tissue Engineering Committee, 2001-Present 37. Pennsylvania Medical Society – On-line Advisory Panel, 2001-present 38. LCME Accreditation Committee; University of Pittsburgh School of Medicine, 2002 39. Faculty, Center for Disabled Women (UPMC), 2002-2008. 40. Standing Committee for Non-Tenured Faculty Promotions and Appointments (NTFPA), University of Pittsburgh School of Medicine, 2002-2005. 41. Department of Urology Academic Promotions Committee, 2003-2007. 42. Clinical Research Steering Committee (CRSC), University of Pittsburgh, 2003-2007. 43. Student Preceptor, University of Pittsburgh School of Nursing, 2003-2007. 44. Northeastern Section Representative, AUA, 2004-2007. 45. University of Pittsburgh Technology Transfer Committee, 2005-2007. 46. Research Mentoring Committee, Department of Urology, University of Pittsburgh, 2007. 47. Scientific reviewer, Accreditation of Human Research Protection Programs (AAHRPP) Willaim Beaumont Hospital. 2011-Present. 48. Faculty: Strategic Research Program Development Workshops, Oakland University William Beaumont School of Medicine, January-April, 2011 49. Beaumont Health System Animal Care Committee, 2012-Present 50. Director: Jule R. and Robert S. Taubman Urology Research Fund, 2013-Present 51. Robert B.& Ann S. Aikens Urology Research Fund, 2013-Present – Conference Chair? 52. Director: Robert B. & Ann S. Aikens Center for Neurourology Research 2014-Present 53. Director: The Diokno and Lapides Prize, 2014-Present 54. Pittsburgh U43 O’Brien Award External Advisory Committee. 2017-Present 55. Beaumont Health System Conflict of Interst Committee, 2018-Present

HOSPITAL APPOINTMENTS

1. Attending Physician, Memorial Hospital of Burlington County, Mt. Holly, NJ, 1988-1989 2. Attending Physician, Southern Ocean County Hospital, Manahawkin, NJ, 1988-1989 3. Consultant in Urology, Mid-Atlantic Kidney Stone Center, Marlton, NJ, 1988-1989 Chancellor 106 of 108 4. Attending Physician, Presbyterian Hospital, New York, NY, 1989-1990 5. Consultant in Urology, Helen Hayes Rehabilitation Hospital, West Haverstraw, NY, 1989-1990 6. Attending Physician, Thomas Jefferson University Hospital, Philadelphia, PA, 1990-1996 7. Consulting Physician, Veterans Administration Hospital, Wilmington, DE, 1990-1996 8. Consulting Physician, Magee Rehabilitation Hospital, Philadelphia, PA, 1990-1996 9. Consulting Physician, Thomas Jefferson University Hospital - Ford Road Campus, Philadelphia, PA, 1990-1996. 10. Director, Urodynamics Laboratory, Thomas Jefferson University Hospital, Philadelphia, PA, 1990-1996. 11. Director, Incontinence Center, Thomas Jefferson University Hospital, Philadelphia, PA, 1990-1996. 12. Facility, Prostate Center, Thomas Jefferson University, Philadelphia, PA, 1990-1996. 13. Consultant in Urology, Wills Eye Hospital, Philadelphia, PA, 1995-1996. 14. Attending Physician, University of Pittsburgh Medical Center, Pittsburgh, PA, 1996-2008. 15. Director, Neuro-Urology and Urinary Incontinence Programs, University of Pittsburgh Medical Center, 1996-2008. 16. Director, Urodynamic Laboratory, University of Pittsburgh Medical Center, 1996-2008. 17. Consultant in Urology, Veterans Administration Hospital, Pittsburgh, PA, 1997-2008. 18. Consultant in Urology, Magee Women’s Hospital, Pittsburgh, PA, 1997-2008. 19. Consultant in Urology, UPMC Rehabilitation Hospital, Pittsburgh, PA, 1997-2008 20. William Beaumont Hospital, Royal Oak, MI, 09/15/2008-Present

COMMUNITY SERVICE

1. Externship in the Study of Acupuncture and Health Care Delivery System in the People's Republic of China, June- August, 1980. 2. Assistant to Dr. W. A. Coleman, Director of Thailand Refugee Camp Medical Aids Program, Medical College of Wisconsin, 1980-1981. 3. Visiting Surgeon, Albert Schweitzer Hospital, Haiti, January, 1986. 4. Nationally syndicated medical television show on gracilis urethral myoplasty for the treatment of stress urinary incontinence. 1995. 5. “Prostate Disease” on Our Healthy Community, WCKJ/AM (1550) with Dr. Earl Belle Smith, June 19, 1997. 6. Urology Program Organizer, National Prostate Cancer Screening Week, September 22-26, 1997. 7. Urinary Incontinence, Physicians News Digest, University of Pittsburgh Medical Center, October, 1997. 8. Incontinence and Prostate Cancer, Faculty at UPMC “Take Action against Prostate Cancer” Symposium, Pittsburgh, PA, September, 13, 1997. 9. Urinary Incontinence Program, UPMC Health, November, 1997. 10. University of Pittsburgh Medical Center television commercial: Physician-Patient Interaction, 1997-Present. 11. Nationally syndicated medical television show on the intraurethral stent for the treatment of benign prostatic hyperplasia, sphincter dyssynergia, and urethral stricture. 1997. 12. Prostate cancer risks in African Americans. Radio talk show with Dr. Smith, 1997. 13. Medical risks of body piercing, Pittsburgh Gazette, 1997. 14. Medical risks of Viagra for impotence, Pittsburgh Gazette, May, 1997. 15. Viagra for the treatment of impotence. KTV news television interview, May 7, 1998. 16. “Medical treatment of erectile dysfunction” on Our Healthy Community, WCKJ/AM (1550) with Dr. Earl Belle Smith, June 17, 1997. 17. Incontinence and Prostate Cancer, faculty at UPMC “Take Action against Prostate Cancer” Symposium, Pittsburgh, PA September 26, 1998. 18. Strathmore’s Who’s Who, 1999-Present. 19. Voiding Problem and Prostate Disease, Rodef Shalom Brotherhood Conference, Pittsburgh, PA, November 3, 1998. 20. Member Network for the AUA National Awareness Campaign on Female Incontinence, 1998-present. 21. Bladder Health Week Media Education, Pittsburgh, PA, November 17, 1998, • WBZZ-FM 93.7 live in studio interview with actress Linda Evans • WWSW-AM 970 live in studio interview with actress Linda Evans • WPXI-TV, Channel 11, NBC live in studio interview with actress Linda Evans • WQEX-TV, Channel 16 PBS live in studio interview with actress Linda Evans • WLTJ-FM 92.9 live in studio interview with actress Linda Evans Chancellor 107 of 108 22. "Real Living" National Multiple Sclerosis Newsletter, Interview: The promise of RTX Therapy. Springhouse Corporation Publication, December, 1998. 23. National radio public education on urinary incontinence. On 15 radio stations across the country. North American Network, Inc. January 29, 1999. 24. Incontinence Treatment Options. UPMC Health System Focus on Health. April 1, 1999. 25. National TV public education on “Take Control Again” urinary incontinence campaign. On 8 TV stations across the country with actress Stephanie Powers. May 5, 1999. 26. Focus on Health, The Jewish Chronicle: Incontinence treatment options abound. June 24, 1999. 27. UPMC Today: Pacemaker cells, discovered by UPMC researchers. May/June, 1999. 28. Chancellor, M.B.: New approaches to bladder control: tissue engineering, gene therapy, and a pinch of pepper. UPMC Public Relation and Americas Doctor live internet chat. January 5, 2000 www.americansdoctor.com 29. Public education on urinary incontinence. On 10 radio and 2 stations across the country. North American Network, Inc. May 2, 2000. 30. Urinary Incontinence, Scope and Severity, CNN International TV Interview, Atlanta, GA, May 2, 2000. 31. Urinary incontinence and Prostate Cancer. UPMC Cancer Institute Public Symposium, Pittsburgh, PA, June 17, 2000. 32. Interview: Incontinence Treatment Options Abound, Pittsburgh Jewish Chronicle, June, 29, 2000. 33. Healthcare Provider Tribute: Interstitial Cystitis Association, 2001. 34. Stem cells injection could one day treat incontinence. Pittsburgh Post-Gazette, June 6, 2001. 35. Bladder Health Week: Local television news story on urinary incontinence and education booth at UPMC Presbyterian Hospital, Nov 14, 2001. 36. NIDDK patient brochure on cystoscopy and ureteroscopy expert review, 2002. 37. Pittsburgh Magazine Innovator of the Year 2002. 38. Researchers Commercializing Technoloyg, Pittsburgh Business Times, February 14, 2004. 39. Botox for Incontinence. CBS News, February, 22, 2003. 40. When you gotta go…Bladder Control Seminar, UPMC Outreach Program, Kaufmann Dept. Store, Pittsburgh, PA, June 11, 2002. 41. Botox injection for bladder problems. ABC 7 News, Chicago, IL, December, 18, 2002. 42. University of Pittsburgh establishes IC Research Center with Fishbein Foundation (CURE-IC), ICA Update Dec. 2002-January 2003. 43. Pittsburgh Business Times: Researchers commercializing technology, February 14-20, 2003. 44. Bladder problem can be controlled. UPMC South Side Health Series, Pittsburgh, PA March, 12, 2003. 45. USA Today: The little neurotoxin that could, April 21, 2003. 46. AUA Annual Meeting Press Release: Gene therapy may be a cure for post-radical prostatectomy erectile dysfunction. April 28, 2003. 47. AUA Annual Meeting Press Program: Meet the Expert: Treating Erectile Dysfunction, April 28, 2003, Chicago, IL. 48. Helping to unlock the bathroom stall, Boston Globe, July 29, 2003. 49. Ask an Expert: Bladder Control, Pittsburgh Jewish Chronicle; August 14, 2003. 50. Incontinence often Unisgnosed, Overlooked. Women’s News September, 20, 2003. 51. Captain of the "Love Boat": Greater Pittsburgh public education on female sexual and bladder dysfunction, KDKA- TV, Pittsburgh Gateway Clipper, November 15, 2003. 52. Botulinum toxin may have efficacy in bladder dysfunction, Medscape Medical News May, 2004. www.medscape.com/viewarticle/47763 53. Urologists stand as last line of defense in management of the refractory overactive bladder. AUA Daily News, May 10, 2004. 54. Botulinum toxin use for incontinence, Reader’s Digest, June, 2004. 55. Taking Viagra and Other New Treatments to Preserve Potency after Prostate Cancer, Wall Street Journal, May 11, 2004. 56. New Options for Treatment of Prostate Problems, Wall Street Journal, May 20, 2004. 57. Volunteer, Hospital Albert Schweitzer, Haiti, December 2004. 58. Incontinence and Impotence and Prostate Cancer, Us TOO Support Group, Pittsburgh, May 18, 2005. 59. Community education on bladder and sexual health, Sokol Club, Pittsburgh, PA June 12, 2005. 60. Urology Volunteer, Hospital Albert Schweitzer, Haiti, 2004-Present. 61. UPMC Health Journal: Back in control with stem cell restore continence, pp. 11-12, July/August 2005. 62. Pittsburgh Post-Gazette Health, Science & Environment: Botox might shrink swollen prostate, September 1, 2005. Chancellor 108 of 108 63. Bladder Health Week Public Symposium: Bladder symptoms and their impact on sexual health. Pittsburgh, PA, Nov 14, 2005. 64. Panelist: Today’s vision, tomorrow’s realities: commercialization academic innovation. March 29, 2006, University of Pittsburgh, Pittsburgh, PA 65. 2006 University of Pittsburgh Public Education Webcast Program Director: CURE-IC Hope and Awareness for Interstitial Cystitis and Speaker: Research Directions in IC. http://mediasite.cidde.pitt.edu 66. Heinz Endowment CURE: Center for Urologic Entrepreneurship Inauguration, 2006. 67. Tissue engineering company Cook MyoSite incorporated opens new headquarters in Pittsburgh, PR Web, May 9, 2007. 68. Breaking developments in tissue engineering offer new sources for stem cell treatments for urologic disorders. AUA News, May 21, 2007. 69. Do natural male enhancement pills actually work? Best Life Magazine, May 28, 2007. 70. Botox better than expected, a single injection eases BPH-related symptoms for up to a year, Renal & Urology News, 6:7; July, 2007. 71. Refractory detrusor overactivity – what’s next? AUA News, August, 2007. 72. Green tea boosts bladder control, UPMC Health Journal, 3: 29, 2007. 73. WebMD: Hope for Overactive Bladder Problems, January 2008. http://www.webmd.com/a-to-z- guides/feautres/hope-overactive-bladder-problems 74. William Beaumont Hospital Research Institute Roundtable: Urology research priorities, January 6, 2009. 75. Interstitial cystitis education and biobank collection, Royal Oak, January 27, 2009 76. Urology Update at Beaumont: First International Symposium on Bladder Neuro-restoration and Nerve Rerouting, September, 2009. Royal Oak, MI. 77. Stem cell biology, Oakland University Department of Biological Sciences, March 30, 2010. 78. Medical Mission Zika and mosquitoes borne virus diseases to Paramedics for Children International (PFCI) Copán Ruinas, Honduras. October 2016.

1/8/2019